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Abstract
Abstract
The mammalian Rab family consists of between 60-70 members, making it the 
largest sub family of the Ras superfamily. Rabs are responsible for vesicle trafficking 
within cells, acting as molecular switches cycling between the GDP inactive and 
GTP bound active forms. Far from being just cellular housekeeping genes, these 
genes have been shown to have specific functions which, when disrupted, can lead to 
clinical disorders and interesting developmental defects.
This thesis therefore seeks to investigate this interesting family of genes and their 
roles in zebrafish development. Using antisense morpholino oligonuleotides in a loss 
of function screen, this thesis identifies the function of 13 zebrafish rabs. Three of 
these, rabla3, rab3cl and rab28 have specific and interesting phenotypes, with 
pigmentation defects seen in rabla3 and rab3cl and behavioural defects seen in 
rab28. In particular, the pigmentation defect in rab3cl resulted in the discovery that 
the embryos were blind.
This thesis also shows an essential role for rab5a2 in zebrafish development and 
Nodal signalling. Disruption of this rab causes a dramatic early phenotype, with 
100% mortality in embryos prior to 24 hours post fertilization. rab5a2 morpholino 
injected embryos show no visable organizer and have reduced nodal target gene 
expression. Overexpression of rab5a2 shows embryos with additional expression of 
Nodal target genes no tail and goosecoid in the animal pole of the embryos but not 
the dorsal marker chd. Microarray analysis of rab5a2 morpholino injected embryos 
showed reduction and upregulation of expression of many genes involved in dorsal 
ventral patterning. This suggests a complex role for rab5a2 in patterning the early 
embryo, as both dorsalizing and ventralizing genes such as chd, bmp4 and wnt8 
were down regulated while, ventralizing genes such as bmp2b were upregulated.
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Abbreviations
ADMP - anti-dorsalizing morphogenic protein
AP -  anterior posterior
Bmp -  Bone Morphogenic Protein
Bmpr - Bone Morphogenic Protein Receptor
Boz - Bozozok
COP 1 - Coatomer complex
Cyc -  Cyclops
Dkk - Dickkopf
Dpp - decapentaplegic
DV -  Dorsal-Ventral
ER -  Endoplasmic Reticulum
EVL -  Enveloping Layer
Fgf -  Fibroblast Growth Factor
FYVE -  named after four proteins Fabl, YOTB/ZK632.12, Vacl, and EEA1
GTPase -  guanosine triphosphate hydrolyze enzyme
Hh -  Hedgehog
Hpf -  hours post fertilization
HSPG - heparin sulphate proteoglycans
MBT- Mid Blastula Transition
MO - Morpholino
NSF - V-ethylmaleimide Sensitive Fusion protein 
Oep -  One eyed pinhead 
ORF -  Open Reading Frame
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Abbreviations
PtdIns(3)P - phosphatidylinositol-3-phosphate 
SFRP - secreted frizzled-related protein 
SNARE - Soluble NSF Attachment Protein REceptor 
Sqt - Squint
TAE - Tris, acetate, EDTA 
TE - Tris EDTA
TGF - Transforming growth factor
VAMP - Vesicle -Associated Membrane Protein
Wg - Wingless
Wnt -  combined from the Drosophila gene wingless and the mouse gene int 
YSL -  Yolk Syncytial Layer 
ZMD -  Zygotic Maternal Dominant
Glossary
Glypicans - the main cell-surface heparin sulphate proteoglycans,
Mid Blastula Transition -  The stage where cell cycles lengthen and become 
asynchronous this begins at the 512-cell stage
Non- cell-autonomous - genotypically mutant cells cause other cells (regardless of 
their genotype) to exhibit a mutant phenotype
Prenylation - addition of hydrophobic molecules to facilitate protein attachment to 
the cell membrane.
Zygotic Maternal Dominant -  effect that is expressed when both zygotic and 
maternal genomes are heterozygous for the mutant locus.
Homophilic cell adhesion - The attachment of an adhesion molecule in one cell to 
an identical molecule in an adjacent cell
8
List of Figures
List of Figures
Figure 1.1.1: Figure showing movement of blastoderm cells during early zebrafish
development................................................................................................................... 17
Figure 1.1.2: Photo of an embryo undergoing convergence and extession
movements.....................................................................................................................25
Figure 1.1.3: Diagram of Wolperts “French flag” model........................................... 29
Figure 1.1.4: Diagramatic representation of cytonemes............................................. 31
Figure 1.1.5: Diagramatic representation of argosomes............................................. 33
Figure 1.2.1: Diagram representing the structure of rab GTPases.............................38
Figure 1.2.2: Diagram showing the regulation of Rab GTPases................................43
Figure 1.2.3: Diagram of myosin Va attachment to melanosomes.............................52
Figure 1.2.4: Diagramatic representation of planar transcytosis................................. 56
Figure 1.3.1: squint homozygous mutants, cyclops homozygous mutants................ 60
Figure 2.2.1: Cleavage site of Nodals in Xenopus and zebrafish................................76
Figure 2.2.2: A diagrammatic representation of the methods used to make a GFP-
nodal fusion construct....................................................................................................77
Figure 2.5.1: The optokinetic response apparatus........................................................90
Figure 3.2.1: rab3cl MO injected embryos................................... ........................... 96
Figure 3.2.2: 5dpf embryos: rab3cl MO injected embryo showing mild and severe
phenotype.......................................................................................................................97
Figure 3.2.3: The dorsal view of five dpf rab3cl MO injected embryos...................97
Figure 3.2.4: Still images taken from a short movie dorsal view of a five dpf control 
embryo following the spinning cylinder compared a five dpf rab3cl MO injected
embryo............................................................................................................................99
Figure 3.2.5: Graph showing the penetrance of rab3cl.............................................100
Figure 3.2.6: rab3cl ATG MO and 16ng rab3cl splice MO injected embryos 102
Figure 3.2.7: five dpf 16ng splice MO rab3cl injected embryos and 8ng ATG rab3cl
MO injected embryos...................................................................................................103
Figure 3.2.8: Lateral view of a 48hpf 8ng rabla3 MO injected embryo..................105
Figure 3.2.9: Lateral view of 48hpf lOng rabla3 MO injected embryo..................106
9
List of Figures
Figure 3.3.1: Embryos injected with rab lla l MO....................................................108
Figure 3.3.2: Embryo injected with rabla4 MO 48hpf embryo injected with 8ng of
rabla4 MO (G)............................................................................................................ 109
Figure 3.3.3: Embryo injected with rab 18(2) MO..................................................... I l l
Figure 3.3.4: Embryo injected with rablal M O .......................................................113
Figure 3.4.1: Embryo injected with rab llb l  M O .....................................................114
Figure 3.4.2: Embryo injected with ra b llb l  M O .....................................................115
Figure 3.4.3: Embryo injected with rabllb2  MO......................................................116
Figure 3.4.4: Embryo injected with rab6a M O .........................................................117
Figure 3.4.5: Embryo injected with rablla2  MO......................................................118
Figure 3.5.1: Embryo injected with rab28 M O .........................................................119
Figure 3.6.1: Embryo injected with rab20 M O .........................................................122
Figure 3.6.2: Embryo injected with rabla2 M O .......................................................123
Figure 5.1.1: Time series of 3ng rab5a2 MO injected embryos............................... 149
Figure 5.1.2: Nodal and nodal target gene expression in rab5a2 MO injected
embryos........................................................................................................................150
Figure 5.2.1: fluid between the yolk and the cells in rab5a2 morphant embryos... 152
Figure 5.2.2: Expression patterns of the nodals and nodal-responsive genes rab5a2 
MO injected embryos.................................................................................................. 153
Figure 5.2.3: Graph showing the pecentge of embryos that showed a reduction in 
expression of gsc ......................................................................................................... 154
Figure 5.2.4: Graph showing the pecentge of embryo that showed a reduction in 
expression of chd.........................................................................................................155
Figure 5.2.5: Graph showing the pecentge of embryo that showed a reduction in 
expression of ntl...........................................................................................................155
Figure 5.2.6: 8ng rab5a2 splice MO injected embryo (B)........................................157
Figure 52.1 :gsc, ntl, chd and bik expression in rab5a2 splice MO injected embryo
...................................................................................................................................... 157
Figure 5.2.8: Epiboly movements in rab5a2 MO injected embryos....................... 159
Figure 5.2.9: A time series of embryos cold shocked at 20°C:................................ 161
Figure 5.3.1: rab5a2 overexpression embryos......................................................... 162
10
List of Figures
Figure 5.3.2: Expression patterns of the nodal and dorsal markers in rab5a2 
overexpression embryos............................................................................................. 164
Figure 5.3.3: Time series of gsc, ntl and chd expression in rab5a2i overexpressing 
embryos....................................................................................................................... 166
Figure 5.3.4: Comparison of different doses of da-rab5a2 RNA............................. 168
Figure 5.4.1: Expression of gsc and ntl in control, rab5a2 MO and rab5a2 RNA 
injected embryos when 5pg of sqt RNA are injected into the animal pole of 128 cells 
embryos  ................................................................................................................170
Figure 5.4.2: Expression of gsc and ntl in control, rab5a2 MO and rab5a2 RNA 
injected embryos when lOpg of sqt RNA are injected into the animal pole of 128
cells embryos................................................................................................................172
Figure 5.4.3: Expression of gsc and ntl in control, rab5a2 MO and rab5a2 RNA 
injected embryos when 7pg of eye RNA are injected into the animal pole of 128 cells
embryos........................................................................................................................ 173
Figure 5.5.1: Embryos injected into the yolk with rab5a2 MO at 1000 cell
stage............................................................................................................................. 175
Figure 5.5.2: P-catenin expression in rab5a2 MO injected embryos........................176
Figure 6.1.1: Image capture of microarray slides.................................................... 180
Figure 6.2.1: Graph showing number of genes that changed more than two fold in
rab5a2 MO embryos.......................................................................  181
Figure 6.2.2: ish analysis of w ntll expression in rab5a2 MO injected embryos.... 189 
Figure 6.2.3: Box and whisker plot showing the fold change of gene expression in
rab5a2 MO injected embryos at 30% epiboly...........................................................190
Figure 6.2.4: Box and whisker plot showing the fold change of gene expression in
rab5a2 MO injected embryos at shield stage............................................................. 191
Figure 6.2.5: Pie chart showing of the top 50 genes that decreased in rab5a2 MO
injected embryos at the 30% epiboly stage.................................................................193
Figure 6.2.6: Pie chart showing the top 50 genes that increased in rab5a2 MO
injected embryos at the 30% epiboly stage.................................................................194
Figure 6.2.7: Pie chart showing the top 50 genes that decreased in rab5a2 MO 
injected embryos at shield stage..................................................................................195
11
List of Figures
Figure 6.2.8: Pie chart showing the top 50 genes that increased in rab5a2 MO
injected embryos at shield stage..................................................................................196
Figure 7.1.1 : Expression of vox in rab5a2 MO injected embryos...........................202
Figure 7.2.1: Comparison of sqt and eye RNA to sqt-GFP and cyc-GFP fusion
constructs..................................................................................................................... 210
Figure 7.2.4: gsc, ntl, chd and bik expression in rab5al, rab5b and rab5c MO 
injected embryos.........................................................................................................214
12
List of Tables
List of Tables
Table 1.3.1: Different alleles of cyclops ...............................................................61
Table 1.3.2: Different alleles of squint...............................................  62
Table 2.4.1 Experimental MOs.................................................................................... 87
Table 2.4.2: Experimental primers............................................................................... 88
Table 6.2.1: The fold change of the top 50 genes that decreased in rab5a2 MO
injected embryos at the 30% epiboly stage.................................................................183
Table 6.2.2: The fold change of the top 50 genes that increased in rab5a2 MO
injected embryos at the 30% epiboly stage................................................................ 184
Table 6.2.3: The fold change of the top 50 genes that decreased in rab5a2 MO
injected embryos at the shield stage............................................................................185
Table 6.2.4: The fold change of the top 50 genes that increased in rab5a2 MO 
injected embryos at the shield stage............................................................................186
13
Acknowledgements
Acknowledgements
Firstly I would like to thank the four people without whom this thesis would not have 
been possible. I would like to thank Derek for taking me on as his PhD student for 
reading my thesis and for never having a cross word to say. Secondly I would like to 
thank Matthew Clark and Huw Williams who have helped me with and through my 
experimental work and who volunteered (ok Matt you were volunteered) to read 
drafts of my thesis and because of whom Thursday night has returned to being chip 
and pub night. Lastly I would like to thank James Bull for being well James Bull, for 
feeding me, washing my clothes and for undertaking the rather ominous task of 
trying to spell check my thesis after Word had a nervous breakdown trying to cope 
with my spelling errors.
In addition to these people I would like to thank Isabel Campos for getting me started 
on this project and her invaluable help when I arrived, the rest of the lab and for 
discussions, cake, help and general gossiping and Mark Bushel for offering to read 
my thesis and random diving discussions.
Lastly I would like to thank the fish without whom quite literally this project and 
many others like it would not be possible.
Thank you
14
Introduction
Chapter 1
Introduction
15
Introduction
1.1 Zebrafish Development
Zebrafish (Danio rerio) are small, fresh water fish, which as adults are 
approximately two centimetres in length. They produce small, transparent eggs, 
which are fertilized shortly after laying. Once fertilized, the zebrafish embryos 
develop rapidly with the embryo, being recognisable as a fish by 24 hours post 
fertilization (hpf). By 48 hpf, the juvenile pigment has become apparent and they 
have started to hatch from their protective membrane, known as the chorion. 
Following three days of development the swim bladder has developed and after five 
days the eyes have become fully functional and the young are capable of independent 
feeding. Sexual maturity is reached between three and six months (Westerfield 
2000).
1.1.1 From Fertilization to Gastrulation: An overview o f  
morphological characteristics
Shortly after fertilization, yolk platelets separate from cytoplasm, which collects 
around the point of sperm entry at the animal pole (Kimmel et al., 1995). This animal 
pole cytoplasm cleaves approximately every 20 minutes to form a clump of cells, the 
blastoderm, situated on top of the large yolk cell (Kimmel et al., 1995). When the 
blastoderm reaches 512 cells the cell cycles lengthen and become asynchronous, and 
de novo transcription of the zygotic genome begins in a process called the mid- 
blastula transition (MBT) (Kane and Kimmel, 1993). At approximately four hpf the 
blastoderm cells move over the yolk cell and cover it, in a process called epiboly. 
When the cells have migrated to cover half the yolk - 50% epiboly -  other 
gastrulation movements begin. Blastoderm cells internalise to form two cell layers; 
the outer epiblast and inner hypoblast (Kimmel et al., 1989). Concomitantly, a 
thickened marginal region, termed the germ ring, appears at the margin between the 
blastoderm and the yolk cell. This is followed by a local accumulation of cells in a 
structure called the embryonic shield which corresponds to the Spemann’s organizer 
identified in amphibian development (Schier and Talbot, 2001; Spemann and 
Mangold, 1924). The appearance of the shield is the earliest visual marker of the
16
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dorsal ventral axis in the embryo (Figure 1.1.1). During germ ring formation, epiboly 
temporarily arrests, but after shield formation, epiboly continues and the margin of 
the blastoderm eventually advances around the yolk cell to cover it completely 
(Houart et al., 1998; Kimmel et al., 1989)
Figure 1.1.1: Figure showing movement of blastoderm cells during early 
zebrafish development.
Black arrows indicate the movement of cells during epiboly. Yellow arrows indicate 
the movement of cells during involution. Red arrow identifies the dorsal organizer 
(shield)
1.1.2 Dorsal Establishment
Our understanding of the establishment of the dorsal axis remains incomplete. It has 
been shown however, that the yolk is an important early source of dorsal-ventral 
(DV) patterning signals (Piccolo et al., 1999). Dorsal identity in the embryo is 
established by a dorsal determinant, or determinants, that are initially located at the 
vegetal pole and translocated along microtubules to the future dorsal side before the 
first cleavage division occurs (Aanstad and Whitaker, 1999; Jesuthasan and Stahle, 
1997). Experimental evidence for the presence of maternally inherited dorsal 
determinants has been shown by removal of the vegetal most part of the yolk shortly 
after fertilisation, which resulted in strongly ventralized embryos (Mizuno et al., 
1996). This result suggests that the vegetal part of the yolk contains a dorsalizing 
factor, which is transferred to the future dorsal side early in development (Piccolo et 
al., 1999). Prior to shield formation p-Catenin, is seen to translocate to dorsal nuclei. 
It is thought that an unknown dorsalizing factor may bring about the stabilisation and 
nuclear translocation of P-Catenin and the activation of many dorsally associated
17
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genes (Kelly et al., 2000; Kelly et al., 1995; Schneider et al., 1996). Cytoplasmic p- 
Catenin is targeted for degradation by a complex containing APC, axin, Glycogen 
synthase kinase-P (GSKP) and other components which allow only low levels of p- 
Catenin to accumulate (Hinck et al., 1994; Papkoff et al., 1996). Activation of the 
canonical Wnt signalling pathway inhibits the P-Catenin degradation complex, 
stabilizing p-Catenin and allowing it to enter the nucleus where it then activates 
transcription of canonical Wnt target genes (Kelly et al., 1995; Papkoff et al., 1996; 
Schneider et al., 1996). p-Catenin accumulates specifically in nuclei of dorsal margin 
blastomeres as early as the 128-cell stage (Dougan et al., 2003; Schneider et al., 
1996).
Many of the molecular details of the establishment of dorsal identity are derived 
from experiments done with the amphibian Xenopus laevis. Many of these results 
have been replicated in zebrafish embryos. In zebrafish when P-catenin is activated 
outside the dorsal region, a second dorsal axis is induced (Kelly et al., 1995) and, in 
Xenopus laevis if maternal P-catenin mRNA is inhibited using antisense 
oligonucleotides, then dorsal cell fates are inhibited (Tao et al., 2005). In zebrafish, 
the maternal effect loci ichabod and tokkaebi disrupt the nuclear localization of p- 
Catenin and lead to ventralized embryos (Kelly et al., 2000; Nojima et al., 2004). 
Indeed ichabod has been recently shown to encode P-catenin-2 (Bellipanni et al., 
2006). In Xenopus laevis one target of P-Catenin activation, is the transcription factor 
siamois (Wylie et al., 1996). In zebrafish, dharma, the gene mutated in bozozok (boz) 
mutants, is also a member of the hox family, as is siamois and although probably not 
performing exactly the same function dharma may also encode an important 
mediator of P-Catenin function (Nelson and Gumbiner, 1998). Mutant boz embryos 
often have no notochord or prechordal mesoderm and exhibit cyclopia and 
deficiencies in ventral regions of the CNS. Earlier in development, the shield does 
not form and the expression of several organizer genes is strongly reduced or 
eliminated at late blastula. The Dharma protein is thought to act downstream of p- 
catenin since injection of p-catenin into boz mutants does not rescue the mutant. 
Mutants develop some dorsal tissue, suggesting that Dharma is only essential for a 
portion of organizer functions (Kodjabachian et al., 1999). Both siamois, in frog, and 
dharma, in fish, have been shown to induce the formation of an ectopic body axis 
when overexpressed (Fekany et al., 1999; Nelson and Gumbiner, 1998).
18
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In Xenopus laevis, p-Catenin has been shown to act on Vgl (a transforming growth 
factor-P (TGF-P)) and VegT (a T-box transcription factor) (Nielsen et al., 2000; Tao 
et al., 2005; Zhang et al., 1998). Both Vgl and VegT are localised to the vegetal 
pole. Vgl is synthesized as an inactive precursor protein from maternally supplied 
mRNA and activated dorsally during cortical rotation (Melton, 1987; Yisraeli and 
Melton, 1988; Zhang and King, 1996). Absence of Vgl leads to an absence of 
mesoderm (Melton, 1987; Zhang et al., 1998). VegT, on the other hand, can regulate 
generation of endoderm, in both a cell-autonomous manner and by inducing 
expression of the TGF-p family of secreted cytokines. In addition, the induction of 
TGF-Ps means that VegT is also upstream of the induction of mesoderm (Clements 
et al., 1999). When maternal vegT mRNA is depleted in early embryos it results in 
the loss of the vegetal mesoderm-inducing signals and the loss of endodermal 
markers. Therefore, maternal vegT is essential for mesoderm and endoderm 
development (Clements and Woodland, 2003). The lack of mesoderm and endoderm, 
caused by Vgl and VegT inhibition, can be rescued by injection of RNA encoding 
nodal proteins which are members of the TGF-p family which act downstream of p- 
Catenin, Vgl and VegT (Melton, 1987; Zhang et al., 1998; Zhang and King, 1996). 
In zebrafish, the factors with functional homology to Vgl and VegT are unknown as 
loss of function studies of the closest known orthologues do not produce similar 
phenotypes.
At MBT in zebrafish, the embryo switches from control by the inherited maternal 
products to control by the zygotic genome (Kane and Kimmel, 1993). Soon after this, 
other zygotic genes are activated by p-Catenin. Amongst these genes are chordin, 
dickkopfl (dkkl), squint (sqt) and fibroblast growth factors (fgfs). These genes act to 
inhibit the action of ventralizing factors or, in the case of sqt, to induce 
mesendodermal fates around the margin (Tao et al., 2005). The establishment of 
correct DV patterning is a balancing act between these dorsal associated genes 
antagonising ventral genes such as wnt8 and bone morphogenetic proteins (bmp) 
(This is discussed in more detail in section 1.1.3.3).
Recent research has suggested that DV asymmetry in zebrafish can be identified 
experimentally as early as the two cell stage (Gore et al., 2005). Map kinase p38
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antibody staining localises to the region of the embryo that will eventually become 
the dorsal side (Fujii et al., 2000). P38 has been shown not to specify dorsal fates 
since expression of dorsal genes still occurs in embryos expressing a dominant 
negative version of the gene (Fujii et al., 2000) It is thought, however, that p38 
controls the rate of cell division in the dorsal blastomeres since, when dominant 
negative versions are overexpressed, there are larger, fewer blastomeres on the dorsal 
side (Fujii et al., 2000). Disruption of microtubules, which are thought to participate 
in the specification of dorsal, results in no activation of p38, suggesting that p38 may 
be regulated by the same factors that establish DV asymmetry (Fujii et al., 2000). 
Direct evidence for early asymmetry is provided in recent work that demonstrated 
that maternal transcripts of sqt are localized to two blastomeres of the four cell 
embryo (Gore et al., 2005). Removal of cells containing these transcripts from four- 
to-eight-cell embryos, or oocyte injection of antisense MO oligonucleotides (MOs) 
targeted to sqt, cause a loss of dorsal structures (Gore et al., 2005).
1.1.3 Dorsoventral Patterning and the Organizer.
Formation of the zebrafish embryonic shield is the first morphological indication of 
the DV axis although it is clear that the DV axis has been established prior to shield 
formation. The shield consists of two layers of cells - the epiblast and the hypoblast - 
and is covered by a tight epithelium the enveloping layer (EVL). Despite members of 
the TGF-P and wnt families having been implicated in the formation of the organizer 
(Feldman et al., 1998; Smith and Harland, 1991), no endogenous signalling molecule 
has been identified that results in the direct formation of the organizer. The function 
of the organizer during gastrulation is to inhibit ventral signals, differentiate axial 
structures and facilitate morphogenesis. Many of these organizer functions are 
mediated through the secretion of signalling factors (Feldman et al., 1998; Knecht et 
al., 1995). Amongst the first of the signalling factors to be secreted are members of 
the FGF, Wnt and TGF-p families (Feldman et al., 1998). The organizer is known to 
induce dorsal fates within mesoderm, anterior fates within endoderm and neural fates 
within ectoderm, achieved through opposing morphogenic activities, emanating from 
the ventrolateral regions of the embryo (Kodjabachian et al., 1999).
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1.1.3.1 TGF-P signals.
TGF-p was identified in 1978 by de Larco et al due to its ability to induce 
phenotypic transformation of fibroblasts into diverse mouse cell types (de Larco and 
Todaro, 1978). Subsequently, many more TGF-P-related factors were identified 
resulting in a large family of TGF-ps, present in all metazoa. In humans, the TGF-p 
family contains at least 35 family members, including BMPs and Nodals (Derynck 
and Miyazono, 2006) which are also found in zebrafish. This section is concerned 
with the BMPs and their role in DV patterning, with the Nodals covered in greater 
detail in section 1.3.
The BMP family of growth factors were named for their ability to induce the 
formation of bone and cartilage. The BMPs induce ventral fates within the embryo 
and they accomplish this by binding to the extracellular domains of type I and type II 
BMP receptors (BMPRs) (Koenig et al., 1994; ten Dijke et al., 1994). These are 
transmembrane proteins, which contain intracellular serine/threonine kinase domains 
(Lin et al., 1992). Signal transduction through BMPRs results in mobilization of 
members of the Smad family of proteins, especially Smadl, Smad5 and Smad8 (Hild 
et al., 1999; Nakayama et al., 1998; Xu et al., 1998). These Smads are transcription 
factors, that are phosphorylated by ligand bound receptors, allowing them to 
translocate to the nucleus and, together with the non-receptor-regulated Smad protein 
Smad4, regulate target gene expression (Zhang et al., 1997). Secreted antagonists of 
this pathway include Chordin, Noggin and Follistatin, while the transmembrane 
protein Bambi functions as a decoy receptor (Fainsod et al., 1997; Onichtchouk et al., 
1999). In addition to this, there are inhibitory Smads, Smad6/7, which are thought to 
interfere with Smadl/5/8 phosphorylation (Heldin et al., 1997; Nakao et al., 1997). 
The inhibitory Smads also recruit ubiquitin ligases, known as Smad ubiquitination 
regulatory factor 1 (Smurfl) and Smurf2, to the activated type I receptor, resulting in 
receptor ubiquitination and degradation, and termination of signalling (Ebisawa et 
al., 2001; Zhang et al., 2001)
In zebrafish, a number of BMP pathway components are essential for the formation 
of ventral cell types, including BMP2b and BMP7. These are widely expressed soon 
after MBT but become restricted to the ventral half of the embryo by the onset of
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gastrulation (Dick et al., 2000; Schier and Talbot, 2005). Both of these genes have 
zebrafish mutants, (the bmp2b mutant swirl and the bmp7 mutant snailhouse) that are 
strongly dorsalized. It is thought that the ventralizing signal in vivo is a BMP2b- 
BMP7 heterodimer (Schmid et al., 2000). Previous studies in Drosophila, Xenopus 
laevis and zebrafish have shown that BMP signalling is required for global DV 
patterning decisions during early gastrulation (Gelbart, 1989; Graff et al., 1994; Pyati 
et al., 2005). In DV patterning, the effect of the BMP pathway in zebrafish is a 
balancing act between many factors. The major modifiers in this pathway include 
Alk8, a type I BMP receptor required for the specification of ventral cell fates (Bauer 
et al., 2001; Connors et al., 1999; Mintzer et al., 2001), Smad5 (Hild et al., 1999), 
Chordin, Ogon/Sizzled and the protease Tolloid (Connors et al., 1999). chordin 
mutants have a ventralized phenotype (Schulte-Merker et al., 1997) whereas 
bmp2b;chordin double mutants are dorsalized, suggesting that chordin is not needed 
for dorsal development if BMPs are inactivated (Hammerschmidt et al., 1996b; 
Miller-Bertoglio et al., 1999; Piccolo et al., 1996). The sizzled gene is mutated in 
ogon mutants (Martyn and Schulte-Merker, 2003; Yabe et al., 2003) which have a 
ventralized phenotype similar to chordin mutants. This phenotype can be suppressed 
by overexpression of Chordin (Miller-Bertoglio et al., 1999; Wagner and Mullins, 
2002). Tolloid promotes BMP signalling by cleaving and inactivating Chordin 
(Blader et al., 1997). The antidorsalizing morphogenic protein (ADMP) is a 
divergent member of the BMP family expressed on the dorsal side of the late blastula 
as well as in the axial mesoderm and anterior neuroectoderm during gastrulation 
(Lele et al., 2001; Lin et al., 1997). Overexpression of ADMP causes ventralization 
and a reduction of the organizer. Embryos injected with MOs (MO injected embryos) 
knocking down ADMP show moderate expansion of dorsal mesoderm. ADMP may 
be part of a negative feedback system which limits the size of the organizer region, 
possibly with the aid of bmp2b and bmp7 (Lele et al., 2001; Willot et al., 2002).
1.1.3.2 Wnt Signalling
The Wnt pathway is essential for ventral and posterior fates within the embryo. Early 
in zebrafish development, maternal signalling divides nascent mesoderm into axial 
(dorsal) and non-axial (ventral) domains. Subsequently, subdivision of non-axial 
mesoderm into multiple DV fate domains involves zygotic Wnt8 and BMP signalling
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as well as the Vent/Vox/Ved family of transcriptional repressors (Erter et al., 2001). 
Deletion or inhibition of both ORFs of the bicistronic (two non-overlapping open 
reading frames of wnt8 produces a loss of ventroposterior structures and expansion 
of dorsal fates (Lekven et al., 2001). A reduction of Wnt3a and Wnt8 activity results 
in stronger expansion of dorsoanterior fates, suggesting that these genes have 
overlapping functions (Shimizu et al., 2005a); (Ramel et al., 2005).
The Wnt family of proteins signal through Frizzled-Lrp receptor complexes and 
employ a number of cytoplasmic proteins to stabilize p-Catenin (Cong et al., 2004; 
Sheldahl et al., 1999; Yang-Snyder et al., 1996) . These proteins enable P-Catenin to 
accumulate in the nucleus and activate target gene expression. Secreted antagonists 
of this pathway include secreted ffizzled-related protein (SFRP), Cerberus and Wnt 
inhibitory factor (WIF), which act by binding to Wnt proteins. The Wnt antagonist, 
Dkk, acts by binding the LRP subunit of the receptor (Bafico et al., 2001; Brott and 
Sokol, 2002; Li et al., 2002) counteracting the ventralizing and posteriorizing effects 
of Wnt signalling (Hashimoto et al., 2000). ddk is an early target of maternal p- 
Catenin and is expressed early in the dorsal margin and dorsal yolk syncytial layer 
(YSL -  see section 1.1.4.1) as well as later during gastrulation in the developing 
prechordal plate (Gonzalez-Sancho et al., 2005).
Genes that may be modified by Wnt signalling include vox, vent and ved. 
Inactivation of the redundant homeodomain transcriptional repressors Vox (also 
known as Vegal) and Vent (Vega2) leads to severe loss of ventroposterior structures 
(Kawahara et al., 2000a; Kawahara et al., 2000b). This loss of function phenotype in 
zebrafish is strain dependent, AB strain fish lacking vox/vent are essentially wild type 
(Imai et al., 2001) whereas inactivation of a third gene encoding a homeodomain 
transcriptional repressor ved strongly dorsalizes all strains of embryos, including the 
AB strain (Shimizu et al., 2002). This dorsalized phenotype is similar to that seen in 
zebrafish wnt8 mutants and there is evidence that wnt8 activates vox and vent 
expression repressing dorsal genes (Ramel et al., 2005). chordin is a key target of 
Vox and Vent and these proteins also repress other dorsal genes including boz, 
goosecoid, floating head and dkkl (Imai et al., 2001; Melby et al., 2000).
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1.1.3.3 FGF signalling
The FGF family has been implicated in mesoderm formation, neural induction, DV 
patterning, and anterior-posterior (AP) patterning of the embryo (Furthauer et al., 
2004; Kimelman and Kirschner, 1987; Lamb and Harland, 1995). In early zebrafish 
development, as soon as the zygotic genes become activcated, FGF has a role in 
restricting bmp RNAs to the ventral side of the embryo (Furthauer et al., 2004). The 
FGF signal is initiated on the dorsal side of the embryo by the expression of fgf3,fgf8  
(a mutation in which is responsible for the zebrafish mutant acerebellar (Reifers et 
al., 1998) and fgf24, and this expression then spreads progressively to lateral and 
ventral domains. The restriction of BMP signalling shows an important role for FGFs 
in DV patterning. The FGF pathway is first active at the dorsal blastoderm margin, 
along the entire margin and, finally, in the tail bud (Furthauer et al., 2004; Ulrich et 
al., 2003). FGFs bind and activate receptor tyrosine kinases, the dimerization of the 
receptor results in frans-phosphorylation, as well as the recruitment and activation of 
downstream effectors (Bellot et al., 1991; Kombluth et al., 1988). Downstream 
targets of FGF include pea3, erm, and sprouty4 which are induced over broad 
domains in neighbouring cells (Furthauer et al., 2004; Ulrich et al., 2003). These 
genes are activated at different thresholds of FGF. In zebrafish wild type embryos, it 
has been shown that erm is activated furthest from the source of FGF, followed by 
pea3 and, finally, sprouty4 is activated closest to the source (Scholpp and Brand, 
2004).
In zebrafish, FGF signals may effect mesoderm formation via interactions with the 
Nodal signalling pathway (Furthauer et al., 2004), possibly relaying the action of 
TGF-p ligands over long distances. FGF is required downstream of Nodal signalling 
to induce the co-receptor One-Eyed Pinhead (Oep) in cells distant from the source of 
Nodal (Griffin and Kimelman, 2003; Mathieu et al., 2004). This mechanism 
contributes to the amplification and propagation of Nodal signals (Mathieu et al., 
2004). Partial inhibition of FGF signalling, and blocking of Oep, disrupts posterior 
development and leads to the death of dorsal mesoderm cells by the end of 
gastrulation (Griffin and Kimelman, 2003; Mathieu et al., 2004). The FGF and BMP 
pathways have also recently been shown to have a repressive effect on endodermal 
precursors induced by Nodal signalling (Poulain et al., 2006).
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1.1.3.4 Convergence Extension movements
The term convergent extension is used in the context of the developing zebrafish 
embryo to describe the movements that lead to the accumulation of cells at the dorsal 
side of the embryo followed by the anterior-posterior (AP) extension of the body axis 
(Warga and Kimmel, 1990) (Figure 1.1.2). Convergence and extension allows the 
thinning and spreading of the germ layers during epiboly. When Nodal signalling is 
lost both mesoderm formation and extension of the embryonic axis are inhibited. 
This loss does not, however, prevent the dorsal accumulation of cells suggesting that 
convergence and extension are not mutually exclusive (Feldman et al., 1998). It is 
thought that during convergence and extension, the cells move as a cohesive group as 
molecules that mediate cell polarity, sorting and adhesion have also been shown to 
be required for convergence and extension movements (Heisenberg et al., 2000; 
Ulrich et al., 2003; Wallingford et al., 2000). A mutation in zebrafish Wntl 1 (sib) - 
which has been shown to control cell cohesion through E-cadherin - results in 
embryos with compromised convergence and extension movements during 
gastrulation (Heisenberg et al., 2000; Ulrich et al., 2005).
Figure 1.1.2: Photo of an embryo 
undergoing convergence and extession 
movements.
Yellow arrow indicates convergence 
movements as cells move towards the 
dorsal side of the embryo. Blue arrow 
indicates extension movements as cells 
extend along the AP axis.
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1.1.4 The Yolk Cell
1.1.4.1 The Yolk Syncytial Layer (YSL) and its role in patterning
The YSL is an extra embryonic region, produced in zebrafish at the midblastula 
stage, when deep marginal blastoderm cells collapse and release their nuclei into the 
underlying yolk cell (Kimmel and Law, 1985). The YSL is a source of mesoderm 
and endoderm inducers (Chen and Kimelman, 2000; Hsu et al., 2006; Mizuno et al., 
1996). Transplantation experiments have shown that when the YSL is transplanted 
into the animal-pole region of the host after MBT, the yolk cell and the YSL can 
induce mesoderm and organizer gene expression in the blastoderm (Mizuno et al., 
1996). The YSL has been compared to the Nieuwkoop centre in Xenopus, a group of 
cells located in the dorsal-vegetal region of the blastula that are thought to induce the 
Spemann organizer in the overlying marginal zone in a non-cell-autonomous manner 
(Bischof and Driever, 2004; Gimlich and Gerhart, 1984). An important early step in 
the formation o f the Nieuwkoop centre in Xenopus is the nuclear localization of p- 
Catenin in an area that will become dorsal (Guger and Gumbiner, 1995). In 
zebrafish, P-Catenin accumulates in the nuclei of dorsal blastomeres and the dorsal 
YSL, where, with the Tcf/Lef family proteins, it activates the expression of zygotic 
genes that mediate the formation of dorsal structures. One of the first of these zygotic 
genes activated in zebrafish is boz, which is expressed shortly before MBT within 
dorsal blastomeres and then at late blastula/early gastrula in the dorsal YSL (Solnica- 
Krezel and Driever, 2001). It has been suggested that boz is a direct target of p- 
Catenin-Tcf/Lef signalling (Geng et al., 2003; Leung et al., 2003).
1.1.4.2 Epiboly and the importance of the yolk cell
At the start of epiboly, the cells of the blastoderm sit on top of the yolk cell. The yolk 
itself is surrounded by a thin anuclear yolk cytoplasmic layer. Between the 
blastoderm and the yolk are the YSL and the blastoderm rim. The YSL is divided 
into two sections both of which contain yolk syncytial nuclei. These are the external 
YSL, a relatively thick belt of cytoplasm, and the internal YSL, a thinner layer 
(Betchaku and Trinkaus, 1986; Kimmel and Law, 1985). In the killifish, Fundulus
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heteroclitus, the mechanism of epiboly has been more extensively researched 
(Trinkaus, 1963) but a similar process has been observed in zebrafish (Warga and 
Kimmel, 1990). Early work in Fundulus showed that epiboly begins with the 
contraction of the external YSL an autonomous process which can occur in the 
absence of the blastoderm. As epiboly progresses, the EVL, which tightly covers the 
blastoderm ensuring the correct physiological environment for the developing cells, 
moves down the yolk (Keller and Trinkaus, 1987). The underlying blastoderm cells 
link tightly with the YSL at the margin and are driven down the yolk by the YSL’s 
epiboly movements, which are, in turn, driven by an intercrossing network of 
microtubules (Trinkaus, 1984). In zebrafish changes in configuration of the yolk 
microtubules are strictly correlated with epibolic movements, with disruption of 
microtubules blocking the vegetal movement of the YSL but only partially disrupting 
the epiboly of the EVL and deep cells (Solnica-Krezel and Driever, 1994). Recent 
evidence in zebrafish has shown that pregnenolone, a steroid in the yolk cell, is 
required to maintain an adequate level of polymerized microtubules and so normal 
epiboly (Hsu et al., 2006).
In addition to the movements of microtubules in the yolk, epiboly is driven by 
endocytosis (Betchaku and Trinkaus, 1986; Solnica-Krezel and Driever, 1994). In the 
external YSL, immediately beneath the EVL attachment region, endocytosis removes 
sections of the external YSL membrane reducing it and pulling the EVL vegetaly. 
The external YSL membrane is then fused with the internal YSL membrane to 
expand the internal YSL and drive further epibolic movement (Betchaku and 
Trinkaus, 1986). At approximately 50% epiboly an actin band forms in the external 
YSL, beneath the EVL margin - the region of active endocytosis (Cheng et al., 
2004). This actin band is vital for epiboly, as shown by experiments in zebrafish 
inhibiting the formation of the actin cytoskeleton which result in a slowing of, and 
failure to complete, epiboly (Cheng et al., 2004; Zalik et al., 1999). betty boop the 
zebrafish homologue of MAPKAPK2 (a regulator of actin filament formation) 
displays premature constriction of the margin and is thought to regulate epiboly 
(Holloway, unpublished data, 2006; Wagner et al., 2004).
A further important factor in epiboly is the requirement for the intracellular adhesion 
molecule E-cadherin. Whilst a reduction in E-cadherin in zebrafish impairs epiboly, a
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stronger loss-of-function interferes with early cells divisions and halts development 
completely (Babb and Marrs, 2004). Interestingly, the first zebrafish epiboly mutant 
identified, half baked (hab) (Kane et al., 1996), has a defect in the E-cadherin (cdhl) 
gene. In the hab mutant, the deep cells cease movement at mid-gastrulation, whilst 
epiboly of EVL and YSL proceeds further (Kane et al., 2005; Shimizu et al., 2005b).
1.1.5 Morphogen Gradients in the Developing Embryo
A morphogen can initially be described as a substance which governs the pattern of 
tissue development in an organism, where different concentrations of morphgen can 
induce different cell fates. In the early 20th century, biological morphogen gradients 
were first suggested by Child and Boveri from their work in Hydra and nematode 
respectively (Child, 1915; Child, 1941; Gilbert, 1997; Slack, 1994; Tsikolia, 2006), 
with the discovery of their importance in developmental biology being accredited to 
the work done in Drosophila by geneticist Thomas Hunt Morgan (Lawrence, 2004; 
Lawrence, 2001; Oppenheimer, 1983; Yucel and Small, 2006). These ideas were 
later refined in the 1960’s by Lewis Wolpert with his 'French flag' model that 
described how morphogens could subdivide a tissue into discrete domains of 
different target gene expression (Figure 1.1.3) (Wolpert, 1996). Wolport’s work in 
chick limb development demonstrated that grafting the region with morphogenic 
properties to successive positions along the antero-posterior axis could modify the 
positional information along the axis and so modify the pattern of digits obtained. He 
concluded that the interpretation of positional information can provide the basis for 
pattern formation in limb morphogenesis and that this pattern was consistent with a 
model based on diffusion of a labile morphogen (Tickle et al., 1975), similar to that 
proposed for the development of pattern in invertebrates (Wolpert, 1996).
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Figure 1.1.3: Diagram of Wolperts “French flag” model
Showing how morphogens could subdivide a tissue into discrete domains of different 
target gene expression (reproduced from (Wolpert, 1996).
In developmental biology, following the work of researchers such as Wolpert, 
morphogens can be described as signalling molecules which form spatial 
extracellular concentration gradients emanating from a restricted source of 
production. Cells receive a different concentration of morphogen depending on their 
distance from the source and this elicits a concentration-specific response. A more 
solid understanding of morphogens was obtained when Gurdon and collaborators 
used the animal cap assay in Xenopus laevis (Gurdon et al., 1985). This exogenous 
model system showed that the selection of genes expressed by animal cap cells is 
determined by the distance from a source of Activin - a peptide growth factor of the 
TGF-P family contained in vegetal cells and capable of inducing other cells to form 
mesoderm. Activin’s long-range signal spreads over at least ten cell diameters in a 
few hours and does so by passive diffusion by-passing cells that do not respond to 
the signal or synthesize protein themselves. These results provided support for the 
operation of morphogen concentration gradients in vertebrate development as well as 
for a diffusion based model of these concentration gradients (Gurdon et al., 1994).
Following the general acceptance of morphogen gradients as a potential mechanism 
for patterning naive tissue, four models have been proposed for the establishment and
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maintenance of stable morphogen concentration gradients within tissues. The 
mechanisms underlying these models are trancytosis, cytonemes, argosomes and 
diffusion and will be discussed in the next sections.
1.1.5.1 Transcytosis
The transcytosis model suggests that a morphogen can be passed through a series of 
neighbouring cells in order to be transported over long distances (Strigini and Cohen, 
1997; Bellaiche et al., 1998). Enchev et al investigated morphogenesis in the wing 
imaginal disk of Drosophila. Their research suggested that simple diffusion could 
not explain the morphogenic gradient of Dpp and that receptor-mediated endocytosis 
was essential for Dpp’s long range movement (Entchev et al., 2000). Enchev et al 
proposed that Dpp was transported by transcytosis and suggested a role for Rabs, 
small GTPases of the Ras superfamily (Entchev et al., 2000). The transcytosis model 
will be expanded on in section 1.2 where the Rab family will be looked at in greater 
detail alongside the roles of Rabs in this method of morphogen movement.
1.1.5.2 Cytonemes
Cytonemes (‘cell threads’ neme = thread) is a term coined by RamTrez-Weber et al 
who discovered very thin projections from fluorescently labelled cells in the 
Drosophila imaginal disc emanating from the lateral flank towards the disc centre. 
These projections were shown to represent cytoplasmic extensions and were 
designated cytonemes. The cytonemes extend from disc cells toward the AP 
compartment border, but not from AP border cells outward. RamTrez-Weber et al 
(Ramirez-Weber and Komberg, 1999) hypothesized that the cytoplasmic extensions 
grow in response to a chemoattractant. Different parts of the imaginal disc were 
placed next to anterior or posterior fragments to ascertain which parts of the disc 
could act as an attractant. The results showed that the anterior or posterior fragments 
only grew projections if placed next to the excised boundary region from between the 
anterior and posterior. Branchless -  the drosophila homologue of FGF (dFGF) - was 
identified as a chemoattractant for these projections suggesting that activated FGF 
protein could be produced at the compartment border or that dFGF could function as 
a growth factor and stimulate non-polarized cell growth of cytonemes. Rami'rez-
30
Introduction
Weber et al (Ramirez-Weber and Komberg, 1999) also showed that projections 
similar to cytonemes could be seen in cultures from mouse limb bud as well as those 
from chick. The authors suggested that cytonemes might play a role in disc cells 
defining their relationship with signalling centres so that cytonemes link outlying 
cells directly to signalling cells. This mechanism has been suggested as an efficient 
long distance transport for morphogens such as Hh and Dpp whose movement is said 
to be inconsistent with simple diffusion in the imaginal disc. The hypothesis is that 
Hh and Dpp are released at sites of cytoneme contact delivering the morphogens 
efficiently to target cells and limiting their spread (Ramirez-Weber and Komberg, 
1999) (Figure 1.1.4). Recently Hsiung et al has shown evidence for cytonemes 
involvment in Dpp signalling with the Dpp receptor, Thickveins, present in punctae 
that move along cytonemes (Hsiung et al., 2005).
Ligand
o Cell
Cytoneme
Figure 1.1.4: Diagramatic representation of cytonemes possible role in 
morphogen gradient formation.
Diagram shows cytonemes projectiong from distant to expressing cells (adapted from 
(Williams et al., 2004).
1.1.5.3 Argosomes
Many morphogens have been found to be tightly associated with membranes; the 
Wnt family bind heparin sulphate proteoglycans (HSPG) whilst hedgehog binds to 
membranes via covalently attached cholesterol and palmitate (Hashimoto et al.,
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2000; Mann and Beachy, 2000; Nakato et al., 1995; Pepinsky et al., 1998). Greco et 
al observed that all hypotheses for the spread of morphogens assumed the release of 
the molecule from the membrane of the producing cells (Greco et al., 2001). Greco et 
al set out to investigate whether for the spread of morphogens might include their 
transport in vesicles at every stage of transport. This hypothesis was tested using 
fluorescent labelled markers (CFP-GPI) on the cytoplasmic and external faces of the 
membranes of the Drosophila imaginal disc. The expression of these markers was 
specifically driven in certain populations of cells within the wing disk but not others 
allowing the visualisation of vesicles derived from these populations in the non­
expressing tissue. These ‘exovesicles’, found distant from the tissue expressing the 
membrane marker, were termed argosomes presumably from the mythical Greek 
ship, Argo, captained by Jason. Argosomes were shown to consist mainly of 
membrane with a fraction present in the early endocytic compartment. This led 
Greco et al (Greco et al., 2001) to surmise that argosomes are of endocytic origin. 
The endocytic compartments that contain the endosomes were shown to move 
rapidly with some compartments containing multiple argosomes (Greco et al., 2001). 
Two methods were suggested for argosome production. The first involves the 
production of vesicles within endosomes, when the endosome fuses with the plasma 
membrane the internal vesicles (exosomes) are released into the extracellular space 
(Figure 1.1.5). The second method suggests that part of the producing cell is 
internalised by its immediate neighbour forming a vesicle (derived from the 
producing cell) in the endosomes of the receiving cell (Figure 1.1.5). Greco et al 
suggested that Wingless can move through the disc epithelium on argosomes since 
Wingless in receiving cells colocalizes with argosomes derived from cells that 
synthesize wingless (Greco et al., 2001). Further, the rate of Wingless spread is 
consistent with the spread of argosomes. As removal of HSPG results in Wingless 
not associating with argosomes the authors propose that one function for the 
interaction of Wingless with HSPG might be to allow the incorporation of Wingless 
into argosomes (Greco et al., 2001).
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Figure 1.1.5: Diagramatic representation of argosomes possible role in 
morphogen gradient formation.
Diagram showing membranes from producing cells transporting ligands through 
reciving tissue in “exovesicles” (adapted from (Williams et al., 2004))
1.1.5.4 Diffusion
The original and simplest model for the movement of morphogens in a tissue has 
been by extracellular free diffusion. The diffusion model implies that intermediate 
cells do not play any role during the movement of the morphogen. Support for this is 
seen in Xenopus laevis animal caps, when endocytosis is blocked but TGF-p 1 still 
spreads through the tissue (McDowell et al., 2001). Since morphogens signal over 
long distances doubt has been cast on the ability of free diffusion to form stable long- 
range concentration gradients with much of this stemming from the nature of the 
morphogen (Belenkaya et al., 2004; Entchev et al., 2000). The ideal morphogen to 
fit the diffusion model would need to be a small ligand which did not adhere to 
anything other than the receptor. Often this is not the case, both Wnt and Hh have 
been shown to adhere to proteoglycans in Drosophila and mouse cell culture, with 
Hh showing a high affinity for membranes (Blitzer and Nusse, 2006; Rietveld et al., 
1999). This would result in their diffusion being hindered by extracellular binding 
proteins and proteoglycans (Kerszberg and Wolpert, 1998; Piek et al., 1999). TGF-p 
is a small ligand but its movement in Xenopus laevis is limited by the expression of 
the TGF-p type 2 receptor (McDowell et al., 2001.), which in addition to its role in
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transducing the signal, also targets the TGF-P ligand for degradation thus removing it 
from the extracellular environment and restricting its signalling.
Investigations into the four proposed methods of morphogen movement were carried 
out in Xenopus laevis using the Xenopus nodal-related 2 protein (Xnr2) (Williams et 
al., 2004). Cytonemes were ruled out as a possible explanation since even though 
Xenopus cells did extend protrusions these were no longer than one cell diameter. A 
variation on the animal cap assay was used to examine whether argosomes could be 
responsible for the movement of Xnr2 (Williams et al., 2004). This was considered 
not to be the case when eGFP-Xnr2 was not observed in association with CFP-GPI 
positive vesicles in receiving cells. Transcytosis was also ruled out, since affecting 
endocytosis using constitutively active or dominantly negative Rab5 had no effect on 
the expression domain or level of activation of endogenous Xbra a target gene of 
Xnr2. Williams et al showed that eGFP-Xnr2 in the receiving cells was extracellular 
and confined to interstices between cells. They therefore, proposed that eGFP-Xnr2 
exerts its effects by diffusion. Time lapse corroborates this notion and shows that 
Xnr2 can travel ten cells within two hours on the exogenous animal cap assay. The 
authors admit the limitations of the animal cap assay and suggest that different 
morphogens in different developmental contexts use different means of transport 
(Williams et al., 2004).
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1.2 Cell Trafficking and Transport
Embryonic development relies on many different cell biological processes including 
cell signalling and cell adhesion. These would not be possible, however, without the 
cells ability to traffic and transport substances into, around and out of the cell. 
Eukaryotic cells routinely traffic substances, not only between organelles but also 
across the outer cell membrane, using vesicles - microscopic fluid filled sacs 
surrounded by a lipid membrane. Vesicles are involved in secretion, endocytosis and 
various recycling processes within the cell (Armstrong, 2000). There are four main 
stages to vesicle trafficking: formation - the vesicle must be formed and packed with 
its cargo; targeting -  the vesicle is released from its membrane and directed towards 
the target membrane; tethering/docking -  the vesicle aligns and attaches with the 
target membrane; and finally fusion - allowing the vesicle to release the cargo at its 
destination (Armstrong, 2000; Zerial and McBride, 2001). Each stage of the vesicle 
trafficking process requires specialized protein machinery, many of which belong to 
the Ras superfamily of guanosine triphosphatases (GTPases).
1.2.1 Introduction to Rabs
In 1983, the accidental discovery of Yptlp, in Saccharomyces cerevisiae by Gallwitz 
et al (Gallwitz et al., 1983) showed that vesicular transport is governed by conserved 
monomeric GTPases. Subsequently, Salminen and Novick (Salminen and Novick, 
1987) provided the first evidence that a Ras-like GTPase (Sec4) was directly 
involved in vesicular transport whilst Tavitian and colleagues (1987) cloned the first 
mammalian homologs of SEC4/YPT termed rab (ras-like in rat brain) genes 
(Touchot et al., 1987). Yptlp was shown to be necessary for the docking process of 
vesicles with the Golgi. Yeast cells lacking functional Yptlp showed accumulation 
of endoplasmic reticulum (ER) membranes, vesicles and ER core glycosylated 
proteins before they died (Schmitt et al., 1988). The yptlp  gene showed 70% 
sequence homology to the rabl gene found in mammalian cells and, furthermore, 
rabl could replace the essential function of yptlp  in yeast, suggesting that these 
genes are orthologous (Touchot et al., 1987). Continuing studies in yeast and
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mammalian cells showed that different Ypt/Rab-GTPases were performing the same 
function, however, each localized to different parts of the secretory and endocytic 
pathways (Lazar et al., 1997). The localization of these proteins and their effectors, 
aided by SNARE proteins, help determine the specificity of the vesicle, ensuring 
they are transported, docked and fused with the correct target (Hammer and Wu, 
2002; Ossig et al., 1995; Price et al., 2000a). The complete sequencing of the 
Saccharomyces cerevisiae genome has revealed the total number of ytp genes to be 
11, some of which are phenotypically redundant (Lazar et al., 1997). Only those ytp 
genes involved in the biosynthetic pathway are essential for cell viability. Loss of the 
Ytp proteins Yptlp, Ypt51p , Yptp6, Ypt7p, Sec4p and Ypt31p/Ypt32p (Benli et al., 
1996; Haubruck et al., 1989; Schmitt et al., 1986; Singer-Kruger et al., 1994; 
Wichmann et al., 1992), proved fatal for the cell and demonstrated their essential 
nature. These essential Ytp proteins correspond to Rabl, Rab5, Rab6, Rab7 Rab8 
and Rabl 1 in mammalian cells and are now considered ‘core’ Rabs (Lazar et al., 
1997; Singer-Kruger et al., 1995; Ullrich et al., 1996).
The Rabs are now known to be the largest sub family in the Ras superfamily. The 
Ras-superfamily comprises of over 150 human members (with evolutionarily 
conserved orthologs found in Drosophila, Caenorhabditis elegans, S. cerevisiae, 
Saccharomyces pombe and Dictyostelium as well as in plants (Bush et al., 1993; 
Garrett et al., 1993; Haubruck et al., 1990; Nonet et al., 1997). The Ras superfamily 
is divided into five major branches on the basis of sequence and functional 
similarities: Ras, Rho/Rac, Rab, Ran and Arf. (Colicelli, 2004; Pereira-Leal and 
Seabra, 2000; Wennerberg et al., 2005). The Rab family is found in all eukaryotes, 
with over 60 rab genes uncovered in the human genome (Colicelli, 2004; Zerial and 
McBride, 2001) and over 80 in zebrafish (Clark, MD, pers. com.). Rab proteins 
localize to specific intracellular compartments, consistent with their function in 
distinct vesicular transport processes (Zerial and McBride, 2001). This localization is 
dependent on prenylation (addition of hydrophobic molecules to facilitate protein 
attachment to the cell membrane) and specificity is dictated by divergent C-terminal 
sequences (Khosravi-Far et al., 1991). For example, Rabl is found in the 
intermediate compartment of the c/s-Golgi network and is involved in ER to Golgi 
transport (Ayala et al., 1989), while Rab5 is located in early endosomes (vesicles
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involved in endocytosis) and regulates clathrin-mediated vesicle transport from the 
plasma membrane to early endosomes (Gorvel et al., 1991).
Although Rab proteins are localized within individual cells, at the level of the whole 
organism many of the rab transcripts identified to date have ubiquitous distribution, 
although their level of expression may vary from one cell type to another. This is 
surprising given the high degree of regulation at the protein level (see section 1.2.3). 
However, there are exceptions with some Rabs being cell type- or tissue-specific. For 
example, in mammals Rab3A is only expressed in neurons and neuro-endocrine cells 
(Fischer von Mollard et al., 1990; Johnston et al., 1991) while Rab 17 has only been 
detected in epithelial cells (Lutcke et al., 1993).
1.2.2 Rab Homology and Classification.
The similarities between the members of the Ras-superfamily make them difficult to 
classify. All of the Ras family contain the conserved regions referred to as G1-G3 
and PM1-PM3. These regions are involved in binding guanine nucleotide and 
phosphate/Mg2+ respectively (Valencia et al., 1991). There are two regions that 
undergo a significant conformational change upon GTP binding and hydrolysis: the 
switch I (Ras residues 30-38) domain and the switch II (59-67) domain (Figure 
1.2.1). Although the GTP-bound and GDP-bound state of the Rabs (as with rest of 
the Ras family) have similar conformations they also have pronounced differences. 
Critically the GTP-bound conformation has higher affinity for effector targets 
(Bishop and Hall, 2000; Milbum et al., 1990). This difference corresponds to the 
changes in the switch I and switch II regions. It is mainly through the conformational 
changes in these two switch regions that regulatory proteins and effectors distinguish 
the nucleotide status of the GTPases (Dumas et al., 1999). Although the GTP-bound 
form is the active form for all Ras superfamily GTPases it is the cycling between the 
two states, in which distinct functions are associated with each nucleotide-bound 
form, that is also critical for the activities of Rabs (Geyer et al., 1996; Pereira-Leal 
and Seabra, 2000).
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■
PM1 R 1 PM3 G2
Figure 1.2.1: Diagram representing the structure of rab GTPases
Gl-3 (black) are regions involved in guanine nucleotide binding, PM 1-3 (blue) are 
regions involved in phosphate/Mg2+ binding, RabFl-5 (pink) are Rab family motifs 
and RabSFl-4 (green) are subfamily-specific sequences. Adapted from (Bucci et al.,
Studies undertaken by Pereira-Leal and Seabra (2000) facilitated the classification of 
Rabs. They showed the existence of five short conserved stretches of residues which 
appear to be diagnostic for the Rab family (Pereira-Leal and Seabra, 2000). These are 
termed Rab family motifs (RabF), with the section termed RabFl localising to the 
effector domain. Most, though not all Rabs, also have a double-cysteine motif in the 
C-terminus which is regarded as a good diagnostic of a Rab protein. Rab8 and Rab 13 
are the exceptions as they contain only a single cysteine residue. Therefore the 
double-cysteine motif may confirm that a given small GTPase is a Rab, but it’s 
absence should not be used to prove it is not (Pereira-Leal and Seabra, 2000).
The rab genes can also be placed into sub groups (such as Rab la and Rab lb) in 
which the genes share over 70% amino acid identity to one another. It could be 
assumed that these genes are functionally related and interact with the same type of 
effector but this is not necessarily the case. For example, the Rab3 subgroup has at 
least 4 members in humans showing 77-85% amino acide identity with the greatest 
variance evident within the N- and C-terminal regions. Although they have high 
sequence homology their subcelluar targets and functional roles are distinct (Pavlos 
et al., 2001). Rab3a is expressed in neurons and neuroendocrine cells and together 
with Rab3c regulates neurotransmitter release, Rab3b is specifically expressed in 
polarized epithelial cells, while Rab3d is mainly expressed in adipocytes and is 
possibly involved in glucose transporter trafficking in response to insulin stimulation 
(Bucci et al., 1995). While working on Rab3a Ostermeier and Brunger (1999) 
identified three regions that contribute to an effector region pocket that mediates 
binding to the effector. These regions were named Rab complementary-determining 
regions (RabCDR’s) with the individual regions called RabCDRI-III. These regions
1995)
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were shown to correspond to subfamily-specific sequences RabSF3 and RabSF4 
found by Moore (Moore et al., 1995; Pereira-Leal and Seabra, 2000). Taken together 
these bioinformatic analyses suggests that a GTPase can be identified as a Rab if it 
has the five Rab specific domains and usually, but not necessarily, a conserved PM/G 
(GTPase binding region) motif and a double-cystine C-terminal motif. Sub-families 
can be classified as such if they have 70% identity and conservation at the RabSF 
and RabF motifs (Pereira-Leal and Seabra, 2000).
Lastly, alternative splicing of a gene can result in different forms or a protein. rab6a 
is the only know rab to do this. The gene has a duplicated exon, and incorporation of 
either of the two exons by alternative splicing is shown to generate the isoforms 
named Rab6a and Rab6a’ in human, which differ in only three amino acid residues 
(Echard et al., 2000). Interestingly this is conserved in zebrafish where two isoforms 
of Rab6a have also been found (Clark, MD, pers. com.).
1.2.3 Rab Regulators
Rabs are described as molecular switches, able to cycle between GTP bound (active) 
and GDP bound (inactive) forms and thus, recruiting a diverse group of “effector 
proteins” to the cytoplasmic leaflet of vesicular membranes (Zerial and McBride,
2001). When a Rab switches conformation to the inactive form, the effectors 
dissociate, the Rab is removed from the membrane and recycled back to a donor 
compartment. Rab function is promoted by the following factors: 1) guanine- 
exchange factors (GEFs) which accelerate guanine-nucleotide exchange and promote 
formation of the active, GTP-bound form on targeting to a donor membrane (Camus 
et al., 1995; Schmidt and Hall, 2002). 2) GTPase activation factors (GAPs) which 
stimulate guanine-nucleotide hydrolysis to promote formation of the inactive GDP- 
bound form (Settleman et al., 1992) and 3) GDP-dissociation inhibitors (GDIs) 
which prevent nucleotide dissociation, extracting the Rab from the target membranes 
and recycling it back to the donor membranes by binding it only in its GDP rather 
than GTP state (Fischer von Mollard et al., 1994; Sasaki et al., 1991; Seabra et al.,
2002). GDI’s transport the Rab back to the donor compartment for recycling without 
the Rab becoming active (Figure 1.2.2).
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All members of the Ras superfamily of proteins undergo protein prenylation, a post- 
translational lipid modification that involves the attachment of a famesyl (15-carbon) 
or geranylgeranyl (20-carbon) group to cysteine or serine residues at or near the C- 
terminus. These modifications are essential for the GTPases to associate tightly with 
cell membranes. Without this lipid modification, the proteins remain in the cytosol 
and are unable to associate with membranes or localise subcellularly, processes 
which are critical for their biological activities (Wennerberg et al., 2005, Casey and 
Seabra, 1996). Three different protein prenyltransferases have been identified which 
perform this role, protein famesyl transferase (PFT or FTase), protein geranylgeranyl 
transferase type-I (PGGT or GGTase-I) and Rab geranylgeranyl transferase (RGGT 
or GGTase-II). These proteins have a heterodimeric structure and consist of distinct 
a- and p-subunits (Leung et al., 2006). FTase and GGTase-I recognise only 
substrates containing a CAAX motif at the C-terminus and these are found in the Ras 
sub familys of Rac and Rho. GGTase-II recognises only Rab substrates of which 
there are six different C-terminal motifs -CC, -CXC, -CCX, -CCXX, -CCXXX and -  
CXXX (Pereira-Leal and Seabra, 2000).
There are two conditions in which prenylation can occur. In the first, a newly 
synthesized Rab must form a stable complex with Rab escort protein (REP) to enable 
its recognition by GGTase-II. In the second, a newly synthesized Rab can associate 
with a preformed REP:GGTase-II complex (Mruk et al., 2005). The first scenario 
suggests association of an unprenylated Rab protein with REP where the interaction 
relies mostly on ionic bonds and does not involve the two C-terminal cysteine 
residues (Anant et al., 1998). This complex is then presented to GGTase-II, which 
adds two geranylgeranyl moieties to the Rab protein without prior dissociation of 
REP (Thoma et al., 2001b; Thoma et al., 2001c). After the transfer of the isoprenoids 
onto C-terminal cysteines, the complex remains associated until the binding of a new 
geranylgeranyl diphosphate (GGpp) molecule, which stimulates the release of the 
Rab-GG:REP complex. The REP then delivers the Rab to the target membrane 
(Leung et al., 2006). The second scenario implies that REP-1 and RGGT can form a 
tight complex in the presence of GGpp. This complex can associate with a Rab 
protein, but this occurs ten times more slowly than in the first scenario (Thoma et al., 
2001a). This model depends on the in vivo concentrations of the proteins involved.
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At high concentrations of all the components the second scenario maybe preferred 
whereas at low concentrations, the first scenario may be preferred.
Upon completion of its function at the target membrane the Rab/REP complex must 
then be returned to its membrane of origin. This is mediated by the cytosolic protein 
Rab GDP dissociation inhibitor (GDI). Rab-GDI interacts promiscuously with the 
GDP-bound Rab extracting it from membranes to the cytosolic reservoir for re-use 
(Wu et al., 1996). GDI/Rab forms a soluble complex in the cytoplasm which then 
delivers the Rab to the donor membrane. Once there, the GDI is released to the 
cytosol and the Rab remains membrane-associated. As GDI has a strong binding 
affinity for GDP bound Rabs the less well-characterized GDI-dissociation factor 
(GDF) catalyses the dissociation of Rab GDI complexes in order to enable transfer of 
Rabs from GDI onto membranes. Work in mammalian cells has shown that the 
integral membrane protein Yip3 acts catalytically to dissociate complexes of 
endosomal Rabs bound to GDI and to deliver them onto the membranes (Sivars et 
al., 2003). Rab-GDI’s share homology with REP, but are thought to bind only 
prenylated Ypt/Rab proteins, preferentially in their GDP-bound form, inhibiting GDP 
dissociation and masking the prenyl modification (Seabra and Wasmeier, 2004). 
Once at the membrane the Rab is activated to the GTP-bound form by GEF and is 
ready to transport vesicles from the donor membrane to the target membrane. At this 
point the Rab is hydrolysed back to its GDP bound state with the help of GAP. The 
Rab is then ready to be recycled back to the donor compartment by GDI and the 
whole process starts again. All of the Ras superfamily of small GTPases exhibit 
high-affinity binding for GDP and GTP, and possess low intrinsic GTP hydrolysis 
and GDP/GTP exchange activities. GTPases within a family branch use shared GAPs 
and GEFs whereas GTPases in different branches exhibit structurally distinct but 
mechanistically similar GAPs and GEFs (Bernards and Settleman, 2004; Pan and 
Wessling-Resnick, 1998).
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1.2.4 Rab Effectors and SNARES
Rab effectors are a soluble and diverse collection of proteins that transduce the Rab 
signal. A Rab effector preferentially binds to the GTP-bound conformation of Rab 
and competes for interaction with GAP proteins (Nakafuku et al., 1993; Schimmoller 
et al., 1998). They can be described as a protein - or protein complex - which binds 
the GTPase directly in a GTP-dependent manner and is required for the Rab-specific 
downstream function (Grosshans et al., 2006; Nakafuku et al., 1993). These Rab 
effectors perform diverse functions including vesicle budding, tethering and docking, 
vesicle transport by way of the cytoskeleton and vesicle motility. The Rab effectors 
show structural heterogeneity with some effectors sharing structural features. For 
example, pi 15/Usolp, Rabaptin-5 and early endosome antigen 1 (EEA1), all contain 
predicted coiled-coil regions, Rab3-interacting molecule (Riml), EEA1 and 
Rabenosyn-5 contain FYVE zinc-fingers (named after four proteins Fabl, 
YOTB/ZK632.12, Vacl, and EEA1) (Christoforidis et al., 1999a; McBride et al., 
1999; Stenmark et al., 1996). The best characterized Rab effectors have been shown 
to mediate tethering and docking of a Rab-bearing vesicle with the target membrane 
to which it will fuse (McBride et al., 1999; Zerial and McBride, 2001). Other well 
characterised effectors are involved in vesicle motility while in recent work 
interesting insights into cell adhesion and cell signalling have been identified 
(Eggenschwiler et al., 2001; Eggenschwiler et al., 2006; Gibbs et al., 2004; Lock and 
Stow, 2005; Pellinen et al., 2006; Scholpp and Brand, 2004).
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Figure 1.2.2: Diagram showing the regulation of Rab GTPases during vesicle 
trafficking.
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1.2.4.2 Tethering Effectors
The best characterized Rab effectors have been shown to mediate tethering and 
docking of a Rab-bearing vesicle with the target membrane to which it will fuse 
(McBride et al., 1999; Zerial and McBride, 2001). Membrane tethering is a 
conserved mechanism that depends on Rab effectors. In yeast, tethering of ER- 
derived vesicles to the Golgi complex depends on the membrane recruitment of 
Usolp by Yptlp which is exclusively required on target Golgi membranes (Cao and 
Barlowe, 2000). In mammals the homologue of Usolp, pi 15 binds directly to Rabl 
(Beard et al, 2005). Rabl recruits pi 15 onto coat protein 2 (COPII) vesicles at the 
budding step committing the vesicles to targeting and fusion (Allan et al., 2000). In 
yeast a multi-protein complex called TRAPP (transport protein particle) also targets 
ER-derived vesicles to the Golgi apparatus by accelerating nucleotide exchange on 
Yptlp in the Golgi (Sacher et al., 1998; Wang et al., 2000) The delivery of post- 
Golgi vesicles to the plasma membrane in yeast depends on Sec4p and the tethering 
factor exocyst. The exocyst is a complex of eight proteins that are specifically 
required for exocytosis with an equivalent complex exists in mammals (Kee et al., 
1997; TerBush et al., 1996). The exocyst complex in yeast contains eight different 
proteins namely Sec3p, Sec5p, Sec6p, Sec8p, Seel Op, Secl5p Exo70p and Exo84p. 
Most of these units were discovered when mutations resulted in an accumulation of 
vesicles destined for the plasma membrane (Wiederkehr et al., 2004). The complex 
localizes to sites of exocytosis on the plasma membrane in a process which is 
determined by the subunit Sec3p (Finger et al., 1998). The exocyst mediates vesicle 
targeting and, through another subunit (Secl5p) interacts specifically and directly 
with Sec4p in a GTP-dependent manner, a process that is considered to control the 
assembly of the whole complex (Guo et al., 1999). The mammalian exocyst 
comprises homologues of the eight subunits found in yeast. In mammals the subunit 
responsible for association with Rabs is Sec5, rather than Seel 5 in yeast. Another 
difference between the yeast and mammalian exocyst is that the mammalian complex 
associates with a protein called RalA instead of a Rab (Brymora et al., 2001).
In early endocytosis, mammalian Rab5 regulates both clathrin-coated vesicle- 
mediated transport from the plasma membrane to the early endosomes and 
homotypic early endosome fusion (Bucci et al., 1992; Gorvel et al., 1991). Early
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endosomal autoantigen 1 (EEA1) is the Rab5 effector that mediates 
tethering/docking of early endosomes (Christoforidis et al., 1999a). This will be 
discussed in further detail in Chapter 5.
1.2.4.1 SNAREs
Vesicle tethering and docking requires another group of proteins for completion. 
Once the vesicle reaches its target, the effector triggers the interaction of vesicular 
(v-SNARE) and target (t-SNARE) proteins. This brings the vesicle and the target 
membranes into close apposition and mediates fusion (Kierszenbaum, 2000).
SNARE (Soluble NSF Attachment Protein REceptor) proteins have been proposed to 
mediate all intracellular fusion events (Sollner et al., 1993). The first of these to be 
discovered were the synaptic proteins; SNAP-25, syntaxin (STX1), and VAMP 
(Vesicle -Associated Membrane Protein or synaptobrevin) (Bennett et al., 1992; 
Oyler et al., 1989; Trimble et al., 1988). STX1 and VAMP are anchored to the 
membrane by a carboxyl-terminal transmembrane domain while SNAP-25 is 
peripherally attached to the membrane by the covalent attachment of 16-carbon 
saturated fatty acids (palmitate) to four cysteine residues in the central region of the 
protein (Chen and Scheller, 2001). It was thought that each type of transport vesicle 
had a distinct v-SNARE, which paired with an unique complementary t-SNARE at 
the appropriate target membrane (Rothman and Warren, 1994; Sollner et al., 1993). 
This interaction enabled the vesicle to dock at the appropriate membrane, leading to 
the subsequent dissociation of the SNARE complex, with the ATPase activity of 
NSF (V-ethylmaleimide Sensitive Fusion protein) driving the fusion. This view has 
since been modified and it is now thought that NSF acts as a chaperone to reactivate 
SNAREs after fusion instead of directly driving fusion (Morgan and Burgoyne, 
1995). The specificity of targeting is brought about by the Rab protein family, with 
assembly of the SNARE complex driving the lipid fusion (Chen and Scheller, 2001).
Rabs and SNAREs interact via intermediate proteins the nature and number of which 
can be quite diverse between different steps of membrane traffic (Armstrong, 2000; 
Tall et al., 1999). The active form of the Rab protein generally nucleates the 
assembly of a protein complex that can ultimately bind to or tether the target
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membrane and then a SNARE complex can form (Armstrong, 2000). Certain 
organelles are enriched in SNAREs which helps them to identify the correct target 
and to limit non-specific fusion events. During vesicle transport a given SNARE will 
spread throughout many cellular compartments such that organelles will contain 
SNARE complexes which must remain inactive until they return to their place of 
specific function. This is where the Rabs provide their additional layer of regulation 
(Zerial and McBride, 2001).
1.2.4.3 Budding effectors
It is thought that Rab proteins influence vesicle budding, in a transport event-specific 
manner (Allan et al., 2000; Bucci et al., 1992; Riederer et al., 1994). in vivo studies 
in mammals have indicated a possible role for Rabl in budding of vesicles from the 
ER (Allan et al., 2000; Nuoffer et al., 1994). While Rab9 has been implicated in 
budding from endosomes directed to the trans-Golgi network (TGN) (Riederer et al.,
1994). In yeast a component (Vam2p/Vps41p) of the Ypt7p (Rab7)-tethering 
complex HOPS has been implicated in the budding of vesicles from the Golgi (Price 
et al., 2000a). HOPS stands for homotypic fusion and vacuole protein sorting and is 
also referred to as Class C Vps protein complex (Rieder and Emr, 1997). 
Components of this complex include as mentioned the Vam2p/Vps41p proteins as 
well as Vam6p/Vps39p proteins (Price et al., 2000a; Seals et al., 2000). It should be 
noted that Ytp7p has not been shown to be directly implicated in Golgi budding 
(Price et al., 2000b). in vivo mammalian Rab5 has been shown to modulate the half- 
life of clathrin-coated pits on the plasma membrane during vesicle formation (Bucci 
et al., 1992). in vitro mammalian Rab5 is required for vesicle formation with the 
suggested Rab5 GAP, RN-Tre, downregulating Rab5 and inhibiting receptor 
internalization (Lanzetti et al., 2000; McLauchlan et al., 1998).
1.2.4.4 Motility Effectors
Rabs have been shown to determine the distribution of cellular compartments by 
regulating the movement of vesicles and organelles along cytoskeletal filaments 
(Cheney and Rodriguez, 2001). Probably the best charachterized of these is the Rab 
motility effector myosin Va. In collaboration with Rab27a and melanophilin (another 
Rab effector), myosin Va has been shown to be involved in correct pigment
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patterning in both mice and humans as defects in any of these genes is responsible 
for the human disorder Griscelli’s syndrome (see section 1.2.6.4) (Bahadoran et al., 
2001; Matesic et al., 2001; Menasche et al., 2000). In yeast, interactions have been 
found between Sec4p and the myosin heavy chain Myo2p (Pruyne et al., 1998) 
suggesting that vesicles are propelled by motor proteins along polarized actin cables 
towards the site of exocytosis (Pruyne et al., 1998; Schott et al., 1999). In a screen 
looking for mammalian Rab effectors it was found that Rab6 interacts with a kinesin- 
like protein (Echard et al., 1998), Rabkinesin-6, which has since been shown to be 
important for cytokinesis (Echard et al., 1998; Hill et al., 2000). Rab5 has been 
shown to regulate the attachment of early endosomes to microtubules and their 
motility along those microtubules (Nielsen et al., 1999).
1.2.4.5 Cell Adhesion Effectors
Recent papers have shown a role for Rabs in cell adhesion (Kohler and Zahraoui, 
2005; Ulrich et al., 2005). Small GTPases, such as Rab3b, Rab8 and Rab 13 have 
been shown to localize to tight junctions between cells (Lutcke et al., 1993). These 
tight junctions are multifunctional complexes involved in various signalling events 
controlling cell-cell adhesion, differentiation and polarity. Kohler et al (2004) 
demonstrated that mammalian Rab 13 directly interacts with PKA and inhibits PKA- 
dependent phosphorylation of the actin-remodelling protein VASP resulting in the 
recruitment of VASP, ZO-1 and claudinl to cell-cell junctions to be inhibited 
(Kohler et al., 2004). Kohler also suggested a link between Rab 13 and protein kinase 
A signalling during tight junction assembly in epithelial cells (Kohler et al., 2004).
Pellinen has shown an association, in both yeast and mammalian cells, of Rab21 and 
Rab5 with integrins (Pellinen et al., 2006). Continual trafficking of integrin cell 
adhesion molecules to and from the cell surface is vital to cell migration. Rab21 and 
Rab5 associate with the cytoplasmic domains of a-integrin chains, and their 
expression influences the endo/exocytic traffic of the integrins (Pellinen et al., 2006). 
Knock down of Rab21 impairs integrin-mediated cell adhesion and motility, whereas 
its overexpression stimulates cell migration and cancer cell adhesion to collagen and 
human bone (Pellinen et al., 2006). If there is a point mutation in the integrin in the 
region where the integrin associates with Rab21, when Rab21 is overexpressed, it
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fails to induce cell adhesion (Pellinen et al., 2006). It is thought that these Rabs target 
the integrins to intracellular compartments and this regulates cell adhesion. (Pellinen 
et al., 2006).
1.2.5 Disorders caused by Mutations in Rabs
Although there are now over 60 Rabs uncovered in the human genome only a small 
number of mammalian Rabs have been show to be directly linked with specific 
disorders: These Rabs are Rab3a, Rab7, Rab23, Rab27a and Rab38 (Eggenschwiler 
et al., 2001; Kapfhamer et al., 2002; Loftus et al., 2002; Menasche et al., 2000; 
Verhoeven et al., 2003).
1.2.5.1 Rab3a and the earlybird mouse.
In a screen for mouse mutants with abnormal rest-activity and sleep patterns, a 
“semidominant” mutation called earlybird - which shortens the circadian period of 
locomotor activity and homeostatic response to sleep loss was - identified 
(Kapfhamer et al., 2002). Sequence analysis of rab3a identified a point mutation in a 
conserved amino acid (Asp77Gly) within the GTP-binding domain resulting in 
significantly reduced levels of Rab3a protein suggesting that the Asp77Gly change 
may affect the overall stability of the protein. Phenotypic assessment of earlybird 
mice and mice with a null allele of rab3a revealed anomalies in circadian period and 
sleep homeostasis, providing evidence that Rab3a-mediated synaptic transmission is 
involved in these behaviours (Kapfhamer et al., 2002). Rab3s are known to be the 
most abundant Rab proteins in the brain and have a regulatory role in synaptic 
vesicle trafficking. Mice with a targeted loss-of-function mutation in rab3a have 
defects in Ca2+-dependent synaptic transmission which lead to an increased number 
of vesicles released in response to an action potential in the mutant mice (Kapfhamer 
et al., 2002).
1.2.5.2 Rab7 in Charcot-Marie-Tooth type 2B Neuropathy
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Charcot-Marie-Tooth type 2B (CMT2B) neuropathy is a clinical disorder 
characterized by distal muscle weakness and wasting and a high frequency of foot 
ulcers, which results in the need for amputations of the toes due to recurrent 
infections. The gene responsible has been mapped to chromosome 3ql3-q22 where 
two mis-sense mutations (Leul29Phe and Vall62Met) were found in Rab7. The 
alignment of Rab7 orthologues shows that both missense mutations target highly 
conserved amino acid residues. Rab7 is a late endosomal protein with expression 
found in sensory and motor neurons (Verhoeven et al., 2003). Later work showed a 
further mutation a heterozygous A to C mutation, changing asparagine to threonine at 
codon 161 whose phenotype lacked the motor features of the other mutations. This 
mutation is situated adjacent to one of the previous mutations suggesting hotspot for 
mutations in the highly conserved C terminus of Rab7 (Houlden et al., 2004).
1.2.5.3 Rab23 and the openbrain mouse
Sonic hedgehog (Shh) is essential for many aspects of mammalian embryogenesis 
including the patterning of the neural tube and limbs (Chandrasekhar et al., 1998; 
Couve-Privat et al., 2004; Tsukazaki et al., 1998). Hedgehog acts as an extracellular 
ligand which binds the trans-membrane receptor Patched (Ptc). In the absence of 
Hedgehog, Patched represses the activity of a second transmembrane protein, 
Smoothened (Smo), thereby blocking the downstream signalling pathway (Murone et 
al., 1999).
The mouse open brain (opb) gene product has been shown to have an opposing role 
to Shh (Gunther et al., 1994). In neural patterning opb is required for dorsal cell 
types and Shh is required for ventral cell types in the spinal cord (Eggenschwiler and 
Anderson, 2000). Mutations in opb causes the embryos to die during the second half 
of gestation with an open neural tube in the head and spinal cord, abnormal somites, 
polydactyly and poorly developed eyes (Gunther et al., 1994). opb mutants lack 
dorsal cell types specifically in the caudal spinal cord while Shh mutants lack ventral 
cell types throughout the spinal cord (Eggenschwiler and Anderson, 2000). The opb 
mutant phenotypes resemble those produced by partial loss of function of Ptc which 
acts as a negative regulator of the Shh pathway (Eggenschwiler et al., 2001). The opb 
mutant phenotype could be the result of partial activation of the Shh signalling
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pathway in dorsal and lateral neural cells. When opb was cloned it was found to 
encode for Rab23 (Eggenschwiler et al., 2001). Dorsalizing signals are thought to 
activate transcription of rab23 in order to silence the Shh pathway in dorsal neural 
cells. (Eggenschwiler et al., 2001). More recent research using Rab23-GFP showed 
that Rab23 co-localizes in endosomes with Ptc but it was thought that it may act 
more distally in regulating Shh (Evans et al., 2003).
Additional proteins which influence Shh signalling and whose cellular trafficking 
could be regulated by Rab23 have been uncovered (May et al., 2005). A forward 
genetic approach in mice identified a role for intraflagellar transport (IFT) genes in 
Shh signal transduction, downstream of Ptc and Rab23 (May et al., 2005). IFT 
proteins are essential for cilia assembly and have recently been associated with a 
number of developmental processes, such as left-right axis specification and limb 
and neural tube patterning (Haycraft et al., 2005; May et al., 2005) (Wang et al., 
2006).
Work this year (Eggenschwiler et al., 2006) has shown that, contrary to initial 
speculations suggesting that Ptc and Smo are the targets of Rab23 action, Rab23 
mutants do not appear to affect the localization and dynamics of either protein. 
Genetic analyses have now shown that Rab23 actually functions downstream of Smo 
and affects the function of the Shh-regulated Gli family of transcription factors 
(Eggenschwiler et al., 2006). Double mutant analysis has shown that the primary 
target of Rab23 is the Gli2 activator and that Rab23 and Gli3 repressor have additive 
effects on patterning (Eggenschwiler et al., 2006). Analysis of Gli3 protein suggests 
that Rab23 also has a role in promoting the production of Gli3 repressor 
(Eggenschwiler et al., 2006). Antibodies generated against Rab23 showed that the 
protein is highly enriched in the adult rodent brain and present in low levels in 
multiple tissues of the adult rodent. This suggested a role for Rab23 not only in the 
embryo but also in the adult (Guo et al., 2006).
1.2.5.4 Rab27a in Griscelli syndrome and Ashen mice
Griscelli’s syndrome (GS) is a rare autosomal recessive disease characterized by an 
immune deficiency. Patients have uncontrolled T-lymphocyte and macrophage
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activation (haemophagocytic syndrome, HS) leading to death in the absence of bone- 
marrow transplantation. In addition, patients show partial albinism with striking 
silvery-metallic hair sheen and mild cutaneous depigmentation (Griscelli et al., 
1978). The disease has been attributed to an abnormal melanosome distribution 
(Griscelli et al., 1978). Melanosomes are melanin-containing vesicles in the 
epidermis the uniform distribution of which leads to normal pigmentation.
Originally the mutation responsible for this syndrome was mapped to 15q21 and the 
myosin-V gene (Pastural et al., 1997). However a mutation in the rab27a gene can 
also cause GS (Pastural et al., 2000). Studies have shown that in normal melanocytes 
Rab27a colocalizes with melanosomes but in melanocytes isolated from a patient 
with GS, there is abnormal melanosome distribution and a lack of rab27a expression. 
Re-expression of rab27a in GS melanocytes restores melanosome transport to 
dendrite tips, leading to a phenotypic reversion of the diseased cells implicating 
Rab27a as a key component of vesicle transport machinery in melanocytes 
(Bahadoran et al., 2001). Unlike the GS patients with the myosin-V gene mutation 
GS patients with the Rab27a mutation exhibited reduced T cell cytotoxicity and 
cytolytic granule exocytosis (Menasche et al., 2000).
The pigmentation defect mutants dilute (d), leaden (In), and ashen (ash) in mice 
show mutations in myosin Va, melanophillin and rab27a respectively, with defects in 
myosin V and rab27a and more recently melanophilin corresponding to genes shown 
to be defective in GS (Matesic et al., 2001; Menasche et al., 2003; Mercer et al., 
1991; Wilson et al., 2000). All three mouse mutations produce a lightened coat 
colour due to defects in pigment vesicle transport (Wilson et al., 2000) in addition 
ash mice show platelet defects resulting in increased bleeding times and a reduction 
in the number of platelet dense granules.
Melanosomes are transported by microtubules to the dendrite tips and then are 
retained there by MyoVa-mediated interaction with the cortical actin cytoskeleton 
(Wu et al., 1998). It is thought that Rab27a, melanophilin, and myosin Va form a 
ternary complex in the human melanocyte cells where melanophilin has a role in 
bridging Rab27a on melanosomes and myosin Va on actin filaments during
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melanosome transport. (Costa et al., 1999; Karcher et al., 2001; Nagashima et al., 
2002).
Myosin VaMelanophilin
Rab27
Melanosome
Figure 1.2.3: Diagram of myosin Va attachment to melanosomes via 
melanophilin.
(Adapted from Cheney and Rodriguez, 2001; Costa et al., 1999; Karcher et al., 2001; 
Maciver, 2006)
1.2.5.5 Rab 38 and the chocolate mouse.
Disorders with reduced pigmentation can be placed into two groups according to 
whether they affect melanocyte differentiation or melanosome function. Those that 
affect melanocyte differentiation are characterized by a localized absence of 
melanocytes resulting in “ white patch” patterns. Disorders with affected 
melanosome function include Oculocutaneous albinism (OCA) I-IV and Griscelli 
syndrome (GS). Microarray analysis has revealed that rab38 demonstrates a similar 
expression profile to melanocytic genes and further comparative genomic analysis 
has linked human rab38 to the mouse chocolate (cht) locus (Loftus et al., 2002). 
Mutant mice exhibit a brown coat similar in colour to mice with a mutation in 
tyrosinase-related protein 1 (Tyrpl). This forms a mouse model for OCA (Loftus et 
al., 2002; Suzuki et al., 2003). In the melanocytes of these mice the targeting of 
TYRP1 protein to the melanosome is impaired, suggesting that Rab38 plays a role in 
the sorting of TYRP1 (Loftus et al., 2002). More recent work has also shown that 
rab38 mRNA and native protein are expressed in a tissue-specific manner in the 
lung, skin, stomach, liver, and kidney. Cellular analysis has shown Rab38 mainly
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colocalized with endoplasmic reticulum-resident proteins and also partly with 
intermittent vesicles between the endoplasmic reticulum and the Golgi complex. This 
implies that Rab38 abnormality may cause multiple organ diseases as well as OCA 
(Osanai et al., 2005).
1.2.6 Morphogen Signalling and Vesicular Trafficking.
1.2.6.1 Endocytosis
Endocytosis has been shown to be essential for cell motility, cell signalling and cell 
adhesion and can be broadly placed into two categories; clathrin mediated (CME) 
and non-clathrin mediated (Le Roy and Wrana, 2005). Much of the literature is 
concerned with CME which is of particular interest in development, as a possible 
route by which TGF-p receptors, such as those for the Nodals, are internalized 
(Anders et al., 1998). Clathrin independent endocytosis is used to describe any 
endocytic process that does not involve clathrin (Le Roy and Wrana, 2005). One 
form which is suggested to also play a role in development relies on cholesterol-rich 
membrane domains such as lipid rafts and caveolae (raft/caveolae endocytosis )(Polo 
and Di Fiore, 2006). In this form of endocytosis receptors are internalized and 
thought to be delivered for degradation (Le and Nabi, 2003; Pelkmans et al., 2005). 
Investigations using epiderimal growth factor receptors have suggested that during 
signalling a choice is made between CME and raft/caveolae endocytosis (Polo and 
Di Fiore, 2006). If low doses of receptor are internalized then endocytosis progresses 
via CME. High doses of receptor internalization have been shown to correlate with 
the monoubiquitination of EGFR and so are probably destined for degradation via 
raft/caveolae endocytosis. It has therefore been suggested that CME is preferred at 
low doses for prolonged endosomal signalling but some of the receptors are routed 
through the raft/caveolae endocytosis pathway for degradation at higher does. Such 
routing avoids excess stimulation with signalling considered as the ratio of CME to 
raft/caveolae endocytosis (Polo and Di Fiore, 2006). This view, however, has been 
recently challenged by the suggestion that clathrin coated vesicles may play a part in 
the degradative endocytic pathway (Lakadamyali et al., 2006).
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The correct sorting of endocytic ligands and receptors is essential for proper cell 
function. Early endosomes are considered to be the initial sorting station, where 
cargos for degradation are separated from those for recycling (Lakadamyali et al., 
2006). Live mammalian cell imaging used to monitor individual endosomes and 
ligands has shown that a sorting mechanism takes place prior to early endosome 
entry and that endosomes are comprised of two distinct populations. The first of 
these endosomes are highly mobile on microtubules and mature rapidly toward late 
endosomes. The second are static endosomes that mature much more slowly. Those 
cargos destined for degredation are targeted to the dynamic endosomes whereas 
those destined for recycling are enriched in the larger, static population 
(Lakadamyali et al., 2006). This pre-early endosome sorting process is thought to be 
dependent on microtubule motility, involve endocytic adaptors and interestingly 
begin at clathrin-coated vesicles (Lakadamyali et al., 2006).
In metazoans, CME requires dynamin, a member of a family of self assembling 
GTPases. During endocytosis, dynamin forms an oligomeric ‘collar’, in a GTP- 
dependent manner, which is thought to induce fission of vesicles from the plasma 
membrane (Takei et al., 1995), in addition to recruiting effectors such as actin- 
binding proteins (Elde et al., 2005). The actin cytoskeleton is important in 
endocytosis as demonastrated by interference with actin turnover in mammalian cells 
by pharmacological agents which inhibits endocytic uptake and the formation of 
coated vesicles (Lamaze et al., 1997). However, this block in endocytosis in 
mammalian cells seems to be partial (Fujimoto et al., 2000; Moskowitz et al., 2003).
1.2.6.2 Evidence for vesicle trafficking in morphogen movement
The trancytosis model of morphogen movement proposes that morphogens use 
vesicular trafficking through the cells to reach their target cells. Much of the 
evidence for this comes from work in Drosophila other investigations, however, 
suggest a role for this mechanism in vertebrates.
The Drosophila Dpp protein, the orthologue of Bmp2/4, has been shown to act as a 
morphogen, patterning the early embryo including well characterised roles in 
specifying cell fates along the AP axis of the wing (Eldar et al., 2002; Lecuit et al.,
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1996; Weigmann and Cohen, 1999). Functional GFP-Dpp fusions have enabled 
visualisation of Dpp showing that it forms a long-range dose gradient across 30 cells 
(Entchev et al., 2000; Teleman and Cohen, 2000) travelling at a rate of more than 
four cells per hour in all directions. This is not unusual for signalling factors and is 
consistent with diffusion, however Dpp cannot form a stable gradient by diffusion 
(Entchev et al., 2000; Teleman and Cohen, 2000). It is possible this is due to the 
mature Dpp peptide binding to the extracellular matrix components and so restricting 
its extracellular movement. The binding of Dpp to the receptor may also decrease the 
range of Dpp. Additionally Dpp signalling range may be reduced by internalized Dpp 
being degraded in receiving cells upon targeting to the late endosome/lysosome. 
Labelled GFP-Dpp disappears within 3h and is considered to be actively degraded 
(Entchev and Gonzalez-Gaitan, 2002).
Dpp has been show to be targeted towards degradation by a sorting mechanism 
which depends on the small GTPase Rab7 (Entchev et al., 2000). Dpp’s signalling 
range has been shown to be determined by Rab7-dependent rates of degradation 
(Entchev et al., 2000). Entchev et al have shown that Dpp is internalized by the 
receiving cells where it localizes in endosomes and is then excised with the help of 
dynamin in clathrin-coated pits to form endocytic vesicles (Entchev et al., 2000). In 
the dynamin mutant (shibire) Dpp is not internalized and can only be observed 
extracellularly adjacent to its source (Entchev et al., 2000). In endocytic and 
endosomal-defective tissue Dpp has a range which, Entchev et al propose is 
consistent with their estimated range - less than five cells - of Dpp in the absence of 
transcytosis (Entchev et al., 2000). They proposed that receiving cells are required to 
perform transcytosis in order to form a long-range Dpp gradient (Figure 1.2.4). Their 
transcytosis model implies that Dpp is internalized in the receiving cell, traffics 
through the endocytic pathway and is re-secreted allowing it to signal in adjacent 
cells. Consistent with this is the observation that Rab5 activity can alter the 
signalling range of Dpp (Entchev et al., 2000). Rab5 controls endocytic trafficking 
by directing the budding of endocytic vesicles from the plasma membrane 
(McLauchlan et al., 1998) to their fusion with the early endosome (Bucci et al., 
1992). Cells expressing a dominant negative Rab5 showed reduced range of 
expression of the Dpp target gene spalt, whilst cells overexpressing Rab5 showed 
increased expression range of spalt (Entchev et al., 2000). Enchev et al suggested
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that once Dpp enters the endocytic pathway, it can be sorted towards degradation or 
recycling (Entchev et al., 2000). Recycled Dpp is re-secreted and moves forward into 
the target tissue. Dpp transcytosis is considered to be controlled by endocytic Rab 
proteins which include Rab5 and Rab7.
+ Receotoro Producing cell0 Receivino cells
M orphogen
o V esicles
□ Extracellularmatrix
Figure 1.2.4: Diagramatic representation of planar transcytosis possible role in 
morphogen gradient formation.
Diagram A shows morphogens moving through receiving cells in vesicles. Diagram 
B shows planar transcytosis impeded by a reduction in endocytosis (i.e.rab5 deficient 
cells).
Teleman and Cohen (2000) have an alternative explanation to transcytosis. They 
agree that Dpp-GFP forms an unstable extracelluar gradient which can travel over 
long distances. However, they show with the slow spread of target gene induction 
that this extracellular gradient differs from the activity gradient. They propose that 
the activity gradient is shaped at the level of receptor activation possibly by the need 
to downregulate a Dpp repressor (Teleman and Cohen, 2000). A subsequent paper by 
Belenkaya et al (2004) contradicted earlier studies and showed that Dpp is mainly 
extracellular with its extracellular gradient coinciding with its activity gradient. They 
demonstrated that blocking endocytosis using shibire does not block Dpp movement 
but inhibits Dpp signal transduction suggesting endocytosis is needed but not 
essential for transport. They suggest a model where Dpp moves along the cell surface 
by restriced extracellular diffusion involving glypicans Dally and Dally-like 
(Belenkaya et al., 2004).
The Drosophila Wnt homolog Wingless (Wg), has been found in vesicular structures 
at the target tissue (Gonzalez et al., 1991). It has therefore been suggested that it
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spreads throughout the target tissue by trafficking through the receiving cells during 
patterning of the epidermis in the Drosophila embryo (Bejsovec and Wieschaus,
1995). Wg is thought to be internalized by Dynamin-dependent endocytosis, since in 
dynamin mutant embryos Wg is only able to elicit signalling in the cells 
neighbouring the source (Bejsovec and Wieschaus, 1995). This indicates that long- 
range Wg activity requires endocytosis. The finding that a response is elicited in 
neighbouring cells implies that Wg signal transduction in these neighbouring 
receiving cells could occur in the absence of Wg internalization (Bejsovec and 
Wieschaus, 1995). Alternatively this suggests that dynamin is required for secretion 
(Strigini and Cohen, 2000). In the Drosophila wing, impaired dynamin function 
reduces Wg transcription but when Wg production is unaffected, extracellular Wg 
levels are increased by impaired dynamin (Seto and Bellen, 2006). Despite this, 
target gene expression is reduced, suggesting that internalization at the target is also 
required for efficient Wg signalling in vivo. Rab5 deficient cultured cells showed a 
reduction of the activity of the Wg reporter Super8XTOPflash suggesting that 
internalization and endosomal transport facilitate Wg signalling (Seto and Bellen, 
2006). When endosomal transport is impaired, Wg signalling is reduced however, 
when transport to endosomes is increased expression of Wg targets is enhanced. This 
increased signalling correlates with greater colocalization of Wg, Arrow, and 
Dishevelled on endosomes (Seto and Bellen, 2006). Regulation of endocytosis is the 
mechanism through which Wg signalling levels are determined (Seto and Bellen, 
2006).
Hedgehog (Hh) has been shown to restrict the propagation of Wg signalling 
suggesting that this signalling pathway sets a barrier for the spreading of Wg (Sanson 
et al., 1999). It has been suggested that it does this by vesicular trafficking (Dubois et 
al., 2001). Wg degradation is specifically enhanced posteriorly by a mechanism 
thought to be initiated by Hedgehog activating EGF receptor signalling (Scott, 2001). 
Sequentially EGF receptor signalling is thought to activate the transcription of an 
unknown factor in posterior cells and this in turn enhances Wingless degradation 
(Dubois et al., 2001). In the absence of the Hh ligand, Patched (Ptc) antagonizes Hh 
signalling by binding Smoothened and blocking its signalling activity and possibly 
destabilizing it (Chen and Struhl, 1996; Denef et al., 2000). When Hh is present it 
binds to Ptc triggering its internalization, followed by phosphorylation of
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Smoothened which becomes stabilized and accumulates at the surface and signals 
(Denef et al., 2000). There is the possibility that Hh elicits signalling by diverting Ptc 
into a distinct trafficking route releasing Smoothened from its repression (Chen and 
Struhl, 1996; Denef et al., 2000) and implying a role for Hh in vesicular trafficking. 
Vesicle trafficking may have an additional role in the movement of Nodal and Lefty. 
In chick embryos Nodal-GFP and Lefty-GFP fusion proteins are localized in the 
endosome (Sakuma et al., 2002) suggesting the possibility that Nodal and Lefty 
dispersal occurs by intracellular trafficking. Vesicular trafficking has been suggested 
to play one of two roles depending on the morphogen (Entchev and Gonzalez-Gaitan,
2002). Intracellular trafficking could push forward the ligands when the extracellular 
space restricts its movement as seems to be the case for Dpp in the wing. 
Alternatively, internalization and degradation of the morphogens could restrict the 
range of the morphogen if the extracellular matrix permits its long-range diffusion as 
appears to apply to Wg in the Drosophila embryo (Entchev and Gonzalez-Gaitan, 
2002).
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1.3 Nodal signalling
Zygotic Nodal signalling is essential for mesoderm and endoderm formation in the 
developing embryo (Feldman et al., 1998) with evidence in chick suggesting a 
possible role for endocytosis in its movement (Sakuma et al., 2002). Recently 
maternal transcripts of the zebrafish nodal Squint have been shown to be localized to 
cells that may form the dorsal side of the embryo (Gore et al., 2005) suggesting a 
role for maternal transcripts of Nodal protein in DV patterning. Nodal proteins are 
therefore considered to be of great importance in the study of zebrafish development
1.3.1 Introduction to Nodal Signalling
Nodal is a gene found to be essential for the establishment of the primitive streak, in 
mice, from which mesoderm and endoderm are derived, nodal encodes a TGF-0 
superfamily ligand (Zhou et al., 1993) identified by an insertional mutagenesis screen 
in mouse. Mutant embryos, lacking a functional nodal gene fail to gastrulate and the 
expression of mesoderm markers such as brachyury is severely inhibited (Rebagliatia 
et al., 1998). Zebrafish have 3 homologues of this gene squint (sqt), cyclops (eye) 
and southpaw. Squint and Cyclops are expressed at the blastoderm margin and are 
required for prechordal plate and notochord formation. In their absence there is a 
lack of mesoderm and endoderm formation (Dougan et al., 2003; Feldman et al.,
1998) (Figure 1.3.1). An additional role for Nodal signalling has been observed in 
patterning axial mesoderm precursors in the organizer along the anterioposterior axis 
(Gritsman et al., 2000). This patterning occurs by differential activation of the Nodal 
signalling pathway (Gritsman et al., 2000). Embryos mutant for both squint and 
cyclops do not develop a shield and, in addition markers for dorsal mesoderm such as 
goosecoid and floating head are not expressed at the onset of gastrulation (Feldman 
et al., 1998). The nodal related gene southpaw (spaw) has been shown to regulate 
left-right asymmetry in the visceral organs and brain of the developing embryo, spaw 
is expressed bilaterally in paraxial mesoderm precursors then subsequently within the 
left lateral plate mesoderm (Long et al., 2003) but is not detected prior to
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somitogenesis. Since much of this thesis is concerned with events preceding 
somitogenesis, the actions of spaw will not be fully discussed.
The nodal related genes encode a pro and mature region that once transcribed are 
cleaved to produce a mature ligand which is a covalently disulfide-linked dimer. All 
TGF-p related ligands show a conserved cysteine this is essential for the secretion 
and biological function of the protein (Sampath et al., 1998). A mutation of this 
cysteine is thought to disrupt the formation of disulphide bonds and possibly ligand 
dimerization.
Figure 1.3.1: The zebrafish nodal mutants.
Comparing wild type embryos to squint homozygous mutants, cyclops homozygous 
mutants and both sqt and eye homozygous mutants (Feldman et al., 1998).
1.3.2 Cyclops
cyclops muatants have a variety of alleles of differing types and strengths most 
derived from ENU mutagenesis (Table 13.1) (www.zfin.org) The cyclops (eye) gene 
product is required for the formation of ventrally located cells in the neuroectoderm, 
both in the forebrain and more posteriorly in the floor plate (Solnica-Krezel et al.,
1996). cyclops mutants have been shown to have a failure in specification of cells
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that come to occupy the ventral midline of the neural tube (Hatta et al., 1991) giving 
a cyclopean phenotype (Figure 1.3.1).
Allele Mut. Type Brief Description
b16 Deficiency Strong cyclopia, interrupted floor plate.
m101 Unknown Cyclopia; CNS and floor plate defects.
m122 Unknown Cyclopia; CNS and floor plate defects.
m294 Point Cyclopia; CNS and floor plate defects; null allele. 
Temperature-sensitive allele. Incompletely penetrant at 22 deg. C,
sg1 Point completely penetrant at 28.5 deg C.
st5 Deficiency
te262c Unknown Patchy floor plate; weak allele.
tf219 Unknown Cyclopia, no FP, abnormal RT projection; allele strength = b16.
tu43x Unknown
B299 Deletion
B213 Translocation
Table 1.3.1: Different alleles of e y e ,  their mutation type and a brief description
Adapted from the Zfin website (www.zfin.ors)
cyclops transcripts are not detectable in the fertilized egg, but are activated after the 
MBT, reaching maximal expression level at shield stage, after which there is a 
decrease in expression (Rebagliatia et al., 1998). Expression begins in early 
gastrulation (30% epiboly) in cells encircling the blastoderm margin and is 
progressively restricted to the dorsal organizer. Mid-gastrulation expression extends 
along the midline mesendoderm and by the end of gastrulation cyclops is expressed 
in the prechordal mesendoderm and posterior tail bud mesoderm but disappears from 
both regions by the 2-3 somite stage. In cyclops mutants the expression is initially 
indistinguishable from WT but declines thereafter and is absent in the prechordal 
plate, cyclops expression is initially normal in the mutant oep (see Chapter 3.4), but 
decreases during gastrulation contributing to the cyclopia and floorplate defects of 
oep mutants. This suggests that cyclops and oep are necessary for maintenance rather 
than activation of cyclops expression (Rebagliati et al., 1998). Subsequently it was 
found that oep is a co-receptor required for nodal signalling (Gritsman et al., 1999). 
In bozozok (boz) mutants which show a loss of chordomesoderm (Fekany et al.,
1999) dorsal cyclops expression is greatly reduced or absent throughout gastrulation
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resembles that of cyc, but is usually less severe. The range of phenotypes varies from 
mild phenotypes such as eyes being to close together (hence the name) to more 
severe phenotypes including complete cyclopia (Figure 1.3.1). This is, again, due a 
failure to specify prechordal mesendoderm and subsequent failure to specify the 
midline of the anterior neural plate.
Although very similar and partially functionally redundant, Sqt has been shown to 
differ from Cyc in a number of important ways. While Cyc only has short range 
activity, Sqt can act as morphogen (Chen and Schier, 2001) capable of acting in a 
dose dependent manner directly at a distance. Sqt producing cells can induce 
expression of gsc - a nodal target gene - at the source and in its immediate 
neighbours where there are high levels of nodal signalling. Further away Sqt induces 
first flh  and then at a greater distance ntl and bik where the levels of nodal signalling 
are lower. At reduced levels of Sqt, gsc is not induced and ntl is only induced close 
to the source (Chen and Schier, 2001). This long range signalling was not seen in 
cells producing Cyclops (Chen and Schier, 2001).
1.3.4 Receptors, Co-receptors9 Extracellular Inhibitors
The TGF-p superfamily ligands signal by binding to transmembrane serine-threonine 
kinase receptors. Two sets of receptors have been identified, which are assembled 
into a receptor complex (Dougan et al., 2003). Type I receptors are predominantly 
involved in the activation of downstream transducers while type II receptors 
phosphorylate and activate type I receptors in response to ligand binding (Whitman, 
2001). In addition to these receptors there is a class of factors specifically required 
for signalling by Nodal related ligands. These are EGF-CFC factors; a family of 
membrane attached extracellular glycoproteins that include OEP in zebrafish and 
Cripto in mice. Maternal and zygotic loss of oep function phenocopies the loss of 
both Sqt and Cyc. Loss of oep function renders cells unable to respond to ectopic cyc 
or sqt but does not alter responsiveness to activin (Whitman, 2001) another TGF-p 
family member that signals through the same receptors as the Nodals (Reissmann et 
al., 2001; Sun et al., 2006). This suggests that the requirement for EGF-CFC factors 
is specific to the Nodal superfamily of TGF-p ligands (Gritsman et al., 1999).
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The best characterized Nodal antagonists in zebrafish are the Lefties (Goering et al., 
2003; Parsons et al., 2002a; Schmid et al., 2000). There are at least two zebrafish 
lefties, lefty 1 and lefty 2. Overexpression of these in zebrafish induces phenotypes 
strongly resembling cyclops;squint double mutants or maternal-zygotic one-eyed 
pinhead mutants (Sakuma et al., 2002). Loss of Lefty function leads to enhanced 
Nodal signalling during mesoderm induction with expansion of mesendoderm and 
loss of ectoderm in addition to left-right pattern defects (Parsons et al., 2002a; 
Sakuma et al., 2002). Individually, loss of Leftyl causes aberration during 
somitogeneseis stages including left-right pattern defects, while Lefty2 depletion has 
no obvious consequences. The gastrulation defects of embryos depleted of Leftyl 
and Lefty2 have been shown to result from the deregulation of Sqt signalling 
(Parsons et al., 2002a). In contrast, de-regulation of cyclops does not affect 
morphology or the transcription of Nodal target genes during gastrulation. Cyclops is 
thought to be specifically required for the maintenance of lefty 1 and lefty 2 
transcription. Severe gastrulation defects do not arise in zebrafish unless two Nodals 
or two Leftys are removed (Parsons et al., 2002a). This suggests that the activity of 
Leftys is controlled at the level of transcription with Lefty expression being 
dependent on Nodal signalling in most tissues.
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identifying boz as an early-acting upstream regulator of cyclops (Sampath et al., 
1998).
/ .3.3 Squint
There are two known mutant alleles of the squint both of which are insertion 
mutations (Table 1.3.2) (www.zfin.org). Expression of sqt is both maternal and 
zygotic with sqt RNA found to be uniformly expressed in oocytes at all stages of 
oogenesis (Gore and Sampath, 2002). Five minutes after egg activation sqt RNA 
aggregates in clusters throughout the yolk and is detected in the emerging 
blastoderm. At the one cell stage RNA is restricted to the blastoderm and excluded 
from the yolk cell (Gore and Sampath, 2002). This movement from yolk to 
blastoderm is microtubule dependent (Gore and Sampath, 2002). At the four cell 
stage sqt localizes to two blastomeres that may become the dorsal region of the 
embryo. Removal of these blastomeres can result in loss of dorsal structures. This 
localization requires a highly conserved sequence of the 3’ untranslated region 
(UTR) (Gore et al., 2005).
Allele Mut. Type Brief Description
Cz35 (z1) 
hi975
lncortir>n
Insertion
Cydopia; prechordal plate, ventral nervous system defects; null allele. 
Mild eye cyclopia, u-shaped somites.
Table 1.3.2: Different alleles of squint, their mutation type and a brief 
description.
Adapted from Zfin (wwu.zfin.0r2)
Subsequently in the developing embryo the sqt gene has been shown to be expressed 
in the dorsal region of the blastula including the embryonic YSL which has been 
implicated as a source of signals that induce organizer development and 
mesendoderm formation. Mis-expression of sqt RNA within the embryo or 
specifically in the YSL induces ectopic or expanded dorsal mesoderm (Feldman et 
al., 1998). The expression of Sqt is shown to be at peak abundance around sphere 
stage and declines sharply after shield stage. Loss of sqt results in a phenotype that
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1.4 Thesis aims
With the publication of the zebrafish genome, Dr Matthew Clark has undertaken to 
identify all the Rabs in the genome and classify them according to sequence 
homology to their mammalian counterparts. To date, there are estimated to be over 
80 zebrafish rabs (Clark, MD, pers. com.), compared to over 60 in mammals 
(Colicelli, 2004). This thesis aims to characterise the function of specific members of 
the extensive rab family. To achieve this anti-sense MO oligonucleotides will be 
used to knock-down individual rabs with further analysis including overexpression 
assays and microarrays
This thesis aims to uncover new roles for the rab family in zebrafish development 
with the ultimate aim of identifying the function of all the zebrafish rabs. This thesis 
presents the results obtained when 13 rab genes were knocked-down, bringing the 
total number of genes screened to 37 with a small number of these genes exhibiting 
specific and fascinating defects when knocked-down. In mammalian development a 
small minority of rab genes have been implicated in disorders such as Griscelli’s 
syndrome or the openbrain mutant in mice. Investigations into rabs in zebrafish have 
shown that sequence homology does not necessarily translate to functional homology 
(Campos, 2004).
In addition to screening the zebrafish rabs, this thesis further characterizes the 
function of rab5a2: the only rab gene screened to date which resulted in mortality 
before the completion of epiboly. The essential nature of this rab is not surprising, 
since rab5 has been identified as one of the core rab genes. What is surprising is that, 
although many of the other core rabs have also been screened, none of them have 
shown such a dramatic early phenotype. In addition, there are four rab5 genes in 
zebrafish, however, none of the other rab5s display such early morbidity. Recent 
experiments in zebrafish have shown the zebrafish rab5 family to be important in 
cell signalling and cell migration during early development. This research, coupled 
with results from Dr Campos showing a lack of organizer and nodal responsive
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markers in rab5a2 MO injected embryos, has suggested a role for rab5a2 in Nodal 
signalling.
It is therefore the aim of this thesis to further characterise rab5a2 and in particular its 
effect on Nodal signalling by using antisense morpholino oligonucleotides and 
overexpression of RNA analysis. This thesis also looks at the contribution of 
maternal and zygotic transcripts of rab5a2 in nodal signalling in addition to 
analysing the effect of rab5a2 on exogenously supplied nodal RNA. Finally this 
thesis uses microarray analysis to identify other genes and possible pathways 
affected by the knocking down of rab5a2. The results show a complex and vital role 
for rab5a2 in cell signalling and zebrafish development and that its loss of function 
impacts on many hundreds of genes.
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Chapter 2
Materials and Methods
67
Materials and Methods
2.1 Embryology methods
2.1.1 Embryo Fixation
At different stages of embryo development 10 embryos were placed in Eppendorf 
tubes and the water replaced with 4% PFA in PBS. These were stored overnight at 
4°C. If embryos were over 20 somites the chorions were removed before fixing in 
PFA. If the embryos were younger than 20 somites the chorions were removed after 
fixing. Fixed embryos were dehydrated by washing 3 times with 100% MeOH. They 
were then stored in 100% MeOH at -20°C.
2.1.2 In Situ Hybridization Analysis.
The embryos were rehydrated by serial incubations of PBT and methanol (75% 
MeOH /25% PBT for 5 min, 50% MeOH -/50% PBT for 5 min, 25% MeOH /75% 
PBT for 5 min, 100% PBT for 5 min twice). They were then placed in hybridisation 
mix (HM) for 5 min, the HM was changed and the embryos placed in the incubator at 
68°C for no less than 1 hour. The HM was then removed and replaced with 200pl of 
HM containing 1 pg/ml of probe and left to hybridise overnight at 68°C.
The embryos were washed in 50% HM/50% 2xSSC for 5 min, 2xSSC for 15 min, 
and 0.2xSSC for 2 x 30 min at 68°C. They were then washed with 50% 
0.2xSSC/50% PBT for 10 min and PBT for 10 min at room temberature (RT). The 
embryos were finally washed in fresh PBT/2% goat serum/2mg:ml BSA and left for 
several hours at RT. The PBT was then replaced with PBT/2% goat serum/2mg:ml 
BSA containing 1:2500 dilution of anti-dig solution (Roche) and left at 4°C 
overnight.
The PBT antibody solution was removed and the embryos washed with PBT (PBT 
quick wash, PBT for 3x5 min, PBT for 4x15 min all at RT). The embryos were then 
washed with staining buffer (2x5 min) incubated in staining solution (NBT/BCIP 
(Roche)) in the dark and monitored for expression. The staining reaction was stopped
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by removing the staining solution and washing the embryos in PBS pH 5.5/2mM 
EDTA for 3 min. The embryos were then fixed in PFA for 20 min at RT.
2.1.3 Designing UTR or ATGMorphlino’s
Antisense MO-modified oligonucleotides or MOs will be used for loss of function 
anlysis. In zebrafish these are both effective and specific translation inhibitors 
(Nasevicius and Ekker, 2000). The MOs were designed using the known sequences 
for each zebrafish rab and 25 bases of sequence unique to that gene designed either 
against the start codon (ATG) of the open reading frame or against the 5’ UTR 
region. These were then sent for synthesis to Genetools (www.gene-tools.com). The 
MOs arrived back in a powdered form that was re-hydrated in distilled water. The 
MOs were quantified and the working doses achived by dilution with phenol red and 
MO buffer (see section 2.1.5). Phenol red was used as it is pH sensitive and therefore 
enables visualization of those embryos that were not correctly injected.
2.1.4 Designing Splice MO’s
Splice MOs were designed by identifying an intron exon boundary of the gene of 
interest. A MO was then designed against 25 bases of this region with at least 10 
bases in the intonic region and at least 10 bases in the exonic region. The sequence 
was then sent to Genetools for synthesis. The MO was then diluted as in section 
2.1.5.
2.1.5 Resuspension, cleaning and dilution of MOs
The powdered MO was dissolved in 60pl of distilled water. 1 pi of MO was diluted 
in 800pl of HC1 0.1M and quantified using a spectrophotometer. The concentration 
of MO was calculated as follows:
C(pg/pl)= (A x 800 x MW)/ molar absorbency(s)
Where A was the value from the spectrophotometer. The stocks were diluted in 
phenol red at 2ng, 4ng and 8ng per 1.4nl.
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2.1.6 Microinjection o f embryos at the 1- 8 cell stage
The embryos were injected using a pneumatic picopump (World Precision 
Instruments inc.) attached to nitrogen-filled tubing and holder. This was mounted on 
a Narishigne micro manipulator which was in turn mounted on a Kanetec stand. The 
injection needles used were filamented borosilicate glass capillaries (World Precision 
Instruments inc 1B00F-4) pulled using a Kopf needle puller (model 720 at solenoid 
level 3 and heat level 15) and the edge cut with a razor blade, and calibrated under 
the microscope with a millimetre ruler. The embryos were aligned for injection along 
a glass slide placed in a glass petri dish. 1.4nl of the desired solution was injected 
into the yolk of the embryo at the 1 -4 cell stage under a Leica dissecting microscope.
2.1.7 Microinjection o f embryos for 1 cell in 128
Embryos were de-chorionated on agarose in lx danieau solution at the four cell 
stage. A ramp was made by placing a glass slide at a slight angle into a small petri 
dish containing 2% molten agarose (Sigma) in lx Danieau solution. When the 
agarose was set the slide was removed and the dish filled with lx Danieau solution. 
A filamented borosilicate glass capillarie (World Precision Instruments inc 1B00F-4) 
was pulled into a needle and the end cut with a razor blade. The needle was filled 
with the desired solution and calibrated to inject lOOpl. When the embryos reached 
the 64 cell stage they were lined up on the ramp, when they reached the 128 cell 
stage a single cell in the animal pole was injected (see section 2.1.6 for apparatus 
used).
2.1.8 Visualizing biotinylated-dextran.
Embryos were fixed (see section 2.1.1), rehydrated (see section 2.1.2) and incubated 
for 30 minutes in 1:5000 avin in PBT. The embryos were then washed 3 times with 
PBT and soak for 30mins in 0.4mg/ml DAB/PBT (Sigma). The solution was then 
changed for DAB/PBT with 0.003% H2 O2 and watched for 30mins. Once the desired 
staining was achieved the reaction was stopped by rinsing with PBT. The embryos 
were then fixed in PFA for 20 mins at RT.
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2.1.9 Fixing Embryos for Protein and/or RNA extraction.
Embryos were transferred into a clean Petri dish and washed once in lx Danieau 
solution. The required number of embryos were placed in a 1.5ml Eppendorf and 
washed again. All the Danieau solution was removed leaving. The tubes were then 
flicked so the embryos are arranged along the side of the tubes. The tubes were then 
snap frozen in dry ice and stored at -80.
2.1.10 Assaying epiboly movements
The embryos were de-chorinated at dome stage, 30% epiboly and shield stage in a 
petri dish containing 1% agarose and filled with lx Danieau solution. The embryos 
were then placed in glass dishes contaning 5mg/ml of biotinylated-dextran 
(Molecular probes 10,000mw lysine fixable) in lx Danieau solution for 20 minutes. 
The embryos were then washed 3 times over 15 minutes and fixed in 4% PFA.
2.1.11 Staging embryos
During the Rab screen in Chapter 3 the embryos were staged according to time post 
fertilization. Therefore, both the control MO injected embryos and the rab 
morpholino injected embryos are the same age but not necessarily the same 
developmental stage. This enables any developmental delay to be visualized. In 
contrast during both the characterization- and microarray analysis of rab5a2 
(Chapters 5 and 6) the experimental and control embryos were analyzed at the same 
developmental stage. Here, the time post fertilization differed due to the 
developmental delay seen in the experimental embryos. Staging in this way was 
necessary to compare the pathways affected by rab5a2 at set developmental stages.
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2.2 Molecular Methods
2.2.1 Synthesis o f Probe
2pg of plasmid was linearised by digesting with the appropriate enzyme for 2hrs at 
37°C. The total volume was then made up to lOOpl. lOOpl of 
phenol/chloroform/isoamylalcohol solution was added to the linearised DNA 
vortexed briefly and centrifuged for 2 minutes at 13000rpm. The top layer was 
removed and put in a clean Eppendorf. lOOpl of chloroform/isoamylalcohol solution 
was added vortexed and centrifuged for a further 2 minutes. The top layer was again 
removed and put in a clean Eppendorf. lOul of NaAc (3M pH 5.2) and 3x100% 
ethanol was added. This was left at -20°C for lhour and then centrifuged at 
13000rpm for 30 minutes. The ethanol was removed and 300pl of ice cold 70% 
ethanol added and then centrifuge at 13000rpm for 10 minutes. The ethanol was 
removed and the DNA pellet dried at 37°C. The DNA was then resuspended in 8.5pl 
of water.
The RNA was synthesized by adding 4pl of 5x transcription buffer (NEB), 2pi of 
0.1M DTT, 2pi of NTP-DIG-RNA (Roche), 1.5pl of RNAse inhibitor (NEB) and 2pl 
of polymerase (NEB) to the resuspended DNA. This was incubated at 37°C for 2hrs. 
A lpl aliquot of the RNA was removed and run on a 1% agarose/TAE gel to estimate 
the amount of RNA synthesized. The volume of the reaction was then increased to 
50pl and 2pl of DNase I (ribonuclease-free) (Promega) was added. The reaction was 
then incubated at 37°C for 30 minutes to remove the DNA template and leave only 
RNA.
The RNA was recovered by centrifuge using a Chroma spin-100 column (Clontech). 
The column was first centrifuged to remove the water. The volume of RNA was 
increased to lOOpl and added to the column which was spun at 3000rpm for 5 min to 
recover the RNA. The RNA was quantified in a spectophotometer and diluted to the 
desired concentration using RNAse free water.
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2.2.2 PCR amplification o f DNA
5 pi of template DNA, 5pl of forward primer (lOpM), 5pi reverse primer (lOpM), 
0.5pi polymerase (eg. Taq), lOpl 5x PCR buffer and 24.5pi H2 O were mixed 
together in a 0.2ml PCR tube. The tube was placed in the thermal cycler (MJ 
Research inc) at:
1) 94°C for 2min
2) 94°C for 15 seconds
3) Annealing temperature of primers for 30seconds
4) 72°C for 30 seconds
5) Goto 2 29 times more
To check the size of the PCR product lpl of the reaction was run on a 2% agrose 
(Sigma) gel with an appropriate DNA ladder.
2.2.3 Cloning
2pl of PCR product, 1 pi of salt solution, 1 pi of TOPO cloning vector and 1 pi of 
sterile water were mixed together in and Eppendorf tube and left to incubate at room 
temperature for 20 minutes. They were then placed on ice.
2.2.4 Transformation
2ul of the TOPO Cloning reaction was added to 20pl of One Shot TOPO 10 
chemically competent E.Coli and mixed gently. The mixture was incubated on ice 
for 20minutes and then heat-shocked for 30 seconds at 42°C. The tubes were 
immediately transfered on to ice and left for 2 minutes. 250pl of room temperature 
SOC medium was added to the reaction, the tubes were caped tightly and shake 
horizontally (200rpm) at 37°C for 1 hour. Pre-warmed selective plates were spread 
with either 25 pi or 200pl of the transformation reaction and incubated overnight at 
37°C. Finally 3-5 colonies were picked and cultured in L-broth with a suitable 
selective antibiotic over night at 37°C. The culture was then centrifuged and the 
supernatant drained. The plasmid DNA was then recovered from the remaining pellet 
by the use of a Qiagen miniprep kit.
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2.2.5 Recovery o f Plasmid DNA from E.ColL
This was done using a Qiagen mini prep kit using the protocol set out by the 
manufacturer.
2.2.6 59 capped RNA synthesis
5pl of linearised DNA, lOpl of 5x transcription buffer, 5 pi of 0.1M DTT, 5pl of 
5mM CAP (NEB), 5pl of ImM GTP (NEB), 5pl of 5mM UTP (NEB), 5pl of 5mM 
ATP (NEB), 5pl of 5mM CTP (NEB), 2pl of RNAse inhibitor (NEB) and 3 pi of 
polymerase (NEB) were mixed together in a 1.5ml Eppendof tube and incubateed at 
37°C for 20mins. 4pl of lOmM GTP was added to the reaction which was incubate at 
37°C for a further 2 hours, lpl of the reaction was then run on a 1% agarose gel 
(Sigma) to check whether the RNA was synthesized. 3 pi of RNAse free DNAse 
(Promega) was added and the reaction incubated at 37°C for a further 20 mins. 1 pi of 
the reaction was then run on a 1% agarose gel. The volume of the reaction was 
increase to lOOpl and the RNA recovered using chroma-100 spin columns (see 
section 2.2.1).
2.2.7 Agarose Gel Electrophoresis.
A 1% agarose gel was prepared by dissolving agarose in TAE and adding 5 pi of 
ethidium bromide per 100ml. The gel was poured into a gel tray and combs placed in 
until set. Once set the combs were removed and the gel placed in the gel tank with 
TAE poured to the fill line on the tank. lOpl of ladder was loaded into the first lane 
with lpl of the sample mixed with 9pl of orangeG load buffer loaded into 
subsequent lanes.
2.2.8 Extracting RNA from injected embryos
30 embryos were prepared as described in section 2.1.9. lOOpl of Trizol was added 
to the frozen samples which were then homogenised (blue pestles from Eppendof). 
20ul of chloroform was added and the tubes shaken vigorously for 15 seconds. The 
tubes were left at room temperature for 2-3minutes then centrifuged at 1200xg for 
15minutes at 4°C. 70pl of the clear supernatant was removed and place in a clean 1.5
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ml Eppendorf tube with 70pl of isopropanol. The samples remained at room 
temperature for 10 minutes and were then spun for lOminutes at 4°C. The 
isopropanol was removed leaving a pellet.The pellet was washed with 120pl of 70% 
ethanol and vortexed briefly. The pellet and ethanol were spun at 7,500xg for 10 
minutes. The ethanol was removed and the pellet dried. The pellet was resuspended 
in 30pl of H2O and 1 pi run on a 1% agarose gel.
2.2.9 Making cDNA
1.5pg of RNA was placed in a clean Eppendorf and the volume made up to 12pl with 
water, lpl of 0.5pM random primers were added to the RNA and the tube spun 
briefly. The samples were then incubated at 70°C for 10 minutes. 4pi of (5x) 1st 
strand buffer, lpl of (lOuM) DNTP’s and 2pi of (0.1M) DTT was added and 
incubated at 42°C for 2minutes. lpl Superscript RT (200U/ul) was added and the 
reaction incubated at 42°C for 1 hour. The reaction was heated to 70°C for 15 
minutes and spun briefly. Finally the reaction was placed on ice for 10 minutes and 
stored at -20
2.2.10 Taqman RT-PCR
Using cDNA made from the protocol in section 2.2.9 a dilution plate was made. A 
control sample was diluted 1/10, 1/100 and 1/1000. All other samples were diluted 
1/ 10.
2pl of the undiluted control was placed in the first well of a 96 well of an Applied 
Biosystems ABI optical plate, 2pl of 1/10 control dilution was placed in the second 
well, 2pl of of the 1/100 control dilution was placed in the third well and 2pl of the 
1/1000 dilution placed in the fourth well. 2pl of all other samples were placed in the 
remaining wells. To each sample (including control dilutions) was added lOpl of 
Applied Biosystems TaqMan Universal PCR Master Mix, lpl of TaqMan primer and 
7pl of water. This was repeated using all the required primers and control primers
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Each plate was then sealed with Applied Biosystems ABI optical adhesive covers 
(4311971). The plates were then placed in the RT-PCR (ABI prism) machine. Using 
the 7000system software the programme was set to absolute quantification for a 96 
well plate and set for a 20pl reaction. The programme was then run and results saved 
for analysis.
2.2.11 Producing GFP-Nodal Fusion constructs
The cleavage sites for both Sqt and Cyc were identified (Figure 2.2.1) (Squint - 5‘ 
CGGCGCCACAGAAGG'3 .Cyclops-5 "CTCAGGAGCCGCAGG"3 ) (Rebagliatia et 
al., 1998) and primers designed to isolate the pro and mature regions (Table 2.4.2)
Squint 
C yclops
Figure 2.2.1: Cleavage site of Nodals in Xenopus laevis and zebrafish.
The yellow blocks identifiy the cleavage regions in zebrafish squint and cyclops.
The pro and mature regions of sqt and cyc were amplified from cDNA by PCR using 
KOD polymerase. A one percent agarose gel was run to check for the correct size 
product. The PCR products were cleaned using a Qiagen MinElute kit.lpl of Taq 
was added to lOpl of PCR product and 5pi of buffer and incubated at 72°C for 10 
minutes. The products were cloned into the Invitrogen GFP cloning vectors 
(pcDNA3.1/CT-GFP TOPO and pcDNA3.1/NT-GFP TOPO) according to the 
Invitrogen protocol with the pro regions in the C-terminal linked GFP vector (pro- 
GFP) and the ligand regions in the N-terminal linked GFP vector (GFP-ligand).The 
clones were sent away for sequencing for conformation of correct insert.
The pro-GFP and GFP mature constructs were digested using the restriction enzymes 
BsrGl and Xmal. The digests were then run on a gel and the large fragment from the 
pro-GFP construct cut from the gel and cleaned using a Qiagen gel extraction kit. 
This process was repeated for the smaller fragment of the GFP-ligand construct. The
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large pro-GFP fragment was treated with SAP (Promega) as described by the 
manufacturer. The large pro-GFP fragments and the small GFP-ligand fragments 
were then ligated together (Figure 2.2.2) using T4 DNA ligase (Promega) as 
described by the manufacturer. The constructs were then transformed as described in 
section 2.2.4 and the DNA recovered using a Qiagen minprep kit.
The DNA was sequenced and the correct fusion constructs amplified using primers 
from Table 2.4.2 which add restriction sites to the amplified products. The amplified 
products and the insertion vector (pCS2+) were digested using EcoRl and BamHl 
and the products run on a gel. These were cleaned and ligated using T4 DNA ligase 
(Promega) as described by the manufacturer. The constructs were then transformed 
as described in section 2.2.4 and the DNA recovered using a Qiagen minprep kit. The 
constructs were sequenced and the correct fusion constructs used to produce capped 
RNA (see section 2.2.6) for injection (see section 2.1.6).
T7 Pro-domain
BsrGI '
Xma1
Vector
i
jFT Lioand-domain
BsrGI Xmal
Liaand-domain [ BG”T7 Pro-domain
Vector
Figure 2.2.2: A diagrammatic representation of the methods used to make a 
GFP-nodal fusion construct
Showing the promoter domains and the restriction enzymes used and where they cut.
2.2.12 p-catenin stain
Embryos were fixed in 4% paraformaldehyde in phosphate-buffered saline (PBS) for 
four hours at 4°C. The embryos were then dechorionated and washed with PBS/ 
0.1% Triton X-100 (PBS-Tr) five times. The embryos were then washed with
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PBS/0.1% Triton X-100/% DMSO (PBS-DT) and blocked with 5% bovine serum in 
PBS-DT for one hour. After one hour the embryos were incubated with anti-p- 
catenin antibodies (1/500 dilution, Sigma C2206) overnight at 4°C. The embryos 
were then washed four times with PBS-Tr and incubated with secondary anti- rabbit 
antibody at 1/500 dilution, from the VECTASTIN ABC kit, for six hours at room 
temperature. The embryos were washed four times with PBS-Tr. Two drops of 
solution A and two drops of solution B (vectastain ABC kit) were added to PBT and 
left for 30min at RT after which time they were added to the embryos and left at RT 
for one hour. At the end of the hour the embryos were washed six times over the 
period of one hour. A diaminobenzidine (DAB, Sigma) tablet was dissolved in 33ml 
of PBT and any particulate spin out. 1ml of this was added to each of the goups of 
sample embryos which were left to incubate for lOminutes in the dark on glass. Ip of 
30% H2O2 is then added to the DAB and embryos these were then left in the dark and 
observed for staining. When it was time to stop the reaction the embryos were wahed 
in PBT.
2.2.13 Producing a dominant negative and constitutively active 
Rab5a2.
Primers were designed enabling a point mutation to be made in the GTP binding 
region of rab5a2 producing resulting in the Rab being either in the GTP-bound 
conformation (constitutively active) or the GDP-bound conformation (dominant 
negative). The constitutively active primer produced an A to T mutation (shown in 
lower case in Materials section 2.4 Table 2.4.2) resulting in the amino acid at 
position 81 changing from Q to L. While the dominant negative primer also 
produced an A-T mutation (shown in lower case in Materials section Table 2.4.2) 
resulting in the amino acid at position 133 changing from N to L.
Using the Stratagene QuikChange Site-Directed Mutagenesis Kit lpl of ds-DNA 
template (50ng) was added to a PCR tube containing 2.5pl of 10X QuickChange 
Multi reaction buffer (Stratagene), 18.3pl of double-distilled H2 O, 1.2pl of lOpM 
mutagenic primers, lpl of dNTP mix (Stratagene) and lpl of QuickChange Multi
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enzyme blend (Stratagene). The reaction was placed in the thermal cycler (MJ 
Research inc) at:
1: 95°C for 1 minute
2: 95°C for lminute
3: 55°C fori minute
4: 65°C for 4minutes 45 seconds
5: Repeat from step 2 29 more times
The reaction was placed on ice for 2 minutes, lul of Dpn I (Stratagene) restriction 
enzyme (10U/ pi) was added to the reaction which was pipetted up and down several 
times to mix the reaction. The reaction was spun for 1 minute then incubated at 37°C 
for lhour.
45 pi of the XL 10-Gold (Stratagene) ultracompetent cells were transferred to a 
prechilled 14ml BD Falcon polypropylene round-bottom tube (BD biosciences 
Catalog 352059). 2pl of the P-ME mix (Stratagene) was added to the cells. The 
contents were swirled and incubated on ice for lOminutes swirling every 2 minutes.
1.5 pi of the Dpn I -treated DNA was added to the ultracompetent cells which were 
then incubated on ice for a further 30 minutes. The cells were then heat pulsed in a 
42°C water bath for 30 seconds and then incubateed on ice for 2 minutes.0.5ml of 
preheated (42°C) NZY+ broth was added to the reaction. The reaction was incubated 
at 37°C for 1 hour shaking at 225-250rpm. The DNA was then recovered using a 
Qiagen miniprep kit and sequenced to check for only the required mutation. All 
controls were performed as described in the Stratagene QuikChange Site-Directed 
Mutagenesis Kit
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2.3 Expression Array
2.3.1 Total RNA extraction from tissue using TrizoL
The embryos were homogenised in 1.5ml Eppendorf tubes in 10 volumes of Trizol 
per embryo with a pestle (Eppendorf). The homogenate was then triturated six times 
with a 1ml filtered pipette tip then six times with a 200pl filtered pipette tip. The 
embryos were incubated for 5 minutes at room temperature. Phase Lock Gel-Heavy 
tubes were prespun at 1500rpm for 30seconds. The cell lysate was added to the Phase 
Lock Gel-Heavy and incubate at room temperature for 4 minutes. 0.2 ml of 
chloroform per 1 ml of TRIzol reagent initially used was added to the tubes. The 
tubes were capped and shaken vigorously for 15 seconds after which they were 
centrifuged at 12,000xg for 10 minutes at 2-8°C. The clear aqueous phase containing 
the RNA was transferred to a fresh 1.5ml Eppendorf tube. The RNA was 
precipitated by adding 0.5 mlof Isopropyl alcohol per 1ml Trizol reagent initially 
used. The samples were mixed by repeated inversion and allowed to incubate at 
room temperature for 10 minutes. The samples were centrifuged for 10 minutes at 
12,000xg at 2-8°C. The supernatant was removed and the RNA pellet washed by 
adding 1ml of 75% ethanol per 1ml Trizol reagent initially used. The samples were 
vortexed and centrifuged at 7,500xg for 5 minutes at 2-8°C. The supernatant was 
removed and the pellet briefly air-dried. The RNA pellet was dissolved in 20pl of 
RNase free water and incubated at 55-60°C for 10 minutes. The RNA was 
quantitated using a Nano drop and 1 pi of each sample run on a 1% gel.
2.3.2 Generation o f Amino Allyl-modified Amplified RNA (aRNA)
This protocol uses the Ambion Amino Allyl MessageAmp™ II aRNA Amplification 
Kit all reagents were from this kit unless otherwise stated.
2pg of RNA was prepared in lOpl of RNase-free water in a 0.5ml tube and placed on 
ice.lpl of T7 Oligo (dT) Primer (Ambion) and lpl of 0.1 X bacterial mRNA cocktail 
were added. The RNA oligo mixture was incubated at 70°C for 10 min and snap- 
chilled on ice. 2plof lOx First Strand Buffer (Ambion), 4pl of dNTP mix (Ambion),
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1 pi of Rnase inhibitor (Ambion) and 1 pi of ArrayScript (Ambion) were added to the 
mixture.The reaction mixture was spun briefly and incubated at 42°C for 2 hours and 
then chilled on ice for 2 minutes. 63 pi of Nuclease-free water, lOplof 10X Second 
Strand Buffer, 4pl of dNTP Mix, 2pl of DNA Polymerase and lpl of Rnase H was 
added on ice to the reaction mixture and mixed gently. The samples were spun 
briefly and incubated at 16°C for 2 hours. 250pl of cDNA Binding Buffer was added 
to the samples and mixed by pipetting up and down 3-4times. The samples were 
transferred to a Filter Cartridge (Ambion kit) and centrifuge for 1 minute at 
10,000xg. The flow-through was discarded. 500pl of wash buffer (Ambion kit) was 
added to the cDNA filter cartridge and centrifuged for 1 minutes at 10,000xg. The 
flow through was discarded. The cDNA Filter Cartridge was spun for an additional 
minute to remove trace amounts of buffer. 9pl of nuclease-free water (pre-heated to 
55C) was added to the centre of the filter in the cDNA Filter Cartridge, left at room 
temperature for 2 minutes and then centrifuged for 1 minute at 10,000xg. A second 
9pl of preheated nuclease-free water was added to the cartridge and spun as 
previously.
3pi of aaUTP (50mM), 12pl of ATP, CTP, GTP mix (25mM), 3pl of UTP Solution 
(50mM), 4pl of T7 10X Reaction Buffer and 4pl of T7 Enzyme Mix were added to 
the double-stranded cDNA at room temperature and mixed gently. The reaction 
mixture was spun briefly and incubated for 16 hours at 37°C. 60pl of room 
temperature nuclease-free water was added to the in vitro transcription reaction. 
350pl of aRNA Binding Buffer and 250pl of 100% ethanol was added to each aRNA 
sample and mixed by pipetting the mixture up and down 3-4 times. The sample was 
pipetteed onto the centre of the filter in an aRNA filter Cartridge and centrifuged for 
1 minute at 10,000xg. The flow through was discarded. 650pl of wash Buffer was 
added to each aRNA Filter Cartridge and centrifuged for 1 minute at 10,000xg. The 
flow-through was disgarded and the aRNA Filter Cartridge spun for an additional 1 
minute to remove trace amounts of wash buffer. lOOpl of nuclease-free water 
preheated to 60°C was added to the centre of the filter. The filter cartridge was left at 
room temperature for 2 minutes and then centrifuged for 1 minute at 10,000xg. The 
aRNA in the elute was then quantitated.
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2.3.3 Dye Coupling Amino Allyl-modified aRNA 
Dye Coupling Reaction
The aRNA was spun for 5 minutes at 13000rpm. For each labelling reaction (2 per 
sample cy3 and cy5) 15pg of aRNA was removed and placed in a fresh tube. To this 
l/lO111 volume of 3M NaAc pH5.2 and 2.5 volumes of 100% ethanol was added and 
the mixture incubateed at -20°C for 30 minutes to precipitate. The precipitated aRNA 
was spun at 13000rpm for 5minutes. The pellet was washed with 500pl of 80% 
ethanol and spun at 13000rpm for 2-5minutes. The ethanol was removed and the 
pellet was resuspended thoroughly in 9pl of coupling buffer (Amino Allyl 
MessageAmp II aRNA Amplification Kit, Ambion). Light levels were reduced and 
activated CyDyes (CyDye Post-Labelling Reactive Dye Packs, Amersham) packs 
were left to equilibriate to room temperature. 11 pi of DMSO (Amino Allyl 
MessageAmp II aRNA Amplification Kit, Ambion) was added per vial of dye pack. 
The resuspended CyDye was added to the aRNA in coupling buffer, mixed and 
incubate at room temperature in the dark for 45 minutes. 4.5ul of 4M hydroxylamine 
was added to the reaction mixture and incubated at room temperature for 15 minutes.
Purification of dye couples aRNA.
To each labelling reaction was added 75pl of RNase-ffee water and 350pl of buffer 
RLT from RNeasy mini kit (Qiagen). This was mixed thoroughly. 250pl of 100% 
ethanol was added and mixed thoroughly by pipetting. The sample was transfered to 
a RNeasy Mini column and spun for 1 minutes at 8000rpm. The column was 
removed to a fresh collection tube and 500pl of buffer RPE was added. The column 
was spun for 1 minute at 8000rpm.This was repeated twice. The column was placed 
in an elution tube and 50pl of water added. The column was incubated at room 
temperature for 2 minutes then spun at 8000rpm for 1 minute. Another 50pl of water 
was added to the column and incubated at room temperature for 2 minutes. The 
column was spun at 8000rpm for 1 minutes and the column discarded. The dye 
coupled aRNA was then quantified.
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2.3.4 Competitive Hybridisation o f labelled aRNA to Microarrays.
The labelled aRNA is spun for 5 minutes at 13000rpm. 2 fig of labelled aRNA is 
removed and combined with those aRNAs to be compared on the array. 8 pi of Cot-1 
DNA (lug/ul, Invitrogen), 4pl of polyA DNA (2ug/ul, Sigma), 25pi of salmon sperm 
DNA (lOmg/ml, Ambion), 1/10* volume 3M NaAc pH5.2, 2.5 volumes of 100% 
ethanol were added to the combined aRNAs. The sample was incubated at 20°C for 
30minutes and spun for 5 minutes at 13000rpm. The pellet was washed with 500pl 
80% ethanol. The ethanol was removed and the pelley was dried for a few minutes at 
70°C to remove any remaining ethanol. lOpl of water was then added and the sample 
incubated at 70°C for 5 minutes to dissolve the pellet. 50pl of RNA hybridisation 
buffer was added and mixed. The sample was the incubated at 70°C for 5 minutes 
and at room temperature for 10 minutes. The sample was then spun briefly, mixed 
and spun for 5 minutes at 13000rpm. 55pl of the hybridisation sample mixture was 
applied to a coverslip (25 x 60mm) placed on a flat surface. A microarray slide was 
gently lower onto the coverslip and placed DNA side up in the humid chamber to 
incubate at 47°C for 12-24 hours.
Array washes
The microarray was removed from the humid chamber and quickly placed in a slide 
rack submerged in 200ml of room temperature wash solution 1 (See Materials 
section 2.4). The slide was washed at room temperature for 5 minutes with gentle 
shaking. The slide rack was transfered to wash solution 2 and wash at room 
temperature for 15 minutes with vigorous shaking. This step was repeated with clean 
solution 2. The slide rack was then transfered to wash solution 3 and wash at room 
temperature for 5 minutes with vigorous shaking. This step was repeated with clean 
solution 3. After a final rinse in fresh wash solution 3, the slide rack is quickly 
transfered to a centrifuge and spun at lOOOrpm for 1-2 minutes to dry the slides. The 
slides were then scanned using a laser-based scanner by PerkinElmer (ScanArray 
ExpressHT). The slides were analysed using image analysis software by PerkinElmer 
(version 3) which aligns the oligo spots and analyses the intensity of each of the dyes 
for each oligo spot on the array. The intensity data for each slide was then transferred 
into Agilent’s Genespring software for analysis the difference in intensities between 
both dyes. This data was then grouped with the other replicates including the dye
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swapped slides and analysed for differences between experimental and controls 
samples. The data was normalized using LOWESS (see Methods section 2.6) and 
finally the threshold for the fold change of gene expression between the experimental 
and control genes was set. For example only those genes that showed a 1.5 fold 
change in expression between the control samples and the experimental samples are 
listed to have changed. From the normalized data set those genes that show a 
significant change (p<=0.05) in a t-test were also listed to have changed. Therefore 
the genes that were finally selected to have changed were those that showed both a 
three fold change in expression and that were statistically significant. This ensures 
the minimum of false positive.
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2.4 Materials
Phenol/chlorophorm/isoamylalcohol solution:
phenol:chloroform:isoamylalcohol = 25:24:1
Hybridisation Mix (HM):
50% formamide 
5xSSC
0.1% Tween 20
pH adjusted to 6 with citric acid
50 pg/ml heparin
500 pg/ml Torula RNA
Staining buffer (NTMT):
lOOmMtris HC1 pH 9.5 
50 mM MgCl2 
lOOmMNaCl 
0.1% Tween 20
Staining solution:
NBTlOOmg/ml-112.5 pi 
BCIP 50 mg/ml -175 pi 
Staining buffer - 50 ml
For 500 ml:
250 ml formamide
125 ml 20xSSC
500 pi Tween 20
4.6 ml citric acid 1M, pH6
500 pi heparin 50 mg/ml 4xSSC
0.25 g Torula RNA
For 50 ml
5 ml 1M tris HC1 pH 9.5
2.5 ml 1M MgCl2 
1 ml NaCl 5M 
50 pi Tween 20
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PCR buffer (5x):
2.5ml 2M KCL 
lml 1M Tris pH8.4 
0.25ml 1M MgCl2 
200pl dATP 100|iM 
200|il dTTP 100(iM 
200|il dCTP lOOpM 
200pldGTP lOOpM 
1.7ml BSA 10|ig/ml
Phenol Red MO buffer:
1:4 25mg/ml phenol red : 5mM HEPES (pH7.2), 200mM KC1 
Danieau Solution:
30x
5M NaCl 1740mM
KC1 21mM
1M MgS04 12mM
Ca(N03)2 18mM
HEPES pH7.6 150mM
Expression Array:
Wash solution 1: 2X SSC filter sterilised
Wash solution 2: 0.1X SSC, 0.1% SDS, filter sterilised
Wash solution 3: 0.1X SSC, filter sterilised
RNA hybridisation Buffer:
50% formamide 
5X SSC 
0.1% SDS 
0.1 mg/ml BSA
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Agarose gel for embryo manipulation
2% Agarose gel with lx daneaus.
NZy+ Broth
lOg of NZ amine (casein hydrolsate)
5g of yeast extract 
5g of NaCl
Deionized H20 to a final volume of 1 liter 
pH7.5
Autoclave then to 50mls of above was added:
625pi 1M MgC12 
625pl 1M MgSo4
lml of 20% glucose (or 500pl of 2M glucose)
Gene
name
MO
Name Type Sequence Clone
Rab3c1 zRab3c1 Splice T G AC AT C AACTTACCAGTCCTGTAC
Rab3c1 zRab3c1 ATG TTGTCTTGCGTAGCAGCCATCTTCC IMAGp99801811847
Rab5a1 zrab5a1 ATG G AC AGTT GT C AAT C ACCCCGTCTT C I MAGp998J226597
Rab5a2 zrab5a2 ATG TCGTTGCTCCACCTCTTCCTGCCAT IRAKp961M19104
Rab5b zrab5b ATG CCTGCCTGTCCCACGGGTACTCATG CHBOp575A2123
Rab5c zrab5c ATG CGCTGGTCCACCTCGCCCCGCCATG IRAKp961l04102
Rab1a3 MC14 UTR GATTCATCGTGGACTGGACACTG IRAKp961 G04102
Rab11a1 MC3 UTR TACGAACTCCGTGI I I ICAAATGTA IMAGp998H109110
Rab20 MC5 UTR AG ACT C AACT CT CACAGGT AAACTC I MAG p998N 1514300
Rab3c1 MC7 UTR CGTATAACTCCATTTGCTTTAGACA I MAG p99801811847
Rab11b1 MC9 UTR AIM IAGACAAGCCGCCCCGTCCTG IMAGp998P2011849
Rab1a2 MC11 UTR GTTCAGCAGGAGATCGGACTCTTTT I RAKp961C23103
Rab11b2 MC13 UTR ACCGC ACT G AAAT GTT GTTATTT AG IRAKp961G01102
Rab6a MC15 UTR CAGACATGCTGCCGGTTCCACT IRAKp961H19102
Rab28 MC17 UTR GCTTCAGCTCGGCAGCGCGACAC IRAKp961N08101
Rab11a2 MC19 UTR ATCTCGATCAAAACAAAAGCGCAAA LLKMp964G0315
Rab18(2) MC21 UTR ACCGGAAAATGCCT CTAT G AGCAAA MPMGp637E1023
Rab1a4 MC23 UTR CATGACGGACAGCACGCGAAAATCC Singapore 58G07
Rab1a1 MC25 UTR AAAGGGCTTGTTATTGTTTGTCCAG
Rab5a2 zRab5a2 Splice AT G AAGCGTTT GT CTTACCT CCTAT
Table 2.4.1 Experimental MOs showing sequence, type of MO, target gene and 
corresponding gene clone.
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Primer Nam e S eq u en ce
Rab5a2 forward 
Rab5a2 reverse
Constitutively active Rab5a2 forward 
Constitutively active Rab5a2 reverse 
Dominant negative Rab5a2 forward 
Dominant negative Rab5a2 reverse 
Forward Squint pro primer 
Reverse Squint pro Primer 
Forward Squint ligand primer 
Reverse Squint ligand primer 
Forward Cyclops pro primer 
Reverse Cyclops pro primer 
Forward Cyclops ligand primer 
Reverse Cyclops ligand primer 
pCs2 Cyc F 
pCs2 Cyc R 
pCs2 Sqt F 
pCs2 Sqt R
CGGGAT CCCGGT CAT GGCAGGAAGAGG
GGAATTCCGAGGAGCGTGGTTTAGGT
GGATACAGCTGGCCtGGAGCGCTACCACAG
CT GT GGT AGCGCTCCaGGCCAGCT GT AT CC
AGCTTT GGCT GGGAtCAAGGC AGACCTT GC
GCAAGGT CT GCCTT GaTCCCAGCCAAAGCT
ATGTTTTCCTGCGGGCTCCTGA
T CCTT CT GT GGCGCCGA
AACCACAGAACTGATGATAG
T CAGT GGCAGCCGCATTCT
AT GCACGCGCTCGGAGT
CCCTGCGGCTCCTGA
GGCCGCCGGGGGCCA
T CACAGGCAT CCGCACT
GGAATTCCATGCACGCGCTCGGAGT
AAGGCCTTTCACAGGCATCCGCACT
GGAATT CC AT GTTTT CCT GCGGGCTCCT G A
AAGGCCTTT CAGT GGCAGCCGCATT CT
Table 2.4.2: Experimental primers showing sequence, direction and target gene.
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2.5 Equipment
2.5.1 Photography
Photographs were acquired using either a Zeiss Axioplan 2 compound microscope 
with the Axioplan camera and Axiovision 4 software or on a Leica dissecting scope 
with the Zeiss Axioplan camera and Axiovision 4 software.
2.5.2 Microscopy
General microscope work was done on a Leica (M295) dissecting microscope. For 
live embryos the microscopes own light was used. For in situ's an external light 
source was used.
2.5.3 Confocal Microscopy
Embryos were placed in a depression slide in lx danieau solution and covered with a 
22mm x 40mm coverslip. The embryos were then viewed under a Biorad confocal 
microscope.
2.5.4 Optokinetic response apparatus
The optokinetic response apparatus consists of a spinning cylinder of alternating 
black and white colour. Inside this cylinder is a stable immobile platform on which 
the petri dish containing fish imobalised in methyl cellulose (Sigma) were placed 
(Figure 2.5.1 inset). The spinning cylinder is controlled by a dial which dictates the 
direction of cylinder movement and the speed (Figure 2.5.1). The apparatus was 
made by Loyd Stemple from technical Lego.
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Figure 2.5.1: The optokinetic response apparatus for assaying embryos for 
blindness. Apparatus is seen placed under a under a Leica (M295) dissecting 
microscope. Inset picture shows white platform on which embryos in dish are 
placed and alternating white and black pattern of the spinning disk.
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2.6 Statistical Analysis
The microarray data was analysed using Genespring (Agilent Technologies) which 
uses a standard t-test for analysis. The data is normalized to try and correct for 
systematic bias and remove non-biological influences. Genespring uses locally 
weighted scatterplot smoothing (LOWES S) for for global normaliztion. This adjusts 
for overall dye bias
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Chapter 3
Screening the Zebrafish Rabs
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3.1 Introduction
This study is a continuation of work by Dr. Isabel Campos, a former PhD student in 
the Stemple laboratory (Campos, 2004). With the sequencing of the zebrafish 
genome, more Rabs have been uncovered and there are now estimated to be over 80 
rab genes (Clark, MD, pers. com.). cDNA clones for many of these genes have either 
been cloned by PCR and/or 5’ and 3’ RACE, or were obtained from outside sources 
(RZPD) and confirmed by sequencing. Design of the morpholinos (MO) for the first 
pass of this screen was primarily undertaken by Dr. Matthew Clark, with any 
additional MOs, for more in depth studies, designed by the author.
3.1.1 Loss o f Function Screen
The MO for the initial pass of the loss of function screen are designed against 25 
bases of the UTR region immediately 5’ of the ATG start codon. There are three 
reasonsfor this: The first is that the UTR is considered to be more unique to the gene, 
a MO designed against this area is unlikely to bind any other gene, but to be sure 
each MO was checked by both Dr Clark and the author. Secondly, a MO in this area 
allows more efficient rescue by the injection of RNA encoding solely the open 
reading frame, as this does not contain sequence complementary to the MO. Lastly in 
our hands UTR MOs are usually more subtle than ATG MOs. An ATG MO, that 
would normally be lethal at a low dose, could show a distinct phenotype at higher 
does if a UTR MO were used.
In the initial pass of the Rab MO screen the embryos were injected with three 
different doses of MO: 8ng, 4ng or 2ng producing a dose response curve. The 
embryos were checked for a phenotype at gastrulation, 24 hours post fertilisation 
(hpf), and then each day until 5 days post fertilization (dpf). If all the embryos died 
then a lower dose was used, until the embryos no longer showed a phenotype. If the 
embryos show an abnormal phenotype, they were re-injected to check for 
reproducibility and photographed at shield stage if there was a gastrulation 
phenotype, 24hpf, 48hpf and, in some cases, later, up to 5 dpf. All rab MO injected
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embryos were compared against embryos injected with a standard control MO 
supplied by Genetools at a dose 2ng higher than that of the highest does of rab MO.
This chapter concentrates on the Rabs screened solely by the author and shows the 
diverse range of phenotypes observed when rab expression is disrupted. These 
include heart phenotypes, pigmentation phenotypes, hatching phenotypes and some 
less specific phenotypes, such as greying of the brain indicative of cell death or tail 
abnormalities. Although, the Rabs do not typically exhibit a single phenotype but, 
rather, a host of malformations, this chapter has grouped the Rabs based on the 
common phenotypic features.
3.2 Pigmentation defects following knockdown of 
zebrafish rabs
This section focuses on those Rabs which following MO knockdown resulted in 
pigmentation defects. Stripe formation and colour patterning in zebrafish is an 
interesting system in which to study how spatial patterns form. It is also an 
interesting and visual way of examining at neural crest function. Most pigmented 
cells of vertebrates are derived from the neural crest, a transient population of cells 
that arises during neurulation along the dorsal neural tube and then migrates 
throughout the embryo (Kelsh et al., 1996). The neural crest also specifies many 
other cell types including neurons and glia of the peripheral and enteric nervous 
systems and cartilage of the head and neck (Eisen and Weston, 1993; Raible et al., 
1992).
There are three types of pigment cells in zebrafish: the black melanin-containing 
melanophores; the yellow or orange pteridines and carotenoids containing 
xanthophores and the silvery guanine-rich reflecting platelets -  iridophores (Parichy, 
2003). Melanophores in zebrafish start to appear at 24hpf, increasing in number until 
around 60hpf (Yang et al., 2004), at which point, the embryo has approximately 400 
melanophores. This number remains constant until approximately two weeks post 
fertilization, at which time the juvenile fish starts to develop its adult pigment (Milos 
et al., 1983; Parichy et al., 1999). A melanophore cell contains hundreds of melanin-
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filled pigment vesicles, known as melanosomes. These melanosomes can be 
aggregated in the centre of the cell or dispersed through the cytoplasm. This pigment 
movement takes place in response to extracellular cues such as neurotransmitters 
(Levina and Gordon, 1983). The melanosome dispersion is induced by elevation of 
intracellular cAMP levels, while aggregation is triggered by depression of cAMP 
(Horowitz et al., 1980). Melanosomes are known to be associated with the 
microtubule based motors, dynein and kinesin (Lambert et al., 1999). Movement of 
the melanosome towards the centre of the cell is believed to involve the activation of 
the associated dynein motors (Skold et al., 2002). Movement towards the cell 
periphery is believed to involve the associated kinesin motors. Kinesin-2 is thought 
to mediate the long-range transport of melanosomes on microtubules, while myosin 
V, on actin filaments, is considered to be required for uniform distribution (Levi et 
al., 2006; Rogers and Gelfand, 1998; Wu et al., 1997). Interestingly two mammalian 
disorders casued by mutations in rab27a and rab38 result in pigmentation defects 
(section 1.2.6.4 and 1.2.6.5).
3.2.1 Rab3cl
3.2.1.1 Initial Screening
Embryos injected with the rab3cl MO initially appeared normal and underwent 
successful gastrulation. By 24h hpf, about 80% of the 2ng rab3cl embryos had 
survived as the dose of rab3cl morpholino increased the number of embryos that 
survived decreased (2ng n = 31/38, 4ng n = 25/38, 8ng n = 22/43). While the 2ng 
embryos looked phenotypically normal many of the embryos that had been injected 
with either 8ng or 4ng of the rab3cl MO had small heads and brains (4ng n = 10/25, 
8ng n = 22/22) (Figure 3.2.1 C), compared to control MO injected embryos 
(controls) (n = 40) (Figure 3.2.1 A). The MO injected embryos had poorly defined 
brain structures with the fore-, mid-, and hindbrain being disrupted (Figure 3.2.1 D). 
Some of these embryos also displayed heart oedema sometimes with no discemable 
heart tube (not shown).
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At 48hpf, many of the embryos appeared normal, with the remainder possessing 
smaller brains, which appeared to be tinged yellow (2ng n= 2/31, 4ng n = 10/25, 8ng 
n = 22/22). In addition, some showed curved tails and malformed, oedematous hearts 
and had no circulation (2ng n= 2/31, 4ng n = 10/25, 8ng n = 12/22).
Rab3c
Figure 3.2.1: Lateral view of 24hpf embryos: control MO injected embryo (A) 
compared to 8ng rab3cl MO injected embryo (C). Dorsal anterior view of 24hpf 
embryos: control MO injected embryo (B) compared to 8ng rabScl MO injected 
embryo (D).
By day five, the surviving embryos, were either normal or showed either defects in 
the distribution of melanophores, with thicker blotches of pigment being laid down 
on the head (2ng n = 7/31, 4ng n = 5/25, 8ng n = 10/22) (Figure 3.2.2 B and A) or a
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shorter body, a smaller brain and pericardial oedema (2ng n = 2/31, 4ng n = 10/25, 
8ng n = 12/22) (Figure 3.2.2 D and C). A closer look at the milder pigmentation 
phenotype revealed several aspects: Firstly, it showed a tight packing of 
melanophores on the head of the MO injected embryos (Figure 3.2.3 D and A). 
Secondly, the eyes of the MO injected embryos were smaller and the lens appears to 
be protruding (Figure 3.2.3 E and B). Finally, the swim bladder was either absent or 
not inflated (Figure 3.2.3 F and C). This interesting pigmentation phenotype is a 
characteristic of fish that have adapted themselves to darker surroundings (Logan et 
al., 2006). These observations led to the hypothes that the embryos were blind with 
constantly dark adapted pigment pattern, consistent with the defects observed in eye 
morphology.
Figure 3.2.3: The dorsal view of pigment patterns in the head of five dpf control 
injected embryos (A) compared to five dpf rabScl MO injected embryos (D). 
The dorsal view of eye morphology in 5 dpf control MO injected embryos (B) 
compared to rab3cl injected MO embryos (E). Side view of swim bladder in five 
dpf control MO injected embryos (C) compared to five dpf rab3cl MO injected 
embryos (F).
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Figure 3.2.2: Dorsal view of 5dpf embryos: control MO injected embryo (A) compared to mild phenotype in rab3cl 
MO injected embryo (B) Lateral view of 5dpf embryos: control MO injected embryo (C) compared to severe 
phenotype in rab3cl MO injected embryo (D)
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3.2.1.2 Assaying for blindness
To establish whether the embryos were blind, an optokinetic response apparatus was 
constructed (see Figure 2.5.1 Materials and Methods section 2.5.4). Each embryo 
was assayed individually so that movements from one embryo did not affect any 
other embryo. Both the control and the MO injected embryos were assayed for their 
ability to follow the clockwise and anti-clockwise motion of an alternating back and 
white spinning cylinder (see inset Figure 2.5.1 section 2.5.4). The control embryos 
followed the movement of the cylinder in both the anti-clockwise and clockwise 
directions (Figure 3.2.4 A and B see supplemental disk Mov 3.2.1 A and Mov 
3.2.IB). Conversely, the rab3cl MO injected embryos showed no response to the 
spinning cylinder, in either direction (Figure 3.2.4 C and D see supplemental disk 
Mov 3.2.1C and Mov 3.2.ID). The embryos were lightly touch-stimulated using a 
pair of forceps, resulting in eye movement in both control injected and rab3cl MO 
injected embryos.
Figure 3.2.4: Still images taken from a short movie (see supplemental disk Mov 
3.2.1). The stills at the top of the figure show the dorsal view of a five dpf control 
embryo following the spinning cylinder first in a clockwise direction (A), 
compared to no cylinder movement (A’), and then in an anticlockwise direction 
(B) compared to no cylinder movement (B’). The stills at the bottom of the 
figure show a five dpf rab3cl MO injected embryo not responding to cylinder 
movement in any of the directions (C, C’ D and D’).
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3.2.1.3 Penetrance of phenotype
None of the three doses of the rab3cl MO produced a fully penetrant mild or severe 
phenotype. Therefore, the dose was increased until it became fully penetrant, or all 
the embryos died. The pigment phenotype increased in penetrance in a dose 
dependent manner (Figure 3.2.5) until 16ng. At 16ng, it was still not fully penetrant 
but at 19ng, all embryos displayed a phenotype far more severe. These embryos had 
very small brains and eyes, a short body axis and curved tail. These individuals were 
not assayed for blindness, since the eyes were so small that they appeared virtually 
absent.
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Figure 3.2.5: Graph showing the penetrance of rab3cl (black triangles) in a dose 
dependent manner (points with no error bars n=1 clutch, points with error bars 
n=2 or more clutches) compared to control embryos (red circles). The number 
of rab3cl injected embryos showing a phenotype at 2ng: n=7/23, 2/11 4ng: 5/19, 
8ng: 10/39, lOng: 4/19, 10/25, 14ng: 18/41 and 16ng: 35/48, 12/19, 35/39, 33/87. 
The number of control injected embryos showing a phenotype 2ng: 0/29, 0/15 
4ng: 0/20 8ng: 0/44 lOng: 0/32, 0/30 14ng: 0/45 and 16ng: 0/45, 0/23, 0/41, 0/44.
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3.2.1.4 Confirmation of rab3c1 MO injected phenotype using alternative 
MOs.
To ascertain whether the phenotype observed due to the rab3cl MO, was a verifiable 
effect, two additional MOs were designed. The first was designed against the start 
codon of the open reading frame of the rab3cl gene and the second is a splice MO, 
designed to bind part of an intron and an exon. Either 16ng or 18ng of the splice MO 
was injected, as a comparison with the UTR MO. The 3 standard doses (2ng, 4ng, 
8ng) of the ATG MO were injected for the screen.
At 24hpf, the 4ng ATG MO injected embryos showed smaller brains and eyes and a 
curved tail (Figure 3.2.6 D) (n = 35/35, 7 died), compared with controls (Figure 3.2.6
A). The 8ng ATG MO injected embryos showed a more severe phenotype, with very 
little brain, massively reduced eyes and reduced tail structures (n = 22/22, 17 died). 
The 16ng splice MO injected embryos showed a smaller brain and a mildly curved 
tail (n = 34/34, 5 died) (Figure 3.2.6 E), compared to controls (Figure 3.2.6 A). The 
18ng splice MO injected embryos showed very small brain and head structures and 
significantly reduced tail structures (n = 30/30, 12 died). On closer inspection, both 
the splice MO injected (Figure 3.2.6 F) and the 4ng ATG MO injected (Figure 3.2.6 
D) had less well defined brain structures, compared to controls (Figure 3.2.6 B).
By 5dpf, the 16ng rab3cl splice MO injected embryos had smaller eyes and the 
concentrated melanophores, seen in the UTR MO injected embryos. They also 
showed a severely curved body axis (n = 17/34) (Figure 2.3.7 B) when compared to 
controls (Figure 2.3.7 A). When assayed, some of the rab3cl splice MO injected 
embryos did not respond to the spinning cylinder of the optokinetic response 
apparatus (n = 7/34). As with the UTR MO injected embryos, this phenotype is not 
fully penetrant and many of the injected embryos appear normal (n = 17/34) and 
respond to the optokinetic response assay. By 5dpf, the 18ng splice MO injected 
embryos have all died. The 2ng rab3cl ATG MO injected embryos appear normal 
but have a mildly curved body axis (n = 25/40) (Figure 2.3.7 D). When assayed, 
most of the 2ng rab3cl ATG MO injected embryos responded to the spinning 
cyclinder of the optokinetic response apparatus (n = 36/40). At 4ng, they present a 
more severe phenotype, with the head becoming smaller (n = 35/35) but, as with the
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2ng ATG MO injected embryos, these embryos were assayed and not considered 
blind as they responded to the spinning cyclinder of the optokinetic response 
apparatus (n = 34/35). The embryos injected with 8ng of ATG MO had striking 
defects: the body axis was greatly reduced; tail structures were reduced; and there 
was pericardial oedema. In the head, not only was the brain reduced but the eyes 
were drastically reduced in size or absent (n = 18/18) (Figure 3.2.7 F and G).
Control
Splice MO
Figure 3.2.6: Lateral view of 24hpf embryos comparing control MO injected 
embryos (A) with 4ng injected rab3cl ATG MO injected embryos (C) and 16ng 
injected rab3cl splice MO injected embryos (E). A close up view comparing the 
brain structures of control MO injected embryos (B) with 4ng injected rab3cl 
MO injected embryos (D) and 16ng injected rab3cl splice MO injected embryos
(F).
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Figure 3.2.7: Dorsal view of five dpf control injected embryos (A) compared to 
five dpf 16ng splice MO injected embryos (B) and five dpf 2ng ATG MO 
injected embryos (D) compared to control (C). Lateral view of five dpf control 
injected embryos (E) compared to 8ng ATG MO injected embryos (F and G).
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3.2.2 Rabla3
The rabla3 embryos all gastrulated normally and were similar to the controls. By 
24hpf, the 2ng and 4ng MO injected embryos appeared normal (2ng n = 42/42, 4ng n 
= 40/43). However a small proportion of the 4ng MO injected embryos had slightly 
reduced head size, compared to control MO injected embryos (n = 3/43). At 8ng, c. 
60% of the MO injected embryos had died (n = 28/49), with 25% of the embryos 
exhibiting a normal phenotype. The last 15% of embryos showed a slightly reduced 
head size (n = 7/49).
At 48hpf, the 2ng injected embryos still appeared normal, as did the majority of the 
4ng injected embryos. The remaining 4ng rabla3 MO injected embryos and 15% of 
the 8ng injected embryos still displayed slightly reduced brain size and reduced 
melanophore density (4ng n = 3/43 , 8ng n = 7/49) (Figure 3.2.8 D) when compared 
to controls (Figure 3.2.8 A). Upon closer inspection, the head (Figure 3.2.8 E) and 
yolk sac (Figure 3.2.8 F) had a reduced density of melanophores, in the 4ng and 8ng 
MO injected embryos, when compared with controls (Figure 3.2.8 B and C).
Since this phenotype was not fully penetrant the dose was increased to lOng. Many 
of the embryos died prior to 24hpf, as would be expected (n = 28/46). Surviving 
embryos, however, all exhibited a common phenotype (n = 18/18). By 48hpf, the 
lOng injected rabla3 MO injected embryos displayed a slightly reduced head size 
and a curved body axis, as well a reduced density of melanophores (Figure 3.2.9 B), 
compared to controls (Figure 3.2.9 A). Since the curved body axis was a new 
phenotype, compared with the last pass of injections, further study was warranted. 
The MO injected embryos possessed U-shaped somites and, interestingly, a 
shortened body axis, kinks in the notochord (Figure 3.2.9 D and C) and intermittent 
failure of vacuolation in some of the notochord cells (Figure 3.2.9 F and E).
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Figure 3.2.8: Lateral view of a 48hpf control MO injected embryo (A) compared 
to an embryo injected with 8ng rabla3 MO (D). Dorsal magnified view of head 
pigmentation of a control injected embryo (B) compared to an embryo injected 
with 8ng rabla3 MO (E). Ventral magnified view of the yolk pigmentation of a 
control MO injected embryo (C) compared to an embryo injected with 8ng 
rabla3 MO (F).
105
Screening the Zebrafish Rabs
Figure 3.2.9: Lateral view of 48hpf control MO injected embryo (A) compared 
to lOng rabla3 MO injected embryo (B).
lOx magnification of the lateral view of the mid section of control MO injected 
embryo (C) compared to lOng rabla3 MO injected embryo (D).
lOx magnification of the lateral view of the mid section of a control MO injected 
embryo (E) compared to lOng rabla3 MO injected embryo (F) under reflected 
light enabling a clearer view of embryo somites and notochord.
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3.3 Slowed Development
This section focuses on those Rabs which following MO knockdown resulted in 
developmental delay. In all cases this delay was seen as early as shield stage with 
many MO injected embryos reaching shield stage hours after their control MO 
injected siblings.
3.3.1 Rah l l a l
Injection of 2ng, 4ng or 8ng’s of rablla l MO showed an early phenotype. When the 
control injected embryos had reached shield stage (n = 45) (Figure 3.3.1 A), the 
rab lla l MO injected embryos were still beginning epiboly (2ng n = 46/48, 4ng n = 
38/38, 8ng n = 48/50) (Figure 3.3.1 B) and took two hours more than control injected 
embryos to reach shield stage (Figure 3.3.1 C). At shield stage an accumulation of 
cells became apparent at the animal pole (2ng n = 43/45, 4ng n = 38/38, 8ng n = 
46/50) (Figure 3.3.1 C and A).
By 24hpf, the majority of embryos died, leaving approximately 10% of the 2ng 
rab lla l MO injected embryos (n = 5/48) and approximately 8% of the 4ng MO 
injected embryos (n = 3/38). All of the embryos injected with the highest dose of 
rablla l MO died. The surviving rab lla l MO injected embryos (2ng and 4ng) had 
all either arrested at late gastrulation or had shortened tails with U-shaped somites 
and small heads (2ng = 5/5, 4ng = 3/3) (Figure 3.3.1 E and D).
When the embryos reached 48hpf, the embryos injected with rab lla l MO exhibited 
reduced distance between the eyes and smaller brains (Figure 3.3.1 G and F) and 
possessed a bent tail, a malformed heart and no evident circulation (Figure 3.3.1 G) 
(2ng n = 5/5, 4ng n = 3/3)
By 5dpf, the embryos injected with 4ng rab lla l MO had died while many of the 
remaining 2ng injected embryos had failed to hatch, (n = 5). Survivors showed some 
circulation, however, it was absent from the intersomitic region and blood cells 
appeared to adhere to the yolk.
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Figure 3.3.1: Shield stage embryos injected with control MO (A) compared to 
the same time point in embryos injected with rabllal MO (B) and shield stage 
in embryos injected with rabllal MO, arrow indicates accumulation of cells 
(C). 24hpf embryos injected with control MO (D) compared to 24hpf embryos 
injected with rabllal MO (E). 48hpf embryos injected with control MO 
compared to (F) to 48hpf embryos injected with rabllal MO (G).
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3.3.2 Rabla4
At shield stage, the embryos injected with 2ng of rabla4 MO (n = 45), along with 
the majority of the 4ng rabla4 MO injected embryos (n = 40/46), were comparable 
to control MO injected embryos (n = 47). A small proportion of the 4ng rabla4 MO 
injected embryos (6/46) and all the 8ng rabla4 MO injected embryos (n = 41) 
exhibited delayed gastrulation, this resulted in the rabla4 MO injected embryos only 
reaching approximately 20% epiboly (Figure 3.3.2 B) by the time the control 
embryos reached shield stage (Figure 3.3.2 A). When the 8ng rabla4 MO injected 
embryos did reach shield stage, approximately two hours later than controls, they 
possessed an enlarged shield (n = 40/41) (Figure 3.3.2 C and A).
o
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Figure 3.3.2: Shield stage control MO injected embryo (A) compared to the 
same time point embryo injected with 8ng of rabla4 MO (B) and shield stage 
embryo injected with 8ng of rabla4 MO (C). Lateral view of 24hpf control MO 
injected embryo (D) compared to 24hpf embryo injected with 8ng of rabla4 MO 
(E). Lateral view of 48hpf control MO injected embryo (F) compared to 48hpf 
embryo injected with 8ng of rabla4 MO (G).
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By 24hpf, the majority of the 2ng and 4ng rabla4 MO injected embryos appeared 
normal (2ng n = 45, 4ng n = 40/45) although a small proportion displayed smaller 
brains and kinked tails (2ng n = 0, 4ng n = 6/45). When the 8ng rabla4 MO injected 
embryos reached 24hpf, about. 35% of the embryos were dead (n = 14/41). Those 
that survived had reduced head structures and a curved tail (n = 27/27) (Figure 3.3.2 
E and D).
At 48hpf many of the 2ng and 4ng rabla4 MO injected embryos appeared normal; 
however, a small proportion still possessed small brains and shortened curved tails 
(2ng n = 0, 4ng n = 6/45). In addition the 4ng rabla4 MO injected embryos also 
showed some pericardial oedema (n = 6/45) and did not hatch (n = 22/45). The 8ng 
rabla4 MO injected embryos did not hatch and displayed pericardial oedema, 
similar to that seen in the 4ng rabla4 MO injected embryos. These embryos also 
displayed yellowing of the brain, smaller eyes, shortened tails with U-shaped somites 
and a curving notochord (n = 24/27) (Figure 3.3.2 G and F).
At 3dpf, all the 2ng rabla4 MO injected embryos hatched (n = 45) although some 
had an inward curving body axis and swam in circles (n = 4/45). Although fewer 
embryos hatched this phenotype was exaggerated in the 4ng rabla4 MO injected 
embryos where the embryos exhibited a curved body axis and swam in a large 
circular motion on their sides (n = 24/46). Those 4ng rabla4 MO injected embryos 
that failed to hatch exhibited abruptly curved, or ‘kinked’, tails and pericardial 
oedema (n = 22/46). At 8ng, only about 10% of embryos hatched (n = 3/27) and 
these, in common with the 4ng rabla4 MO injected embryos, had difficulty 
swimming normally swimming on their back and sides. Those that did not hatch 
showed the same phenotype as the 4ng rabla4 MO injected embryos (n = 24/47).
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3.3.3 Rabl8(2)
Injection of 2ngs, 4ngs or 8ng’s of rabl8(2) MO resulted in an early phenotype, with 
gastrulation in these embryos delayed by approximately two hours (2ng n = 42, 4ng 
n = 45, 8ng n = 37/39). When the embryos reached shield stage, they showed an 
elongated and pinched yolk (2ng n = 42, 4ng n = 45, 8ng n = 37/39) (Figure 3.3.3 B 
and A).
Figure 3.3.3: Shield stage embryos: control MO injected embryo (A) compared 
to embryo injected with 4ng of rabl8(2) MO (B). Lateral view of 24hpf 
embryos: control MO injected embryo (C) compared to embryo injected with 
4ng of rabl8 MO (D). Lateral view of 48hpf embryos: control MO injected 
embryo (E) compared to embryo injected with 4ng of rabl8(2) MO (F).
By 24hpf, the embryos injected with 2ngs of rabl8(2) MO possessed a smaller head, 
while, about. 50% of the 4ng rabl8(2) MO injected embryos were dead (n = 24/45). 
The remaining 4ng rabl8(2) MO injected embryos displayed brain cell death and 
small eyes (n = 21/21) (Figure 3.3.3 D and C). In addition the 4ng rabl8(2) MO
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injected embryos had tails that were either very short and curved with U-shaped 
somites, or absent (n = 21/21) (Figure 3.3.3 D). When the dose of the rabl8(2) MO 
was increased to 8ng, approximately 87% of the MO injected embryos were dead 
before 24hpf (n = 34/39). Those that remained were an accumulation of dying cells 
on the yolk (n = 5/5).
By 48hpf, the 8ng rabl8(2) MO injected embryos were dead. The 2ng rabl8(2) MO 
injected embryos failed to hatched, showed kinked tails and pericardial oedema (n = 
37/37). The 4ng rabl8(2) MO injected embryos showed a similar, if more severe, 
phenotype, with a small proportion of embryos exhibiting no tail structures and eyes 
that were substantially reduced, or absent (n = 16/16)(Figure 3.3.3 F). In addition the 
head structures were greatly reduced (Figure 3.3.3 F and E).
At 3dpf, the 2ng rabl8(2) MO injected embryos had not hatched and their heads 
started to develop a yellow/green colour and a thick layer of melanophores (n = 
37/37). Consistent with the pericardial oedema the heart was beating slowly and 
there was no movement of blood. The 4ng rabl8(2) MO injected embryos did not 
hatch and exhibited a similar, if slightly more severe, phenotype than the 2ng 
rabl8(2) MO injected embryos (n = 16/16).
3.3.4 Rablal
Embryos injected with rablal MO exhibited a developmental delay (2ng = 45 ,4ng = 
38, 8ng n = 42). When the control embryos had reached shield stage, all of the 
rablal MO injected embryos, regardless of the dose of rablal MO injected, were at 
least two hours delayed.
By 24hpf, c. 50% of the 2ng rablal MO injected embryos were dead (n = 23/45). 
Approximately 10% of the embryos appeared normal (n = 4/45), whereas, the 
remainder had massive brain cell death and curved tails (n = 18/45) (Figure 3.3.4 B 
and A). In addition, a small proportion of the phenotypic rablal MO injected 
embryos displayed grey cells in the tail indicative of cell death (n = 3/18) (Figure
3.3.4 B). The majority of the 4ng rablal MO injected embryos had died by 24hpf (n 
= 35/38). Approximately, 10% survived and these had severe defects, missing head
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structure, some tail structure and massive widespread cell death over the whole 
embryo (n = 3/38). The 8ng rablal MO injected embryos were all dead.
C D
Figure 3.3.4: Lateral view of 24hpf embryos: control MO injected embryos (A) 
compared to 2ng rablal MO injected embryos (B) Lateral view of 48hpf 
embryos: control MO injected embryos (C) compared to 2ng rablal MO 
injected embryos (D)
By 48hpf only about 25% of the original clutch of 2ng rablal MO injected embryos 
survived (n = 12/45) a third of those remaining appeared normal (n = 4/12). Those 
rablal MO injected embryos with a phenotype exhibited reduced head structures 
with brain cell death, some being so disrupted that they comprised only a pair of eyes 
on an elongated yolk (n = 3/12). Other rablal MO injected embryos had pericardial 
oedema, in addition to short, bent tails with indistinguishable somites (n = 5/12) 
(Figure 3.3.4 D and C). By this time point, the 4ng rablal MO injected embryos 
were all dead.
At 3dpf, remaining rablal MO injected embryos were either normal (n = 4/9) or 
displayed a similar phenotype to those at 48hpf, with kinked tails, indistinguishable 
somites and reduced head structure when compared to controls (n = 5/9).
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3.4 Hatching Defects
This section describes those rabs that, when knocked-down led to a failure to hatch. 
Hatching results from the combined effort of the hatching enzyme secreted from the 
hatching gland, along with osmotic and mechanical mechanisms (Denuce, 1985; 
Yamagani, 1988). The hatching gland is derived from the prechordal plate which, in 
turn, is derived from the embryonic shield in the area of the dorsal margin. The 
prechordal plate cells differentiate to form various different types of cells. Those 
cells that will become the hatching gland migrate from the dorsal margin of the 
embryo along the dorsal midline to anterior of the forebrain, where they accumulate 
to form the polster, upon completion of gastrulation. By 24hpf, the cells of the 
hatching gland are located on the pericardial membrane. They can be visualised as a 
semi-circle around the yolk and are prominent due to the presence of brightly 
refractive cytoplasmic granules within the hatching gland cells (Houart et al., 1998).
3.4.1 Rabllbl
Figure 3.4.1: Lateral view of 24hpf embryos: control MO injected embryo (A) 
compared to embryo injected with 4ng of rabllbl MO (B). Dorsal anterior view 
of 24hpf embryos: control MO injected embryo (C) compared to embryo 
injected with 4ng of rabllbl MO (D).
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All of the embryos gastrulated successfully with the majority of the 2ng rab llb l MO 
injected embryos appearing normal by 24hpf (n = 36/42). However a few 2ng 
rab llb l MO injected embryos exhibited a grey brain, indicative of cell death and a 
reduction in the size of the eyes (n = 6/42). Increasing the dose of rab llb l MO to 
4ng resulted in all embryos exhibiting this abnormal phenotype, in addition they 
exhibited a shortened tail with U-shaped somites (n = 46/46) (Figure 3.4.1 B and A). 
Injection of 8ng of the rab llb l MO resulted in a more severe phenotype with the 
entire embryo turning grey, indicative of cell death. The 8ng rab llb l MO injected 
embryos exhibited massively reduced brain and head size as well as tail defects (n = 
39/39). Closer inspection of 4ng rab llb l MO injected embryos revealed small, 
malformed eyes and badly defined brain structures, resembling an unstructured mass 
of cells than clearly defined regions (Figure 3.4.1 D and C).
Figure 3.4.2: Lateral view of 48hpf embryos: control MO injected embryo (A) 
compared to embryos injected with 4ng of rabllbl MO (B). Dorsal view of 
48hpf embryos: Control MO injected embryo (C) compared to embryos injected 
with 4ng of rabllbl MO (D).
When the phenotypic rab llb l MO injected embryos reached 48hpf, they possessed 
smaller brains and eyes (2ng n = 36/42, 4ng n = 46/46, 8ng n = 39/39) (Figure 3.4.2 
B and A) and exhibited bent tails and a curved body axis (Figure 3.4.2 D), compared 
to controls (Figure 3.4.2 C).
115
Screening the Zebrafish Rabs
At 4dpf, none of the phenotypic rab llb l MO injected embryos had hatched (2ng n = 
36/42, 4ng n = 46/46, 8ng n = 39/39) and many displayed pericardial oedema (2ng n 
= 6/42,4ng n = 46/46, 8ng n = 39/39).
3.4.2 Rabllb2
The rabllb2  MO injected embryos all gastrulated comparably with the control 
embryos (2ng n = 40/40, 4ng n = 42/42, 8ng n = 45/45). At 24hpf, all embryos, 
regardless of which dose was injected, showed the same phenotype (2ng n = 40/40, 
4ng n = 42/42, 8ng n = 45/45). The MO injected embryos all had reduced sized, 
greying brains, indicative of cell death. Furthermore, they had U-shaped somites, 
shortened tails and pericardial oedema (Figure 3.4.3 B and A).
Figure 3.4.3: Lateral view of 24hpf embryos: control MO injected embryo (A) 
compared to an embryo injected with 4ng of rabllb2 MO (B). Lateral view of 
48hpf embryos: control MO injected embryo (C) compared to an embryo 
injected with 4ng of rabllb2 MO (D arrow represents hatching gland cells).
When the embryos reached 48hpf, the rabllb2  MO injected embryos showed a 
disjointed ‘patchy’ hatching gland, with the cells accumulating in peaks in individual 
areas around the yolk (shown by arrow in Figure 3.4.3 D). The brains of these 
embryos remained small and had a yellowish tinge (Figure 3.4.3 D), compared to 
controls (Figure 3.4.3 C). In addition rabllb2  MO injected embryos had curved and 
shortened tails, the eyes were small and closer together and they had pericardial 
oedema (Figure 3.4.3 D) (2ng n = 40/40, 4ng n = 42/42, 8ng n = 45/45).
A B
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By 72hpf, none of the rabllb2  MO injected embryos hatched, the brain remained 
yellow, the embryos were shortened and pericardial oedema persisted (2ng n = 
40/40, 4ng n = 42/42, 8ng n = 45/45). By 5dpf, all the rabllb2  MO injected 
embryos were dead.
3.4.3 Rab6a
When the embryos reached shield stage, the rab6a MO injected embryos were 
visually normal. When they reached 24hpf, the 2ng rab6a MO injected embryos had 
small heads, with the distance between the eyes severely reduced, compared to 
controls. In addition the 2ng rab6a MO injected embryos possessed short bent tails 
with straight somites (n = 43/43) (Figure 3.4.4 B), compared to the V-shaped somites 
of the controls (n = 45/45) (Figure 3.4.4 A). The majority of the 4ng (n = 42/43), and 
all the 8ng rab6a MO injected embryos (n = 47/47) died. Those of the 4ng rab6a 
MO injected embryos that survived possessed no head structures and greatly reduced 
tail structures (1/1).
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Figure 3.4.4: Lateral view of 24hpf embryos: control MO injected embryo (A) 
compared to embryo injected with 2ng of rab6a MO (Figure B). Lateral view of 
48hpf embryos: control MO injected embryo (Figure C) compared embryo 
injected with 2ng of rab6a MO (Figure D).
By 48hpf, all of the 4ng rab6a MO injected embryos were dead (n = 1/1), the 2ng 
rab6a MO injected embryos had very small brains and small closely spaced eyes. 
The tail was shortened and bent posteriorly (n = 43/43) (Figure 3.4.4 D and C).
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By 4dpf, most of the rab6a MO injected embryos had not hatched and the hatching 
gland appeared disjointed and patchy with possible pericardial oedema (n = 39/43).
3.4.4 Rab lla2
All embryos appeared phenotypically normal at gastrulation. At 24hpf, the embryos 
injected with 2ng of rablla2  MO displayed a slightly reduced head size (Figure
3.4.5 B and A) and shortened tails, with U-shaped somites (n = 44). When the dose 
of rablla2  MO was increased to 4ng or 8ng the phenotype remained consistent, but 
a greater proportion of embryos died before 24hpf (4ng n = 38/41, 8ng n = 43/46 
died).
By 48hpf, the 2ng rablla2  MO injected embryos had kinked or, in some cases, 
absent tails, and some pericardial oedema (n = 44). The 4ng rablla2  MO injected 
embryos displayed a yellow tinged head with thick pigment (n = 3/3). At the higher 
dose of 8ng, the majority of the rablla2  MO injected embryos were dead (n = 2/3) 
while survivors were phenotypically similar to the 4ng rablla2  MO injected 
embryos.
Figure 3.4.5: Lateral view of 24hpf embryos: control injected embryo (A) 
compared to embryo injected with 2ng of rablla2 mopholino (B).
When the embryos reached 4dpf, a large proportion of the 2ng rablla2  MO injected
4ng rablla2  MO injected embryos were dead and the remainder appeared normal, 
except for the thick pigment on the dorsal side of the embryo (n =1/1). At 8ngs, all of 
the rablla2  MO injected embryos were dead by 4dpf.
A B
embryos remained unhatched and had pericardial oedema (n = 39/44). Most of the
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3.5 Swimming Defects
3.5.1 Rab28
During gastrulation the rab28 MO injected embryos are phenotypically normal. By 
24hpf all rab28 MO injected embryos exhibited a reduced head size (Figure 3.5.1 C 
and A) regardless of the dose of rab28 MO injected (2ng n = 43/43, 4ng n = 42/42, 
8ng n = 39/39). The 8ng rab28 MO injected embryos exhibiting greying of the brain, 
indicative of cell death, and, in a small percentage of cases (n = 5/39) the tail curved 
upwards.
o
Figure 3.5.1: Lateral view of 24hpf embryos: control MO injected embryo (A) 
compared to embro injected with 4ng of rab28 MO (Figure C). Lateral view of 
48hpf embryos: control MO injected embryo (Figure B) compared to embryo 
injected with 4ng of rab28 MO (Figure D).
By 48hpf, the 2ng rab28 MO injected embryos appeared normal (n = 43/43), 
whereas the 4ng rab28 MO injected embryos had a curved and shortened body axis, 
in addition to a smaller head and pericardial odeama (n = 42/42) (Figure 3.5.1 D and
B). These 4ng rab28 MO injected embryos showed modified swimming behaviour, 
with the embryos twitching and swimming in circles. When the dose of rab28 MO 
was increased to 8ng embryos showed a similar phenotype to the 4ng rab28 MO
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injected embryos and in addition the 8ng MO injected embryos possessed kinked 
tails (n = 39/39).
By 4dpf, 2ng rab28 MO injected embryos appeared phenotypically normal (n = 
43/43). The 4ng rab28 MO injected embryos continued to show pericardial oedema, 
a shortened body axis and a high proportion of them had bent tails. In addition, the 
4ng rab28 MO injected embryos still displayed abnormal swimming behaviour (n = 
42/42). The 8ng rab28 MO injected embryos again showed a similar phenotype to 
those injected with 4ng of rab28 MO (n = 39/39).
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3.6 Non-Specific Defects
This section focuses on those Rabs that, when knocked-down, exhibited no specific 
phenotypes. Each of these Rabs showed brain defects and defects in the tail.
3.6.1 Rab20
The rab20 MO injected embryos gastrulated normally, regardless of the dose of MO 
injected. By 24hpf, approximately 20% of the 2ng and 4ng rab20 MO injected 
embryos died (2ng n = 9/46, 4ng n= 13/49). The majority of those that survived were 
phenotypically normal (2ng n = 34/37, 4ng n = 35/36) however, some exhibited 
reduced head and brain size and slightly shortened tails (2ng n = 3/37, 4ng n = 1/36). 
When the dose of rab20 was increased to 8ng a larger percentage of embryos died (n 
= 34/56) while all the surviving embryos showed reduced head and brain size and 
slightly shortened tails. In addition, they displayed a slow heart beat and no blood 
flow (n = 22/22) (Figure 3.6.1 B and A).
By 48hpf, the 8ng rab20 MO injected embryos exhibited curved tails (Figure 3.6.1 D 
and C), a sigmoidal body axis (n = 22/22) (Figures 3.6.1 F and E) and reduced head 
structures.
At 5dpf, the rab20 MO injected embryos displayed reduced hatching success (n = 
15/22) and a shortened curved tail (not shown) when compared to controls. In excess 
of one third of the rab20 MO injected embryos failing to hatch exhibited pericardial 
oedema and had no circulation (n = 5/22).
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Figure 3.6.1: Lateral view of 24hpf embryos: control MO injected embryo (A) 
compared to embryo injected with 8ng of rab20 MO (B). Lateral view of 48hpf 
embryos: control injected embryo (C) compared to embryo injected with 8ng of 
rab20 MO (D). Dorsal aspect of 48hpf embryos: control MO injected embryo 
(E) compared to embryo injected with 8ng of rab20 MO (F).
3.6.2 Rabla2
At shield stage, rabla2 MO injected embryos were comparable with the control MO 
injected embryos, exhibiting no delayed gastrulation and no morphological 
differences between the organizers, at any of the doses injected. By 24hpf, the 
majority of the 2ng rabla2 injected embryos appeared normal (n = 42/42). The 4ng 
rabla2 MO injected embryos exhibited reduced head size and brain cell death (n = 
40/40), when compared to controls (n = 48/48). Increasing the rabla2 MO dose to 
8ng resulted in the embryos exhibiting a more severe reduction in head size and 
severe brain cell death (n = 33/33) (Figure 3.6.2 D), when compared with controls (n 
= 48/48) (Figure 3.6.2 C). In addition to this the 8ng rabla2 MO injected embryos
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showed severe reduction in tail structures (Figure 3.6.2 B) when compared with 
controls (Figure 3.6.2 A)
c
Figure 3.6.2: Lateral view of 24hpf embryos: control MO injected embryo (A) 
compared to embryo injected with 8ng of rabla2 MO (B). lOx magnification of 
anterior dorsal view of 24hpf embryos: control MO injected embryo (C) 
compared to embryo injected with 8ng of rabla2 MO (D).
At 48hpf, the 2ng rabla2 MO injected embryos had smaller heads and smaller eyes 
(n = 42/42), when compared to controls (n = 48/48). In addition, the 2ng rabla2 MO 
injected embryos had curved tails. The 4ng rabla2 MO injected embryos displayed 
reduced head size, eye size and brain cell death. They also exhibited shortened axis 
and curved tails (n = 40/40). The 8ng rabla2 MO injected embryos had severely 
reduced head and eye size and brain cell death (Figure 3.6.3 D and C). In addition the 
8ng rabla2 MO injected embryos showed an oedematous area around the yolk, 
severely reduced tail structures, with the remainder of the tail being kinked 
posteriorly (n = 33/33) (Figure 3.6.3 B and A). The notochord in the 8ng rabla2 MO
D
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injected embryos was either, curved and misshapen (Figure 3.6.3 F and E) or was not 
visible (Figure 3.6.3 G and E).
At 4dpf, the 2ng and 4ng rabla2 MO injected embryos had smaller heads and eyes 
than controls and curved tails. The 8ng rabla2 MO injected embryos showed 
severely reduced head and eyes, when compared to controls. In addition they 
exhibited shortened, kinked tails and an oedematous area round the yolk. Only about 
20% of the 8ng rabla2 MO injected embryos hatched (n = 7/33).
mJmrnK
Figure 3.6.3: Lateral view of 48hpf embryos: control MO injected embryo (A) 
compared to embryo injected with 8ng of rabla2 MO (B). Dorsal view of 48npf 
embryo: control MO injected embryo (C) compared to embryo injected with 8ng of 
rabla2 MO (D). lOx magnified lateral view of rear of head and midtrunk region of 
48hpf embryos: control MO injected embryo (E) compared to embryo injected 
with 8ng of rabla2 MO (F). lOx magnified posterior lateral view of 48hpf embryo 
injected with 8ng of rabla2 MO (G).
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Gene Summary of phenotypes in rab morpholino injected embryos
Rab1a1 Developmental delay, brain cell death, tail defects, pencardial oedema
Rab1a2 Brain cell death, tail defects inc notochord, pericardial oedema
Rab1a3 Reduced head size, reduced pigment, kinks in notochord
Rab1a4 Developmental delay, enlarged organizer, reduced head size and tail defects, pericardial oedema, reduced hatching success
Rab3c1 Reduced head size, thicker bands of pigment, smaller eyes, protruding lens, swim bladder defect, blind
Rab6a Reduced head size, tail defects, fail to hatch
Rab11 a 1 Developmental delay, shield - accumulation of cells on animal pole, tail defects, reduced head size, malformed heart, limited circulation
Rab11a2 Reduced head size, tail defects, pericardial oedema, fail to hatch
Rab11b1 Brain cell death, tail defects, pencardial oedema, fail to hatch
Rab11b2 Brain ceil death, tail defects, pencardial oedema, patchy hatching gland, fail to hatch
Rab 18(2) Developmental delay, shield - elongated embryo, reduced head size, tail defects, pericardial oedema, reduced blood flow, fail to hatch
Rab20 Reduced head size, tail defects, pericardial oedema, limited circulation
Rab28 Brain cell death, curved axis, abnormal swimming behaviour, pericardial oedema
Table 3.6.1: Showing the range of phenotypes seen in embryos injected with morpholinos to different rabs.
Discussion and Further Work
Chapter 4
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4.1 Screening the Zebrafish Rabs
The rab genes have classically been thought of as housekeeping genes because of 
their ubiquitous expression and vesicle trafficking role (Gurkan et al., 2005; Le 
Gallic and Fort, 1997). It is easy to assume that, given this ubiquitous expression, 
loss of a given Rab function would not yield a specific phenotype. However, this is 
not necessarily the case, a few rabs have been implicated in mammalian disorders 
such as Griscelli’s syndrome (Menasche et al., 2000) or Charcot-Marie-Tooth type 
2B neuropathy (Verhoeven et al., 2003). The specificity of rabs, in addition to some 
control at the gene expression level, is achieved by post-translational protein 
modification and the actions of protein regulators i.e. RabGDI. It is, therefore, 
important to investigate each rab to identify any specific role. The continuation of 
the Rab screen has resulted in the identification of a further 13 Rabs (bringing the 
total number of rabs screened to 37) that, when knocked-down, show defects in 
normal development. In many of these cases, the defects are very similar and include 
reduced head size and defects to the tail. However, some rabs show more individual 
phenotypes, including pigmentation defects, slowed development and a failure to 
hatch.
4.1.1 Pigmentation Defects
The knocking down of the Rab genes rab3cl and rabla3 resulted in defects in 
pigmentation. While rab3cl MO injected embryos showed a thicker layer of pigment 
the rabla3 MO injected embryos showed the opposite with a reduction in 
pigmentation.
4.1.1.1 Rab3c1
In mammals Rab3c localizes to synaptic vesicles and cycles on and off the synaptic 
vesicle membrane with the exocytic release of neurotransmitters. Rab3c dissociates 
from the synaptic vesicles after the stimulation of exocytosis (Fischer von Mollard et 
al., 1994) and is thought to perform an important regulatory role in exocytosis rather
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than direct involvement (Geppert et al., 1997; Nonet et al., 1997). This synaptic 
localization may explain the phenotype seen in the rab3cl MO injected embryos. At 
24hpf, the brain is severely disrupted with forebrain and mid brain structures ill 
defined, by 5dpf these fish show pigmentation defects and are unable to respond to 
visual stimulus. When touched, the rab3cl MO injected fish were capable of moving 
their eyes which suggested the fish were blind and unable to see the stimulus, rather 
than incapacitated and unable to respond. The pigmentation defect in the rab3cl MO 
injected embryos can be explained by their failure to respond to light as control 
embryos which are capable of subtly altering their chromatophores to blend into their 
environment (Logan et al., 2006). In bright sunlight or against light backgrounds, 
zebrafish can aggregate their melanosomes becoming considerably lighter, while in 
the dark or against a dark background, they can disperse the melanophores and 
become darker. As the MO injected embryos are unable to see their environment, 
they are constantly dark adapted so their melanophores are always dispersed, 
resulting in them appearing darker (Logan et al., 2006). In addition, the rab3cl MO 
injected embryos have no visible swim bladder. This may be due to the swim bladder 
not developing or not inflating. The abnormal eye morphology in the MO injected 
fish - small eyes with protruding lenses - may be the cause of the blindness, possibly 
via a reduced retina, a problem with the lens or other eye components. Malformation 
or disruption to the optic nerve or visual centres of the brain is also a viable 
explanation since Rab3c is known to be involved in synaptic transmission (Fischer 
von Mollard et al., 1994). In the adult rat brain, staining for Rab3a, with which 
Rab3c has been shown to be localized (Fischer von Mollard et al., 1994), showed no 
localisation in the optic tract (Xu et al., 1998). However, expression of rab3cl in 
zebrafish shows expression throughout the brain including the post optic areas 
(Campos, 2004).
A screen in Drosophila seeking to identify potential targets for retinal calmodulin 
proteins found one of the groups of potential targets included proteins with domains 
similar to the Rab3 GDP/GTP exchange factors (Alvarez et al., 2003). Interestingly 
although Rab3c itself has never been associated with human disease and disorders its 
regulators have. Homozygous inactivating mutations in the GTPase activating 
protein Rab3GAP has been shown to be responsible for Warburg Micro syndrome 
(WARBM1) (Aligianis et al., 2005). WARBM1 is a severe autosomal recessive
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disorder that is characterized by developmental abnormalities of the eye (including 
microcomea, congenital cataracts and optic atrophy) and the central nervous system 
(including microcephay). It is thought that defects in Rab3GAP causes a failure of 
the exocytic pathway to release ocular and neurodevelopmental trophic factors 
(Aligianis et al., 2005). A more recent paper showed that Martsolf syndrome, which 
has overlapping characteristics with WARBM1, also has defects in RAB3GAP. 
RAB3GAP is a heterodimeric protein with one catalytic (RAB3GAP1) and one 
noncatylitic subunit (RAB3GAP2). Warburg microsyndrome shows defects in 
RAB3GAP1, while Martsolf syndrome shows defects in the second (Aligianis et al., 
2006).
Rab escort protein REP1 is the zebrafish homologue of the human choroideremia 
gene and the first characterized REP. The human disease choroideremia shows X- 
linked degeneration of the retinal pigment epithelium, resulting in affected males 
developing night blindness in their teens with progressive loss of peripheral vision 
and then complete blindness. Loss of function of the gene choroideremia found on 
the X chromosome is responsible (Cremers et al., 1992). Interestingly, a zebrafish 
mutant for REP1 shows startling similarities to rab3cl MO injected embryos. At 
5dfp the REP1 mutants had uninflated swim bladders, noticeably smaller eyes and 
irregular eye pigmentation. The REP1 mutants also showed a patchy, discontinuous 
distribution of iridophore pigment cells. Electron microscopy showed that the retinal 
layers were disrupted in the mutants. At 6dpf, oedema was observed around the heart 
and abdomen. In addition, REP1 mutants had defects in hair cells including the 
lateral line and the inner ear (Starr et al., 2004).
There is still some concern over the incomplete penetrance of the phenotype 
observed in rab3cl MO injected embryos which could be due to several factors. The 
first theory is that the phenotype seen in the rab3cl MO injected embryos isn’t the 
result of knocking down rab3cl alone. It is possible that some of the embryos may 
have a mutation in other genes only uncovered on knocking down rab3cl. A second, 
more likely possibility is that there is a mutation in the rab3cl gene itself. To 
confirm this it will be necessary to sequence the gene in the rab3cl MO injected 
phenotypic and non-phenotypic siblings and compare.
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4.1.1.2 Rab1a3
The rabla3 MO injected embryos showed less pigmentation than controls. This 
phenotype appears to be due to fewer melanophores rather than abnormal distribution 
of melanosomes within the melanophores. However, the melanosomes in the 
remaining melanophores of the rabla3 mutant embryos appeared to have aggregated. 
One possibility for this reduction in melanophores is that the cells don’t migrate 
properly from the neural tube, resulting in fewer melanophores reaching their 
destination. This may result from a defect in neural crest cells. Dr Isabel Campos 
showed a similar phenotype in the rab which she named rablb. Unfortunately, once 
the zebrafish genome was sequenced, the MO used for this rab was shown to 
partially knock down two additional rabl genes. However, the clone which Dr 
Campos used for the expression pattern of rablb has equally close homology to 
rab la  as it does for rablb, showing 98% identity to the rabla3 clone. Therefore, it is 
probable that these genes are the same. The expression pattern for rablb showed 
localization in the chordamesoderm, polster, neural crest and blood. The localization 
in the neural crest is consistent with the phenotype seen in rabla3 MO injected 
embryos. Defects in neural crest cells have been seen in zebrafish to be responsible 
for the loss of pigment (Kelsh et al., 1996; Parichy et al., 1999; Southard-Smith et al., 
1998).
In the zebrafish mutant colourless (els) there is extensive loss of pigment cells and 
enteric nervous system, with large reductions in sensory and sympathetic neurones 
and putative satellite glia and Schwann cells (Dutton et al., 2001; Kelsh and Eisen,
2000). This phenotype suggests that els functions in specification, proliferation or 
survival of progenitors for all nonectomesenchymal crest derivatives (Dutton et al.,
2001). The els gene encodes a sox 10 homologue, loss of which causes neural crest 
cells to take ectomesenchymal fates rather than form non-ectomesenchymal fates. If 
cells do form non-ectomesenchymal fates, they generally fail to migrate and do not 
overtly differentiate, dying by apoptosis between 35 and 45 hours post fertilisation 
(Dutton et al., 2001). The melanophore defects in els mutants are thought to be 
mostly explained by disruption of expression of microphthalmia (Mitf). M itf is a 
basic helix-loop-helix/leucine zipper transcription factor, known to be required for 
development of eye and crest pigment cells in the mouse. Interestingly, the human
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disorder Waardenburg- Shah syndrome shows reduced enteric nervous system and 
reduced pigment cell number (Dutton et al., 2001).
An additional explanation for the reduction in melanocytes in rabla3 morphant 
embryos may be a defect in migration. A possible explanation for this defect in 
migration could be defective cell adhesion, since this has been shown to be required 
for cell migration (Ulrich et al., 2005). In chick, during delamination in neural crest 
cells, N-cadherin is down-regulated in migrating neural crest (Bronner-Fraser et al., 
1992; Nakagawa and Takeichi, 1995; Nakagawa and Takeichi, 1998), whilst 
cadherin-6B, which is expressed in the dorsal neural tube is also down-regulated 
(Nakagawa and Takeichi, 1995; Nakagawa and Takeichi, 1998). These expression 
patterns suggest that cadherins mediate strong cell contacts in the neuroepithelium 
and must be down-regulated for neural crest cells to become migratory (Halloran and 
Bemdt, 2003), suggesting a role for cadherins and cell adhesion in the distribution of 
melanophores. However, the zebrafish N-cadherin mutant, parachute, has no defects 
in pigmentation (Lele et al., 2002). The zebrafish mutant sparse encodes a type III 
receptor tyrosine kinase, kit, which is expressed in melanocytes and is required, cell 
autonomously, for melanocyte dispersal and migration from the neural tube (Parichy 
et al., 1999). The sparse mutant exhibits only half the normal complement of 
melanocytes (Kelsh et al., 1996; Nasevicius and Ekker, 2000; Odenthal et al., 1996).
The rabla3 MO injected embryos, in addition to showing reduced melanophore 
numbers, showed increased aggregation in the remaining melanophores. To ascertain 
whether the melanophores in theses embryos are unable to diffuse their 
meloanosomes, it would be interesting to place the rabla3 MO injected and control 
MO injected embryos into either caffine or adrenalin and compare: the aggregation 
of melanosomes can be achieved by addition of adrenalin, while dispersion can be 
achieved by addition of caffeine (Rodionov et al., 1998).
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4.1,2 Slowed Development
Four of the Rabs in the screen showed slowed development and were deformed as 
early as shield stage. Such early phenotypes could be down to problems with 
convergence extension and dorsoventral patterning or epiboly.
In the epiboly mutant hab, epiboly begins normally in the blastula and early gastrula 
stage but, by 70% to 80%, epiboly mutants begin to arrest and dissociate, with their 
blastoderm peeling off the yolk. When the zygotic and maternal genomes are 
heterozygous (ZMD) for hab, the embryos complete epiboly an hour after their wild 
type siblings (McFarland et al., 2005). In addition, morphogenesis of the neural tube 
is abnormal, with gaps forming in the midline during segmentation stages. At later 
stages, ectopic rows of neurons form in the widened spinal cord and hindbrain 
(McFarland et al., 2005). The hab mutant is caused by a mutation in the zebrafish 
homolog of the adhesion protein E-cadherin (Shimizu et al., 2005b). E-cadherin is 
required for the epiblast cells from the interior layer to sequentially move into the 
exterior layer, where they become restricted to that layer; and participate in subtle 
cell shape changes that further expand the blastoderm. In hab mutants, cells that 
intercalate into the exterior layer do not change cell shape or become restricted, with 
many of these cells moving back into the interior layer, hablE-cadherin is necessary 
for the cell rearrangements that spread the teleost blastoderm over the yolk (Shimizu 
et al., 2005b). Although the hab mutant shows slowed development, the phenotype is 
quite different from those observed in the slowed development rabs. The severest 
hab mutants died before 24hpf, with cells peeling off the yolk -  a phenotype not seen 
in any of the rab loss of function experiments in this chapter. The hab mutants also 
show asynchronous movement of cells down the yolk and a large streak of 
accumulated cells on one side of the embryo. In the rab loss of function embryos, 
this asynchronous movement is not evident and, although there is some cell 
accumulation in these embryos, it is not as extensive as in the hab mutants. This 
suggests that the phenotypes seen in rab loss of function are for the most part 
unlikely to be due to an effect on epiboly.
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The process of convergence and extension occurs during epiboly and it is thought 
that these movements must be interdependent, as epiboly is slowed in Xenopus laevis 
by treatments that block convergence (Hikasa et al., 2002).The zebrafish trilobite 
(tri) mutant, however, shows reduced convergence and extension movements, while 
epiboly and involution are not affected (Hammerschmidt et al., 1996a; Sepich et al., 
2000; Solnica-Krezel et al., 1996). Since convergence/extension cell movements 
contribute to lengthening of the embryo (Kimmel et al., 1995), the tri mutant embryo 
is shorter and its somites are wider than in a wild-type embryo. These mutant 
embryos show normal organizer formation, tissue patterning, and overall 
development (Sepich et al., 2000; Solnica-Krezel et al., 1996). The convergence 
movements of lateral cells in tri mutants are normal from shield through yolk plug 
closure, but are reduced, compared with wild-type, by the one somite stage (Sepich 
et al., 2000). A second convergence/extension mutant knypek is required for 
convergence movements of lateral cells and convergence extension movements of 
dorsal tissue. The mutants show reduced body length and a shortened malformed tail. 
The knypek gene product regulates cellular movements but not cell fate specification, 
with the convergent extension movement defects in knypek associated with abnormal 
cell polarity, as mutant cells fail to elongate and align medio-laterally. The knypek 
locus encodes a member of the glypican family of heparan sulfate proteoglycans. 
Glypican is required during vertebrate gastrulation, as a positive modulator of non- 
canonical Wnt signalling, to establish polarized cell behaviours, underlying 
convergent/extension movements (Topczewski et al., 2001). All of the rab loss of 
function experiements that showed slowed development also, showed reduced body 
length. rabla4 and rab 18 showed a more pronounced reduction than rab lla l, which 
is consistent with a defect in convergence and extension. The tri mutant showed 
thicker somites, whereas the somites in these rabs appeared normal thickness, 
although they were U-shaped rather than the chevron shape seen in controls. The tri 
mutant also showed convergence extension defects after the yolk plug closure stage, 
whereas the rab loss of function embryos showed defects in gastrulation at shield 
stage. Although both tri and knypek mutants show cyclopia, the head defects seen in 
the rab MO injected embryos are not consistent with this phenotype; they show a 
more severe phenotype, with smaller head and eye structures. This suggests that 
altered convergence and extension movement defects are either not responsible for
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the defects seen in these rab loss of function embryos or that they are accompanied 
by other defects.
Defects in epiboly and convergence/extension alone don’t explain the defects seen in 
these slow developing rab MO injected embryos but a combination of both factors 
may explain some of the phenotypes seen. The early arrest mutants such as zombie, 
spectre and speed bump show head defects similar to those seen in the rab MO 
injected embryos, in addition to a reduction in body axis and defects in the tail (Kane 
et al., 1996b). However, these arrest mutants do not arrest until 80% epiboly at the 
earliest, which is inconsistent with the slowed development in the rab MO injected 
embryos apparent at shield stage. Since Rab proteins are responsible for vesicle 
trafficking, it is possible that these rabs might be involved in both epiboly and 
convergence extension in addition to other as yet unknown process.
4,1.3 Hatching Gland
Zebrafish embryos hatch from their chorions, using a combination of processes. The 
osmotic pressure of the perivitelline fluid within the chorion increases, while the 
hatching gland releases enzymes that digest the chorion membrane. The chorion is 
thus weakened and the embryo can use muscular movements (eg. a flip of the tail), to 
release itself from the chorion (Buznikov and Ignat'Eva, 1958). Hatching gland cells 
produce secretory granules that contain the hatching enzyme. These secretory 
granules increase in number until the hatching gland disappears after hatching 
(Buznikov and Ignat'Eva, 1958)
In zebrafish, the hatching gland is composed of two cell populations: mesodermally 
derived hatching gland cells, which express the hatching gland gene (hgg), and 
ectodermally derived support cells (Kimmel et al., 1990). The hatching gland is 
derived from the polster, an accumulation of cells found anterior and below the 
forebrain of the embryo at tail bud stage. The polster, in turn, is derived from the 
anterior mesendoderm. Differentiation of the polster and, later, the hatching gland 
cells, is controlled by specific gene regulation, a process programmed early in 
embryogenesis (Inohaya et al., 1995; Inohaya et al., 1999). There are many genes
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expressed in the pre-polster, the best characterised of these is Cathepsin L {CatL or 
hggl), a protease secreted by the hatching gland. Also expressed in the pre-polster, is 
cyclase associated protein- 1 (Capl), which is thought to be required for the 
regulation of actin dynamics within pre-polster cells, influencing cell behaviour 
during the generation and migration of the polster (Daggett et al., 2004).
An important family of transcription factors in the formation of the polster are the 
zebrafish Kruppel-like factors (zKLF4). zKLF4 is a zinc finger family of 
transcription factors, expressed early during polster formation, which are required for 
further specification of the polster into the hatching gland (Kawahara and Dawid, 
2000; Kawahara and Dawid, 2001). KLF4 is one of the earliest markers of the polster 
and lateral plate mesoderm (LPM), and marks the fate of the hatching gland, blood, 
and vasculature (Amatruda and Zon, 1999; Oates et al., 2001), with zKLF4 having a 
critical role in erythroid cell differentiation in zebrafish (Kawahara and Dawid, 2000; 
Kawahara and Dawid, 2001). If zKLF4 is knocked-down, the hatching gland is 
absent and the embryos do not hatch (Gardiner et al., 2005), although the embryos 
were normal until this stage, including those cell types derived from the same parent, 
such as heart and anterior macrophages. If the embryos were manually 
dechorionated, they developed normally and survived into adulthood.
The four rab genes that showed a failure to hatch when knocked-down, also showed 
a variety of other phenotypes: most notably, pericardial oedema. It is possible 
thereofore that the hatching defect seen in these rab MO injected embryos is due to 
an effect on the polster or anterior mesoderm. It is, also, possible that these rabs 
affect specification of the hatching gland from the polster. However, due to the 
multitude of other phenotypes, it is unlikely that these rabs affect just the hatching 
gland cells. The rabllb2 MO injected showed the hatching gland cells to have 
accumulated at two points on the yolk, rather than the uniform stripe of cells seen in 
controls, suggesting a defect in the dispersal of the hatching gland cells. In addition, 
this accumulation of cells appeared to be dying, which could be due to a number of 
factors, including apoptosis due to the cells being mis-dispersed or hatching gland 
cells being poisoned by disrupted secretion. Three out of four of the MO injected 
rabs that showed the hatching defect were from the Rab 11 family. It is, therefore, 
possible that these Rabs may function in the same pathway.
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All of the rab MO injected embryos with hatching gland defects also showed defects 
in the tail structures, with rabllb l, rabllb2 and rab6a showing the severest defects. 
These tail defects could be responsible for the inability of MO injected embryos to 
hatch, since even with a fully functional hatching gland, the embryos would be 
unable to break their way out of the chorion as their tail movements would be 
compromised. It is, therefore, possible in such cases that the hatching gland has little 
to do with the inability to hatch. It is more likely, though, that there is a defect in the 
hatching gland in some, if not all, of the rab genes, especially rabllb2  MO injected 
embryos, which show an abnormal hatching gland. This defect in the hatching gland 
may then be aggravated by the defects in tail structure, resulting in the embryos 
inability to hatch. To establish if the reduction in hatching success is the result of 
defects in the hatching gland, expression of genes associated with the gland, such as 
hggl, could be assayed. While to establish if muscle defects in the tail could be 
responsible, phalloidan staining could be employed.
4.1.4 Swimming Defects
Many of the MO injected embryos showed some sort of tail defect and, therefore, 
had abnormal swimming behaviour. The rab28 MO injected embryos, however, 
appeared largely normal, compared to many of the other rab MO injected embryos in 
the screen. There was some brain cell death at 24hpf and, by 48hpf, pericardial 
oedema. However, the most striking defect was the modified swimming behaviour 
these embryos showed. Some of these MO injected embryos had kinked tails but 
many of them, other than a slightly shortened body axis, showed normal tail 
structures. The rab28 MO injected embryos swam in a circular pattern.
There are many possible explanations for the swimming defect in the rab28 MO 
injected fish, including muscle abnormalities, defects in the notochord, basement 
membrane or neuromuscular junctions and impaired balance.
Embryos with defects in neuromuscular junction usually show short swimming 
response, twitch once mutant embryos, when touched, respond with one or two
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swimming strokes, instead of an escape response. This response is called use- 
dependent fatigue and has been shown to be a consequence of a mutation in the 
tetratricopeptide domain of muscle rapsyn. This mutation inhibits the formation of 
subsynaptic acetylcholine receptor clusters. This loss of receptor clusters results in 
reduced synaptic strength, is augmented by a postsynaptic depression not seen at 
normal neuromuscular junctions, and results in use-dependent muscle fatigue (Ono et 
al., 2002). The shocked (sho) mutant also exhibits an aborted escape response 
(Granato et al., 1996). shocked (sho) is a mutation which causes motor deficits 
attributable to CNS defects. Mutant embryos display reduced spontaneous coiling of 
the trunk, diminished escape responses when touched, and an absence of swimming. 
The shocked mutant shows a mutation in the slc6a9 gene that encodes a glycine 
transporter (GlyTl). glytl is expressed in the hindbrain and spinal cord, which are 
regions known to be required for generation of early locomotory behaviours (Cui et 
al., 2005). A lack of muscle acetylcholinesterase in the mutant ache shows slowed 
synaptic current and so sustained contractions on both sides of the tail (Behra et al.,
2002). Embryos with muscle defects, such as dystroglycan MO injected embryos, 
respond to touch but appear to be less flexible than controls. By 48 hpf, dystroglycan 
MO injected embryos are curved and dystrophic, compared with controls, and move 
in an uncoordinated fashion (Parsons et al., 2002b). In lama2 MO injected embryos, 
there is defective organisation of the muscle tissue and they responded poorly to 
touch, with uncoordinated movements (Parsons et al., 2002b). None of these defects 
show comparable swiming behaviour to that seen in the rab28 MO injected embryos, 
suggesting the neuromuscular junction, notochord or muscle tissue may not be 
responsible for the defective swimming behaviour seen in these MO injected 
embryos. In order to ascertain if this is the case, expression of genes required for 
notochord, such as laminins or coatomers, could be assayed, while defects in muscle 
structure can be investigated by phalloidin. Defects in the neuromuscular junction 
could be identified by expression analysis of neuronal markers and by 
pharmaceutical methods, such as addition of acetylcholinesterase inhibitors.
Fish with defects in balance show characteristic swimming behaviour, with the fish 
swimming in circular motions, resulting in the name “circler” mutants (Nicolson et 
al., 1998). The causes of balance defects include defects in ear and the lateral line. 
The inner ear contains two macular organs, the saccule and utricle, which are found
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in all vertebrates. The saccule and utricle are pouch-like vestibules which contain a 
bed of hair cells coupled to calcium carbonate crystals. In fish, the crystals coalesce 
to form a single large polycrystalline mass called an otolith. Forces that result in the 
movement of the otolith are transduced to the underlying hair bundles (Nicolson, 
2005), with defects in the otoliths or the hair cells causing defects in balance. The 
gene starmaker is needed for otolith formation. Knocking down this gene results in a 
small fraction of MO injected embryos displayed circling behaviour (Sollner et al.,
2003). Defects in hair cells in zebrafish can affect both the ear and the lateral line, 
since the lateral line is a system of superficial canal hair cells that detects water 
movements. Glial cells have been implicated in preventing premature development 
of lateral line hair cells (Grant et al., 2005; Lopez-Schier and Hudspeth, 2005). The 
swimming defect in these rab28 MO injected embryos seems quite similar to the 
defects seen in fish with ear or balance defects. This does not though explain the 
oedematous region around the heart.
Defects in hair cells could result from defects in all forms of cilia. Monocilia have 
been proposed to establish the left-right (LR) body axis in vertebrate embryos by 
creating a directional fluid flow that triggers asymmetric gene expression. Cilia 
inside Kupffer’s vesicle are motile and create a directional fluid flow just prior to the 
onset of asymmetric gene expression in lateral cells. Ciliated KV cells are required 
during early somitogenesis for subsequent LR patterning in the brain, heart and gut 
(Essner et al., 2005). This may explain the brain heart and swimming abnormalities.
4.1.5 Non-Specific Defects
The compex defects seen in the two rab MO injected embryos in this group, such as 
brain cell death, oedema and tail defects, were also seen in many of the other MO 
injected embryos. The brain and tail structures are under the control of many 
pathways. Therefore, it is difficult to ascertain which pathways have been disrupted 
by these rabs being knocked-down. It is necessary to look at the data obtained for 
homologues of these rabs in other models
138
Discussion and Further Work
Amoung the first rab genes uncovered in rat brain was the homologue of ytpl, rabl. 
There have now been two mammalian rabl genes identified rab la  and rablb. Both 
mammalian rabl genes have been suggested to regulate transport of cargo between 
the ER and the Golgi apparatus (Palokangas et al., 1998; Plutner et al., 1991; 
Sannerud et al., 2003; Tisdale et al., 1992). Rabl in rat brain is seen in neuroblasts 
and glioblasts (Ayala et al., 1989). This expression may explain the cell death death 
seen in rabla2 MO injected embryos, in addition to that seen in rabla4 and rablal. 
Interestingly, in yeast, Yptlp associates with cytoplasmic a-synuclein and elevated 
expression of Rabl, protected against a-synuclein induced dopaminergic neuron loss 
in animal models of Parkinsons disease (Cooper et al., 2006).
Rab la and Rablb have been found to be highly expressed in human cardiac tissue. In 
addition, Rablb has been shown to be highly expressed in murine cardiac tissue. 
Cardiac specific overexpression of Rab la in cardiac tissue of mice resulted in a 
dilated cardiomyopathy that resulted in premature death at six weeks of age. Rab la  
overexpression revealed that Golgi stacks and surrounding transitional vesicles were 
markedly enlarged. This shows a role for rabl in heart developmeant and may 
explain the pericardial oedema in rablal, rabla2 and rabla4. If the heart is 
defective in these MO injected embryos, circulation is reduced and oedema may 
result. However, there was no obvious defect, other than the oedema, in the heart of 
these rabl MO injected embryos but it is possible circulation may have been 
reduced.
In human cell tissue culture the inactive form of Rablb has been shown to block 
forward transport of cargo and induces Golgi disruption (Alvarez et al., 2003). The 
phenotype is analogous to that induced by brefeldin A (BFA) and causes resident 
Golgi proteins to relocate to the ER, as well as inducing redistribution of ER-Golgi 
intermediate compartment proteins. The COPI (Coatomer complex ) machinary was 
shown to be compromised by the release of beta-COP into the cytosol. Inactive 
Rablb is reversed by expressing known mediators of COPI recruitment suggesting 
that Rablb function influences COPI recruitment. Further evidence is provided by 
the finding that cells expressing the active form of Rablb are resistant to BFA. 
(Lazar et al., 1997). The notochord defect, seen in the rabla2 MO injected embryos, 
may be the the result of the rabla affecting COPI. The zebrafish mutants sneezy,
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happy, and dopey encode the a, (3 and p’ subunits of COPI. These mutants all show 
defects in their notochord. Coatomer activity is required for normal chordamesoderm 
differentiation, perinochordal basement membrane formation and pigmentation 
(Coutinho et al., 2004). Although associations have been seen for Rablb and COPI 
all zebrafish rabls share high sequences homology with both rabla and rablb. It is, 
therefore, possible that any of the zebrafish Rabls may function in a similar way to 
mammalian Rablb.
rab20 has been shown to be expressed in the kidney tubule and intestinal epithelial 
cells in mice (Curtis and Gluck, 2005). Electron microscopic studies have revealed 
that Rab20 is located on endocytic structures underlying the plasma membrane, 
suggesting that they play a role in endocytosis/recycling (Lutcke et al., 1994). 
However, this is the extent of the current knowlage on rab20. It is, therefore, difficult 
to discuss the mechanisms that could be involved in rab20 function and those that 
are defective in the rab20 MO injected embryos. This problem led Dr Matthew Clark 
to develop a small inexpensive microarray for the routine analysis of molecular 
phenotype. In the future, microarray analysis of this and the other rabs may provide 
valuable information on these lesser studied rabs as well as new insights into those 
that are better characterised.
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Chapter 5
Characterization of Zebrafish Rab5a2
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5.1 Introduction.
5.1.1 An introduction to the Rab5 family.
The rab5 family is the best characterized of all the rab families and has been 
identified as one of the core rabs (Bucci et al., 1992; Chavrier et al., 1990). The Rab5 
protein localizes to clathrin coated vesicles, early endosomes and the plasma 
membrane (Bucci et al., 1992). The protein is essential for in vitro homotypic fusion 
of early endosomes and is able to increase the rate of endocytosis in vivo when 
overexpressed (Gorvel et al., 1991; Gruenberg and Howell, 1989; Li and Stahl, 
1993). Original experiments done in mammalian cells assumed only one Rab5 and 
looked at the function of different parts of the protein (Kinsella and Maltese, 1991). 
Deletion of the entire C-terminal tetrapeptide motif CCSN abolished rab5 activity 
but deletion of only the last three residues showed residual rab5 activity. A mutant 
containing a 4-residue deletion from the N-terminus retained full activity while N- 
terminal deletion of 19 residues partially blocked rab5 activity (Bucci et al., 1992). 
An amino acid dominant negative Rab5 (N133L) inhibited endogenous Rab5 
activity, while a constitutively activate Rab5 (Q79L) had no effect on Rab5 activity 
(Bucci et al., 1992; Li and Stahl, 1993). In contrast, subsequent studies have shown 
that overexpression of constitutively active Rab5 causes dramatic enlargement of 
early endosomes (Stenmark et al., 1994). Overexpression of the wild-type rab5 
enhanced the rate of transferrin receptor internalisation, with rab5 mutants deficient 
for GTP binding inhibiting transferrin receptor uptake (Bucci et al., 1992). Taken 
together these results suggest that Rab5 activity is rate-limiting in the early endocytic 
pathway. Rab5 has a role in fusion of clathrin-coated vesicles to early endosomes. A 
cytosolic component containing Rab5-GDI is essential for the Rab5 clathrin-coated 
pits to sequester transferrin efficiently. Rab5-GDI has been shown to have a role in 
the earliest stages of the endocytic pathway and is a direct link between the processes 
of transport vesicle formation and the recruitment of components required for 
subsequent fusion reactions (Chavrier et al., 1992).
The original Rab5 has now been renamed Rab5a since the discovery of two separate 
highly similar genes, Rab5b and Rab5c (Singer-Kruger et al., 1994; Wilson and
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Wilson, 1992). Interestingly, in the yeast Saccharomyces cerevisiae, three highly 
related Rab5 proteins had already been isolated and named Ypt51p, Ypt52p, Ypt53p 
(Bucci et al., 1995). These three Rab5s colocalize at the plasma membrane and early 
endosomes with Rab5b and Rab5c stimulating early endosome fusion in vitro and 
transferrin endocytosis in vivo. The ability of Rab5a to regulate transport in the early 
endocytic pathway is shared by the Rab5b and Rab5c genes with all three proteins 
being ubiquitously expressed. It has been suggested that the presence of three Rab5 
genes may reflect an evolutionary need to ensure Rab5 function even in the presence 
of a harmful mutation (Chiariello et al., 1999). Alternatively each gene could fulfill a 
distinct role and be responsible for fine regulation of the early endocytic pathway 
(Chiariello et al., 1999). The latter hypothesis is supported by recent work showing 
that all the Rab5 genes are differentially recognized by different kinases. Rab5a is 
efficiently phosphorylated by extracellular-regulated kinase 1 while cdc2 kinase 
preferentially phosphorylates Ser-123 of Rab5b. This differential phosphorylation by 
these kinases could specifically modulate the function of the different Rab5 genes in 
vivo (Christoforidis et al., 1999b).
Rab5 has a large diverse and complex group of interacting molecules, over 20 
polypeptides were isolated from bovine brain cytosol that interact both directly or 
indirectly with the GTP-bound form of Rab5 (Stenmark et al., 1995). The first Rab5 
effector identified was Rabaptin-5 which is essential for early endosome fusion 
(Lippe et al., 2001a; Lippe et al., 2001b). Rabaptin-5 forms a complex with Rabex-5, 
which catalyses nucleotide exchange on Rab5. When Rab5 is activated by Rabex-5, 
the Rabaptin-5-Rabex-5 complex induces its own membrane recruitment through 
Rabaptin-5 (Rybin et al., 1996). This positive-feedback loop counteracts GTP (Lippe 
et al., 2001a) which is thought to enrich active Rab5 on the membrane, a region 
where other Rab5 effectors are recruited (Christoforidis and Zerial, 2000; Lippe et 
al., 2001a; Lippe et al., 2001b). This localized clustering of activated Rab5 proteins 
is thought to regulate tethering machinery. GTP-bound Rab5 interacts with several 
other effectors, such as EEA1, Rabenosin5 (Christoforidis and Zerial, 2000), and 
hVps34 (Nielsen et al., 2000). EEA1 and Rabenosyn5 possess FYVE domains that 
bind to phosphatidylinositoBphosphate (PtdIns[3]P) (these have been shown also to 
be Rab5 effectors) (Bucci et al., 1992; Christoforidis et al., 1999b; Stenmark and 
Aasland, 1999) (Gonzalez-Gaitan et al., 1994). Binding of the FYVE domain to
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PtdIns(3)P, complete with interaction of Rab5, is responsible for specific targeting of 
these proteins to early endosomes.
5.1.2 Rab5 and its role in cell signalling
An important role for Rab5 has been identified in cell signalling. Strigini and Cohen 
proposed a role for Rab5 in planar transcytosis mediated spread of Wg in the 
drosophila imaginal disc (Strigini and Cohen, 2000) (section 1.2.6.2). However, 
more recent data using a temperature-sensitive dynamin mutant, shibire, in 
drosophila which blocks endocytosis suggests Wg spreads extracellularly (Marois et 
al., 2006). Wg is expressed in a stripe of cells straddling the dorsal-ventral boundary 
and forms a symmetrical gradient in dorsal and ventral compartments along the 
imaginal wing disk. When a dominant negative form of Rab5 was expressed in the 
dorsal compartment, initially Wg protein levels were elevated in dorsal tissue nearest 
the Wg-expressing cells but, as time progressed, large amounts of Wg invaded the 
entire dorsal compartment. The authors theorised that this spatial progression of Wg 
accumulation resulted from intervening tissue no longer internalizing Wg when 
endocytosis was disrupted. This suggested that Rab5-dependent endocytosis of Wg 
normally limits the range over which Wg spreads (Marois et al., 2006). In addition, 
transcription of both fz2  (a wingless receptor) and dip (a member of the glypicans 
which have been implicated in the movement of the morphogens Hh, Dpp and Wg) 
increases, while that of arrow (thought to be a wingless co-receptor) decreases 
rapidly (Marois et al., 2006).
5.1.3 Rab5 genes in zebrafish
There is very little literature on Rabs in zebrafish, with much of this done by Dr 
Isabel Campos for her PhD thesis (Campos, 2004) and Dr Mathew Clark (Clark, 
MD, pers. com.). There are two further publications on the zebrafish Rabs and in 
particular the Rab5 family, from the laboratories of Brand and Heisenberg at Max 
Planck Institute for Cell Biology (Scholpp and Brand, 2004; Ulrich et al., 2005). 
Scholpp and Brand (2004) investigated the control of signalling range of Fgf8 by
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endocytosis, while Ulrich, Krieg et al. (2005) investigated Rab5c in cell cohesion 
during gastrulation and the role of Wntl 1 (Ulrich et al., 2005).
5.1.3.1 Rab5 in the spread of Fgf8
Scholpp and Brand (2004) report that Rab5s function in endocytosis as regulators of 
FgfB spread. The data showed that FgfB colocalises with Rab5 in 54% of vesicles. 
Injection of a dominant-negative, form of the Fgf receptor XFD decreased 
internalization of FgfB (Amaya et al., 1993). This resulted in an accumulation of the 
FgfB protein around the receiving cells and detection of the FgfB protein at greater 
distances from the source, when compared to uninjected control embryos. When 
Rab5 function was disrupted by injecting RN-tre (a GAP), FgfB was absent from 
intracellular vesicles and accumulated extracellularly at a greater distance from the 
source. However, overexpression of Rab5 reduced the range of FgfB spreading and 
increased the size of the FgfB-positive intracellular compartments. Transplantation 
experiments showed that when cells injected with RN-tre were transplanted into 
control embryos near a source of Fgf8, host cells took up the protein, even if cells 
inhibited for Rab5 function were located between the source and the receiving cells. 
In these embryos, little extracellular Fgf8 accumulated, unlike embryos where all 
cells received RN-tre. In embryos where Rab5-overexpressing cells were 
transplanted, these cells showed an accumulation of FgfB, while cells that lay behind 
them were deficient of FgfB. In embryos injected with RN-tre, expression of Fgf8 
target genes spry4, pea3 and erm showed broadened expression compared to 
controls, knock down of rab5a2 also showed a broadened expression of spry4. 
Conversely, embryos injected with rab5a RNA showed a severe reduction in the 
induction of spry4. This paper has, therefore, suggested a restrictive clearance model 
for the spread of FgfB. Endocytosis serves to restrict spreading of FgfB protein away 
from the source, by clearing FgfB protein from the extracellular space via 
endocytosis, defining how far the protein is able to spread and determining the width 
of the target tissue responding to FgfB signalling. Given that FgfB and Rab5 only 
localizes in a percentrage of cases Scholpp and Brand suggested that the vesicles, 
which, didn’t co-localise with Rab5 might be destined for degradation (Scholpp and 
Brand, 2004), as FgfB was seen in the intracellular degradative pathway of receiving 
cells. Therefore, they argue that FgfB spreads extracellularly by a diffusion-based
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mechanism where target cells can actively influence the gradient through endocytosis 
and subsequent degradation, with the involvement of Fgf receptors (Scholpp and 
Brand, 2004).
5.1.3.2 Rab5c and its role in cell cohesion
Ulrich, Kreig et al (2005) used Rab5 and in, particular, Rab5c’s role in endocytosis, 
to elucidate the effect of Wntl 1 on cell cohesion during gastrulation. In particular, 
the study is concerned with Wntl 1 ’s role in controlling prechordal plate progenitor 
cell movements. Previous work by the authors had shown that prechordal plate in 
zebrafish is formed by a highly cohesive group of axial mesendodermal progenitor 
cells which move in a straight path from the germ ring toward the animal pole of the 
gastrula (Ulrich et al., 2003) and that E-cadherin-mediated cell cohesion is required 
for the coordinated movement of prechordal plate progenitor cells during zebrafish 
gastrulation (Montero et al., 2005). Ulrich et al. (2005) showed that in wild-type 
embryos, prechordal plate progenitors moved both toward the overlying epiblast cell 
layer and along it toward the animal pole. However, embryos lacking wntl 1 
(silberblick mutants (sib)) showed slower movement toward the animal pole with 
cells often moving in the opposite direction toward the vegetal pole, although cells 
moved normally towards the epiblast. The coherence of the prechordal plate 
progenitor cell movements at the onset of gastrulation were also reduced in slb/wntll 
mutants. The authors suggest that W ntll is required to align the movement of 
individual prechordal plate progenitors and that this alignment might represent a way 
by which W ntll efficiently coordinates prechordal plate progenitor movement 
toward the animal pole. In addition, the authors suggested that Wntl 1 might control 
alignment of prechordal plate progenitor movement by regulating the cohesion of 
these cells. In cell cultures, mutant for w ntll, large cell aggregates were reduced 
while small cell aggregates were increased when compared to wild-type. However, 
when E-cadherin was knocked-down in cultured wntH'A mutant cells showed no 
significant differences in aggregates while wild-type cells displayed an increase in 
small cell aggregates and a decrease in large cell aggregates, compared to wild-type 
cells with E-cadherin. Wntl 1 expression was, therefore, suggested to lead to changes 
in the subcellular localization of E-cadherin from the plasma membrane into 
cytoplasmic dots (Ulrich et al., 2005), these dots localized with injected mRNA YFP-
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fusion of the zebrafish Rab5c. W ntll overexpression was shown to lead to an 
increase in the proportion of Rab5c-positive endocytic E-cadherin vesicles as did the 
overexpression of a constitutively active form of rab5c-YFP in slb/wntll mutant 
embryos, rab5c MO injected embryos were shown to frequently have a posteriorly 
displaced and elongated prechordal plate at the end of gastrulation, phenocopying the 
slb/wntll mutant phenotype. However, slb/wntll mutant embryos, expressing da- 
rab5c-YFP, formed a prechordal plate that was wild-type in appearance, suggesting a 
rescue of the mutant phenotype. The de-adhesion forces needed to dissociate wild- 
type versus slb/wntll mutant cells from E-cadherin substrates were decreased, but 
could be rescued by expressing low amounts of w ntll mRNA. Similarly in rab5c 
MO injected cells there was a decrease in the de-adhesion forces when compared to 
wild type. The study suggests that Wntl 1 modulates E-cadherin dynamics through 
endocytosis and recycling. E-cadherin being partially, but not exclusively, required 
for W ntll control of mesendodermal cell cohesion, suggests a role for other 
adhesion molecules such as integrins.
5.1.3.3 The zebrafish rab5s
Dr Matthew Clark and Dr Isabel Campos have identified 4 zebrafish Rab5s; two 
Rab5as, Rab5b and Rab5c. Both Rab5as are in the zebrafish online resource zfin 
(www.zfin.org) - they are termed ‘Rab5a’ and ‘Rab5a like’. In Dr Campos’ thesis 
these Rabs are re-named Rab5al and Rab5a2 respectively (Campos, 2004). Embryos 
showed no obvious phenotype when rab5al was knocked-down by Dr Campos, 
however rab5a2 MO injected embryos showed a very striking gastrulation 
phenotype, the embryo showed no morphological organizer and died before the 
completion of epiboly (Figure 5.1.1). In addition, development is drastically slowed 
when control embryos reach 90% epiboly, compared to rab5a2 MO injected 
embryos, which only reach 50% epiboly. In cases where rab5a2 MO injected 
embryos reached 80-90% epiboly the blastoderm margin contracted and pinched off 
the yolk causing its contents to leak and the physiological environment surrounding 
the blastoderm cells to be disrupted resulting in death (Campos, 2004). rab5b MO 
injected embryos showed thinner and u-shape somites, forebrain defects and cell 
death in the brain (Campos, 2004). Finally, rab5c MO injected embryos showed a 
similar phenotype to embryos with depleted rab5b with u-shape somites, shortened
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tail, forebrain defects and cell death in the brain (Campos, 2004). The lack of 
morphological organizer in the rab5a2 MO injected embryos led Dr Campos to 
perform expression analysis for the nodals and their downstream markers. rab5a2 
MO injected embryos displayed a startling lack of expression of the nodals and a 
majority of their target genes. The MO injected embryos showed no sqt, eye, bik, gsc 
or flh expression and a severe reduction in ntl expression compared to control 
injected embryos (Figure 5.1.2). The dramatic early phenotype seen in rab5a2 MO 
injected embryos has, so far, only been seen following the depletion of this Rab, out 
of all the Rabs screened. Rab5a2’s phenotype and the dramatic loss of nodal 
signalling have led me to further investigate its function and, in particular, its role in 
nodal signalling.
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Control rab5a2 MO
Figure 5.1.1: Time series of 3ng rab5a2 MO injected embryos (B,D,F,H) 
compared with control injected embryos (A,C,E,G). Animal view (A) and side 
view (C) of control injected embryo at shield stage compared to animal view (B) 
and side view (D) of 3ng rab5a2 MO injected embryos at the same time point. 
Control injected embryos at 90% epiboly (E) compared to the same time point 
in the 3ng rab5a2 MO injected embryos (F). 8 somite stage control embryo (G) 
compared to 3ng rab5a2 MO injected embryo at the same time point (H). 
(Campos, 2004)
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Control MO Rab5a2 MO
Figure 5.1.2: Comparison of ish expression patterns for sqt, eye, gsc flh  bik and 
ntl in shield stage control MO injected (left column) and shield stage 3ng rab5a2 
MO injected embryos (right column)(Campos, 2004).
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5.2 Reproducibility and further analysis of the Rab5a2 
loss of function phenotype.
To characterize Rab5a2, first, it was necessary to check the reproducibility of the loss 
of function phenotype and the nodal expression pattern seen in the rab5a2 MO 
injected embryos. Following this, it was necessary to look more closely at this 
expression pattern in order to ascertain if there is a temporal element to the 
expression pattern seen in the rab5a2 MO injected embryos. In addition it would be 
interesting to investigate whether the loss of Nodal signalling was due to maternal or 
zygotic transcripts. Finally, in all other systems that have been studied Rab5a 
localized to endosomes and has been shown to be responsible for clatherin-mediated 
endocytosis (Bucci et al., 1995; Bucci et al., 1992; Gorvel et al., 1991). It was 
therefore important to investigate Rab5a2s effect on other endocytic pathways, and, 
for this, the role of endocytosis in epiboly was studied.
The rab5a2 MO injected embryos (rab5a2 MO injected embryos) are throughout this 
study compared to lOng of control MO injected embryos. This control MO is the 
rab5a2 MO containing a five base mismatch.
5.2.1 Reproducing the loss of function phenotype
Using the MO designed by Dr Campos, at the dose used in the original 
investigations, 3ng of rab5a2 MO was injected and compared to control MO injected 
embryos. Since the rab5a2 MO injected embryos showed no phenotype, the dose 
was increased until an effect was observed. At 5ng of rab5a2 MO, all embryos died 
before completing epiboly (n = 47), while at 4ng of MO they all appeared similar to 
control MO injected embryos (n = 44). When the dose was increased still further to 
6ng, the rab5a2 MO injected embryos died between 30% and 50% epiboly (n = 
41/45). In the 5ng rab5a2 MO injected embryos, at approximately 30% epiboly, fluid 
appeared to accumulate between the blastoderm cells and the yolk (Figure 5.2.1) this 
was not seen in control MO injected embryos. In the 6ng rab5a2 MO injected 
embryos, this build-up of fluid up, occurred at the earlier stage of approximately 10% 
epiboly and was more pronounced. In the control MO injected embryos, the cells
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appeared as a smooth blastoderm covering the yolk cell, in the rab5a2 MO injected 
embryos, the cells appeared to have a substantially rougher blastoderm with cells 
appearing as a less cohesive group. Finally the rab5a2 MO injected embryos, as 
described by Dr Campos, showed substantial developmental delay, compared to 
control MO injected embryos (Figure 5.2.1).
Figure 5.2.1: Control embryo at 70% epiboly (A) compared to 5ng rabSa2 MO 
injected embryo at the same time point (B) and control embryo at shield stage 
(C). Arrow in B indicates the apparent build-up of fluid between the yolk and 
the cells.
5.2.2 Reproducibility of the expression patterns of nodal and nodal- 
responsive genes in rab5a2 MO injected embryos.
To reproduce the expression patterns of the nodals and the nodal-responsive genes in 
the rab5a2 MO injected embryos, embryos were injected with either 5ng of rab5a2 
MO or lOng of control MO and fixed at 50% epiboly. The rab5a2 MO injected 
embryos showed no expression of the downstream nodal markers gsc or flh  and 
reduced expression of ntl and bhik. They also showed no expression of eye (Figure
5.2.2). As with Dr Campos’ data, it was difficult to see sqt staining in the control 
embryos, so it is difficult to determine whether sqt expression is reduced in the MO 
injected embryos (Figure 5.2.2). Using a higher dose (6ng) of rab5a2, the effect of 
the MO was to visibly abolish the bhik and ntl staining in addition to that of gsc and
B c
flh.
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Control rab5a2 MO
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Figure 5.2.2: Animal view of expression patterns of the nodals and nodal- 
responsive genes in shield stage control MO injected and 5ng of rab5a2 MO 
injected embryos.
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5.2.3 Further analysis o f the loss offunction phenotype
To establish whether the loss of nodal signalling is time and dose dependent, 
embryos were injected with either 2ng, 5ng or 8ng of rab5a2 MO and along with 
lOng control morpholino injected embryos were fixed at four time points (30%, 50%, 
70% and 90% epiboly). Subsequently, expression patterns of gsc and ntl were 
examined. These two genes are induced by differing doses of nodal so should 
provide an accurate picture of Nodal signalling at these time points. Furthermore, the 
expression pattern of the dorsal marker chordin was recorded, to investigate if nodal 
signalling alone was affected, or whether the effect relates to the establishment of 
dorsal in general.
Figure 5.2.3: Graph showing the percentage of embryos that showed a reduction 
in expression of gsc at either 2ng, 5ng or 8ng of rab5a2 MO and at 30%, 50%, 
70% and 90% epiboly stages.
gsc
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Figure 5.2.4: Graph
showing the percentage 
of embryos that 
showed a reduction in 
expression of chd at 
either 2ng, 5ng or 8ng 
of rab5a2 MO and at 
30%, 50%, 70% and 
90% epiboly stages.
ntl
Figure 5.2.5: Graph
showing the percentage 
of embryos that 
showed a reduction in 
expression of ntl at 
either 2ng, 5ng or 8ng 
of rab5a2 MO and at 
30%, 50%, 70% and 
90% epiboly stages.
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The expression of gsc in the 2ng MO injected embryos was reduced in 45-65% of the 
embryos between 30-90% epiboly. However the number of embryos showing a 
reduction in gsc expression fell to only 15% at 50% epiboly (Figure 5.2.3). 
Increasing the dose of MO to 5ng resulted in between 55-85% of the embryos 
showing a reduction in gsc expression between 30-90% epiboly (Figure 5.2.3). At the 
highest dose of morpholino all the 30% and 50% epiboly embryos showed a decrease 
in gsc, however, by 70% epiboly all the 8ng embryos were dead (Figure 5.2.3).
The expression of ntl in all the rab5a2 MO injected embryos was variable. The 2ng 
MO injected embryos showed a reduction in ntl expression of 65% at 30% epiboly. 
At 50% epiboly no embryos showed an obvious reduction in ntl expression, at 70% 
79% of embryos showed reduced expression while at 90% epiboly only 23% of 
embryos showed a reduction in ntl expression (Figure 5.2.5). Increasing the dose to 
5ng resulted in between 50-85% of embryos showing a reduction in ntl expression 
between 30-90% epiboly. However, at 50% epiboly the number of embryos that 
showed reduced ntl expression had fallen to just 3% (Figure 5.2.5). Increasing the 
dose still further resulted in 88% and 57% of the embryos showing reduced 
expression of ntl at 30% and 50% epiboly respectively. At 70% and 90% all the 8ng 
rab5a2 MO injected embryos had died (Figure 5.2.5).
The expression of chd in the 2ng rab5a2 MO injected embryos was reduced in 
between 25-50% of the embryos between 30-90% epiboly (Figure 5.2.4). When the 
dose of the MO was increased to 5ng between 70-90% of the MO injected embryos 
showed a reduction in chd expression at between 30-90% epiboly (Figure 5.2.4). 
When the dose of rab5a2 MO was increased still further all of the embryos showed a 
reduction in chd expression at 50% and 30% epiboly stages. However at 70% 
epiboly and 90% epiboly all the embryos had died (Figure 5.2.4).
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5.2.4 Maternal verses zygotic
The early phenotype of the rab5a2 MO injected embryos and the ubiquitous 
expression pattern of rab5a2 seen as early as the one cell stage (zfin) suggests that 
maternal rab5a2 plays an important role in zebrafish development. In order to 
ascertain whether this is the case a splice MO was designed, this straddles a splice 
site of the gene of interest and so binds, in part, to the intronic and, in part, to the 
exonic section of the gene. This ensures that the MO only binds to transcripts that 
have not yet been spliced, such as zygotic transcripts (Draper et al., 2001).
Embryos were injected with either lOng of rab5a2 splice MO or lOng of control 
MO. At shield stage the rab5a2 splice MO injected embryos were comparable to 
controls showing a visible organizer unlike the rab5a2 morpholino injected embryos. 
However by 24hpf the rab5a2 splice MO injected embryos appeared as an 
accumulation of dead cells on top of the yolk (Figure 5.2.6).
4 T
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Figure 5.2.6: Lateral view of 24hpf embryos: control MO injected embryo (A) 
compared to 8ng rab5a2 splice MO injected embryo (B).
Although the rab5a2 splice MO injected embryos had showed massive cell death at 
24hpf at shield stage they had a visible organizer, it was therefore necessary to look 
at the expression pattern of the nodal responsive genes ntl, bik and gsc and the dorsal 
marker chd. The rab5a2 splice MO injected embryos and control MO injected
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embryos were fixed at 50% epiboly. Analysis of the expression patterns for gsc, ntl 
and chd in the splice MO injected embryos showed them to be similar to those seen 
in the controls (Figure 5.2.7). bik expression however appeared slightly reduced in 
the splice MO injected embryos (n = 10/12).
bik
gsc
ntl
chd
Figure 5.2.7: Animal views of shield stage embryos: gsc, ntl, chd and bik expression 
in control MO injected embryos on the left compared to lOng rab5a2 splice MO 
injected embryos on the right
Control rab5a2 splice MO
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5.2.5 The effect o f loss ofRab5a2 function on epiboly movements
Epiboly in zebrafish is considered, in part, an endocytic event (Betchaku and 
Trinkaus, 1986). Therefore, to ascertain whether the phenotype seen in rab5a2 MO 
injected embryos is, in some part, due to its effect on the role of endocytosis during 
epiboly, the epiboly movements of rab5a2 MO injected embryos were compared 
with those of controls, at three different time points of epiboly. The embryos were 
placed in lx Danieau solution, containing 5mg/ml biotinylated dextran (10,000mw), 
at dome stage (start of epiboly), 30% epiboly and shield stage for 15 minutes, they 
were then washed three times in lx Danieau solution and immediately fixed in 4% 
PFA. Once fixed, the embryos were stained for biotin (Solnica-Krezel et al., 1994). 
The control MO injected embryos, at dome stage and 30% epiboly, all showed a ring 
of staining around the leading edge of the blastoderm (Figure 5.2.8). At shield stage, 
this staining formed more of a gradient moving from the dorsal to ventral side of the 
embryo. The rab5a2 MO injected embryos showed very little staining at dome stage 
(n = 13/17) and even less staining at 30% (n = 12/13). There was no staining seen in 
the rab5a2 MO injected embryos at shield stage (n = 14/15) (Figure 5.2.8).
The rab5a2 MO injected embryos showed defects in endocytosis however epiboly 
did proceed but at a slower pace and did not complete. This suggested that the 
microtubules in the yolk were unaffected and were responsible for epiboly 
proceeding as far as it did. Cold shock depolarizes microtubules therefore 5ng 
rab5a2 MO injected embryos and control MO injected embryos were placed at 20°C 
and monitored overnight. The control embryos developed normally (n =16/16) but 
with some developmental delay whereas the rab5a2 MO injected embryos arrested 
and died at sphere stage to very early epiboly (n = 14/14) (Figure 5.2.9, supplemental 
movie 5.2.9). The rab5a2 MO injected siblings that were incubated at 28°C died at 
the later stage of 70% epiboly while the control MO injected siblings incubated at 
28°C developed normally.
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Figure 5.2.8: The right column shows the effect of 5ng of rab5a2 on different stages of epiboly when 
compared with control MO injected embryos in the left column.
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Figure 5.2.9: A time series of embryos cold shocked at 20°C: 3hpf control MO 
injected embryos (A) compared to rab5a2 MO injected embryos (B). 7.5hpf 
control MO injected embryos (C) compared to rab5a2 MO injected embryos 
(D). 12.5hpf control MO injected embryos (E) compared to rab5a2 MO injected 
embryos (F). 14hpf control MO injected embryos (G) compared to rab5a2 MO 
injected embryos (H).
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5.3 Analysis of overexpression of Rab5a2
5.3.1 Rab5a2 overexpression
Wild type rab5a2 mRNA was overexpressed in wild type embryos by injecting 1.5ng 
of rab5a2 capped mRNA. At 40-50% epiboly, an accumulation of cells became 
apparent on the animal pole of approximately one third of the rab5a2 overexpressing 
embryos (n = 14/41). In the remaining rab5a2 overexpressing embryos, the organiser 
appeared larger (n = 27/41), when compared with MO buffer injected embryos 
(Figure 5.3.1). The rab5a2 overexpressing embryos then appeared to arrest for 
approximately one hour, during which time either the accumulation of cells on the 
animal pole disappeared, or the enlarged organiser reduced in size and the embryo 
became what appeared phenotypically wild type (n = 41/41). At 24hpf, 
approximately two thirds of the rab5a2 overexpressing embryos appeared similar to 
MO buffer injected embryos, except for an enlarged yolk extension (n = 27/39). The 
remaining third had a reduced body axis and reduced head size (n = 12/39). By 5dpf, 
all the rab5a2 overexpressing embryos show a severely shortened body axis and 
thicker, less extended yolks (n = 38/38), compared to MO buffer injected embryos 
(Figure 5.3.1).
5.3.2 Nodal markers expression pattern in Rab5a2 overexpressing 
embryos
To establish whether overexpression of rab5a2 affected the expression pattern of 
nodal markers, embryos were fixed at shield stage and stained for bik, ntl, gsc and 
chd expression by in situ hybridization. In both the MO buffer injected embryos and 
the rab5a2 overexpressing embryos, the bik expression patterns were similar (Figure
5.3.2). A similar expression pattern between MO buffer injected embryos and rab5a2 
overexpressing embryos was also seen for ntl. There appeared to be a small 
difference in the expression pattern of chd, with the rab5a2 overexpressing embryos 
showing chd expression encroaching into the ventral region more than in MO buffer 
injected embryos (Figure 5.3.2). There was a substantial difference in gsc expression 
pattern between the MO buffer injected embryos and the rab5a2 overexpressing
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embryos. The rab5a2 overexpressing embryos showed the same gsc expression 
pattern as the MO buffer injected embryos on the dorsal side of the embryo but in 
addition there was gsc expression on the animal pole closest to the ventral side of the 
embryo (Figure 5.3.2). This expression was not seen in the MO buffer injected 
embryo (Figure 5.3.2) and was stronger than the dorsal expression seen in these 
embryos.
To further analyse this result, rab5a2 overexpressing embryos and MO buffer 
injected embryos were fixed at 30%, 50%, 70% and 90% epiboly so that the 
expression pattern of chd, ntl and gsc could be followed over time. At 30% epiboly, 
the rab5a2 overexpressing embryo showed expression of gsc in the ventral region, in 
addition to its usual dorsal expression. This additional expression pattern was seen in 
83% of the embryos (n = 10/12). Interestingly, at this stage ntl expression in the 
rab5a2 overexpressing embryos shows spots of staining in the animal pole, 
compared to the marginal expression observed in the MO buffer injected embryos. 
This expression of ntl was seen strongly in 50% (n = 6/12) of the rab5a2 
overexpressing embryos, with a further 17% exhibiting weaker staining (n = 2/12) 
(Figure 5.3.3). At 50% epiboly 73% of the rab5a2 overexpressing embryos (n = 
8/11) show strong additional staining in the animal pole of embryos stained for gsc 
expression, while 18% of the experimental embryos showed fainter (n = 2/11), 
additional gsc staining. At this stage, most of the embryos, stained for ntl expression, 
showed no additional staining (n = 11/12). However 67% of rab5a2 RNA injected 
embryos (n = 8/12) showed ntl staining which began to encroach on the animal pole 
from its marginal domain, showing a thicker band of staining round the embryo than 
is seen in MO buffer injected embryo (Figure 5.3.3).
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Figure 5.3.1: A shield stage 1.5ng rab5a2 overexpressing embryo compared to shield stage MO buffer injected embryo. Lateral 
view of 24hpf 1.5ng rab5a2 overexpressing embryo compared to 24hpf MO buffer injected embryo. Lateral view of 5dpf 1.5ng 
rab5a2 overexpressing embryo compared to 48hpf MO buffer injected embryo
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Figure 5.3.2: Animal view of expression patterns of the nodal and dorsal 
markers in control injected and rab5a2 overexpression embryos at shield 
stage.
165
Characterization of Zebrafish Rab5a2
At 70% epiboly, 39% of rab5a2 RNA injected embryos show strong additional gsc 
expression in the animal pole (n = 5/13), while 23% show weak additional gsc 
expression (n = 3/13) when compared to MO buffer injected embryos (Figure 5.3.3). 
ntl expression at this stage in rab5a2 RNA injected embryos is seen in the margin 
comparable with MO buffer injected embryos. In addition, there is strong staining in 
the animal pole in 39% of the experimental embryos (n = 5/13), with similar but 
weaker staining seen in another 31% of experimental embryos (n = 4/13) (Figure
5.3.3). The 90% epiboly rab5a2 RNA injected embryos continue to show 
mislocalized expression of both gsc and ntl with additional staining when compared 
to MO buffer injected embryos (Figure 5.3.3). At this stage, the number of embryos 
that have this unusual gsc staining has fallen to 50% (n = 5/10) while those that have 
the strong unusual ntl staining remains at around 70% (n = 7/10). The chd expression 
pattern is unchanged in experimental embryos, compared to the MO buffer injected 
embryos in 30% (n = 12), 50% (n = 11), 70% (n = 10) and 90% (n = 10) epiboly. 
However, the strength of this expression appears stronger in rab5a2 RNA injected 
embryos compared to MO buffer injected embryos at the 70% (n = 10/10) and 90% 
(n = 10/10) epiboly stages (Figure 5.3.3).
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Figure 5.3.3: Showing the expression patterns of gsc, ntl and chd in control and Rab5a2 overexpressing embryos at 30%, 
50%, 70% and 90% epiboly. gsc expressing embryos are shown as animal pole views as are 30% epiboly ntl expressing 
embryos and 30% and 50% chd expressing embryos. The remainder of the embryos are shown as a side view for 
improved visualisation of expression patterns
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5.3.3 The effect o f constitutively active Rab5a2 on the zebrafish 
embryo
Much of the experimental work described in the literature describes the use of a 
constitutively active version of Rab5 for overexpression experiments. O ne base 
change in the injected RNA ensures that the Rab is locked in its GTP-bound form 
and so constantly active. The dose of wild-type rab5a2 RNA, needed to elucidate an 
overexpression phenotype was high; this is due to the many regulators of Rab 
function found in vivo eg. GAP, GDI etc. In order to overexpress wild type Rab 
protein, these regulators must be overcome by superior numbers of R ab protein. 
However, injection of constitutively active rab5a2 RNA (da-rab5a2 R N A ) would 
not require such a large dose of RNA as it is locked in the GTP-bound form  and, 
therefore, would be little affected by regulatory factors. Embryos injected with 
increasing doses of the da-rab5a2 RNA were examined.
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Figure 5.3.4: Comparison of different doses of da-rab5a2 RNA and the effect it 
has on 24hpf embryos.
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Injection of lOpg of constitutively active rab5a2 RNA resulted in no phenotype 
being observed (n = 10/10, n2 = 28/28) and the embryos were comparable with MO 
buffer injected embryos (n = 51/51) (Figure 5.3.4). Injection of 50pg of da-rab5a2 
RNA showed a small percentage of embryos with a phenotype similar to that seen in 
wild-type rab5a2 RNA injected embryos (nl = 1/39, n2 = 1/15), however, 
approximately 39% died (nl = 2/39, n2 = 11/15), while the remainder looked normal 
(nl = 36/39, n2 = 3/15). When the dose of da-rab5a2 RNA was increased to 75pg, 
again, only a small percentage, approximately 4% (nl = 7/85, n2 = 0/19), showed a 
phenotype similar to the wild type rab5a2 RNA overexpression, while 40% of the 
da-rab5a2 overexpressing embryos died (nl = 67/85, n2 = 0/19 ). At lOOpg over 
70% of the da-rab5a2 RNA injected embryos died (nl = 86/91, n2 = 11/23), with 
only 8% showing a wild type rab5a2 RNA overexpression phenotype (nl = 0/91, n2 
= 4/23) (Figure 5.3.4). Although the percentage of embryos showing a phenotype 
seemed to increase in relation to the percentage of normal embryos, the actual 
number that survived became smaller. This reduction in viable embryo numbers, 
coupled with the fact that constitutively active rab RNA has been artificially 
modified, resulted in the decision not to use this da-rab5a2 RNA for further studies 
but to use the wild type rab5a2 RNA.
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5.4 The effect of Rab5a2 on exogenous Nodal 
signalling
Examining the effect of Rab5a2 on exogenous nodal signalling enables the events 
that induce nodal signalling in the developing embryo to be separated from those that 
transport the nodal signal. Squint has been proposed as a morphogen (Chen and 
Schier 2001) acting directly on target cells over a distance while Cyclops signals in a 
more localized manner, because of these difference in signalling action it is 
important to look at both of these nodal proteins. To examine the role of exogenous 
nodal signalling, RNA encoding either sqt or eye was injected, along with the lineage 
label biotinylated-dextran into a single cell at the centre of the animal pole of 
embryos at the 128 cell stage. These embryos were allowed to develop for three 
hours and then fixed for ntl and gsc expression analysis. The daughter cells of the 
original injected cell will all produce the nodal signal derived from the RNA with 
which the original cell was injected. These daughter cells will also stain for 
biotinylated-dextran allowing accurate visualisation of those cells producing the 
nodal signal. Injection into the middle of the animal pole avoids the exogenous 
produced gsc or ntl expression from encroaching on the area of the embryo where 
endogenous expression of gsc or ntl is evident. These single cell injections were 
performed into embryos injected at the one cell stage with either a control MO, 5ng 
of rab5a2 MO or 1.5ng of rab5a2 RNA.
5.4.1 Injection o f 5pg o f squint into a single cell of 128 cell stage 
embryo
Control MO injected embryos showed gsc expression close to the cells producing Sqt 
(Figure 5.4.1) (n = 15/19) with possible faint expression in an additional three 
embryos (n = 3/19). The rab5a2 MO injected embryos showed a considerably fainter 
but broader band of gsc expression (n = 8/10) (Figure 5.4.1). In embryos 
overexpressing rab5a2 gsc expression was similar to that seen in control embryos (n 
= 6/12) with faint expression in an additional four embryos (Figure 5.4.1). Control 
MO injected embryos showed expression of ntl in a broad ring around the Sqt
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producing cells (n = 25/25) (Figure 5.4.1). The rab5a2 MO injected embryos showed 
reduced intensity of expression of ntl (n = 4/14), whilst there was very faint possible 
expression in an additional seven embryos (Figure 5.4.1). In embryos overexpressing 
Rab5a2, there was strong ntl expression, similar to that seen in control embryos 
(n=7/8) (Figure 5.4.1).
Control rab5a2 MO rab5a2 RNA
Figure 5.4.1: Showing the expression of gsc and ntl in control, rab5a2 MO and 
rab5a2 RNA injected embryos when 5pg of sqt RNA are injected into the 
animal pole of 128 cell stage embryos (where blue is gsc or ntl expression and 
brown the cells injected with sqt RNA).
5.4.2 Injection o f lOpg o f squint into a single cell of 128 cell stage 
embryo
Control injected embryos showed exogenous gsc expression close to the cells 
producing the Sqt signal (n = 7/11) (Figure 5.4.2) with reduced expression in the 
remainder, ntl expression in the control embryos was seen as a thick band 
surrounding the Sqt producing cells (n = 7/8) with reduced expression in the 
remaining embryo. The rab5a2 MO injected embryos showed a broad band of faint 
gsc expression (n = 3/12), while some embryos showed very faint staining (n =2/12).
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However, over half of the embryos showed no gsc expression (n = 7/12). The rab5a2 
MO injected embryos showed faint ntl expression (n = 5/21) an additional eight 
embryos showed very faint to no expression whilst the remaining eight showed no 
staining (Figure 5.4.2). Exogenous gsc expression in rab5a2 overexpressing cells 
was comparable to control exogenous expression of gsc in (n =10/13). The remaining 
three embryos showed no gsc expression. Exogenous expression of ntl in the rab5a2 
overexpressing embryos showed expression comparable to controls (n = 12/21) with 
reduced expression in an additional seven embryos. The remaining embryos showed 
no ntl expression (Figure 5.4.2).
R ab5a2 RNA
Figure 5.4.2: Showing the expression of gsc and ntl in control, rab5a2 MO and 
rab5a2 RNA injected embryos when lOpg of sqt RNA are injected into the 
animal pole of 128 cell stage embryos (where blue is gsc or ntl expression and 
brown the cells injected with sqt RNA).
C ontrol
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5.4.3 Injection of 7pg of cyclops into a single cell of 128 cell stage 
embryo
Control MO injected embryos showed gsc expression close to the cells producing 
Cyclops (n = 7/10) (Figure 5.4.3) with fainter staining in an additional three 
embryos. The rab5a2 MO injected embryos showed a fainter expression of gsc than 
in controls (n = 6/19), with the remainder showing no staining (n = 13/19). rab5a2 
overexpressing embryos showed no expression of gsc in half of the embryos (n = 
6/12), three embryos showed expression comparable to controls while the last three 
showed faint expression (Figure 5.4.3). Control injected embryos showed a band of 
ntl expression thinly round the Cyclops producing cells (n = 8/9). rab5a2 MO 
injected embryos showed no ntl expression in nearly half the embryos (n = 7/15) 
while four showed possible very faint staining and the remainder showed ntl 
expression comparable with controls. The rab5a2 overexpressing embryos showed 
ntl expression comparable to controls in the majority of embryos (n = 10/14) with the 
remaining four showing no visible ntl expression (Figure 5.4.3).
Control rab5a2 Mo rab5a2 RNA
Figure 5.4.3: Showing the expression of gsc and ntl in control, rab5a2 MO and 
rab5a2 RNA injected embryos when 7pg of eye RNA are injected into the animal 
pole of 128 cell stage embryos (where blue is gsc or ntl expression and brown the 
cells injected with eye RNA).
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5.5 Additional functions for Rab5a2 in the developing 
embryo
5.5. /  The contribution o f Rab5a2 in the YSL
A source of many patterning and signalling factors, including Nodal is the YSL; it 
was, therefore important to ascertain whether Rab5a2 plays a role in the YSL. In 
order to achieve this, rab5a2 MO was injected into the yolk cell of 1000 cell stage 
embryos. Injection into the yolk at this stage is thought to ensures that the MO only 
has an effect in the yolk as the cells of the embryo after the four cell stage no longer 
enable free movement of RNA between cells (Hsu et al., 2006).At 24hpf the rab5a2 
MO injected embryos showed slightly curved tails compared to control. By 48hpf, 
the rab5a2 MO injected embryos looked dramatically different from controls; 
retaining the curved tails seen at 24hpf they now showed a thinner axis with reduced 
pigment (Figure 5.5.1 B) when compared to controls (Figure 5.5.1 A). Most 
dramatically though, the rab5a2 MO injected embryos showed an accumulation of 
what appeared to be dead cells on the part of the yolk attached to the embryo. This 
section of the embryos in controls is the site of the developing heart with blood being 
observed on the dorsal part of the yolk (Figure 5.5.1 C). In addition, this section will 
give rise to organs such as the gut kidney and liver. In the rab5a2 MO injected 
embryos there is no apparent heart (Figure 5.5.1 D and E) and the embryos die at 
approximately 3dpf.
Control Rab5a2 MO
Rab5a2 MORab5a2 MO
Control
Figure 5.5.1: Lateral view of embryos injected with rab5a2 MO at 1000 cell stage (B) compared to those injected 
with a control MO at 1000 cell stage (A). Magnified images of the head and yolk of embryos when injected with 
rab5a2 MO at 1000 cell stage under reflected and direct lighting (D and E) compared to those injected with a 
control MO a_ 1117 cell stage (C).7
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5.5.2 Expression of p-catenin in rab5a2 MO injected embryos
(3-Catenin localizes to the future dorsal side of the embryo early in development and 
is one of the earliest DV markers. The rab5a2 MO injected embryos showed not only 
a lack of nodal target genes but also a lack of eye expression. This suggested that, 
rab5a2 may affect a factor upstream o f nodal signalling. It is, therefore, possible that 
Rab5a2 may be involved in localization of p-Catenin. In order to investigate, this, 
control and rab5a2 MO injected embryos were stained, using a P-Catenin antibody 
conjugated to biotin. The control embryos showed a gradient of staining emanating 
from the dorsal side of the embryo. H alf of the rab5a2 MO injected embryos showed 
no staining while three out of 12 o f  the embryos showed staining all over the 
embryos, the remainder were similar to controls (Figure 5.5.2).
Control I rab5a2 MO (6/12) I rabSa2 MO (3/12)
Figure 5.5.2: Animal view of p-catenin expression in control injected and rab5a2 
MO injected embryos at shield stage.
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6.1 Introduction
Microarrays are a powerful tool which can be used to compare, not only the 
expression of thousands of gene within a sample but, also, between multiple samples. 
The arrays comprise ‘spots’ of DNA, RNA or oligonucleotides (probes), which 
correspond to genes, immobilized on slides or chips made from glass, silicone or 
plastic. A sample of RNA or cDNA is labelled with a fluorescent dye and hybridized 
to the microarray. The ‘spots’ on the slide then bind any complimentary RNA (or 
cDNA) in the sample in a dose dependent manner. The expression of these genes can 
then be quantified.
6.1.1 Why Microarray Rabs?
There are currently over 80 zebrafish Rabs, some of these as investigated in this 
thesis have very specific phenotypes (Chapter 3.). However, many show similar and 
complex phenotypes which include brain cell death, shortened AP axis and irregular 
somites. Others have shown no morphological phenotype. The similar and complex 
phenoypes seen in many of the Rabs makes it very difficult to identify any specific 
pathway which is affected in MO injected embryos while the presence of MO 
injected embryos with essentially wild type phenotypes, substantially compounds the 
problem. In these Rabs which show no phenotype a pathway may be affected, 
however, it is possible the loss of this Rab in ideal conditions is compensated for. 
Microarrays provide an efficacious method of screening all these Rabs and 
elucidating which pathways they affect.
6.1.2 The Microarray
The microarray used in the following experiment was a custom made oligonucleotide 
array designed specifically to investigate zebrafish developmental genes. Each slide 
contained 1898 separate oligos which were 65 base pairs in length and were carefully 
selected so that the 65 bases were unique to the particular gene they were targeting. 
The genes on the array included XPAT transcripts from ZFIN, approximately 300
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handpicked transcripts chosen by the Stemple lab, 213 transcripts thought to be 
involved in cell -  cell signalling chosen by the Wright lab at the Sanger Institute and 
109 housekeeping transcripts. These oligos were then immobilized onto a glass slide 
by an array spotting robot; each oligo was spotted twice to ensure greater 
reproducibility. This custom oligoarray was probed using two dyes enabling the 
control RNA samples to be labelled with one dye and hybridized to an array slide 
whilst the experimental RNA samples were labelled with a second and hybridized to 
the same array slide (Figure 6.1.1). Placing both control and experimental samples on 
the same array slide results in reduced experimental variation. To ensure any 
experimental variations resulting from differences in the dyes is minimised, the dyes 
were swapped resulting in one slide with Cy5 labeled control and Cy3 labeled 
experimental RNA and a second slide with Cy3 labeled control and Cy5 labeled 
experimental RNA.
6.1.3 The Experiment
In order to obtain samples for the array 300, single cell stage embryos were collected 
from three pairs of parent fish resulting in three groups of 300 embryos. Replicate 
parent fish came from the same line to reduce variation. Each clutch of 300 embryos 
is split into two groups with 150 embryos in each dish. One of the groups from each 
parent is injected with 6ng of control MO. The second is injected with 5ng of rab5a2 
MO. The embryos are left to develop at 28°C until they reached 30% epiboly, at 
which point 65 embryos are then removed from each of the control embryo injected 
groups and placed in a 1.5ml Eppendorf tube. The embryos were washed three times 
with zebrafish egg water. All the water is removed and the embryos are frozen in dry 
ice for 20minutes before being stored at -80. The same procedure is observed for the 
rab5a2 MO injected embryos. At shield stage a further 65 embryos were removed 
from both the control injected embryo groups and the rab5a2 MO injected embryos. 
The method employed for the 30% epiboly stage embryo is repeated for these 
samples. The remaining embryos are left to develop until 24hpf and their phenotype 
checked ensuring that there are no anomalies in these embryos and that they show 
the phenotype expected for these embryos. Embryos were frozen at 30% epiboly and 
shield stage enabling comparisons to be made between the former stage at which
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there is little visual difference between control and MO injected embryos and shield 
stage when the phenotype becomes apparent in the rab5a2 MO injected embryos.
Figure 6.1.1: Image capture of one of the custom made oligonucleotide 
microarray slides showing hybridization of control and rab5a2 samples as two 
colour data, (blue = cy5, red = cyc3 , other colours are a combination of the two 
samples)
RNA is isolated directly from the frozen samples by homoginising in trizol and the 
RNA quantified. Given the early stage of these embryos it was necessary to amplify 
the RNA (see Methods section 2.3.3).
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6.2 Results
6.2.1 Establishing an appropriate fold
The fold change for each gene that changes in the microarray experiment is plotted 
by the computer programme Genespring. The programme will then only show genes 
that change above the fold threshold, in the case of Figure 6.2.1 this is a two fold 
change. The blank area between the lines represents the majority of the genes while 
those points outside the lines represent those genes that changed by two fold or more. 
Due to the large number of genes that changed at the two fold level the fold change 
threshold was increased to three fold.
X-axis: rab 5a2  MOKO d y e sw a p  so lv e  
Y-axis rab 5a2  MOKO d y e sw a p  so lv e
C olored  by rab 5a2  MOKO d y esw a p  s  
G e n e  List 16v1 ?-2fold (255 )
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Figure 6.2.1 : Graph plotted in the microarray analysis programme Genespring 
showing the number of genes that changed more than two fold when rab5a2 MO 
injected embryos were compared to control embryos.
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6.2.2 The top 50 genes that increased and decreased in rab5a2 MO 
injected embryos when compared to controls.
After analysis by Genespring the data was tabulated with the accession number from 
NCBI, the oligo number and the fold change of that oligo. The accession number was 
then identified and the corresponding gene tabulated. Since most genes have two 
oligos the list was examined for a second oligo and the fold change for both 
averaged. Dr Wright’s oligos were also checked for duplicates with known genes on 
the slide, if these matched the fold change was again averaged. Due to the large 
number of genes that changed more than 3 fold the top 50 genes that increased and 
the top 50 genes that decreased at each stage were tabulated with their average fold 
change, the name of the gene and the number if oligos for that gene that changed 
(Tables 5.2.1-5.2.4).
6.2.2.1 Expression changes at 30% Epiboly Stage
In the 30% epiboly stage embryos at the 3 fold stringency 382 genes changed in the 
rab5a2 MO injected embryos when compared to control embryos. 201 genes showed 
a decrease in activity in rab5a2 MO injected embryos compared to controls while 
181 showed an increase in gene activity in rab5a2 MO injected embryos when 
compared to controls. The top 50 genes that decrease and the top 50 genes that 
increase between rab5a2 MO injected embryos and control embryos at the 30% 
epiboly stage are presented in Table 6.2.1 and 6.2.2 respectively.
6.2.2.2 Expression changes at Shield Stage
In the shield stage embryos at the three fold stringency 426 genes changed in the 
rab5a2 MO injected embryos when compared to control embryos. 211 genes showed 
a decrease in activity in rab5a2 MO injected embryos compared to controls while 
215 showed an increase in gene activity in rab5a2 MO injected embryos when 
compared to controls. The top 50 genes that decrease and the top 50 genes that 
increase between rab5a2 MO injected embryos and control embryos at shield stage 
are presented in Table 6.2.3 and Table 6.2.4 respectively.
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Av. fold change No oligo's Description
0.13 1 T-box gene 16
0.17 3 trophoblast glycoprotein-like
0.19 2 bone morphogenetic protein 4
0.22 1 zic family member 3 heterotaxy 1 (odd-paired homolog)
0.22 1 keratin 4
0.23 2 SRY-box containing gene 2
0.25 1 ATPase, Na+/K+ transporting, alpha 1b polypeptide
0.26 2 T-box transcription factor TBX6
0.26 2 zgc:101612
0.27 2 fibroblast growth factor 8
0.28 2 U1 small nuclear ribonucleoprotein polypeptide A
0.29 1 UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5
0.30 1 Unknown
0.30 2 zgc:92414
0.30 2 Type I cytokeratin, enveloping layer
0.32 1 CCAAT/enhancer binding protein alpha
0.32 1 caudal type homeo box transcription factor 4
0.32 1 tyrosine 3-monooxygenase
0.33 2 chordin
0.33 1 fibroblast growth factor 24
0.33 1 methyl-CpG binding domain protein 3b
0.34 2 bonnie and Clyde
0.34 2 LIM homeobox 1b
0.35 2 Ved
0.35 1 fibroblast growth factor 19
0.36 1 mannosidase, beta A, lysosomal
0.36 2 protocadherin 8
0.37 1 tyrosyl-tRNA synthetase
0.37 2 gastrulation brain homeobox 1
0.37 1 peroxisomal biogenesis factor 3
0.38 2 mki67 interacting nucleolar phosphoprotein (human) -  like
0.38 3 deltaD (did),
0.39 2 zgc:101000
0.39 2 transgelin 2
0.39 1 AHA1, activator of heat shock ATPase homolog 1, like
0.40 1 hairy and enhancer of split related-7
0.40 2 solute carrier family 3, member 2 like
0.40 2 Vent
0.40 2 lymphocyte cytosolic plastin 1
0.40 2 ubiquitin-activating enzyme E1-domain containing 1
0.40 2 Wnt-11 protein precursor
0.40 2 Rab14
0.40 1 iroquois homeobox protein 1, a isofbrm 1
0.41 2 CB967 5- similar to Filamin A
0.41 1 glutamate-ammonia ligase
0.42 1 minichromosome maintenance protein 3
0.42 1 tumor protein p73-like isoform alpha 1
0.42 1 SRY-box containing gene 3
0.43 1 cysteine and glycine-rich protein 1
0.43 1 Homeobox protein Hox-B2a (Hox-B2)
Table 6.2.1: The fold change of the top 50 genes that decreased in rab5a2 MO
injected embryos at the 30% epiboly stage compared to control embryos.
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Av. fold change No oligo's Description
6.70 2 T-box 24
6.04 2 v-fbs FBJ murine osteosarcoma viral oncogene homolog
5.99 2 fbrkhead box 11
4.49 1 unc-45 homoiog B (C. elegans) (unc45b),
3.93 1 muscle segment homeobox E
3.91 2 claudin g (cldng),
3.71 2 Insulin gene enhancer protein ISL-2 (Islet-2).
3.69 2 Myoblast determination protein 1 homolog (Myogenic factor 1)
3.55 1 enolase 3, (beta, muscle)
3.53 2 heat shock protein 47
3.50 2 Homeobox protein Dlx6a (DLX-6)
3.43 2 matrix metalloproteinase 13
3.32 1 DIG0228_268
3.26 2 hemoglobin alpha embryonic-1 (hbael),
3.22 1 septin 9
3.11 2 insulin-like growth factor binding protein 1
3.10 2 Ribosome binding protein 1 homolog (dog)
3.06 2 H1 histone family, member X
3.01 2 Microphthalmia-associated transcription factor a (mitfa),
3.00 1 friend leukemia integration 1
3.00 2 Hypothetical protein
3.00 2 iroquois homeobox protein 7
2.99 2 Eomesodermin homolog
2.89 1 Aminolevulinate, delta-, synthetase 2
2.87 1 endothelium-specific receptor tyrosine kinase 2 (tie2),
2.83 1 hypothetical protein LOC405860
2.67 1 Ras homolog gene family, member E
2.65 1 CB1077 5- similar to Myosin Vb,
2.65 1 hemoglobin beta embryonic-1
2.64 1 SRY-box containing gene 31,
2.63 2 deltaA
2.61 1 myogenic factor 6
2.61 1 Forkhead box B1.1
2.56 2 suppressor of fused homolog (Drosophila) (sufu),
2.55 2 similar to CCCH zinc finger protein C3H-2
2.54 1 HHGP protein
2.53 1 Hypoxia-inducible factor 1 alpha inhibitor
2.52 1 hairy-related 5
2.49 1 bone morphogenetic protein 2b
2.46 2 transforming growth factor, beta receptor II (tgfbr2),
2.45 1 Bcl2-like
2.44 2 ATP synthase, H+ transporting, mitochondrial F0 complex, subunit c
2.43 2 LIM homeobox 8
2.41 2 four and a half LIM domains (fhl),
2.37 1 eyes absent homolog 1 (eyal),
2.34 2 dachshund a (dacha),
2.34 1 Ictacalcin
2.34 1 CUG triplet repeat, RNA-binding protein 1
2.32 1 growth associated protein 43 (gap43),
2.32 2 muscle-specific beta 1 integrin binding protein 2
Table 6.2.2: The fold change of the top 50 genes that increased in rab5a2 MO
injected embryos at the 30% epiboly stage compared to control embryos.
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Av. fold change No oligo's Description
0.07 2 T-box gene 6
0.07 1 zic family member 1 (odd-paired homolog) (zic1),
0.09 2 membrane protein, palmitoylated 1 (mpp1)
0.14 2 Carbonic anhydrase (Carbonate dehydratase)
0.17 3 Trophoblast glycoprotein-like
0.17 2 myeloid ecotropic viral integration site 3
0.20 1 myeloid ecotropic viral integration 1 (m eisl),
0.20 1 LTP4
0.21 2 GLI2a
0.21 2 Zgc:92414
0.21 2 myogenic factor 5
0.23 2 Macrophage stimulating 1 (hepatocyte growth factor-like)
0.23 2 type I cytokeratin, enveloping layer
0.23 2 Zgc:101612
0.23 1 midkine-related growth factor b
0.24 2 chordin (chd),
0.24 1 Keratin 4 (krt4),
0.24 2 Mki67 (FHA domain) interacting nucleolar phosphoprotein (human) -  like
0.25 1 Caudal type homeo box transcription factor 4 (cdx4),
0.25 2 Beta-2-microglobulin precursor
0.26 2 forkhead box C1b (foxclb),
0.26 2 protocadherin 8 (pcdh8),
0.27 1 zic family member 3 heterotaxy 1 (odd-paired homolog)
0.27 2 Rab14
0.27 1 tyrosine 3-monooxygenase
0.27 1 mutL homolog 1, colon cancer, nonpolyposis type 2
0.28 2 Clone CB926 5- similar to Gem-associated protein 5
0.28 1 minichromosome maintenance protein 3
0.29 2 Hypothetical protein LOC378998
0.29 2 Bone morphogenetic protein 4
0.29 1 seryl-tRNA synthetase (sars),
0.30 1 Kinesin family member 11 (kif11),
0.30 2 Oep
0.31 2 U1 small nuclear ribonucleoprotein polypeptide A
0.31 1 DIG04101903
0.31 2 Ved
0.31 2 Lymphocyte cytosolic piastin 1
0.31 2 Roundabout homolog 3 (robo3),
0.32 2 cDNA clone CB473 5
0.32 2 Sine oculis homeobox homolog 3b
0.33 1 Apolipoprotein A-l precursor (Apo-AI) (ApoA-l)
0.33 2 Sp5 transcription factor-like
0.33 3 delta D (did)
0.34 2 hypothetical protein LOC550434
0.35 1 fibroblast growth factor 19
0.35 2 interleukin 17 receptor D (ill 7rd),
0.36 2 Sonic hedgehog protein precursor (SHH) (VHH-1)
0.36 1 3-beta-hydroxysteroid dehydrogenase
0.36 2 Hypothetical protein.
0.36 1 retinol dehydrogenase 10
Table 6.2.3: The fold change of the top 50 genes that decreased in rab5a2 MO
injected embryos at the shield stage compared to control embryos.
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Av. fold change No oligo's Description
11.89 1 bomeo box B5a
8.90 2 claudin g
7.37 1 MAD homolog 3
7.06 2 neogenin 1
6.46 1 forkhead box B1.1
5.98 1 tyrosyl-tRNA synthetase
5.86 2 protein tyrosine phosphatase, non-receptor type 2, like
5.64 2 v-fos FBJ murine osteosarcoma viral oncogene homolog
5.37 1 sp8 transcription factor
5.14 2 forkhead box 11
4.95 1 dachshund a
4.37 2 ribosome binding protein 1 homolog (dog)
4.22 2 T-box 24
4.08 2 suppressor of fused homolog
3.91 1 Homeobox protein Hox-B5b (Hox-B5-like) (Zf-54)
3.89 1 enolase 3, (beta, muscle)
3.87 2 Insulin gene enhancer protein ISL-2 (Islet-2)
3.64 1 orthodenticle homolog 5
3.52 2 TSC22 domain family 2
3.50 2 zgc:86701 (zgc:86701),
3.50 1 ras homolog gene family, member E
3.43 2 selenoprotein P, plasma, 1b
3.43 1 ATPase, Na+/K+ transporting, alpha 1a.2 polypeptide
3.41 2 musashi homolog 2
3.40 2 Ena-vasodilator stimulated phosphoprotein
3.39 2 linker histone H1M
3.36 2 fused toes homolog
3.36 2 H1 histone family, member X
3.29 3 epithelial V-like antigen 1
3.19 2 Homeobox protein Dlx5a (DLX-4)
3.16 2 Heat shock protein 9B
3.15 2 Epididymal secretory protein E1 precursor
3.15 2 phenylalanine hydroxylase
3.12 2 similar to CCCH zinc finger protein C3H-2
3.10 2 jun B proto-oncogene
3.10 2 unc-45 (C. elegans) related
3.09 1 jagged 1b
3.07 2 zgc:101900 (zgc:101900)
3.07 2 DIX domain containing 1
3.05 1 septin 9
3.04 1 Paired-like homeodomain transcription factor 2a
3.01 2 insulin-like growth factor binding protein 1
2.94 2 dachshund b
2.92 2 translocating chain-associating membrane protein
2.82 3 deltaB
2.79 1 endothelium-specific receptor tyrosine kinase 2
2.77 2 Eomesodermin homolog
2.73 2 Homeobox protein Dlx6a (DLX-6)
2.68 1 T-box 20
2.68 2 Ribonucleoside-diphosphate reductase M2 chain
Table 6.2.4: The fold change of the top 50 genes that increased in rab5a2 MO
injected embryos at the shield stage compared to control embryos.
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6.2.3 Validation o f Results
RT-PCR was used to validate the results of the microarray. The remainder of the 
uncoupled RNA from the microarray was used in conjuction with fluorescent taqman 
oligonucleotides for some of the genes that were shown to change and others that 
were not. The oligos used were for the genes chordin, patched 2.1, transferrin 
receptor (tr), wnt8a, fgfS, ntl, gsc, bmp4, bmp2, Iftyl, lfty2, sqt, copa. The data for 
these was then plotted in a box and whisker plot showing the fold difference between 
rab5a2 MO injected embryos and control embryos. Since not all the genes could be 
put on a single plate, three different plates and three different dilutions were made. 
Therefore the housekeeping gene tr is plotted three times (blue boxes on Figure 6.2.3 
and Figure 6.2.4) on each graph, to evaluate the reproducibility of each dilution plate. 
The spread of the data seen in tr receptor expression (Figure 6.2.3 and Figure 6.2.4) 
for each plate dilution made it difficult to evaluate the differences between each 
plate. All the tr receptor expression data did fall within the same range but this range 
was extensive. The 30% epiboly data range for tr receptor was less extensive and 
suggests that at least for the 30% epiboly data each plate dilution was comparable to 
the other plate dilutions (Figure 6.2.3). tr and copa are described as housekeeping 
genes suggesting that their expression does not change (Batista et al., 2004). The 
microarray data showed that at 30% epiboly the expression of transferrin a, a tr 
ligand, was slightly increased (appendix) however there was no change at shield 
stage. RT-PCR data for tr expression both at 30% epiboly and (Figure 6.2.3) at shield 
stage (Figure 6.2.4) is inconclusive with no obvious fold change, copa showed little 
change in expression, however the median for the 30% data set fell below the one 
fold change boundary suggesting some weak support for a decrease in gene 
expression (Figure 6.2.3) although this is inconclusive. The microarray data showed 
a slight increase in copa gene expression in rab5a2 MO injected embryos at the 30% 
epiboly stage; however there was no change at shield stage (appendix).
The RT-PCR data set for bmp2b spans an extensive range at the 30% epiboly stage, 
thus proving inconclusive (Figure 6.2.3). The microarray data shows a large increase 
in bmp2b expression in rab5a2 MO injected with the gene appearing in the top 50 
genes that increase at the 30% epiboly stage (Table 6.2.2). At shield stage the
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microarray data continues to show an increase in bmp2b gene expression but to a 
lesser extent (appendix). The RT-PCR data for bmp2b at shield stage however 
appears not to change (Figure 6.2.4).
chd and bmp4 both showed dramatic decreases in gene expression in rab5a2 MO 
injected embryos in the RT-PCR data both at 30% epiboly and shield stage (Figure
6.2.3 and Figure 6.2.4). This correlates with the data seen in the microarray where 
both chd and bmp4 appear in the top 50 genes that decrease at both the 30% epiboly 
stage and shield stage (Table 6.2.1 and Table 6.2.3). The decrease in chd expression 
also corresponds to the abolition of chd expression seen in ish analysis reported in 
chapter 4. fgf8  also shows a decrease in gene expression of rab5a2 MO injected 
embryos in the RT-PCR data at both the 30% epiboly stage and shield stage (Figure
6.2.3 and Figure 6.2.4) corresponding to the substantial decrease in fgf8 gene 
expression seen in the microarray data at the 30% epiboly stage (Table 6.2.1). The 
microarray data did not show any difference for fgfS  expression at shield, however, 
this could be a result of the high fold change threshold set.
The nodal target genes gsc and ntl showed a trend towards decreased expression in 
rab5a2 MO injected embryos in the RT-PCR data set at both the 30% epiboly stage 
(Figure 6.2.3) and shield stage (Figure 6.2.4). ntl expression was also reduced in the 
microarray data at the 30% epiboly stage (appendix), while gsc and ntl expression 
have been shown by ish analysis to be reduced by ish analysis in rab5a2 MO 
injected embryos (Chapter 5 Figure 5.2.2). The nodal target gene flh  was also 
reduced in rab5a2 MO injected embryos in chapter 5 (Figure 5.2.2) in addition to 
being reduced in the 30% epiboly stage microarray data (appendix). Interestingly the 
expression of nodal sqt in rab5a2 MO injected embryos did not reach the three fold 
change threshold in the microarray data and the RT-PCR data is inconclusive 
however there is a weak trend towards decreased expression at the 30% epiboly stage 
(Figure 6.2.3).
Finally wnt8 and w ntll both showed decreased expression in rab5a2 MO injected 
embryos in the microarray data, w ntll showed a significant decrease at the 30% 
epiboly stage (Table 6.2.1) but did not reach the fold change threshold at shield 
stage, however expression of w ntll at shield stage in the rab5a2 MO injected
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embryos was shown by ish analysis to be decreased (Figure 6.2.2). wnt8a expression 
was decreased in both 30% and shield stage MO injected embryos in the microarray 
data (appendix) and the RT-PCR data (Figure 6.2.3 and Figure 6.2.4).
Control Rab5a2 MO
writ 11
Figure 6.2.2: ish analysis of w ntll expression in rab5a2 MO injected embryos 
compared to control embryos at shield stage.
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Figure 6.2.3.: Box and whisker plot showing the fold change of gene expression 
in rab5a2 MO injected embryos when compared to control embryos at the 30% 
epiboly stage. Where the upper and lower bounds of the box represent the 
upper and lower quartiles respectively, the line that bisects the box represents 
the median and the whiskers extend 1.5 times the inter-quartile range beyond 
the 25% and 75% quartiles (boxes). The red dotted line represents the point at 
which there was no change in expression and the blue boxes show tr.
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Figure 6.2.4: Box and whisker plot showing the fold change of gene expression 
in rab5a2 MO injected embryos when compared to control embryos at shield 
stage. Where the upper and lower bounds of the box represent the upper and 
lower quartiles respectively, the line that bisects the box represents the median 
and the whiskers extend 1.5times the inter-quartile range beyond the 25% and 
75% quartiles (boxes). The red dotted line represents the point at which there 
was no change in expression and the blue boxes show tr.
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6.2.4 Identifiction o f groups o f genes with similar function whoose 
expression changed with knock down o f rab5a2.
The top 50 genes that increased at the 30% epiboly stage were grouped according to 
their gene ontology (GO) terms (www.geneontology.org). This is a database of genes 
from different animals that have been given standardized terms to describe their 
function, location and biological process. This enables all known genes with know 
functions, locations and biological processes to have standardized terms enabling 
faster and more accurate comparisons between genes and pathways and animals. The 
top 50 genes that decreased and increased at the 30% epiboly stage and the top 50 
that decreased and increased at the shield stage were also grouped according to their 
GO terms. These groups were then displayed in pie charts (Figures 6.2.5 -  6.2.8).
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6.2.4.1 Groups of gen es that decreased at 30% epiboly stage
The majority of the genes that decreased at the 30% epiboly stage had either no gene 
ontology or the gene function was unknown. The majority of genes with known 
function are involved in transcription whilst genes involved in DV patterning are also 
significantly represented (Figure 6.2.5).
Unknown
Protein Translation
Transcription
Migration
Figure 6.2.5: Pie chart showing the gene ontology biological processes of the top
50 genes that decreased in rab5a2 MO injected embryos at the 30% epiboly
stage.
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6.2.4.2 Groups of g en es that increased at 30% epiboly stage
The majority of genes that increased were either unknown or had unknown function 
in the gene ontology database. As with the genes that decreased the majority of genes 
with known gene ontology function are involved in transcription. Interestingly 
ranked joint forth are genes involved in DV patterning (Figure 6.2.6).
Transcription
Figure 6.2.6: Pie chart showing the gene ontology biological processes of the top
SO genes that increased in rab5a2 MO injected embryos at the 30% epiboly
stage.
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6.2.4.3 Groups of genes that decreased at shield stage
In the top 50 genes that decreased at shield stage the majority had unknown function 
in the gene ontology data base or were unknown genes. Interestingly the majority of 
known genes that decreased at shield stage were implicated in DV patterning while 
those genes involved in transcription were ranked third (Figure 6.2.7).
Unknown
Biosynthesis
different,*a(jon
Figure 6.2.7: Pie chart showing the gene ontology biological processes of the top
50 genes that decreased in rab5a2 MO injected embryos at shield stage.
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6.2.4.4 Groups of genes that increased at shield stage
In the top 50 genes that increased at shield stage the majority again had unknown 
function in the gene ontology data base or were unknown genes. The majority of 
known genes that increased appear to be implicated in transcription, with those 
involved in protein processing ranking third. Interestingly the number of genes 
involved in DV patterning at shield stage, compared to 30% epiboly stage, appeared 
to have fallen resulting in the DV patterning genes being ranked at the bottom 
(Figure 6.2.7).
Unknown
Transcription
Figure 6.2.8: Pie chart showing the gene ontology biological processes of the top
50 genes that increased in rab5a2 MO injected embryos at shield stage.
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7.1 Characterization of Rab5a2
In total, 37 rab genes have been screened by knocking down the rabs using 
oligonucleotide MOs. Those rabs screened include members of the rabl, rab6, rab7, 
rab8, rabl 1 and all the members of the rab5 family, genes whose homologues in 
yeast are considered essential because of their lethality when knocked-down. rab5a2 
is the only rab gene in zebrafish which, when knocked-down, causes death before 
24hpf.
In 1996, the Tubingen screen for new zebrafish mutants uncovered four zygotic 
mutants that affect epiboly. The most severe of these, hab, resulted in death before 
24hpf (Kane et al., 1996; McFarland et al., 2005). Subsequently, it was shown that 
all these mutants resulted from mutations in E-cadherin (Kane et al., 2005). E- 
cadherin has been shown, in conjunction with Rab5c, to be responsible for Wntl l ’s 
function in cell cohesion during zebrafish gastrulation. The hab mutant is presently 
the only known zebrafish epiboly mutant. Although there is no evidence for E- 
cadherin involvement in the rab5a2 MO injected phenotype, w ntll was seen to be 
decreased in the microarray data (Figure 6.2.1) for the rab5a2 MO injected embryos. 
Disrupted cell adhesion may be responsible for the rougher appearance of the 
blasdoderm in rab5a2 MO injected embryos. A loss of adhesion between the 
blastoderm cells and the yolk may also be responsible for the liquid observed 
building up between the yolk and the blastoderm in the rab5a2 MO injected embryos 
(Figure 5.2.1). Interestingly, the homophilic cell adhesion gene protocadherin8 was 
shown by the microarray data to be decreased in rab5a2 MO injected embryos 
(Figure 6.2.1 and 6.2.3).
The reduction of Nodal signalling seen in the rab5a2 MO injected embryos (Figure
5.1.2 and 5.2.2) implies a role for Rab5a2 in nodal signalling. This involvement of 
rab5a2 with zebrafish signalling factors is not without precedent, as zebrafish rab5 
has been shown to play a role in the effective signalling range of Fgf8 (Scholpp and 
Brand, 2004). A reduction of Rab5, using the reportedly Rab5 specific GAP RN-tre, 
showed an increase in the range of FgfB signalling. In contrast to these results, the
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microarray data suggests that rab5a2 reduces Fgf8 signalling (Figure 6.2.1). The 
microarray shows that, at 30% epiboly, fg/S  gene expression is severely reduced in 
rab5a2 MO injected embryos.
The contrast between Scholpp’s data and that reported by the microarray, may be due 
to the use of RN-tre, a Rab5 GTPase activation factor (GAP). Although it is reported 
to be a Rab5 specific GAP (Lanzetti et al., 2004), further research has shown that its 
Rab5 activity is weak and that RN-tre has a greater specific catalytic activity towards 
Rab41 (Haas et al., 2005). In addition, RN-tre is reported to act as a Rab5 effector, 
although this is also disputed in the later report. It is, therefore, unclear whether the 
increased Fgf8 signalling range is the result of a reduction in rab5. Scholpp (2004), 
however, addressed this issue by using antisense oligonucleotides to knock down 
rab5a function and showed that the result is the same as that seen for RN-tre.
The conflict beween those results seen in the microarray and Scholpp’s data may, 
therefore, lie in the dose of MO used. The dose of MO used for the microarray was 
chosen to ensure the embryos showed a phenotype (Section 5.2.1). This is higher 
than that used for Scholpp’s data, where the dose used would possibly have only 
been enough to reduce rab5a signalling by a small amount. Also, there is an 
additional rab5a gene and, although the clone used for overexpression analysis 
corresponds to rab5a2, the identity of the MO used is not stated. Scholpp implies 
that rab5c RNA is used in some of these experiments and on occasion refers to the 
mRNA as rab5. Therefore, it becomes unclear as to which RNA is being used, which 
could explain the conflict seen between the microarry data and Scholpp’s data, since, 
although both rab5a and rab5c share high sequence homology, their functional 
homology in zebrafish has not been fully explored. However, overexpression of 
rab5a mRNA from the clone that corresponds to rab5a2 does show reduction of 
Fgf8 signalling, allegedly corroborating the effect seen in the rab5a MO. The 
reduced range of Fgf8, seen in the rab5a overexpressing embryos, does not directly 
measure Fgf8 signalling range but uses expression of the Fgf8 target gene spry4. In 
addition, it measures this effect using exogenously supplied Fgf8. The rab5a MO 
used also looks at the target gene spry4 but uses endogenous Fgf8. This thesis 
suggests that the conflict might be reconciled if a potential dual role is performed by 
rab5a2 in early zebrafish development.
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Overexpression of rab5a2 results in expression of gsc and ntl in the animal pole of 
the embryo (Figure 5.3.2) in addition to the normal expression pattern of these genes 
seen at the margin. The rab5a2 overexpression embryos also show either 
accumulation of cells in the animal pole or an enlarged organiser (Figure 5.3.1). 
These results, coupled with the lack of visible organizer and the reduction of eye, chd 
and nodal responsive genes in rab5a2 MO injected embryos, suggest a role for 
Rab5a2 in DV patterning and the establishment of the organizer. Interestingly, many 
of the genes that decreased in rab5a2 MO injected embryos, when compared to 
controls, have been implicated in DV patterning (Fainsod et al., 1997; Fekany et al., 
1999; Furthauer et al., 2004). At shield stage, this became more pronounced. In 
addition, some of the genes that increased in rab5a2 MO injected embryos have also 
been implicated in DV patterning (Hild et al., 1999; Melby et al., 2000; Ramel et al., 
2005). This is unsurprising, since DV patterning is a balancing act between genes 
which promote or antagonise ventral and dorsal signals. Those which promote 
ventral domains and inhibit dorsal include bmp4, ved and vox. While those which 
promote dorsal and inhibit ventral include chd, fgfS  and fgf24.
In the rab5a2 MO injected embryos chd, fgf8 andfgf24 are all decreased. This would 
suggest that an increase in expression of ventralizing genes should be seen in the 
rab5a2 MO injected embryos due to a reduction of pro-dorsal genes inhibiting them. 
However, this is not the case. The microarray data shows that genes which decrease 
in rab5a2 MO injected embryos both promote and antagonise ventral and dorsal 
domains. Expression of bmp4, which is known to induce ventral fates within the 
embryo, was shown to be decreased (Figure 6.2.1 and 6.2.3) as was wnt8a another 
ventralizing gene. wnt8a has been shown to act through the transcriptional repressors 
ved and vent also shown to decrease in the microarray (Figure 6.2.1 and 6.2.3). ved 
and vent act to repress dorsalizing genes, their main target is chd but in addition, 
they repress gsc and flh. Therefore, a decrease in vent and ved expression should 
result in an increase in gsc, chd and flh  expression. However, the expression of these 
genes is also decreased (Figure 5.1.2 and 5.2.2). In addition if rab5a2 were 
responsible for the establishment of the organizer, the accumulation of cells in the 
animal pole of rab5a2 overexpressing embryos might be a second organizer, while 
the enlarged organizer would show an expansion of the dorsal domain However,
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there is no additional or expanded expression of chd in these embryos and a second 
axis is not apparent, which is what would be expected if the accumulation of cells in 
the animal pole were a second organizer. Instead, the embryos show mostly normal 
development, except for a severely reduced body axis (Figure 5.3.1). Interestingly, 
the microarray data shows that expression of the ventralizing gene bmp2b is 
increased in 30% epiboly stage rab5a2 MO injected embryos. It was also increased 
in shield stage MO injected, but not to the extent seen at the 30% stage. While, the 
RT-PCR was inconclusive. This increase in bmp2b is unsurprising, as those factors 
which inhibit bmp2b are down regulated in rab5a2 MO injected embryos. However, 
bmp4, which is also inhibited by these factors, is decresed (Table 6.2.1 and 6.2.3).
The transcriptional repressor genes vent, ved and vox prevent the transcription of boz 
and other dorsal genes, particularly chd but also gsc and flh  (Imai et al., 2001) 
(Kawahara et al., 2000a; Kawahara et al., 2000b; Melby et al., 2000; Shimizu et al., 
2002). All three genes vox, ved and vent are activated by wnt8 (Ramel and Lekven, 
2004), which has been suggested to regulate these genes in conjunction with bmp2b, 
since loss of function of vox, vent and ved phenocopies the wnt8/swr (bmp2b) double 
mutant phenotype (Ramel et al., 2005). Both vent and ved are decreased in rab5a2 
MO injected embryos, as is wnt8 but to a lesser extent (Appendix 1 and 2). 
Interestingly, analysis of vox expression in control and rab5a2 MO injected embryos, 
showed an increase in vox expression in the rab5a2 MO injected embryos (Figure 
7.1.1). The possible increase in vox expression may be due to the increase in bmp2, 
whilst the decrease in ved and vox may be the result of decreased wnt8 expression. 
Therefore, it is possible that the reduction in chd, flh  and gsc expression is the result 
of an increase in Bmp2b repression acting through vox. It has been suggested that 
chd is not needed if bmps are inactivated (Schulte-Merker et al., 1997), since chordin 
mutants have a ventralized phenotype (Chen and Schier, 2001), whereas 
bmp2b;chordin double mutants are dorsalized. This implies it is more likely that the 
increase in Bmp2b may be repressing chd, rather than decreased Chd effecting 
bmp2b.
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Control
Figure 7.1.1 : Difference in expression pattern of the homeobox gene vox in 
rab5a2 MO injected embryos when compared to controls.
bmp4 acts to specify the formation of ventral mesoderm and suppress neural fates, 
whilst bmp2b is described as necessary for mesoderm cell fate commitment (Graff et 
al., 1994; Hawley et al., 1995; Schneider et al., 1996; Suzuki et al., 1994). Both 
bmp2b and bmp4 act to specify ventral identity and are negative regulators of 
endodermal cell fate specification. Therefore, it may be the difference between 
mesoderm cell fate commitment and mesoderm formation that results in the different 
expression profiles in the rab5a2 MO injected embryos. Other genes down regulated 
in the rab5a2 MO injected embryos also have roles in the mesoderm. fgf8  and fg/24 
are coexpressed in mesoderm precursors during gastrulation (Draper et al., 2003). A 
defect in the gene tbxl6  is responsible for the mutant spadetail. tbx6 and ntl are 
expressed in mesoderm and are known to regulate region-specific gene expression 
and developmental fate (Goering et al., 2003).
An additional interesting twist is that bonnie and clyde, which is involved in 
endoderm formation, is down regulated in rab5a2 MO injected embryos at 30% 
(Table 6.2.1) but increased slightly at shield (Appendix 2). Endodermal 
determination, initiated by the Nodal signalling pathway, has been shown to require a 
multitude of genes. Included in these are, as mentioned, bonnie and clyde (Trinh et 
al., 2003), as well as eomesodermin (eomes) (Bjomson et al., 2005), which is up 
regulated in the rab5a2 MO injected embryos, eomes, a maternal T-box gene and 
transcriptional activator, has also been shown to determine dorsal identity. Initially
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after fertilization eomes is expressed in a vegetal animal gradient in the embryo, with 
Eomesodermin protein (Eom) distributed cytoplasmically throughout the blastoderm. 
However, following midblastula transition, nuclear-localized Eomesodermin is only 
detected on the dorsal side of the embryo (Bruce et al., 2003). Overexpression of 
eomes results in Nodal-dependent and nieuwkoid/dharma (nwk/dhm) independent 
ectopic expression of the organizer markers gsc, chd and flh , and in the formation of 
a secondary axis (Bruce et al., 2003). Interestingly, the knocking down of rab5a2 
results in the increase of eomes (Figure 6.2.2 and 6.2.4) with the decrease of gsc, chd 
and flh  (Figure 5.1.2 and 5.2.2) and pre-24hpf embryonic lethality (Figure 5.1.1).
Overexpression of eomes has been shown not to have any effect on eye, sqt, bmp2b, 
vegal/vox or nwk/dhm, although eomes ’ effect on gsc, chd and flh  is nodal dependent 
and it has been speculated that eomes possibly regulates sqt (Bruce et al., 2003). 
Therefore, this raises the possibility that rab5a2 may affect nodal signalling by 
interfering with the pathway between eomes and sqt. eomes is suggested to activate, 
and possibly maintain, its own transcription (Bruce et al., 2003). If knock down of 
rab5a2 does disrupt the pathway between eomes and sqt the eomes expression might 
be increased to compensate. However, eomes autoregulation is suggested to be 
Nodal-independent, since injection of eomes into MZoep embryos resulted in 
induction of eomes expression (Bjomson et al., 2005). This increased expression of 
eomesodermin in rab5a2 MO injected embryos may be linked to the conflicting 
expression seen for bmp2b and bmp4 although there is no direct evidence linking the 
bmps to eomesodermin
Another possibility is that rab5a2 knock down results in mislocalization, or 
inhibition, of the early localization to individual cells of sqt, seen in the four cell 
embryo (Gore et al., 2005). Preliminarily data looking at the effect of rab5a2 on 
early sqt expression shows no sqt localization to individual cells in the 8-16 cells 
stage of control or rab5a2 MO injected embryos but does show localization in 
rab5a2 overexpresing embryos (Figure 7.1.2). Since there is no localized expression 
of sqt in the controls, as reported by Gore et al (2005), the signal was increased by 
injecting 15pg in 1.4nl of alexa-sqt into the yolk of control MO injected, rab5a2 MO 
injected and rab5a2 overexpressing embryos. Gore reports that this localizes in the 
same manner as endogenous sqt. Localization to individual cells of the 8-16 cell
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stage embryos was seen in control MO injected embryos, rab5a2 MO injected 
embryos and rab5a2 overexpressing embryos (Figure 7.1.2). However, the 
expression of sqt in the rab5a2 overexpressing embryos developed before that of the 
control and rab5a2 MO injected embryos. These data suggest that rab5a2 may effect 
zebrafish development at a very early stage. This would be consistent with the 
misexpression of p-catenin expression seen in the rab5a2 MOs, when compared to 
the gradient of p-catenin expression emanating from the dorsal side of control 
embryos (Figure 5.5.2). Such results imply a role for rab5a2 early in development, 
although it is unclear how and what role the early maternal transcripts of sqt or /?- 
catenin may play in this.
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zygotic transcripts of rab5a2 resulted in embryos with a visible organizer and normal 
speed of development, as well as expression of bik, ntl, gsc and chd being unaffected. 
However, the rab5a2 MO injected embryos, deficient in only zygotic transcripts, 
died before 24hpf, suggesting an equally important role for zygotic rab5a2 in later 
development.
To examine how Rab5a2 might directly affect nodal signalling, sqt or eye was 
injected into one cell of a 128 stage embryo. Sqt has been proposed as a morphogen 
acting directly on target cells over a distance while Cyclops signals in a more 
localized manner (Chen and Schier, 2001).
In embryos overexpressing rab5a2, injection of either 5pg or lOpg of sqt resulted in 
similar gsc and ntl expression to that seen in controls (Figure 5.4.1 and 5.4.2). This 
conflicts with evidence from the signalling factor fgf8, where overexpression of 
rab5a resulted in the fgfS  target gene spty4 showing a reduction in range of 
expression. This reduction in range was suggested to result from increased clearance, 
by rab5a, of the FgfS ligand present in the extracellular space -  a process termed 
“restrictive clearance”. Injection of 5pg of sqt into rab5a2 MO injected embryos 
resulted in a large proportion of embryos showing severe reduction of intensity of 
both gsc and ntl expression, with gsc showing a broader range of expression. 
However, many of the rab5a2 MO injected embryos showed no expression of either 
gsc or ntl. When the dose of sqt was increased to lOpg, a greater proportion of the 
embryos showed no expression of gsc or ntl.
This data is contradictory: the broader range of gsc expression would be consistent 
with the Scholpp’s theory of “restrictive clearance”, however, many embryos showed 
no expression, which is at odds with this (Scholpp and Brand, 2004). In addition, 
since gsc is induced at high doses of nodal and ntl induced at lower doses, the ntl 
expression would also be expected to be expanded. This contradictory data might be 
the result of the high background staining seen in rab5a2 MO injected embryos, 
masking the already weak gsc and ntl expression. The weak signal, seen in the 
rab5a2 MO injected embryos may result from the broader expression pattern. 
Therefore, if the embryo produced an even broader expression pattern this might be 
masked by the background staining. One theory is that extracelluar Sqt binds to its
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receptor but the receptor cannot be internalized and, therefore, it cannot activate 
target genes. If the receptors cannot be internalized, then Sqt cannot be restrictively 
cleared form the extracellular space and extracellular Sqt can travel further. If there 
is not complete knock down of rab5a2, then some of the receptors will be 
internalized and will activate target genes. Since Sqt has not been cleared, the 
extracellular dose would be high, so gsc is induced. This theory assumes that 
percentage of receptor occupancy is responsible for the type of target gene 
expression, i.e. if greater than a certain percentage of receptors are occupied, one 
target gene is induced, whereas, if less than this percentage are occupied, a different 
target gene is induced.
The effect of Rab5a2 on Cyc signalling differed to that of Sqt. Injection of eye into 
rab5a2 MO injected embryos resulted in the majority of embryos showing a lack of 
gsc and ntl expression (Figure 5.4.3 ). Those which did show gsc expression failed to 
show the expanded expression pattern observed for the sqt injected embryos, while 
those that showed ntl derived from the exogenous cyc also showed endogenous ntl 
expression, suggesting that there was not complete knock down of rab5a2. Injection 
of cyc into rab5a2 overexpressing embryos showed either absence or reduction of 
intensity of gsc expression in the majority of embryos, while ntl signalling was 
unaffected (Figure 5.4.3). These data seem contradictory but suggest a role for 
rab5a2 in Cyc signalling. It is possible that rab5a2 may have role in the secretion of 
the Cyc protein and with its internalization, once bound to a target cell receptor. If 
rab5a2 had a role in secretion, reduction of this gene would cause impaired secretion 
of Cyc and no target gene expression. Overexpression, on the other hand, might 
result in normal secretion, since the production of Cyc would be unaffected, but 
would result in increased internalization. This increased internalization would result 
in Cyc being removed from the extracellular space, lowering its extracellular dose 
and resulting in ntl expression rather than gsc. Since the rab5 genes have been well 
characterized as regulators of endocytosis (Bucci et al., 1992; Chavrier et al., 1990; 
Gorvel et al., 1991), it is probable that rab5a2 wouldn’t be directly responsible for 
secretion. The microarray data showed a reduction in the expression of rabl4 in 
rab5a2 MO injected embryos (Figure 6.2.1 and 6.2.3). Rabl4 has been shown to be 
involved in membrane trafficking between the golgi complex and endosomes. It is
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possible that these two rabs work in co-operation to ensure normal Cyc signalling, 
however, the data is inconclusive.
The RT-PCR data, used to validate the microarray, is also inconclusive. Much of this 
is due to the large degree of variation seen in these samples. This variation is 
controlled in the microarray data by the increased number of replicates, as well as by 
normalization of the data. Although the RT-PCR data is inconclusive for some of the 
genes, particularly the supposed non-changing housekeeping genes, the trend 
observed does suggest that the microarray data is accurate. Stronger evidence 
corroborating this is found in the expression patterns of chd, flh, and ntl in chapter 4. 
The down regulation of chd seen in the microarray data for rab5a2 MO injected 
embryos is validated by ish with the abolishment of chd expression seen in rab5a2 
MO injected embryos.
The microarray data showed hundreds of genes whose expression was changed when 
rab5a2 was knocked down even when the base line for change was set as high as 
three fold. This data suggests an early effect for rab5a2 and correspond with the 
early phenotype seen in these embryos. Even at the 30% stage, where there is no 
visual difference between the rab5a2 embryos and the control embryos, hundreds of 
genes changed their expression. The shield stage data showed an increase in the 
genes which changed, when compared to 30% epiboly embryos. This is expected 
given the suggestion that raba5a2 acts early in development and has an effect on 
signalling factors (Campos, 2004; Scholpp and Brand, 2004; Ulrich et al., 2005). The 
earlier in development rab5a2 acts, the further up the signalling cascade it is likely to 
act and, in disrupting an upstream signalling factor, Rab5a2 affects all the 
downstream factors acted upon by that initial factor. Therefore, analysis of gene 
expression at later stages of development should be predicted to show an increased 
number of genes that change.
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7.2 Further Work
7.2.1 Further analysis o f Rab5a2
Due to the complex nature of rab5a2 and the high degree of regulation of the protein 
it has been very difficult to fully explore its effect on Nodal signalling. It is possible 
that rab5a2 knock down or overexpression could be indirectly interfering with the 
secretion or synthesis of the Sqt and Cyc proteins. Transplantation of sqt and cyc 
overexpression cells into rab5a2 MO injected or overexpressing embryos would 
enable the role of rab5a2 in cells producing or receiving the sqt or cyc to be 
separated. This results from the cells transcribing and secreting the Nodal related 
proteins having wild type rab5a2 expression.
So far, much of the analysis has involved looking at Nodal responsive genes as an 
indicator of Nodal, rather than Nodal itself. To this end, sqt-gfp and cyc-gfp fusion 
proteins have been made by inserting a GFP region after the cleavage site, between 
the pro and mature domains of sqt and cyc (see Methods section 2.2.11). This ensures 
that when the proteins are cleaved, the GFP attaches to the mature domain.
To ascertain whether the sqt-gfp construct was producing the same effect as wild 
type sqt, lOpg of sqt-gfp RNA was injected into single cells of 128 cell stage 
embryos. These were then compared to embryos injected in the same manner with 
lOpg of wild type sqt RNA and those injected with lOpg of control RNA. 
Subsequently, each group of embryos was fixed at shield stage and examined for ntl 
expression. A similar procedure was completed for cyc-gfp, where it was compared 
against wild type cyc and control RNA. Expression of ntl was seen in the animal pole 
in both wild type sqt and sqt-gfp injected embryos, while the controls showed normal 
expression round the margin (Figure 7.2.1). Embryos injected with either cyc or cyc- 
gfp also showed expression of ntl in the animal pole (Figure 7.2.1). This suggested 
that the sqt-gfp and cyc-gfp was producing a similar affect to the wild type sqt and 
cyc RNA.
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To further compare wild type sqt and cyc with sqt-gfp and cyc-gfp, 5pg or 10 pg of 
either sqt, cyc, sqt-gfp or cyc-gfp were injected into single cell embryos. These were 
left to develop until shield stage, when they were snap frozen and prepared for RT- 
PCR analysis (see Methods section 2.2.10), using taqman oligos for Nodal 
responsive markers, gsc, flh, chd and lfy2 expression was increased compared to 
controls in embryos injected with either 5 or lOpg of sqt, 5 or lOpg of cyc, 5 or 10 pg 
of sqt-gfp or 10 pg of cyc-gfp (Figure 7.2.2). ntl and Ityl expression was increased in 
embryos injected with either 5pg or lOpg of sqt, 5pg of sqt-gfp 5pg of lOpg of cyc- 
gfp. Ifyl was also increase in embryos injected with 5 or lOpg of cyc (Figure 7.2.2)
Figure 7.2.1: Comparison of sqt and cyc RNA to sqt-GFP and cyc-GFP fusion 
constructs.
Comparison of ntl expression in embryos injected with lOpg of sqt RNA 
compared to embryos injected with lOpg of sqt-GFP RNA and embryos injected 
with lOpg of cyc RNA compared to embryos injected with lOpg of cyc -GFP 
RNA. ntl expression in control injected embryos are also shown.
Finally, the sqt-gfp construct was checked for GFP activity. This was achieved by 
injecting a single cell in a 128 cell stage embryos with the lineage label rhodamine 
and lOpg of sgt-gfp. The embryos were then observed under a confocal microscope 
for GFP activity. GFP was seen accumulating round cells containing rhodamine, 
which suggested that the sqt-gfp was functional (Figure 7.2.3 supl mov 7.2.3).
Injection of these GFP-nodal fusion constucts would enable the Nodal ligand to be 
followed in the developing embryo. Therefore, it would be possible to observe the
CvcGFP-1
Control
Cvcloos
SotGFP-1
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range of the ligand directly, instead of using target gene expression. Injecting these 
constructs into one cell of 128 cell embryo, either overexpressing rab5a2 or with 
rab5a2 knocked-down, would potentially enable visualization of the ligand being 
secreted or produced, and enable investigation into whether rab5a2 effects the 
secretion of the ligand. In addition, it would be interesting to transplant cells from 
embryos overexpressing these constructs into embryos, overexpressing rab5a2 or 
knocked-down for rab5a2. This would enable the visualization of these Nodals 
through the developing embryo without the secretion, or production, of the Nodal- 
GFP ligands being altered by alterations in rab5a2.
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Figure 7.2.3: Assessing the viability of the Squint-GFP fusion protein.
Confocal image of lOpg squint-GFP RNA injected embryos. The green 
colour identifies the Squint-GFP protein and the red (rhodamine) 
identifies the lineage of the cells injected with the squint-GFP RNA.
7.2.2 Investigations into the other members of the rab5 family.
In zebrafish, there are four members of the Rab5 family. Rab5c and Rab5b show 
similar phenotypes, which include brain cell death and tail defects, while Rab5al 
shows no phenotype. This thesis has shown that, out of all four Rabs, Rab5a2 is the 
most essential for early embryo development. Therefore, it is now important to
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establish whether these remaining Rab5s are even partially redundant and whether 
they have a role in cell signalling, in particular Nodal signalling.
Initial studies looking at the expression of dorsal and Nodal responsive gene have 
shown that rab5al appears to be redundant in regard to Nodal signalling (Figure 
7.2.4). However, rab5c and rab5b show a degree of down regulation. Rab5b 
particularly showed downregulation of all the genes investigated, while Rab5c 
showed down regulation of bhik. Therefore, it would be interesting to conduct 
microarray analysis on each of these genes to further quantifly to what extent these 
rabs effect cell signalling and which of these pathways, if any, overlap with other 
members of the Rab5 family.
Chd
G sc
Ntl
Bhik
Figure 7.2.4: Animal views of shield stage embryos: gsc, ntl, chd and bik 
expression in control MO injected embryos on the left compared to embryos 
injected with 12ng of rab5al MO, 8ng of rab5a2 MO and 8ng rabSc MO.
C ontrol Rab5a1 Rab5a2 Rab5b Rab5cn m n n□□□□□
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Conclusions
This thesis presents the results of extensive experiments into the functions of 
members of the rab family of GTPases in the zebrafish. Results for more than a third 
(13) of the 37 rab genes that have been investigated to date are presented in this 
thesis. The results demonstrate the essential nature of many of these genes for early 
embryonic development, with a loss-of function screen using antisense MO 
oligonucleotides leading to severe, and in some cases, highly specific, developmental 
defects.
Of the 13 rabs investigated in detail and described in this thesis, rab3cl, rab28 and 
rabla3 show very specific defects when knocked down. rab3cl MO injected 
embryos display pigment defects, investigations into which demonstrate that these 
MO injected embryos are blind. rab28 MO injected embryos show circular 
swimming behaviour, which may result from defects in balance, while knocking 
down rabla3 shows a reduction in pigmentation. These defects show that, far from 
being purely housekeeping genes, rabs can exhibit tissue specificity. This 
corresponds to the effect seen in mammals, where five rabs have shown very specific 
phenotypes, with two of these responsible for human disorders (Menasche et al., 
2000; Verhoeven et al., 2003).
To date, members of the rabl, rab6, rab7, rab8 and rab 11 families, as well as all the 
members of the rab5 family -  genes whose homologues in yeast are considered 
essential due to the ensuing lethality when absent -  have been studied. Of these, only 
rab5a2, when knocked-down, causes death before 24hpf. Given the proposed 
housekeeping function of many of the rab genes, in particular those considered 
essential, it seems counter-intuitive that only rab5a2 should show such a dramatic 
early lethality. This thesis elucidates a novel, essential and complex role for the 
maternal transcripts of rab5a2 in Nodal signalling. The knocking down of rab5a2 
results in a severe reduction of cyc, Nodal-responsive genes and the dorsal marker 
chd. Overexpression of rab5a2 results in locally up-regulated expression of gsc and 
ntl in the animal pole, in addition to endogenous expression in the margin, but had
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little effect on chd expression. These results suggest that rab5a2 is a vital 
component of the Nodal signalling pathway. The results of this study show no 
evidence for the restrictive clearance model, suggested by Scholpp (Scholpp and 
Brand, 2004), for the movement of Fgf8, in Nodal signalling. However, this cannot 
be ruled out as experiments using exogenous sqt and cyc to investigate the effect of 
overexpression or knock-down of rab5a2 on Nodal signalling proved inconclusive. 
To address this, further studies using GFP tagged Nodals are necessary.
This thesis suggests a complex role for rab5a2 in DV patterning, since knocking 
down rab5a2 affects many DV patterning signals. Intriguingly, both dorsal 
promoting genes and some dorsal antagonists are affected by knocking down rab5a2, 
while other dorsal antagonists, such as bmp2b, are not affected. An important role is 
also established for rab5a2 in epiboly, and so early zebrafish development. Evidence 
for this is provided by the large number of genes whose expression changed when 
rab5a was knocked down
In conclusion, the rab genes are an interesting group of genes whose function can 
specifically impact on many important developmental processes. Although many of 
these genes show similar phenotypes, some show interesting and unique phenotypes 
that deserve further study. The unique phenotype of rab5a2 has shown this gene to 
be essential for early development and Nodal signalling with an interesting role in 
DV patterning, one again worthy of further study.
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Appendix 1
Genes in rab5a2 morpholino injected embryos that changed more than 3 fold compared to controls at the 30% epiboly stage
Gene Name Fold Change Av. Description
NM_131058.1_3prime500bases378 0.13 0.13 ENSDARG00000007329:T-box gene 16 [Source:RefSeq_pepticle;Acc:NP_571133];
NM_194392.1_3prime500bases 194 0.20 0.17 0.12 0.16 ENSDARG00000040216;trophoblast glycoprotein-like [Source:RefSeq_peptide;Acc:NP_919373];
NM_131342.2_3prime500bases296 0.18 0.19 0.19 ENSDARG00000019995:bone morphogenetic protein 4 [Source:RefSeq_peptide;Acc:NP_571417];
NM 001001950.1_3pri me500bases 137 0.22 0.22 ENSDARG00000009849:zic family member 3 heterotaxy 1 (odd-paired homolog, Drosophila) [Source:RefSeq_peptide;Acc:NP_001001950];
NM_131509.1_3prime500bases430 0.22 0.22 keratin 4
NM_213118.1_3prime500bases147 0.19 0.28 0.23 ENSDARG00000014243:SRY-box containing gene 2 [Source:RefSeq_peptide;Acc:NP_998283];
NM_131690.1_3prime500bases388 0.25 0.25 ENSDARG00000019856:ATPase, Na+/K+ transporting, alpha 1b polypeptide [Source:RefSeq_peptide;Acc:NP_571765];
NM_131052.1_3prime500bases417 0.27 0.24 0.26 ENSDARG00000006939:T-box transcription factor TBX6 (T-box protein 6). [Source:llniprot/SWISSPROT;Acc:P79742];
NM_001007454.1_3prime500bases299 0.25 0.28 0.26 ENSDARG00000027699:zgc:101612 [Source:RefSeg_peptide;Acc:NP_001007455);
NM_131281.2_3prime500bases201 0.26 0.28 0.27 ENSDARGOOOOOOO3399fibroblast growth factor 8 [Source:RefSeq_peptide;Acc:NP_571356];
NM_001003875.1_3prime500bases285 0.29 0.27 0.28 ENSDARG00000037931 :U1 small nuclear ribonucleoprotein polypeptide A [Source:RefSeq_peptide;Acc:NP_001003875];
NM_198876.1_3prime500bases405 0.29 0.29 ENSDARG00000018971:UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5 [Source:RefSeq_peptide;Acc:NP_942577];
DIG0410J903 0.30 0.30
NM_001002332.1_3pri me500bases404 0.26 0.34 0.30 ENSDARG00000007024:zgc:92414 [Source;RefSeq_peptide;Acc;NP_001002332];
NM_131108.1_3prime500bases390 0.31 0.30 0.30 ENSDARG00000036830:type 1 cytokeratin, enveloping layer [Source:RefSeq_peptide;Acc:NP_571182];
NM_131885.2_3prime500bases167 0.32 0.32 ENSDARG00000036074:CCAAT/enhancer binding protein alpha [Source:RefSeq_peptide;Acc:NP_571960];
NM_131109.1_3prime500bases25 0.32 0.32 ENSDARG00000036292;caudal type homeo box transcription factor 4 [Source:RefSeq_peptide;Acc:NP_571184];
NM_201513.1 _3prime500bases433 0.32 0.32 ENSDARG00000042539:tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, theta polypeptide
NM_130973.1_3pri me500bases361 0.30 0.36 0.33 ENSDAREST G00000005532 chordin
NM_182871.1_3prime500bases170 0.33 0.33 ENSDARG00000037677:fibroblast growth factor 24 [Source:RefSeq_peptide;Acc:NP_878291];
NM_212580.1_3prime500bases426 0.33 0.33 ENSDARESTG00000023644 methyl-CpG binding domain protein 3b
NM_130940.1_3prime500bases425 0.32 0.37 0.34 ENSDARG00000009737:bonnie and clyde [Source:RefSecLPeptide;Acc:NP_571015];
NM_131207.1_3pri me500bases 102 0.33 0.35 0.34 ENSDARG00000007944:LIM homeobox 1b [Source:RefSeq_peptide;Acc:NP_571282];
NM_183074.1_3prime500bases334 0.37 0.32 0.35 ENSDARG00000042503:ventrally expressed dharma/bozozok antagonist [Source:RefSeq_peptide;Acc:NP_898897];
NM_001012246.1_3prime500bases23 0.35 0.35 ENSDARG00000035748:fibroblast growth factor 19 [Source:RefSeci_peptide;Acc:NP_001012246];
NM_200159.1_3prime500bases291 0.36 0.36 ENSDARG00000008238:mannosidase, beta A, lysosomal [Source:RefSeq_peptide;Acc:NP_956453];
NM_131209.1_3prime500bases394 0.41 0.32 0.36 protocadherin 8
NM_201316.1_3prime500bases415 0.37 0.37 ENSDARG00000035913:tyrosyl-tRNA synthetase [Source:RefSeq_peptide;Acc:NP_958473];
NM_174861.2_3prime500bases259 0.41 0.34 0.37 ENSDARG00000019268:gastrulation brain homeobox 1 [Source:RefSeq_peptide;Acc:NP_777286];
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NM_200228.1_3pri me500bases99 0.37 0.37
NM_173288.1_3prime500bases371 0.38 0.38 0.38
NM_001003774.1_3prime500bases342 0.32 0.45 0.39
NM_201576.1_3prime500bases131 0.43 0.36 0.39
NM_212602.1_3pri me500bases425 0.39 0.39
NM_131609.1_3prime500bases422 0.40 0.40
NM_201514.1 _3pri me500bases375 0.38 0.41 0.40
NM_131700.1_3prime500bases289 0.38 0.41 0.40
NM 130955.1 3prime500bases324
DIG0402_1561 0.35 0.39 0.45 0.40
NM_131320.1_3prime500bases353 0.39 0.41 0.40
BC046031.1_3prime500bases262 0.43 0.38 0.40
NM_130956.1_3prime500bases 123 0.42 0.39 0.40
NM_201495.1_3pri me500bases221 0.32 0.48 0.40
NM_207184.1_3pri me500bases429 0.40 0.40
CF673281,1_3prime500bases425 0.43 0.39 0.41
NM_205732.1_3prime500bases414 0.41 0.41
NM_212567.1_3prime500bases8 0.42 0.42
NM_152986.1_3prime500bases147 0.42 0.42
NM_001001811,1_3prime500bases418 0.42 0.42
NM_205567.1_3prime500bases270 0.43 0.43
NM_131116.2_3prime500bases13 0.43 0.43
DIG0203_403 0.43 0.43
DIG0395_973 0.43 0.43
NM_198817.1_3prime500bases426 0.53 0.34 0.43
NM_214722.1_3prime500bases256 0.45 0.41 0.43
NM_130908.1_3prime500bases 107 0.43 0.44 0.43
BU670752.1_34 0.44 0.44
NM_001003501.1_3prime500bases284 0.43 0.44 0.44
NM_131882.2_3prime500bases379 0.40 0.48 0.44
NM_131163.1 _3pri me500bases430 0.44 0.44
NM_131884.2_3prime500bases139 0.46 0.42 0.44
NM_201493.1_3prime500bases 125 0.44 0.44
DIG0109_1354 0.45 0.45
ENSDARG00000013973:peroxisomal biogenesis factor 3 [Source:RefSeq_peptide;Acc:NP_956522];
ENSDARG00000040666:mki67 (FHA domain) interacting nudeoiar phosphoprotein (human) - like [Source:RefSeq_peptide;Acc:NP_775395]; 
ENSDARG00000015123:zgc:101000 [Source:RefSeq_peptide,Acc:NP_001003774],
ENSDARG00000034351 :transgelin 2 [Source:RefSeq_peptide;Aec:NP_963870];
ENSDARG00000011127:AHA1, activator of heat shock 90kDa protein ATPase homolog 1, like [Source:RefSeq_peptide;Acc:NP_997767]; 
ENSDARG00000017917:hairy and enhancer of split related-7 [Source:RefSeq_peptide;Acc:NP_571684];
ENSDARG00000037012:solute carrier family 3, member 2 like [Source:RefSeq_peptide;Acc:NP_958922];
ENSDARG00000017164:ventral expressed homeobox [Source:RefSeq_peptide;Acc:NP_571775];
ENSDARESTG00000012353 deltaD (did),
ENSDARG00000023188:lymphocyte cytosolic plastin 1 [Source:RefSeq_peptide;Acc:NP_571395];
ENSDARG00000029074 ubiquitin-activating enzyme E1-domain containing 1, mRNA, containing frame-shift errors 
ENSDARG00000004256:Wnt-11 protein precursor. [Source:Uniprot/SWISSPROT;Acc:073864];
RAB14
ENSDARG00000009510:iroquois homeobox protein 1, a isoform 1 [Source:RefSeq_peptide;Acc:NP_997067];
ENSDARESTG00000018874 CB967 5- similar to Filamin A 
glutamate-ammonia ligase
ENSDARG00000024204:minichromosome maintenance protein 3 [Source:RefSeq_peptide;Acc:NP_997732];
ENSDARG00000044356:tumor protein p73-like isofbrm alpha 1 [Source:RefSeq_peptide;Acc:NP_694518];
ENSDARG00000036440:SRY-box containing gene 3 [Source:RefSeq_peptide;Acc:NP_001001811];
ENSDARG00000006603:cysteine and glycine-rich protein 1 [Source:RefSeq_peptide;Acc:NP_991130];
ENSDARG00000000175:Homeobox protein Hox-B2a (Hox-B2). [Source:Uniprot/SWISSPROT;Acc:042367];
ENSDARESTG00000016981 starmaker (stm),
ENSDARG00000018806:cathepsin C [Source:RefSeq_peptide;Acc:NP_999887];
OTTDARG00000002166:zgc:55628:Novel_CDS
ENSDARG00000039072 Similar to ectoplacental cone, invasive trophoblast giant cells, extraembryonic ectoderm and chorion sequence 3, 
ENSDARG00000012341 :zgc:92451 [Source:RefSeq_peptide;Acc:NP_001003501];
ENSDARG00000022476 chemokine (C-X-C motif) receptor 4a (cxcr4a)
ENSDARG00000039694:Beta-2-microglobulin precursor. [Source:Uniprot/SWISSPROT;Acc:Q04475]; 
ENSDARG00000045369:CCAAT/enhancer binding protein beta [Source:RefSeq_peptide;Acc:NP_571959]; 
ENSDARG00000036291:nudeobindin 2a [Source:RefSeq_peptide;Acc:NP_958901];
ENSDARG00000054161 :fibroblast growth factor receptor 4 [Source:RefSeq_peptide;Acc:NP_571505];
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NM_131110.1_3prime500bases292 0.41 0.49 0.45 ENSDARG00000011166:Carbonic anhydrase (EC 4.2.1.1) (Carbonate dehydratase). [Source:Uniprot/SWISSPROT;Acc:Q92051];
NM_200659.1_3prime500bases358 0.45 0.45 ENSDARG00000025948:mutL homolog 1, colon cancer, nonpolyposis type 2 [Source:RefSeq_peptide;Acc:NP_956953],
NM_131861.1_3prime500bases69 0.50 0.41 0.45 ENSDARG00000030289:Jagged-1 a precursor (Jaggedla) (Jaggedl). [Source:Uniprot/SWISSPROT;Acc:Q90Y57];
NM_001002717.1_3prime500bases329 0.51 0.41 0.46 ENSDARG00000010206:p21-activated kinase 2 [Source:RefSeq_peptide;Acc:NP_001002717];
NM_131162.1_3prime500bases301 0.48 0.45 0.46 ENSDARG00000009905:Brachyury protein homolog (T protein homolog) (T-box protein ZFT) (ZF- T) (No tail protein).
CF673253.1_3prime500bases 193 0.46 0.46 ENSDARESTG00000008362 CB894 5- similar to Nogo-66 receptor homolog-1, mRNA sequence
NM_152980.1_3prime500bases185 0.46 0.46 ENSDARG00000031855:macrophage stimulating 1 (hepatocyte growth factor-like) [Source:RefSeq_peptide;Acc:NP_694512];
NM_173244.1_3prime500bases425 0.47 0.47 ENSDARG00000024904:TAL1 (SCL) interrupting locus like [Source:RefSeq_peptide;Acc:NP_775351];
CF569085.1_3prime500bases370 0.47 0.47 ENSDARG00000020386 CB939 5- similar to ATP-binding cassette transporter 1
NM_131287.2_3prime500bases377 0.40 0.55 0.47 ENSDARG00000041345:SRY-box 17 [Source:RefSeq_peptide;Acc:NP_571362];
NM_130946.1_3prime500bases316 0.48 0.47 0.47 ENSDARG00000010355:wnt8-iike protein 2 [Source:RefSeq_peptide;Acc:NP_001018637];
NM_131668.3_3prime500bases390 0.48 0.48 ENSDARG00000013144:ATPase, Na+/K+ transporting, beta 1a polypeptide [Source:RefSeq_peptide;Acc:NP_571743];
NM_212612.1_3prime500bases264 0.47 0.48 0.48 DEAD (Asp-Glu-Ala-Asp) box polypeptide 5 (ddx5),
NM_214808.1_3pri me500bases249 0.49 0.47 0.48 ENSDARG00000023520:Fibroblast growth factor-17b precursor (FGF-17b). [Source:Uniprot/SWISSPROT;Acc:Q6SJP8];
NM_173261.1_3prime500bases339 0.49 0.48 0.48 ENSDARG00000010948:kinesin family member 11 [Source:RefSeq_peptide;Acc:NP_775368];
CB333812.1_3prime500bases133 0.45 0.52 0.48 cDNA done CB159 5- similar to Epiplakin
DIG0345_1024 0.48 0.48 ENSDARG00000040815:hypothetical protein LOC325958 [Source:RefSeq_peptide;Acc:NP_956027];
NM_131557.1_3pri me500bases429 0.49 0.49 ENSDARG00000035831 :GATA-binding protein 6 [Source:RefSeq_peptide;Acc:NP_571632];
NM_194371,2_3pri me500bases 155 0.51 0.46 0.49 ENSDARG00000010124:Sp5 transcription factor-like [Source:RefSeq_peptide;Acc:NP_919352];
CD808440.1_3pri me500bases377 0.49 0.49 gastrula stage cDNA library Danio rerio cDNA clone CB473 5
NM_173221.2_3prime500bases432 0.49 0.49 ENSDARG00000013839:aldehyde dehydrogenase 3 family, member D1 [Source:RefSeq_peptide;Acc:NP_775328];
NM_001005390.1_3pri me500bases 12 0.41 0.57 0.49 ENSDARG00000035329:calpain, small subunit 1 [Source:RefSeq_peptide;Acc:NP_001005390];
NM_131025.2_3prime500bases229 0.42 0.56 0.49 ENSDARG00000035750:G1/S-spedfic cydin D1. [Source:Uniprot/SWISSPROT;Acc:Q90459];
NM_201124.1_3pri me500bases423 0.49 0.49 ENSDARG00000011545:arrestin, beta 2 [Source:RefSeq_peptide;Acc:NP_957418];
NM_131414.1 _3prime500bases435 0.50 0.50 ENSDARG00000040346 eph receptor B4a (ephb4a),
NM_212770.1_3prime500bases190 0.50 0.49 0.50 ENSDARG00000005185;carboxypeptidase N, polypeptide 1 [Source:RefSeq_peptide;Acc:NP_997935];
NM_131027.1_3prime500bases413 0.50 0.50 ENSDARG00000002952:smoothened homolog [Source:RefSeq_peptide;Acc:NP_571102];
NM_131092.1_3pri me500bases291 0.43 0.57 0.50 ENSDARG00000035095:one-eyed pinhead [Source:RefSeq_peptide;Acc:NP_571167];
DIG0366_880 0.50 0.50 ENSDARG00000056950:hypothetical protein LOC550602 [Source:RefSeq_peptide;Acc:NP_001017903];
AB097826.1_3prime500bases19 0.51 0.51 ENSDARG00000002403:Hypothetical protein YF-9 (Fragment). [Source:Uniprot/SPTREMBL;Acc:Q7T2W2];
NM 201475.1_3prime500bases382 0.47 0.55 0.51 ENSDARG00000031495:SET translocation (myeloid leukemia-assodated) A [Source:RefSeq_peptide,Acc:NP_958883];
NM_131245.1_3prime500bases275 0.48 0.53 0.51 inhibitor of DNA binding 6
NM_001004578.1_3pri me500bases336 0.55 0.47 0.51 ENSDARG00000014793:zgc:92331 [Source:RefSeq_peptide;Acc:NP_001004578];
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NM_199211.1_3prime500bases380 0.54 0.48 0.51 ENSDARG00000030700:CTP synthase [Source:RefSeq_peptide,Acc:NP_954681 ];
NM_199429.1_3pri me500bases 154 0.51 0.51 ENSDARG00000038097:phosphatidylinositol glycan, class Q [Source:RefSeq_peptide;Acc:NP_955461 ];
NM_201586.1_3pri me500bases423 0.47 0.56 0.51 dapper homolog 2. antagonist of beta-catenin
NM_131300.1_3prime500bases423 0.51 0.51 ENSDARG00000011956:Homeobox protein Dlx4a (DLX-8). [Source:Uniprot/SWISSPROT;Acc:Q98879];
NM_131221.1 _3pri me500bases428 0.51 0.51 ENSDARG00000015790:ATPase, Na+/K+ transporting, beta 3a polypeptide [Source:RefSeq_peptide;Acc:NP_571296];
NM_131114.1_3prime500bases186 0.53 0.50 0.52 ENSDARG00000036141 even-skipped-likel (evel)
CF673239.1_3prime500bases30 0.49 0.54 0.52 ENSDARESTG00000011746 CB996 5- similar to Poly [ADP-ribose] polymerase-2 (
NM_131560.1 _3prime500bases60 0.47 0.56 0.52 ENSDARG00000027205:mix-type homeobox gene 1 [Source:RefSeq_peptide;Acc:NP_571635];
NM_201331.1_3prime500bases423 0.52 0.52 ENSDARG00000012369:retinol dehydrogenase 10 [Source:RefSeq_peptide;Acc:NP_958488];
NM_194369.1_3pri me500bases417 0.52 0.52 ENSDARG00000037563:CD99 antigen-like 2 [Source:RefSeq_peptide;Acc:NP_919350];
NM_212777.1_3prime500bases392 0.53 0.53 ENSDARESTG00000022602 bromodomain containing 8 (brd8),
NM_131415.1_3prime500bases4 0.52 0.54 0.53 ENSDARG00000017354:eph-like receptor tyrosine kinase 6 [Source:RefSeq_peptide;Acc:NP_571490];
NM_213047.1_3prime500bases244 0.49 0.57 0.53 ENSDARG00000037109:PWP2 periodic tryptophan protein homolog [Source:RefSeq_peptide;Acc:NP_998212];
NM_131205.1_3prime500bases434 0.53 0.53 ENSDARG00000029079 ets related protein erm (erm),
nomo_3prime500bases177 0.53 0.53 ENSDARG00000034683
NM_131637.1 _3prime500bases240 0.56 0.51 0.54 ENSDARG00000014047:Claudin-like protein ZF4A22 (Claudin-7). [Source:Uniprot/SWISSPROT;Acc:Q9YH92];
NM_131146.2_3prime500bases230 0.54 0.54 ENSDARG00000033999:Cytochrome P450 26A1 (EC 1.14.-.-) (Retinoic add-metabolizing cytochrome) (P450RAI) (Retinoic add 4-hydroxylase).
NM_205585.1_3prime500bases175 0.54 0.54 ENSDARG00000035521 :secreted frizzled-related protein 1 [Source:RefSeq_peptide;Acc:NP_991148];
NM_199558.1_3prime500bases365 0.54 0.54 ENSDARG00000027109:zinc finger RNA binding protein [Source:RefSeq_peptide;Acc:NP_955852];
NM_130960.1_3prime500bases226 0.56 0.52 0.54 ENSDARG00000019920:lefty1 [Source:RefSeq_peptide;Acc:NP_571035];
NM_131851.1_3prime500bases133 0.51 0.57 0.54 ENSDARG00000041341 :SRY-box containing gene 32 [Source:RefSeq_peptide;Acc:NP_571926];
NM_214692.1_3pri me500bases406 0.53 0.56 0.54 membrane protein, palmitoylated 1 (mpp1),
DIG0389_910 0.54 0.54
NM_131482.1_3prime500bases380 0.60 0.49 0.55 ENSDARG00000005645:roundabout homoiog 3 [Source:RefSeq_peptide;Acc:NP_571557];
NM_200099.1_3prime500bases116 0.60 0.49 0.55 ENSDARG00000012000:dynein light chain (10.3 kD) (dlc-1) [Source:RefSeq_peptide;Acc:NP_956393];
NM_200104.1_3prime500bases385 0.55 0.55 ENSDARG00000036675:heterogeneous nudear ribonudeoprotein A1 [Source:RefSeq_peptide;Acc:NP 956398];
AY648733.1_3pri me500bases414 0.51 0.59 0.55 ENSDARG00000045321 :DNA polymerase alpha (Fragment). [Source:llniprot/SPTREMBL;Acc:Q6DRM6];
NM_001002312.1_3prime500bases360 0.55 0.55 ENSDARG00000041870:intraflagellar transport 172 [Source:RefSeq_peptide;Acc:NP_001002312];
AY216588.1_3pri me500bases 143 0.56 0.56 ENSDARG00000023220:Selenoprotein T2 (Fragment). [Source:llniprot/SPTREMBL;Acc;Q802G4];
CB923492.1_3pri me500bases387 0.57 0.54 0.56 ENSDARG00000004713:hypothetical protein LOC550434 [Source:RefSeq_peptide;Acc:NP_001017739];
NM_131227.1_3prime500bases133 0.56 0.56 ENSDARG00000043071:Retinal homeobox protein Rx3. [Source:Uniprot/SWISSPROT;Acc;042358];
NM_201452.1_3pri me500bases308 0.56 0.56 ENSDARG00000009484:ADP-ribosylation factor 1 [Source;RefSeq_peptide;Acc:NP_958860];
NM_131450.2_3prime500bases260 0.58 0.54 0.56 ENSDARG00000020711;Ribonudeoside-diphosphate reductase M2 chain (EC 1.17.4.1) (Ribonudeotide reductase protein R2 dass I).
DIG0121_607 0.56 0.56 E NSDARGOOOOO017320:F11 receptor [Source:RefSeq_peptide;Acc:NP_001004667];
NM_131455.1_3prime500bases385 0.56 0.56. ENSDARG00000014017:Ribonudeoside-diphosphate reductase large subunit (Ribonudeoside-diphosphate reductase M1 subunit)
BQ826572.1_3prime500bases187 0.57 0.57 cDNA done CB349 5- similar to Complement component C7
DIG0349_1819 0.57 0.57
NM_201463.1_3pri me500bases 130 0.57 0.57 ENSDARG00000022232:peter pan homolog [Source:RefSeq_peptide;Acc:NP_958871];
DIG0099_2026 0.57 0.57
DIG0346_877 0.57 0.57 ENSDARG00000021607:lglon1 [Source:RefSeq_peptide;Acc:NP_001003851 ];
DIG0131J438 0.57 0.57 ENSDARG00000058538:hypothetical protein LOC323048 [Source:RefSeq_peptide;Acc:NP_997799];
CF673237.1 _3prime500bases83 0.57 0.57 ENSDARG00000007781 CB994 5- similar to P70193 Membrane glycoprotein
NM_131291.1 _3pri me500bases223 0.57 0.57 fibroblast growth factor 3 (fgf3
NM_131098.1_3prime500bases249 0.59 0.57 0.58 ENSDARG00000040295:Apolipoprotein Eb precursor (Apo-Eb). [Source:Uniprot/SWISSPROT;Acc:042364];
AJ494837.1_3pri me500bases199 0.50 0.66 0.58 ENSDARG00000036558:Collagen XVIII (Fragment). [Source:Uniprot/SPTREMBL;Acc:Q8AWC6];
NM_212609.1_3pri me500bases 159 0.58 0.58 ENSDARESTG00000014051 guanine nudeotide binding protein (G protein), beta polypeptide 1 (gnb1),
NM_199547.1 _3prime500bases139 0.62 0.55 0.58 ENSDARG00000029252:Sjogren syndrome antigen B (autoantigen La) [Source:RefSeq_peptide;Acc:NP_955841];
NM_198871.1_3prime500bases153 0.60 0.57 0.59 zgc:63569 (zgc:63569),
BC075970.1_3prime500bases424 0.59 0.59 ENSDARG00000006427:Intestinal fatty add-binding protein. [Source:llniprot/SPTREMBL;Acc:Q8AX65];
NM_207048.1_3pri me500bases204 0.60 0.57 0.59 ENSDARESTG00000012052 cydin F (ccnf).
NM_131066.1_3prime500bases239 0.59 0.59 ENSDARG00000044163:snail homolog 1a [Source:RefSeq_peptide;Acc:NP 571141];
NM_200111.1_3prime500bases156 0.59 0.59 ENSDARG00000017748:hypothetical protein LOC378998 [Source:RefSeq_peptide;Acc:NP_956405];
DIG0401_1450 0.59 0.59 ENSDARG00000002336:Delta-like protein C precursor (DeltaC protein) (deIC). [Source:llniprot/SWISSPROT;Acc:Q9IAT6];
NM_200080.2_3prime500bases345 0.56 0.63 0.59 ENSDARG00000029086:keratin 8 [Source:RefSeq_peptide;Acc:NP_956374];
NM_173219.1_3pri me500bases266 0.60 0.60 LIM domain only 1 (lmo1),
NM_200084.1_3pri me500bases329 0.60 0.60 ENSDARG00000040464 phosphomannomutase 2 (pmm2),
CK445313.1_3prime500bases394 0.62 0.58 0.60 ENSDARG00000004017 CB1089 5- similar to sperm associated antigen 1,
BQ169366.1_3prime500bases3 0.60 0.60 ENSDARG00000013841 CB272 5- similar to TYROSINE-PROTEIN KINASE ABL2
NM_130964.1_3prime500bases414 0.61 0.61 ENSDARG00000007204 islet3 (isl3),
NM_181559.1_3prime500bases359 0.61 0.61 ENSDARG00000039128:glutamine synthetase 1 [Source:RefSeq_peptide;Acc:NP_853537];
NM_201459.1_3pri me500bases430 0.61 0.61 ENSDARG00000002792;archain 1 [Source:RefSeq_peptide;Acc:NP_958867];
NM_001008615.1_3prime500bases182 0.59 0.63 0.61 ENSDARG00000041065:heat shock protein 1 [Source:RefSeq_peptide;Acc:NP_001008615];
NM_001003882.2_3prime500bases425 0.61 0.61 ENSDARG00000008237:seryl-tRNA synthetase [Source:RefSeq_peptide;Acc:NP_001003882];
NM_130937.1_3prime500bases293 0.61 0.61 0.61 ENSDARG00000034894:Wnt-5 protein precursor. [Source:Uniprot/SWISSPROT;Acc:Q92050];
NM_205702.1_3pri me500bases229 0.61 0.61 zgc:76868 (zgc:76868),
NM_131874.1_3prime500bases111 0.58 0.65 0.62 ENSDARG00000035622:X-box binding protein 1 [Source:RefSeq_peptide;Aec:NP_571949];
NM_001002869.1_3prime500bases19 0.59 0.64 0.62 ENSDARG00000024593:DEAD (Asp-Glu-Ala-Asp) box polypeptide 27 [Source:RefSeq_peptide;Acc:NP_001002869];
NM_131834.1_3prime500bases233 0.62 0.62 ENSDARG00000041959:chemokine (C-X-C motif), receptor 4b [Source:RefSeq_peptide;Acc:NP_571909];
NM_198922.1_3pri me500bases281 0.62 0.62 ENSDARG00000029305:BAI1 -associated protein 2-like 1 [Source:RefSeq_peptide;Acc:NP_944604];
CF417054.1_3prime500bases17 0.63 0.62 0.62 cDNA clone CB850 5- similar to Methylmalonate-semialdehyde dehydrogenase
NM_212603.1_3prime500bases166 0.63 0.63 ENSDARG00000023330:addic (leucine-rich) nuclear phosphoprotein 32 family, member B [Source:RefSeq_peptide;Acc:NP_
NM_198908.1_3prime500bases138 0.62 0.64 0.63 ENSDARG00000007294:aconitase 2, mitochondrial [Source:RefSeq_peptide;Acc:NP_944590];
CF417014.1 _3pri me500bases203 0.63 0.63 ENSDARESTG00000002702 done CB810 5- similar to Beta-1 integrin
CK445305.1 _3prime500bases82 0.63 0.63 cDNA done CB896 5- similar to Spalt transcription factor SalU
NM_131055.1_3prime500bases433 0.63 0.63 ENSDARG00000021201 floating head [Source:RefSeq_peptide;Acc:NP_571130];
NM_181757.2_3prime500bases66 0.64 0.62 0.63 ENSDARG00000016470:annexin A5 [Source:RefSeq_peptide;Acc:NP_861422];
NM_131511.1_3prime500bases250 0.62 0.65 0.63 ENSDARG00000014673:frizzled 9 [Source:RefSeq_peptide;Acc:NP_571586];
NM_131516.1_3prime500bases368 0.64 0.64 ENSDARG00000002768:Parvalbumin beta. [Source:Uniprot/SWISSPROT;Acc:Q9l8VO];
NM_199274.1_3prime500bases294 0.64 0.64 ENSDARG00000040175:regulator of G-protein signalling 4 [Source:RefSeq_peptide;Acc:NP_954968];
DIG0408_1690 0.64 0.64
NM_131363.1_3prime500bases153 0.64 0.64 ENSDARG00000045102:sine oculis homeobox homolog 3b [Source:RefSeq_peptide;Acc:NP_571438];
DIG0557_1492 0.64 0.64
CF269292.1_3prime500bases211 0.64 0.64 CB751 5- similar to Vitamin K-dependent gamma-glutamyl carboxylase
NM_131235.2_3prime500bases8 0.64 0.64 GATA-binding protein 5 (gata5),
BI326806.1_3prime500bases170 0.65 0.65 ENSDARESTG00000000352 CB63 5- similar to SW:PGCV_CHICK Q90953 VERSICAN CORE PROTEIN PRECURSOR,
NM_183410.1_3prime500bases289 0.65 0.65 ENSDARG00000039645:annexin 11a isoform 1 [Source:RefSeq_peptide;Acc:NP_861430];
NM_131784.1_3prime500bases435 0.65 0.65 BMP and activin membrane-bound inhibitor (Xenopus laevis) homolog (bambi),
BU670702.1_3pri me500bases280 0.65 0.65 ENSDARG00000003509 CB407 5- similar to SPT:Q8UW4 ATP-binding cassette transporter 1,
NM_130988.1_3prime500bases427 0.65 0.65 ENSDARG00000038798:Patched protein homolog 1 (Patched 1) (PTC1). [Source:Uniprot/SWISSPROT;Acc:Q98864];
NM_131115.1 _3pri me500bases327 0.65 0.65 ENSDARG00000008174:Homeobox protein Hox-B1a (Hox-B1). [Source:Uniprot/SWISSPROT;Acc:042366];
CF269323.1_3pri me500bases 12 0.65 0.65 cDNA library Danio rerio cDNA clone CB732 5- similar to Centrin
NM_198870.1_3prime500bases332 0.65 0.65 ENSDARG00000009336:hypothetical protein LOC321033 [Source:RefSeq_peptide;Acc;NP_942571];
NM_131290.1_3prime500bases274 0.65 0.66 0.65 ENSDARG00000021032Torkhead box D3 [Source:RefSeq_peptide;Acc:NP_571365];
NM_131632.1_3prime500bases37 0.65 0.65 ENSDARG00000022606:atonal homolog 7 [Source:RefSeq_peptide;Acc:NP 571707];
NM_201292.1_3pri me500bases426 0.65 0.65 ENSDARG00000029928:adaptor-related protein complex 3, mu 1 subunit [Source:RefSeq_peptide;Acc:NP_958449];
NM_001002686.1_3prime500bases394 0.66 0.66 ENSDARG00000021003:zgc;91854 [Source:RefSeq_peptide;Acc:NP_001002686];
NM_201176.1_3prime500bases372 0.66 0.66 ENSDARG00000017775:similar to ATP synthase, H+ transporting, mitochondrial F0 complex, subunit c (subunit 9) isofbrm 3
CF673299.1_3prime500bases379 0.66 0.66 ENSDARESTG00000014248 CB926 5- similar to Gem-associated protein 5
DIG0123_592 0.66 0.66
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NM_131860.1 _3prime500bases339 0.66 0.66
NM_200075.1_3prime500bases316 0.66 0.66
BC055500.1_3prime500bases312 0.66 0.66
DIG0163_640 0.66 0.66
NM_201491.1_3prime500bases432 0.66 0.66
NM_213103.1_3prime500bases427 0.67 0.67
CB333792.1_3prime500bases355 1.50 1.50
NM_130948.1_3prime500bases53 1.50 1.50
NM_131305.1_3prime500bases228 1.51 1.51
NM_131734.2_3prime500bases396 1.51 1.51
NM_201329.1_3pri me500bases38 1.51 1.51
DIG0188_1237 1.52 1.52
NM_201178.1_3prime500bases414 1.52 1.52
NM_213387.1_3prime500bases47 1.53 1.53
NM_131878.1_3prime500bases369 1.53 1.53
NM_001004122.1_3pri me500bases414 1.53 1.53
DIG0311_361 1.54 1.54
NM_198912.1_3pri me500bases424 1.54 1.54
NM_131047.1_3prime500bases235 1.54 1.54
NM_212823.1_3prime500bases272 1.55 1.55
NM_131664.1_3prime500bases338 1.55 1.55
NM_173255.1_3prime500bases278 1.55 1.55
NM_201577.1_3prime500bases427 1.55 1.55
NM_153662.1_3prime500bases434 1.56 1.56
NM_213058.1_3prime500bases432 1.56 1.56
NM_200074.3_3prime500bases186 1.57 1.57
CF269307.1_3pri me500bases359 1.62 1.51 1.57
CD808453.1_3prime500bases353 1.55 1.58 1.57
BU808703.1_3prime500bases5 1.57 1.57
NM_199333.1_3pri me500bases 147 1.57 1.57
NM_201213.1_3prime500bases388 1.57 1.57
NM_001007282.1_3prime500bases238 1.65 1.50 1.58
NM_200088.1_3pri me500bases361 1.58 1.58
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ENSDARG00000015472:knypek{Source:RefSeq_peptide,Acc:NP_571935];
ENSDARG00000007665:Similar to RIKEN cDNA 1500019G21 gene [Source:RefSeq_peptide;Acc:NP_956369]; 
ENSDARG00000029172:Polr1 a protein (Fragment). [Source:Uniprot/SPTREMBL;Acc:Q7SXQ2];
ENSDARG00000003061 PREDICTED: similar to CD276 antigen isoform b [Source:RefSeq_peptide_predicted;Acc:XP_700973]; 
ENSDARG00000042853:isovaleryl Coenzyme A dehydrogenase [Source:RefSeq_peptide;Acc:NP_958899]; 
ENSDARG00000045902:hypothetical protein LOC406376 [Source:RefSeq_peptide;Acc:NP_998268]; 
cDNA library Danio rerio cDNA done CB116 3
ENSDARG00000037995:DVR-1 protein precursor. [Source:Uniprot/SWISSPROT;Acc:P35621];
ENSDARG00000013125:Homeobox protein Dlxla (DLX-1). [Source:Uniprot/SWISSPROT;Acc:Q98875]; 
ENSDARG00000005039:glutathione S-transferase pi [Source:RefSeq_peptide;Acc:NP_571809];
ENSDARG00000034771 :RAB13, member RAS oncogene family [Source:RefSeq_peptide;Acc:NP_958486]; 
ENSDARG00000056084:PREDICTED: similar to CG33141-PA [Source:RefSeq_peptide_predicted;Acc:XP_696105]; 
ENSDARG00000014577:Rhophilin 2 (GTP-Rho binding protein 2). [Source:llniprot/SWISSPROT;Acc:Q6TNR1]; 
ENSDARG00000044399:phosphoglycerate kinase 1 [Source:RefSeq_peptide;Acc:NP_998552];
ENSDARG00000025516:nanos homolog [Source:RefSeq_peptide,Acc:NP_571953];
ENSDARG00000042947:myostatin-2 [Source:RefSeq_peptide;Acc:NP_001004122];
ENSDARESTG00000005713 peptidase D (pepd),
ENSDARG00000043276:ca!reticulin [Source:RefSeq_peptide;Acc:NP_571122];
ENSDARG00000040602 ?
ENSDARESTG00000014726 epithelial protan lost in neoplasm (eplin),
ENSDARESTG00000018904 ATPase, H+ transporting, lysosomal, VO subunit c (atp6v0c),
ENSDARG00000005675 SEC61, beta subunit (sec61b),
ENSDARG00000018788:sialyitransferase 8 [Source:RefSeq_peptide;Acc:NP_705948];
ENSDARG00000004665:heat shock 70kDa protein 5 [Source:RefSeq_peptide;Acc:NP_998223];
ENSDARESTG00000025067 caldum homeostasis endoplasmic reticulum protein (cherp)
ENSDARG00000017906:hypothetical protein LOC554101 [Source:RefSeq_peptide;Acc:NP_001019574]; 
ENSDARESTG00000024342 done CB654 5- similar to Histone protein Hist2h3c1, 
cDNA done CB516 5- similar to C-ets-1 protein
ENSDARG00000003933:pyruvate kinase, muscle [Source:RefSeq_peptide;Acc:NP_955365];
ENSDARG00000010316:glutaminyl-tRNA synthetase [Source:RefSeq_peptide;Acc:NP_957507]; 
glutathione peroxidase 4a
ENSDARG00000035332:hypothetical protein LOC368366 [Source:RefSeq_peptide;Acc:NP_956382];
NM_212835.1_3prime500bases46 1.58 1.58 ENSDARG00000041954:chymotrypsin C (caldecrin) [Source:RefSeq_peptide;Acc:NP_956180];
NM_001007371,1_3prime500bases41 1.58 1.58 ENSDARG00000032640:zgc:101900 (zgc:101900), mRNA [Source:RefSeq_dna;Acc:NM_001007371 ];
NM_201470.1_3prime500bases432 1.58 1.58 ENSDARG00000008310:inositol hexaphosphate kinase 2 [Source:RefSeq_peptide;Acc:NP_958878];
NM_201587.1_3prime500bases206 1.58 1.58 islet cell autoantigen (ica),
NM_200108.1_3pri me500bases408 1.58 1.58 ENSDARESTG00000009408 zgc:55309 (zgc:55309).
NM_200025.1_365 1.59 1.59 ENSDARG00000037071 iribosomal protein S26 [Source:RefSeq_peptide;Acc:NP_956319];
NM_001007774.1_3prime500bases319 1.60 1.60 ENSDARESTG00000005461 zgc:101730 (zgc:101730), mRNA
NM_194401.1_3prime500bases291 1.60 1.60 ENSDARG00000002131:CUG triplet repeat, RNA binding protein 2 [Source:RefSeq_peptide;Acc:NP_919382];
NM_201457.1_3pri me500bases430 1.60 1.60 ENSDARG00000008175:replication factor C (activator 1) 3 [Source:RefSeq_peptide;Acc:NP_958865];
NM_131555.1_3prime500bases397 1.61 1.61 ENSDARESTG00000011910 dopachrome tautomerase (dct), mRNA
NM_131528.1_3prime500bases298 1.61 1.61 ENSDARG00000036693:Homeobox protein Hox-C9a (Hox-C9). [Source:Uniprot/SWISSPROT;Acc:Q9YGS6];
NM_131757.1_3prime500bases427 1.63 1.63 ENSDARG00000015707:dishevelled, dsh homolog 3 [Source:RefSeq_peptide;Acc:NP_571832];
CB891031.1_3prime500bases308 1.63 1.63 CB628 5- similar to Protein-tyrosine phosphatase X precursor
NM_131513.1_3prime500bases430 1.63 1.63 ENSDARG00000038528 cydin B1 (ccnbl),
CF673298.1_3prime500bases136 1.63 1.63 ENSDARESTG00000024736 done CB984 5- similar to Receptor-type protein-tyrosine phosphatase mu precursor
NM_213208.1_3prime500bases114 1.53 1.74 1.64 ENSDARG00000013307:60S ribosomal protein L19. [Source:Uniprot/SWISSPROT;Acc:Q6P5L3];
NM_212707.1_3prime500bases162 1.67 1.61 1.64 ENSDARG00000000068:solute carrier family 9 (sodium/hydrogen exchanger), isoform 3 regulator 1
NM_199216.1_3prime500bases16 1.64 1.64 ENSDARG00000004964:cytochrome P450, family 4 [Source:RefSeq_peptide;Acc:NP 954686];
NM_130939.1_3prime500bases418 1.65 1.65 cth1 (cth1)
BU670753.1_3prime500bases358 1.65 1.65 OTTDARG00000011035:si :ch211 -76m11.4:Novel_CDS;OTTDARG00000011034:si:ch211-76m11.3:Novel_CDS;
NM_131826.1_3prime500bases50 1.58 1.73 1.66 ENSDARG00000009182:sprouty (Drosophila) homolog 4 [Source:RefSeq_peptide;Acc:NP_571901];
NM_212795.1_3prime500bases117 1.74 1.57 1.66 ENSDARG00000022813:Dead end protein 1. [Source:Uniprot/SWISSPROT;Acc:Q7T1 H5];
NM_131105.2_3prime500bases297 1.66 1.66 alpha-tropomyosin (tpma),
DIG0187_604 1.66 1.66
NM_173257.1_3pri me500bases 146 1.66 1.66 ENSDARG00000015911:MCM2 minichromosome maintenance defident 2, mitotin [Source:RefSeq_peptide;Acc:NP
NM_131142.1_3prime500bases105 1.71 1.61 1.66 ENSDARG00000001353:Homeobox protein Hox-B1b (Hox-A1). [Source:Uniprot/SWISSPROT;Acc:Q90423];
NM_001008581.1_3prime500bases327 1.67 1.67 ENSDARG00000040046:hypothetical protein LOC494038 [Source:RefSeq_peptide;Acc:NP_001008581];
NM_131322.2_3prime500bases422 1.67 1.67 ENSDARG00000014626:Homeobox protein Dlx3b (DLX-3). [Source:Uniprot/SWISSPROT;Acc:Q01702];
NM_001002486.1_247 1.67 1.67 ENSDARG00000043977 zgc:92860 (zgc:92860),
NM_199538.1_3pri me500bases295 1.64 1.70 1.67 ENSDARG00000033768:hypothetical protein LOC321203 [Source:RefSeq_peptide;Acc:NP_955832];
NM_131506.1_3prime500bases351 1.68 1.68 ENSDARG00000005150:T-box 20 [Source:RefSeq_peptide;Acc:NP_571581];
NM_201487.1_3pri me500bases385 1.59 1.78 1.68 ENSDARG00000014230:dihydrolipoamide S-succinyltransferase [Source:RefSeq_peptide;Acc:NP_958895];
NM_152956.1_3prime500bases377 1.68 1.68 ENSDARG00000034785:dachshund b [Source:RefSeq_peptide;Acc:NP_694488];
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NM_181766.1_3prime500bases 179 1.77 1.62 1.69
NM_152948.1_3prime500bases351 1.69 1.69
NM_173241.1_3prime500bases267 1.72 1.70 1.71
NM_001003509.1_3prime500bases419 1.72 1.72
NM_178222.2_3prime500bases356 1.72 1.72
CF416980.1_3prime500bases316 1.81 1.64 1.72
NM_198980.1_3prime500bases177 1.51 1.96 1.73
DIG0406_2221 1.74 1.74
NM_153651.1_3prime500bases435 1.74 1.74
NM_178286.2_3prime500bases402 1.72 1.78 1.75
NM_131644.1_3prime500bases279 1.75 1.75
CF943689.1_3prime500bases114 1.76 1.76
CB923498.1_3prime500bases313 1.79 1.79
NM_131294.1_3prime500bases435 1.80 1.80
NM_212574.1_3prime500bases193 1.65 1.95 1.80
NM_200090.1_3prime500bases311 1.97 1.63 1.80
NM_198807.1_3prime500bases67 1.81 1.81
NM_201206.1_3prime500bases257 1.81 1.81
NM_200105.1_3prime500bases210 1.64 1.99 1.81
NM_131267.1_3prime500bases432 1.82 1.82
NM_001001941.1_3prime500bases82 1.84 1.84
NM_131875.1_3prime500bases0 2.16 1.54 1.85
NM_200960.1_3prime500bases153 1.63 2.07 1.85
NM_001007038.1_3pri me500bases269 2.06 1.64 1.85
NM_130945.1_3prime500bases213 1.86 1.86
NM_130947.1_3prime500bases404 1.87 1.87
NM_178297.2_3prime500bases120 1.73 2.02 1.87
NM_201299.1_3prime500bases275 1.73 2.05 1.89
NM_183071.1_3prime500bases384 2.20 1.58 1.89
NM_001004602.1_3prime500bases143 1.76 2.03 1.89
NM_173223.2_3prime500bases346 1.82 1.97 1.90
NM_131665.1_3prime500bases403 1.54 2.28 1.91
NM_194374.1_3pri me500bases 181 1.83 2.01 1.92
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annexin A11 b (anxal 1 b),
ENSDARG00000043658:coxsackie virus and adenovirus receptor [Source:RefSeq_peptide;Acc:NPJ)94480]; 
ENSDARG00000023002:dentideless homolog [Source:RefSeq_peptide;Acc:NP_775348];
ENSDARG00000004806:zgc:92443 [Source:RefSeq_peptide;Acc:NP_001003509];
ENSDARG00000023316:single-minded homolog 1 [Source:RefSeq_peptide;Acc:NP_835740];
ENSDARG00000042428 cDNA clone CB870 5- similar to Glutathione S-transferase 1
ENSDARG00000004311 :low density lipoprotein receptor adaptor protein 1 [Source:RefSeq_peptide;Acc:NP_945331];
ENSDARG0000001 l273:homeo box 11-like [Source:RefSeq_peptide;Acc:NP_705937];
ENSDARESTG00000006588 selenoprotein M (sepm),
ENSDARG00000043923:SRY-box containing gene 9b [Source:RefSeq_peptide;Acc:NP_571719];
ENSDARG00000045305 CB1053 5- similar to High-affinity cAMP-spedfic 3-,5-cydic phosphodiesterase 7A 
ENSDARG00000018678 done CB453 5- similar to Ras-related protein Rab-40C (SOCS box containing protein RAR3), 
ENSDARG00000043848:Superoxide dismutase [Cu-Zn] (EC 1.15.1.1). [Source:Uniprot/SWISSPROT;Acc:073872]; 
ENSDARESTG00000014835 solute carrier family 11 (proton-coupled divalent metal ion transporters), member 2 (slc11a2) 
ENSDARG00000040730:hypothetical protein LOC368478 [Source:RefSeq_peptide;Acc:NP_956384]; 
ENSDARG00000020289:PIF1 homolog [Source:RefSeq_peptide;Acc:NP_942102];
ENSDARGOOOOOOH626:COX15 homolog, cytochrome c oxidase assembly protein [Source:RefSeq_peptide;Acc:NP_957500]; 
ENSDARG00000026862Aised toes homolog [Source:RefSeq_peptide;Aec:NP_956399];
ENSDARG00000036097:iroquois homeobox protein 3a [Source:RefSeq_peptide;Acc:NP_571342]; 
ENSDARG00000004173;coatomer protein complex, subunit alpha [Source:RefSeq_peptide;Acc:NP_001001941];
SRY-box containing gene 10 (sox10),
ENSDARG00000011175:ATPase, H+ transporting, V1 subunit D [Source:RefSeq_peptide;Acc:NP_957254]; 
ENSDARG00000044593:ATP-binding cassette, sub-family C (CFTR/MRP), member 4 (abcc4), mRNA 
ENSDARG00000015717;fms-related tyrosine kinase 4 [Source:RefSeq_peptide;Acc:NP_571020]; 
ENSDARG00000040836:Wnt-4a protein precursor. [Source:Uniprot/SWISSPROT;Acc:P47793];
ENSDARESTG00000020068 selenoprotein P, plasma, 1a (seppla),
ENSDARG00000025904:glycoprotein, synaptic 2 [Source: RefSeq_pepti de; Acc: N P_958456];
ENSDARG00000040344;linker histone H1M [Source:RefSeq_peptide;Acc:NP_898894]; 
zgc:86701
ENSDARG00000002731 :syndecan 2 [Source:RefSeq_peptide;Acc:NP_775330];
ENSDARG00000021389:jagged 2 isoform 1 [Source:RefSeq_peptide;Acc:NP_571937];
ENSDARG00000041217:exportin 6 [Source:RefSeq_peptide;Acc:NP_919355];
NM_212817.1_3prime500bases313 1.89 2.01 1.95
NM_212817.1 _3pri me500bases337 2.01 1.89 1.95
NM_001001399.1_3prime500bases370 1.93 1.96 1.95
NM_201499.1_3pri me500bases421 1.96 1.96
NM_200107.1_3prime500bases149 1.97 2.01 1.99
DIG0379_421 1.99 1.99
CF417020.1_3prime500bases393 2.01 2.01
NM_001002468.1_3prime500bases415 2.01 2.01
NM_199532.1_3prime500bases 125 1.68 2.36 2.02
NM_130922.1 _3prime500bases109 2.24 1.81 2.02
NM_001007124.1_3prime500bases325 2.03 2.03
NM_199212.1_3prime500bases 100 1.93 2.15 2.04
BC081600.1_3pri me500bases407 2.05 2.05
NM_131247.1_3prime500bases435 2.05 2.05
Cab 2.05 2.05
NM_131041.1 _3prime500bases430 2.06 2.06
NM_131500.1_3prime500bases388 2.06 2.06
NM_131503.1_3prime500bases104 2.04 2.12 2.08
BM402118.1_3prime500bases243 2.15 2.02 2.09
NM_200109.1_3prime500bases196 1.72 2.47 2.09
NM_131848.1_3pri me500bases415 1.91 2.30 2.11
CF924885.1_3prime500bases240 2.09 2.13 2.11
NM_198978.1_3prime500bases380 2.12 2.12
NM_198072.1_3prime500bases142 2.03 2.22 2.13
NM_131247.1_3prime500bases423 2.13 2.13
NM_198978.1_3prime500bases371 2.15 2.15
NM_178298.2_3pri me500bases266 1.72 2.59 2.16
DIG0565_1528 2.16 2.16
NM_199519.2_3prime500bases22 1.93 2.45 2.19
NM_199273.1_3prime500bases79 2.32 2.07 2.19
NM_131729.2_3prime500bases151 2.21 2.21
NM_131184.2_3prime500bases100 1.99 2.44 2.22
NM_001003512.1_3prime500bases320 2.24 2.24
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ENSDARG00000038964:tnf receptor-associated factor 4b [Source:RefSeq_peptide;Acc:NP_997982]; 
ENSDARG00000038964:tnf receptor-associated factor 4b [Source:RefSeq_peptide;Acc:NP_997982]; 
ENSDARG00000005230:signal sequence receptor, beta [Source:RefSeq_peptide;Acc:NP_001001399]; 
ENSDARG00000025375:isodtrate dehydrogenase 1 (NADP+), soluble [Source:RefSeq_peptide;Acc:NP_958907]; 
ENSDARG00000037618:hypothetical protein LOC378866 [Source:RefSeq_peptide;Acc:NP_956401];
ENSDARG00000034829 CB816 5- similar to Procollagen-lysine,2-oxoglutarate 5-dioxygenase 3 precursor 
ENSDARG00000025350:hypothetical protein LOC436741 [Source:RefSeq_peptide;Acc:NP_001002468]; 
ENSDARG00000004402:ELOVL family member 6, elongation of long chain fatty adds [Source:RefSeq_peptide;Acc:NP_955826]; 
ENSDARG00000020298:B-cell translocation gene 2 [Source:RefSeq_peptide;Acc:NP_570997];
ENSDARG00000028415 met proto-oncogene (hepatocyte growth factor receptor) (met), 
ENSDARG00000025522:serum/glucocorticoid regulated kinase [Source:RefSeq_peptide;Acc:NP_954682]; 
ENSDARG00000016771:transferrin-a [Source:RefSeq_peptide;Acc:NP_001015057]; 
lactate dehydrogenase B4 (Idhb),
ENSDARG00000037231 :Neurogenin 1 (Neurogenic differentiation factor 3) (NeuroD3) (Neurogenin related protein-1). 
ENSDARG00000040159:wingless-type MMTV integration site family, member 4b [Source:RefSeq_peptide;Acc:NP_571575]; 
ENSDARG00000026534:Axin-1 (Axis inhibition protein 1). [Source:Uniprot/SWISSPROT;Acc:P57094]; 
ENSDARG00000014499:hypothetical protein LOC445204 [Source:RefSeq_peptide;Acc:NP_001003598]; 
ENSDARG00000039527 TSC22 domain family 2 (tsc22d2)
ENSDARG00000004729:transcription factor binding to IGHM enhancer 3a [Source:RefSeq_peptide;Acc:NP_571923]; 
ENSDARESTG00000025399 cDNA done CB1014 5- similar to Q8wux2 Similar to RIKEN cDNA 2510006C20 gene 
ENSDARESTG00000016872 programmed cell death 4b (pdcd4b),
ENSDARESTG00000006053 5-methyltetrahydrofolate-homocysteine methyltransferase (mtr),
ENSDARG00000035139 lactate dehydrogenase B4 (Idhb),
ENSDARG00000041022:programmed cell death 4 [Source:RefSeq_peptide;Acc:NP_945329];
ENSDARESTG00000011008 selenoprotein P, plasma, 1b (sepplb)
ENSDARG00000037493:hypothetical protein LOC553785 [Source:RefSeq_peptide;Acc:NP_001018583];
Enah/Vasp-like a (evla),
ENSDARESTG00000011553 zgc:66433 (zgc:66433),
OTTDARG00000006320:si :dkey-197d 18.1: Novel_CDS 
ENSDARG00000028148 paired box gene 2a (pax2a),
ENSDARG00000031616:zgc:92368 [Source:RefSeq_peptide;Acc:NP_001003512];
NM_182878.1_3prime500bases422 2.24 2.24 ENSDARG00000013443:ATPase, H+ transporting, lysosomal, V1 subunit B, member a [Source:RefSeq_peptide;Acc:NP_878298];
NM_212815.1_3prime500bases352 2.27 2.27 ENSDARG00000026797:v-akt murine thymoma viral oncogene homolog 2, like [Source:RefSeq_peptide;Acc:NP_997980],
NM_212994.1_3prime500bases261 2.41 2.14 2.27 ENSDARESTG00000019878 heterogeneous nuclear ribonudeoprotein K (hnrpk).
NM_130954.1_3prime500bases250 1.61 2.35 2.90 2.29 ENSDARG00000010791 :deltaA [Source:RefSeq_peptide;Acc:NP_571029];
NM_173222.1 _3prime500bases325 1.89 2.72 2.30 ENSDARG00000043257:creatine kinase, brain [Source:RefSeq_peptide;Acc:NP_775329];
NM_198208.1_3pri me500bases 109 1.98 2.66 2.32 ENSDARESTG00000005100 transcription factor Dp-2 (tfdp2),
NM_131893.1 _3prime500bases348 2.32 2.32 ENSDARESTG00000004657 myeloid ecotropic viral integration 1 (meisl),
NM_198877.1 _3prime500bases272 2.30 2.34 2.32 ENSDARG00000042931 :musde-spedfic beta 1 integrin binding protein 2 [Source:RefSeq_peptide;Acc:NP_942578];
NM_131341.1_3prime500bases304 2.32 2.32 ENSDARESTG00000000876 growth assodated protein 43 (gap43).
NM_131613.1_3prime500bases337 2.34 2.34 ENSDARG00000005315:CUG triplet repeat, RNA-binding protein 1 [Source:RefSeq_peptide;Acc:NP_571688];
NM_212761.1_2 2.34 2.34 ENSDARG00000009978:ictacaldn [Source:RefSeq_peptide;Acc:NP_997926];
NM_152955.1_3prime500bases117 1.85 2.84 2.34 ENSDARESTG00000012272 dachshund a (dacha),
NM_131193.1_3prime500bases146 2.37 2.37 eyes absent homolog 1 (eyal),
NM_199217.1_3pri me500bases 187 2.60 2.21 2.41 four and a half LIM domains (fhl),
NM_001003980.1_3pri me500bases380 2.29 2.56 2.43 ENSDARG00000002330:LIM homeobox 8 [Source:RefSeq_peptide;Acc:NP_001003980];
NM_131761.1_3prime500bases338 2.40 2.48 2.44 ENSDARG00000009447:ATP synthase, H+ transporting, mitochondrial F0 complex, subunit c (subunit 9)
NM_131807.1_3prime500bases404 2.45 2.45 ENSDARG00000008434:bd2-like [Source:RefSeq_peptide;Acc:NP_571882];
NM_182855.1 _3prime500bases382 2.57 2.36 2.46 ENSDARG00000040030 transforming growth factor, beta receptor II (tgfbr2),
NM_131360.1_3prime500bases428 2.49 2.49 ENSDARG00000041430:bone morphogenetic protein 2b [Source:RefSeq_peptide;Acc:NP_571435];
NM_131077.1_3prime500bases386 2.52 2.52 ENSDARG00000008796:hairy-related 5 [Source:RefSeq_peptide;Acc:NP_571152];
NM_201496.1_3prime500bases413 2.53 2.53 ENSDARG00000031915:Hypoxia-indudble factor 1 alpha inhibitor (EC 1.14.11.16) (Hypoxia- indudble factor asparagine hydroxylase).
NM_131802.1_3pri me500bases421 2.54 2.54 ENSDARG00000011683:HHGP protein [Source:RefSeq_peptide;Acc:NP_955812];
zfp36l 1 _3pri me500bases67 2.83 2.28 2.55 ENSDARG00000016154
NM_201309.1_3pri me500bases 192 2.31 2.82 2.56 suppressor of fused homolog (Drosophila) (sufu),
NM_131283.1_3prime500bases432 2.61 2.61 ENSDARG00000039228rforkhead box B1.1 [Source:RefSeq_peptide;Acc:NP_571358];
NM_001003982.1_3prime500bases262 2.61 2.61 ENSDARG00000029830;myogenic factor 6 [Source:RefSeq_peptide;Acc:NP_001003982];
BC056835.1_3prime500bases399 2.64 2.64 ENSDARG00000040266 SRY-box containing gene 31,
NM_131759.1_3prime500bases434 2.65 2.65 ENSDARG00000036516:hemoglobin beta embryonic-1 [Source:RefSeq_peptide;Acc:NP_571834];
CF943713.1_3prime500bases61 2.65 2.65 ENSDARG00000003001 CB1077 5- similar to Myosin Vb,
NM_199522.1_3prime500bases430 2.67 2.67 ENSDARG00000034539:ras homolog gene family, member E [Source:RefSeq_peptide;Acc:NP_955816];
DIG0161_670 2.83 2.83 ENSDARG00000017389:hypothetical protein LOC405860 [Source:RefSeq_peptide;Acc:NP_998089];
NM_131461.1_3prime500bases418 2.87 2.87 endothelium-specific receptor tyrosine kinase 2 (tie2),
NM_131682.2_3prime500bases18 2.89 2.89 ENSDARG00000041945:Aminolevulinate, delta-, synthetase 2 (Fragment). [Source:Uniprot/SPTREMBL;Acc:Q5RIZ3];
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NM_131679.3_3prime500bases168 2.72 3.25 2.99 ENSDARG00000006640:eomesodermin homolog [Source:RefSeq_peptide;Acc:NP_571754];
NM_131881.1 _3pri me500bases266 2.83 3.16 3.00 ENSDARG00000002601 Iroquois homeobox protein 7 [Source:RefSeq_peptide;Acc:NP_571956];
CA854263.1_3prime500bases122 2.88 3.11 3.00 ENSDARG00000043457:Hypothetical protein (Fragment). [Source:Uniprot/SPTREMBL;Acc:Q5XJ10];
NM_131348.2_3prime500bases39 3.00 3.00 ENSDARG00000014125rfriend leukemia integration 1 [Source:RefSeq_peptide;Aec:NP_571423];
NM_130923.1_3prime500bases410 2.44 3.59 3.01 microphthalmia-associated transcription factor a (mitfa),
NM_199276.1_3prime500bases122 2.91 3.21 3.06 ENSDARG00000028462:H1 histone family, member X [Source:RefSeq_peptide;Acc:NP_954970];
NM_199431.1_3prime500bases312 3.01 3.19 3.10 ENSDARG00000041703:ribosome binding protein 1 homolog (dog) [Source:RefSeq_peptide;Aec:NP_955463];
NM_173283.3_3prime500bases165 3.32 2.90 3.11 ENSDARG00000014947:insulin-iike growth factor binding protein 1 [Source:RefSeq_peptide;Aec:NP_775390];
NM_198911.1_3prime500bases435 3.22 3.22 ENSDARG00000020235:septin 9 [Source:RefSeq_peptide;Acc:NP_944593];
NM_182940.2_3prime500bases403 2.40 4.13 3.26 ENSDARG00000036515 hemoglobin alpha embryonic-1 (hbael),
DIG0228_268 3.32 3.32
NM_201503.1_3prime500bases263 3.92 2.95 3.43 ENSDARG00000012395:matrix metalloproteinase 13 [Source:RefSeq_peptide;Acc:NP_958911];
NM_131323.1_3prime500bases422 3.70 3.31 3.50 ENSDARG00000042291 :Homeobox protein Dlx6a (DLX-6). (Source:Uniprot/SWISSPROT;Acc:Q98877];
NM_131204.1_3prime500bases136 3.07 3.99 3.53 ENSDARG00000019949:heat shock protein 47 [Source:RefSeq_peptide;Acc:NP_571279];
NM_214723.1_3prime500bases352 3.55 3.55 ENSDARG00000039007:enolase 3, (beta, muscle) [Source:RefSeq_peptide;Acc:NP_999888];
NM_131262.1_3pri me500bases 166 4.00 3.38 3.69 ENSDARG00000030110:Myoblast determination protein 1 homolog (Myogenic factor 1). [Source:l)niprot/SWISSPROT,Acc:Q90477];
NM_130970.1_3prime500bases144 4.63 2.79 3.71 ENSDARG00000003971-.Insulin gene enhancer protein ISL-2 (Islet-2). [Source:Uniprot/SWISSPROT;Acc:P53406];
NM_180965.3_3prime500bases316 3.63 4.20 3.91 ENSDARESTG00000019581 daudin g (ddng),
NM_131273.1_3prime500bases426 3.93 3.93 ENSDARG00000007641 :muscle segment homeobox E [Source:RefSeq_peptide;Acc:NP_571348];
NM_153673.1_3pri me500bases417 4.49 4.49 ENSDARG00000008433 unc-45 homolog B (C. elegans) (unc45b),
NM_181735.1_3pri me500bases304 5.37 6.62 5.99 ENSDARG00000019659:forkhead box 11 [Source:RefSeq_peptide;Acc:NP_859424];
NM_205569.1_3prime500bases115 4.50 7.58 6.04 ENSDARG00000031683:v-fos FBJ murine osteosarcoma viral oncogene homolog [Source:RefSeq_peptide;Acc:NP_991132];
NM 153666.1 3prime500bases311 6.82 6.58 6.70 ENSDARG00000011785:T-box 24 [Source:RefSeq peptide;Acc:NP 705952];
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Appendix 2
Genes in rab5a2 morpholino injected embryos that changed more than 3 fold compared to controls at shield stage
Gene Name Fold Change Av Description
NM_131052.1 _3prim e500bases417 0.07 0.07 0.07 ENSDARG00000006939:T-box transcription factor TBX6 (T-box protein 6).
NM _130933.1_3prim e500bases429 0.07 0.07 zic family m em ber 1 (odd-paired homolog, Drosophila) (zic1),
NM_214692.1 _3prim e500bases406 0.10 0.09 0.09 m em brane protein, palmitoytated 1 (mpp1
NM_131110.1 _3pri m e500bases292 0.14 0.15 0.14 ENSDARG00000011166:Carbonic anhydrase  (EC 4.2.1.1) (C arbonate dehydratase).
N M_194392.1_3pri m e500bases 194 0.16 0.18 0.15 0.17 EN SDARG00000040216:trophoblast glycoprotein-like [Source:Ref5eq_peptide;Acc:NP_919373];
NM_131778.1 _3prim e500bases132 0.21 0.14 0.17 ENSDARG00000002795:myeloid ecotropic viral integration site 3 [Source:RefSeq_peptide;Acc:NP_571853l;
NM_131893.1_3prim e500bases348 0.20 0.20 ENSDARESTG00000004657
LTP4 0.20 0.20
NM_130967.1_3pri m e500bases2  78 0.27 0.15 0.21 ENSDARG00000025641 :GLI-Kruppel family m em ber GLI2a [Source:RefSeq_peptide;Acc:NP_571042];
NM_001002332.1_3prim e500bases404 0.20 0.22 0.21 EN SDA RG00000007024:zgc:92414[Source:RefSeq_peptide;A cc:NP_001002332];
NM_131576.1_3prim e500bases2 0.23 0.20 0.21 ENSDARG00000007277:m yogenic factor 5 [Source:RefSeq_peptide;Acc:NP_571651];
NM_152980.1 _3prim e500bases185 0.19 0.26 0.23 ENSDARG00000031855:m acrophage stimulating 1 (hepatocyte growth factor-like) [Source:RefSeq_peptide;Acc:NP_694512];
NM _131108.1_3prim e500bases390 0.23 0.23 0.23 ENSDARG00000036830:type I cytokeratin, enveloping layer [Source:RefSeq_peptide;Acc:NP_571182];
NM_001007454.1_3prim e500bases299 0.23 0.24 0.23 ENSDARG00000027699:zgc:101612[Source:RefSeq_peptide;A cc:NP_001007455];
NM_131716.1 _3pri m e500bases434 0.23 0.23 ENSDARG00000020708:midkine-related growth factor b [Source:RefSeq_peptide;Acc:NP_571791];
NM_130973.1 _3pri m e5 00bases361 0.23 0.24 0.24 ENSDARESTG00000005532
NM _131509.1_3prim e500bases430 0.24 0.24 keratin 4  (krt4),
NM_173288.1 _3prim e500bases371 0.16 0.32 0.24 ENSDARG00000040666:mki67 (FHA dom ain) interacting nucleolar phosphoprotein (human) - like [Source:RefSeq_peptide;Acc:NP_775395];
NM _131109.1_3prim e500bases25 0.25 0.25 ENSDARG00000036292:caudal type hom eo box transcription factor 4  [Source:RefSeq_peptide;Acc:N P_571184];
NM _131163.1_3prim e500bases115 0.30 0.20 0.25 ENSDARG00000039694:Beta-2-microglobulin precursor. [Source:Uniprot/SWISSPROT;Acc:Q04475];
NM_131729.2_3prim e500bases151 0.17 0.35 0.26 OTTDARG00000006320:si:dkey-197d18.1:Novel_CDS
NM _131209.1_3prim e500bases394 0.24 0.29 0.26 protocadherin 8 (pcdh8),
NM_001001950.1_3prim e500bases137 0.27 0.27 ENSDARG00000009849:zic family m em ber 3 heterotaxy 1 (odd-paired homolog, Drosophila) [Source:RefSeq_peptide;Acc:NP_001001950];
N M_201495.1_3pri m e5 00bases221 0.24 0.30 0.27 Rab14
NM_201513.1 _3prim e500bases433 0.27 0.27 ENSDARG00000042539;tyrosine 3-monooxygenase/tryptophan 5-m onooxygenase activation protein, theta polypeptide
NM _200659.1_3prim e500bases358 0.27 0.27 ENSDARG00000025948:mutL homolog 1, colon cancer, nonpolyposis type 2 [Source:RefSeq_peptide;Acc:NP_956953];
CF673299.1_3prim e500bases366 0.30 0.25 0.28 ENSDARESTG00000014248 clone CB926 5- similar to G em -associated protein 5
NM_212567.1 _3prim e500bases8 0.28 0.28 ENSDARG00000024204:minichromosome m ain tenance protein 3 [Source:RefSeq_peptide;Acc:NP_997732];
NM_200111.1_3prim e500bases156 0.34 0.23 0.29 ENSDARG00000017748:hypothetical protein LOC378998 [Source:RefSeq_peptide;Acc:NP_956405];
NM_131342 .2_3prim e500bases296 0.27 0.31 0.29 ENSDARG00000019995:bone m orphogenetic protein 4 [Source:RefSeq_peptide;Acc:NP_571417];
NM _001003882.2_3prim e500bases425 0.29 0.29 ENSDARG00000008237:seryl-tRNA sy n th e tase  [Source:RefSeq_peptide;Acc:NP_001003882];
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NM_173261.1_3prime500bases339 0.28 0.32 0.30
NM_131092.1_3prime500bases291 0.29 0.31 0.30
NM_001003875.1_3prime500bases285 0.31 0.30 0.31
DIG0410_1903 0.31 0.31
NM_183074.1_3prime500bases334 0.31 0.30 0.31
NM_131320.1 _3prime500bases353 0.34 0.28 0.31
NM_131482.1 _3prime500bases380 0.35 0.28 0.31
C D808440.1_3pri me500bases215 0.31 0.32 0.32
NMJ 31363.1_3prime500bases153 0.32 0.32 0.32
NM_131128.1 _3prime500bases396 0.33 0.33
NM_194371,2_3prime500bases155 0.34 0.33 0.33
NM_130955.1 _3prime500bases324 0.35 0.35 0.31 0.33
CB923492.1 _3prime500bases387 0.36 0.33 0.34
NM_001012246.1_3prime500bases23 0.35 0.35
NM_153660.1_3prime500bases190 0.36 0.34 0.35
NM_131063.1_3pri me500bases24 0.43 0.29 0.36
NM_212797.1 _3prime500bases426 0.36 0.36
AF339031.1 _3prime500bases363 0.36 0.36 0.36
NM_201331.1 _3pri me500bases423 0.36 0.36
CF417004.1_3prime500bases377 0.36 0.36
NM_198876.1 _3prime500bases405 0.37 0.37
CB333812.1_3prime500bases133 0.33 0.42 0.37
NM_177984.1_3prime500bases24 0.35 0.40 0.37
NM_131690.1_3pri me500bases388 0.29 0.48 0.38
NM_194369.1_3prime500bases417 0.38 0.38
NM_131455.1_3prime500bases385 0.43 0.34 0.39
NM_173221.2_3prime500bases432 0.39 0.39
DIG0123_592 0.39 0.39
NM_131139.1_3prime500bases322 0.36 0.42 0.39
NM_131876.2_3prime500bases270 0.45 0.33 0.39
NM_213103.1_3prime500bases427 0.39 0.39
CK445313.1_3prime500bases394 0.32 0.47 0.39
NM_131027.1_3prime500bases413 0.41 0.37 0.39
NM_131882.2_3prime500bases379 0.43 0.37 0.40
ENSDARG00000010948:kinesin family member 11 [Source:RefSeq_peptide;Acc:NP_775368];
ENSDARG00000035095: on e-eyed pinhead [Source:RefSeq_peptide,Acc:NP_571167];
ENSDARG00000037931 :U 1 small nuclear ribonucleoprotein polypeptide A [Source:Re#Seq_peptide;Acc:NP_001003875];
ENSDARG00000042503:ventrally expressed dharma/bozozok antagonist [Source:RefSeq_peptide;Acc:NP_898897]; 
ENSDARG00000023188:lymphocyte cytosolic plastin 1 [Source:RefSeq_peptide;Acc:NP_571395]; 
ENSDARG00000005645:roundabout homolog 3 [Source:RefSeq_peptide;Acc:NP_571557]; 
cDNA clone CB473 5
ENSDARG00000045102:sine oculis homeobox homolog 3b [Source:RefSeq_peptide;Acc:NP_571438]; 
ENSDARG00000012076:Apolipoprotein A-l precursor (Apo-AI) (ApoA-l). [Source:Uniprot/SWISSPROT;Acc:042363]; 
ENSDARG00000010124:Sp5 transcription factor-like [Source:RefSeq_peptide;Acc:NP_919352];
ENSDARESTG00000012353 Delta D
ENSDARG00000004713:hypothetical protein LOC550434 [Source:RefSeq_peptide:Acc:NP_001017739]; 
ENSDARG00000035748:fibroblast growth factor 19 [Source:RefSeq_peptide;Acc:NP_001012246];
ENSDARESTG00000012343
ENSDARG00000035998:Sonic hedgehog protein precursor (SHH) (VHH-1). [Source:Uniprot/SWISSPROT;Acc:Q92008]: 
ENSDARG00000019747:3-beta-hydroxysteroid dehydrogenase [Source:RefSeq_peptide;Acc:NP_9979€2];
ENSDARG00000008487hypothetical protein. [Source:Uniprot/SPTREMBL;Acc:Q503T6];
ENSDARG00000012369:retinol dehydrogenase 10 [Source:RefSeq_peptide;Acc:NP_958488];
ENSDARG00000036999 clone CB800 5- similar to Zygotic DNA replication factor MCM6b
ENSDARG00000018971:UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5 [Source:RefSeq_peptide;Acc:NP_942577]; 
CB159 5- similar to Epiplakin
ENSDARG00000013853:LIM domain only 4 [Source:RefSeq_peptide:Acc:NP_817093]:
ENSDARG00000019856:ATPase, Na+/K+ transporting, alpha 1b polypeptide [Source:RefSeq_peptide;Acc:NP_571765]; 
ENSDARG00000037563:CD99 antigen-like 2 [Source:RefSeq_peptide;Acc:NP_919350];
ENSDARG00000014017:Ribonudeoside-diphosphate reductase large subunit ( (Ribonucleotide reductase protein R1 class I). 
ENSDARG00000013839:aldehyde dehydrogenase 3 family, member D1 [Source:RefSeq_peptide;Acc:NP_775328];
ENSDARG00000041755
ENSDARG00000025372:anti-dorsalizing morphogenic protan [Source:RefSeq_peptide;Acc:NP_571951]; 
ENSDARG00000045902:hypothetical protein LOC406376 [Source:RefSeq_peptide;Acc:NP_998268];
ENSDARG00000004017 clone CB1089 5- similar to sperm associated antigen 1 
ENSDARG00000002952:smoothened homolog [Source:RefSeq_peptide;Acc:NP_571102];
ENSDARG00000022476
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BU492951.1_3prime500bases183 
NM_131285.1 _3prime500bases429 
NM_001001811.1_3prime500bases418 
NM_201176.1_3prime500bases372 
NM_130932.1_3prime500bases430 
NM_200228.1_3prime500bases99 
NM_131557.1 _3prime500bases429 
NM_199211.1_3prime500bases380 
NM_001007768.1_3prime500bases425 
NM_131414.1 _3pri me500bases435 
NM_001005390.1_3prime500bases12 
NM_131250.2_3prime500bases406 
NM_130946.1_3pri me500bases316 
NM_174861.2_3prime500bases259 
NM_131511.1 _3prime500bases250 
NM_130918.1 _3prime500bases156 
NM_131822.1 _3prime500bases414 
NM_212770.1 _3pri me500bases 190 
NM_199545.3_3prime500bases397 
NM_131066.1 _3prime500bases239 
NM_001003501.1_3prime500bases284 
DIG0166_2731
NM_183072.1_3prime500bases189 
N M_213118.1 _3pri me500bases 147 
NM_199949.2_3prime500bases413 
NM_131884.2_3prime500bases139 
NM_130960.1_3prime500bases226 
NM_198817.1 _3prime500bases426 
CF416995.1_3pri me500bases416 
NM_212612.1 _3prime500bases264 
NM_183343.1_3prime500bases271 
NM_200080.2_3prime500bases345 
DIG0408_1690
NM_200297.1_3prime500bases253
0.40 0.40
0.40 0.40
0.40 0.40
0.40 0.40
0.41 0.41
0.41 0.41
0.41 0.41
0.45 0.38 0.41
0.42 0.42
0.42 0.42
0.42 0.44 0.43
0.43 0.43
0.48 0.39 0.43
0.42 0.44 0.43
0.42 0.44 0.43
0.41 0.45 0.43
0.44 0.44
0.44 0.44 0.44
0.44 0.44
0.39 0.50 0.44
0.43 0.46 0.44
0.44 0.44
0.40 0.49 0.45
0.49 0.41 0.45
0.45 0.45
0.43 0.47 0.45
0.43 0.47 0.45
0.42 0.48 0.45
0.42 0.49 0.46
0.41 0.51 0.46
0.36 0.56 0.46
0.42 0.50 0.46
0.47 0.47
0.47 0.47
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ENSDARG00000035835:hypothetical protein LOC437013 [Source:RefSeq_peptide;Acc:NP_001002740]; 
ENSDARG00000045569:forkhead box B1.2 [Sou rce:RefSeq_pep tide ;Acc:NP_571360];
ENSDARG00000036440:SRY-box containing gene 3 [Source:RefSeq_peptide;Acc:NP_001001811];
ENSDARG00000017775:similar to ATP synthase, H+ transporting, mitochondrial F0 complex, subunit c (subunit 9) isofbrm 3 
ENSDARG00000006355 creatine kinase, muscle (ckm),
ENSDARG00000013973:peroxisomal biogenesis factor 3 [Source:RefSeq_peptide ;Acc:NP 956522]; 
ENSDARG00000035831:GATA-binding protein 6 [Source: RefSeq_peplide;Acc:NP_571632];
ENSDARG00000030700:CTP synthase [Source:RefSeqj)eptide;Acc;NP_954681];
ENSDARG00000016864:hypothetical protein LOC493608 [Source:RefSeq_peptide;Acc:NP_001007769]; 
ENSDARG00000040346
ENSDARG00000035329:calpain, small subunit 1 [Source:RefSeq_peptide;Acc:NP_001005390]; 
ENSDARG00000043643:Homeobox protein OTX1 (ZOTX1). [Source:Uniprot/SWISSPROT;Acc:Q91994]; 
ENSDARG00000010355:wnt8-like protein 2 [Source:RefSeq_peptide;Acc:NP_001018637]; 
ENSDARG00000019268:gastrulation brain homeobox 1 [Source:RefSeq_peptide;Acc:NP_777286]; 
ENSDARG00000014673:frizzled 9 [Source:RefSeq_peptide;Acc:NP_571586];
ENSDARG00000015116:frizzled homolog 8a [Source:RefSeq_peptide;Acc:NP 571629];
ENSDARG00000035563:nocA related zinc finger 1 [Source:RefSeq_peptide;Acc:NP_571897]; 
ENSDARG00000005185;carboxypeptidase N, polypeptide 1 [Source:RefSeq_peptide;Acc:NP_997935]; 
ENSDARESTG00000009422 glutamate dehydrogenase 1b (gludlb),
ENSDARG00000044163:snail homolog 1a [Source:RefSeq_peptide;Acc:NP_571141];
ENSDARG00000012341 :zgc;92451 [Source:RefSeq_peptide;Acc:NP_001003501];
ENSDARG00000014323:hypothetical protein LOC436960 [Source:RefSeq_peptide;Acc:NP_001002687]; 
ENSDARESTG00000016845 thioredoxin reductase 1 (txnrdl),
ENSDARG00000014243:SRY-box containing gene 2 [Source:RefSeq_peptide;Acc:NP_998283]; 
ENSDARG00000044521:eukaryotic translation elongation factor 1 beta 2 [Source:RefSeq_peptide;Acc:NP_956243]; 
ENSDARG00000045369:CCAAT/enhancer binding protein beta [Source:RefSeq_peptide;Acc:NP_571959]; 
ENSDARG00000019920:lefty1 [Source:RefSeq_peptide;Acc:NP_571035];
ENSDARESTG00000016981 starmaker (stm)
CB791 5- similar to Cytochrome P450
DEAD (Asp-Glu-Ala-Asp) box polypeptide 5 (ddx5),
ENSDARG00000037593:prickle-like 2 [Source:RefSeq_peptide;Acc:NP_899186];
ENSDARG00000029086:keratin 8 [Source:RefSeq_peptide;Acc:NP_956374];
ENSDARG00000036820:monoglyceride lipase [Source;RefSeq_peptide;Acc:NP_956591];
NM_200703.2_3prime500bases423 
NM_131251.1_3prime500bases2 35 
NM_199543.1_3prime500bases70 
NM_205567.1_3prime500bases270 
NM_131851.1_3prime500bases133 
NM_131637.1 _3pri me500bases240 
CF416991.1_3pri me500bases421 
NM_130908.1_3prime500bases107 
NM_212636.1_3prime500bases290 
CF673281.1_3prime500bases425 
NM_130934.1_3pri me500bases362 
NM_207048.1 _3prime500bases204 
NM_200042.1 _3prime500bases0 
CF673300.1_3prime500bases47 
NM_205702.1_3prime500bases229 
NM_131146.2_3prime500bases230 
DIG0131_1438 
golgb 1 _3prime500bases306 
NM_212602.1_3prime500bases425 
map3k4_3prime500bases366 
NM_182855.1_3prime500bases391 
CF673278.1_148
NM_131207.1_3prime500bases102 
NM_173244.1_3prime500bases425 
NM_131205.1_3prime500bases434 
DIG0144_634
NM_131221.1 _3prime500bases428 
NM_173219.1_3prime500bases185 
NM_199433.1 _3pri me500bases434 
NM_198824.1 _3prime500bases417 
NM_131404.1_3prime500bases5 
NM_131300.1_3pri me500bases373 
NM_131079.1_3prime500bases285 
NM_001003774.1_3prime500bases342
0.47 0.47
0.46 0.50 0.48
0.51 0.45 0.48
0.48 0.48
0.45 0.51 0.48
0.50 0.47 0.49
0.49 0.49
0.48 0.50 0.49
0.46 0.53 0.49
0.47 0.52 0.50
0.48 0.52 0.50
0.55 0.46 0.50
0.62 0.39 0.50
0.54 0.47 0.51
0.51 0.51
0.48 0.53 0.51
0.51 0.51
0.51 0.51
0.52 0.52
0.54 0.51 0.52
0.52 0.52
0.52 0.52
0.53 0.51 0.52
0.52 0.52
0.52 0.52
0.53 0.53
0.53 0.53
0.47 0.60 0.53
0.54 0.54
0.57 0.51 0.54
0.54 0.54
0.55 0.55
0.55 0.55 0.55
0.54 0.56 0.55
ENSDARG00000013627 golgi reassembly stacking protein 2 (gorasp2),
ENSDARG00000011235:Homeobox protein OTX2 (ZOTX2). [Source:Uniprot/SWISSPROT;Acc:Q91981];
ENSDARG00000025147:Cd63 antigen [Source:RefSeq_peptide;Acc:NP_955837];
ENSDARG00000006603:cysteine and glycine-rich protein 1 [Source:RefSeq_peptide;Acc:NP_991130];
ENSDARG00000041341:SRY-box containing gene 32 [Source:RefSeq_peptide;Acc:NP_571926];
ENSDARG00000014047:Claudin-iike protein ZF4A22 (Claudin-7). [Source:Uniprot/SWISSPROT;Acc:Q9YH92];
OTTDARG00000002123:add1 :Novel_CDS 
OTTDARG00000002166:zgc:55628: Novel_CDS 
ENSDARG00000035720
ENSDARESTG00000018874 clone CB967 5- similar to Filamin A,
ENSDARESTG00000012572 hematopoietically expressed homeobox (hhex),
ENSDARESTG00000012052
ENSDARG00000034443:hypothetical protein LOC336959 [Source:RefSeq_peptide;Acc:NP_956336];
ENSDARG00000009569 clone CB882 5- similar to Transcriptional enhancer factor TEF-5
ENSDARG00000033999:Cytochrome P450 26A1 (EC 1.14.-.-) (Retinoic add-metabolizing cytochrome) (P450RAI) (Retinoic add 4-hydroxylase). 
ENSDARG00000058538:hypothetical protein LOC323048 [Source:RefSeq_peptide;Acc:NP_997799];
ENSDARESTG00000025521
ENSDARG00000011127:AHA1, activator of heat shock 90kDa protein ATPase homolog 1, like [Source:RefSeq_peptide;Acc:NP_997767]; 
ENSDARG00000039153:Hypothetical protein (Fragment). [Source:Uniprot/SPTREMBL;Acc:Q5BJ15);
ENSDARG00000040030
ENSDARG00000013040 done CB964 5- similar to adaptor-related protein complex AP-3, beta 1 subunit,
ENSDARG00000007944:LIM homeobox 1b [Source:RefSeq_peptide;Acc:NP_571282];
ENSDARG00000024904:TAL1 (SCL) interrupting locus like [Source:RefSeq_pepMe;Acc:NP_775351];
ENSDARG00000029079
ENSDARG00000040543:LOC407680 protein (Fragment). [Source:Uniprot/SPTREMBL;Acc:Q6NW88];
ENSDARG00000015790:ATPase, Na+/K+ transporting, beta 3a polypeptide [Source:RefSeq_peptide;Acc:NP_571296];
EIMSDARG00000045679:meiosis-specific nudear structural protein 1 [Source:RefSeq_peptide;Acc:NP_955465];
ENSDARESTG00000013713
ENSDARG00000042750:Proliferating cell nudear antigen (PCNA). [Source:Uniprot/SWISSPROT;Acc:Q9PTP1J; 
ENSDARG00000011956:Homeobox protein Dlx4a (DLX-8). [Source:llniprot/SWISSPROT;Acc:Q98879];
ENSDARESTG00000005674
ENSDARG00000015123:zgc:101000[Source:RefSeq_peptide;Acc:NP_001003774l;
234
NM_130943.1_3prime500bases110 
NM_131112.1 _3prime500bases408 
NM_001007282.1_3prime500bases238 
NM_001012263.1_3prime500bases63 
BU808676.1_3prime500bases100 
NM_131290.1_3prime500bases274 
NM_131516.1 _3prime500bases368 
NM_214731.1 _3prime500bases116 
DIG0345J024
NM_152953.2_3prime500bases421 
NM_201586.1_3prime500bases434 
NM_212690.1_3prime500bases326 
NM_200059.1_3prime500bases52 
NM_001008615.1_3prime500bases182 
NM_131668.3_3prime500bases390 
N M_130937.1 _3pri me500bases293 
NM_199521.2_3prime500bases181 
NM_131874.1_3prime500bases111 
NM_212777.1 _3pri me500bases 148 
NM_131685.1 _3prime500bases48 
N M_181559.1_3pri me500bases48 
NM_200025.1_365 
NM_182871.1 _3prime500bases170 
NM_200583.1_3prime500bases141 
NM_200099.1_3prime500bases116 
NM_205585.1_3prime500bases190 
N M_201099.1 _3pri me500bases418 
NM_131114.1_3prime500bases186 
BU670726.1_3prime500bases263 
NM_131058.1 _3prime500bases378 
NM_131417.1 _3pri me500bases247 
CF673276.1_3prime500bases105 
NM_201206.1_3prime500bases257 
BU670702.1_3prime500bases280
0.47 0.63 0.55
0.55 0.55
0.55 0.55
0.55 0.55
0.58 0.53 0.55
0.56 0.55 0.55
0.56 0.56
0.51 0.60 0.56
0.56 0.56
0.56 0.56
0.56 0.56
0.47 0.65 0.56
0.56 0.56
0.55 0.57 0.56
0.56 0.56
0.51 0.63 0.57
0.62 0.52 0.57
0.54 0.61 0.57
0.58 0.58
0.58 0.58 0.58
0.58 0.58
0.58 0.58
0.55 0.62 0.58
0.61 0.56 0.58
0.58 0.59 0.59
0.59 0.59
0.59 0.59
0.59 0.59
0.64 0.55 0.59
0.59 0.59
0.53 0.65 0.59
0.56 0.63 0.60
0.60 0.60
0.66 0.54 0.60
ENSDARG00000018383:frizzled-related protein [Source:RefSeq_peptide;Acc:NP_571018];
ENSDARG00000044774:POU domain, class 5, transcription factor 1 (POU domain protein 2). [Source:Uniprot/SWISSPROT;Acc:Q90270J; 
glutathione peroxidase 4a (gpx4a),
ENSDARG00000036126:fibroblast growth factor receptor-like 1b [Source:RefSeq_peptide;Acc:NP_001912263];
ENSDARESTG00000018543 done CB477 5- similar to Cysteine proteinase 
ENSDARG00000021032:forkhead box D3 [Source:RefSeq_peptide;Acc:NP_571365];
ENSDARG00000002768:Parvalbumin beta. [Source:Uniprot/SWISSPROT;Acc:Q9l8VO];
ENSDARG00000039675:dapper homolog 1, antagonist of beta-catenin (xenopus) [Source:RefSeq_peptide;Acc:NP_999896]; 
ENSDARG00000040815:hypothetical protein LOC325958 [Source:RefSeq_peptide;Acc:NP_956027];
ENSDARESTG00000017250
ENSDARG00000042728:phospholipase A2-activating protein [Source:RefSeq_peptide;Acc:NP_997855];
ENSDARG00000017514:ribosomal protein S3A [Source:RefSeq_peptide;Acc:NP_956353];
ENSDARG00000041065:heat shock protein 1 [Source:RefSeq_peptide;Acc:NP_001008615];
ENSDARG00000013144:ATPase, Na+/K+ transporting, beta 1a polypeptide [Source:RefSeq_peptide;Acc:NP_571743]; 
ENSDARG00000034894:Wnt-5 protein precursor. [Source:Uniprot/SWISSPROT;Acc:Q92050];
ENSDARG00000030871:Ubiquitin ligase Siahl (EC 6.3.2.-) (Seven in absentia homolog 1) (Siah-1). [Source:Uniprot/SWISSPROT;Acc:Q7ZVG6]; 
ENSDARG00000035622:X-box binding protein 1 [Source:RefSeq_peptide;Acc:NP_571949];
ENSDARG00000025071:bromodomain containing 8 [Source:RefSeq_peptide;Acc:NP_997942];
ENSDARG00000018259:ATPase, Na+/K+ transporting, alpha 3b polypeptide [Source:RefSeq_peptide;Acc:NP_571760]; 
ENSDARG00000039128:glutamine synthetase 1 [Source:RefSeq_peptide;Acc:NP_853537];
ENSDARG00000037071:ribosomal protein S26 [Source:RefSeq_peptide;Acc:NP_956319];
ENSDARG00000037677:fibroblast growth factor 24 [Source.RefSeq_peptide;Acc:NP_878291];
ENSDARG00000013475:chaperonin containing TCP1, subunit 4 (delta) [Source:RefSeq_peptide;Acc:NP_956877]; 
ENSDARG00000012000:dynein light chain (10.3 kD) (dlc-1) [Source:RefSeq_peptide;Acc:NP_956393];
ENSDARG00000035521 :secreted frizzled-related protein 1 [Source:RefSeq_peptide;Acc:NP_991148];
ENSDARG00000035320:similar to heterogeneous nudear ribonudeoprotein L [Source:RefSeq_peptide;Acc:NP_957393];
ENSDARG00000036141
ENSDARG00000010946:cystathionine-beta-synthase [Source:RefSeq_peptide;Acc:NP_0Q1014367];
ENSDARG00000007329:T-box gene 16 [Source:RefSeq_peptide;Acc:NP_571133];
OTTDARG00000007314:si;ch211-132p20.4:Novel_CDS 
ENSDARESTG00000010586 done CB960 5- similar to Nudeolar RNA helicase II,
ENSDARG00000011626:COX15 homolog, cytochrome c oxidase assembly protein [Source:RefSeq_peptide;Acc:NP_957500]; 
ENSDARG00000003509 CB407 5- similar to SPT:Q8UW4 ATP-binding cassette transporter 1
235
NM_194388.1_3pri me500bases354 0.59 0.61 0.60 ENSDARG00000036700:tubulin, alpha 1 [Source:RefSeq_peptide;Acc:NP_919369];
NM_131287.2_3prime500bases377 0.56 0.64 0.60 ENSDARG00000041345:SRY-box 17 [Source:RefSeq_peptide;Acc:NP_571362];
NM_199536.2_3prime500bases255 0.59 0.61 0.60 ENSDAREST G00000007995
NM_173236.1_3prime500bases247 0.60 0.60 ENSDARG00000015427:histone deacetyiase 1 [Source: RefSeq_peptide;Acc: NP_775343];
NM_131415.1_3prime500bases4 0.59 0.61 0.60 ENSDARG00000017354:eph4ike receptor tyrosine kinase 6 [Source:RefSeq_peptide;Acc:NP_571490];
NM_201514.1 _3prime500bases375 0.56 0.64 0.60 ENSDARG00000037012:solute carrier family 3, member 2 like [Source:RefSeq_peptide;Acc:NP_958922];
NM_131140.1 _3pri me500bases 144 0.61 0.61
NM_205732.1 _3prime500bases414 0.61 0.61
NM_001007761.1_3prime500bases0 0.61 0.61 ENSDARG00000026759:adaptor-related protein complex 1 mu 1 subunit [Source:RefSeq_peptide;Acc:NP_991277];
NM_199995.1_157 0.61 0.61
NM_201576.1_3prime500bases131 0.61 0.61 ENSDARG00000034351 :transgelin 2 [Source:RefSeq_peptide;Acc:NP_963870];
NM_131245.1_3prime500bases275 0.61 0.61 0.61
NM_201325.1_3prime500bases341 0.61 0.61 ENSDARG00000021242:major vault protein [Source: RefSeq_peptide;Acc:NP_958482];
NM_130971.1_3prime500bases0 0.62 0.61 0.62 ENSDARG00000037879:Beta-1,3-N-acetylglucosaminyltransferase lunatic fringe (EC 2.4.1.222) (O-fucosyipeptide 3-beta-N-acetylglucosaminyltransferase).
NM _131069.2_3prime500bases167 0.62 0.62
NM_131860.1_3pri me500bases339 0.62 0.62 ENSDARG00000015472:knypek[Source:RefSeq_peptide;Acc:NP_571935];
BC090314.1_3prime500bases19 0.62 0.63 0.62 ENSDARG00000013575:hypothetical protein LOC503590 [Source:RefSeq_peptide;Acc:NP_001013296];
NM_001003890.2_3prime500bases158 0.59 0.66 0.62 ENSDARG00000020869:polo-like kinase 1 [Source:RefSeq_peptide;Acc:NP_001003890];
NM_131116.2_3prime500bases13 0.63 0.63 ENSDARG00000000175:Homeobox protein Hox-B2a (Hox-B2). [Source:Uniprot/SWISSPROT;Acc:042367];
NM_201475.1_3prime500bases382 0.63 0.63 ENSDARG00000031495:SET translocation (myeloid leukemia-associated) A [Source:RefSeq_peptide;Acc:NP_958883];
NM_131355.1_3prime500bases253 0.63 0.63 ENSDARG00000014943:kinesin family member 23 [Source:RefSeq_peptide:Acc:NP_571430]:
NM_001005919.1_3prime500bases364 0.64 0.63 0.64 ENSDARG00000019848:Ephrin type-A receptor 4a (EC 2.7.1.112) (Tyrosine-protein kinase receptorZEK2) (EPH-like kinase2) (Fragment).
NM_199430.1_3prime500bases422 0.64 0.64 ENSDARG00000036180:cydin B2 [Source:RefSeq_peptide;Acc:NP_955462];
NM_201488.1_3pri me500bases 105 0.64 0.64 ENSDARG00000020468:protein phosphatase 1G (formerly 2C), magnesium-dependent, gamma isoform [Source:RefSeq_peptide;Acc:NP_958896];
NM_194377.2_3prime500bases431 0.64 0.64 ENSDARG00000011665:aldolase a, fructose-bisphosphate [Source:RefSeq_peptide:Acc:NP_919358];
DIG0407_1918 0.64 0.64 ENSDARG00000038547:Semaphorin-4E precursor (Semaphorin-7) (Semaphorin Z7) (Sema-Z7). [Source:Uniprot/SWISSPROT;Acc:Q9YHX4];
NM_152949.1_3prime500bases275 0.62 0.66 0.64 ENSDAREST G00000006863
AY216588.1_3prime500bases143 0.64 0.64 ENSDARG00000023220:Selenoprotein T2 (Fragment). [Source:Uniprot/SPTREMBL;Acc:Q802G4];
BC075970.1_3prime500bases424 0.64 0.64 ENSDARG00000006427:lntestinal fatty add-binding protein. [Source:Uniprot/SPTREMBL;Acc:Q8AX65J;
NM_200076.1_3prime500bases137 0.65 0.65 ENSDARG00000034396:methionine-tRNA synthetase [Source:RefSeq_peptide;Acc:NP 956370);
NM_201491.1_3prime500bases432 0.65 0.65 ENSDARG00000042853:isovaleryl Coenzyme A dehydrogenase [Source:RefSeq_peptide;Acc:NP_958899];
NM_212603.1 _3pri me500bases94 0.65 0.65 ENSDARG00000023330:addic (leucine-rich) nudear phosphoprotein 32 family, member B [Source:RefSeq_peptide;Acc:NP_997768];
AB097826.1_3prime500bases19 0.65 0.65 ENSDARG00000002403:Hypothetical protein YF-9 (Fragment). [Source:Uniprot/SPTREMBL;Acc:Q7T2W2];
BM402093.1_3 0.65 0.65 ENSDARG00000037980:Hypothetical protein (Fragment). [Source:llniprot/SPTREMBL;Acc:Q7SYJ8];
236
NM_001002312.1_3prime500bases360 0.66 0.64 0.65 ENSDARG00000041870:intraflagellar transport 172 [Source:RefSeq_peptide;Acc:NP_001002312];
NM_200458.2_3prime500bases36 0.65 0.65 ENSDARG00000003016:eukaryotic translation elongation factor 2, like [Source:RefSeg_peptide;Acc:NP_956752];
NM_201153.1 _3prime500bases426 0.65 0.65 ENSDARG00000046119:ribosomal protein S3 [Source:RefSeq_peptide;Acc:NP_957447];
DIG0366_880 0.66 0.66
CF569085.1_3prime500bases370 0.66 0.66 ENSDARG00000020386 CB939 5- similar to ATP-binding cassette transporter 1,
NM_001009884.1_3prime500bases206 0.66 0.66 ENSDARG00000041895:carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase [Source: RefSeq_peptide;Acc: NP_001009884];
NM_200772.1 _3prime500bases421 0.66 0.66 ENSDARG00000007880
NM_194423.1_3prime500bases225 0.66 0.66 ENSDARG00000029370:ankyrin repeat domain 6 [Source:RefSeq_peptide;Acc:NP_919404];
NM_198914.2_3prime500bases225 0.24 1.74 0.99 ENSDARG00000033170:sulfbtransferase family, cytosolic sulfotransferase 2 [Source:RefSeq_peptide;Acc:NP_944596];
N M_130945.1_3pri me500bases213 1.50 1.50 ENSDARG00000015717:fms-related tyrosine kinase 4 [Source:RefSeq_peptide;Acc:NP_571020];
N M_200103.1_3prime500bases358 1.50 1.50 ENSDARG00000005254:KDEL (Lys-Asp-Glu-Leu) endoplasmic reticulum protein retention receptor 2 [Source:RefSeq_peptide;Acc:NP_956397];
NM_201499.1_3pri me500bases421 1.51 1.51 ENSDARG00000025375:isodtrate dehydrogenase 1 (NADP+), soluble [Source:RefSeq_peptide;Acc:NP_958907];
NM_001004494.1_3prime500bases331 1.52 1.52 ENSDARG00000010511:protein regulator of cytokinesis 1 (prc1), mRNA [Source:RefSeq_dna;Acc:NM_001004494];
NM_131684.2_3prime500bases122 1.52 1.52 ENSDARG00000036815:ATPase, Na+/K+ transporting, alpha 3a polypeptide [Source:RefSeq_peptide;Acc:NP_571759];
NM_205716.1_3prime500bases20 1.53 1.53 ENSDARG00000029911 :cancer susceptibility candidate 3 [Source:RefSeq_peptide;Acc:NP_991279];
DIG0311_361 1.53 1.53
NM_001007774.1_3prime500bases195 1.51 1.57 1.54 ENSDARG00000043631 :BCAS2 protein homolog. [Source:Uniprot/SWISSPROT;Acc:Q5RKQO];
NM_201292.1 _3prime500bases426 1.54 1.54 ENSDARG00000029928:adaptor-related protein complex 3, mu 1 subunit [Source:RefSeq_peptide;Acc:NP_958449];
N M_194418.1_3pri me500bases329 1.54 1.54 ENSDARG00000038227:selenoprotein W, 2b (sepw2b), mRNA [Source:RefSeq_dna;Acc:NM_194418];
NM_131105.2_3prime500bases297 1.56 1.56
NM_201178.1_3prime500bases401 1.56 1.56 ENSDARG00000014577:Rhophilin 2 (GTP-Rho binding protein 2). [Source:Uniprot/SWISSPROT;Acc:Q6TNR1];
NM_199218.1 _3prime500bases428 1.56 1.56 ENSDARESTG00000008073
NM_200318.2_3prime500bases431 1.56 1.56 ENSDARG00000035948:ADP-ribosy!ation factor-like 4 [Source:RefSeq_peptide;Acc:NP 956612];
NM_200078.1_3prime500bases197 1.56 1.57 1.56 ENSDARG00000028514:Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 [Source:RefSeq_peptide;Acc:NP_956372];
NM_198811,1_3prime500bases372 1.57 1.57
cos2.fas_3prime500bases156 1.58 1.56 1.57 ENSDARG00000033099:kinesin family member 7 [Source:RefSeq_peptide;Acc:NP_001014816];
NM_131047.1_3prime500bases235 1.57 1.57 ENSDARG00000043276:calreticulin [Source:RefSeq_peptide;Acc:NP_571122];
NM_212676.1_3prime500bases153 1.58 1.58 ENSDARG00000042533
NM_131100.1_3prime500bases400 1.58 1.58 ENSDARG00000042769;orthopedia protein [Source:RefSeq_peptide;Acc:NP_571175];
BU670740.1_3prime500bases139 1.59 1.59 ENSDARG00000035052 CB457 5- similar to SPT:Q96S59 Q96s59 RanBPM
NM_214759.1_3prime500bases129 1.59 1.59 ENSDARG0O000039150:hypotheticat protein LOC406625 [Source:RefSeq_peptide;Acc:NP_999924];
NM_198978.1_3prime500bases380 1.59 1.59 ENSDARESTG00000016872
NM_199432.1_3prime500bases65 1.57 1.62 1.59 ENSDARG00000039168:hypothetical protein LOC368331 [Source:RefSeq_peptide;Acc:NP_955464];
NM_181663.1 _3prime500bases94 1.60 1.60 ENSDARG00000022987:sizzled [Source:RefSeq_peptide;Acc:NP_858049];
237
NM_131233.1_3prime500bases410 
NM_199533.1_3prime500bases407 
CF569098.1_3pri me500bases382 
BU808703.1 _3prime500bases5 
NM_212801.1 _3prime500bases323 
NM 200081.1_3prime500bases230 
N M_212648.1_3pri me500bases409 
NM_131613.1 _3pri me500bases 161 
NM_198871.1 _3prime500bases153 
BM402137.1_3prime500bases375 
NM_131759.1 _3prime500bases434 
NM_212795.1_3prime500bases117 
NM_212572.1 _3prime500bases190 
NM_131282.1 _3prime500bases360 
NM_130923.1 _3prime500bases410 
NM_131227.1_3prime500bases133 
NM_212608.1 _3prime500bases359 
NM_199212.1_3prime500bases100 
NM_200110.1_3prime500bases107 
NM_213348.2_3prime500bases384 
NM_212748.1_3prime500bases192 
NM_194401.1_3prime500bases291 
N M_212664.1_3pri me500bases341 
NM_131246.1_3pri me500bases22 7 
NM_131775.1_3prime500bases4 
NM_131247.1_3prime500bases423 
NM_198805.1 _3prime500bases186 
CF924899.2_42
NM_001007351.1_3prime500bases48 
NM_201465.2_3prime500bases195 
NM_201454.1_3prime500bases258 
NM_131664.1_3prime500bases224 
NM_130954.1_3prime500bases259 
NM_130922.1 _3pri me500basesl 09
1.60 1.60
1.60 1.60
1.60 1.60
1.60 1.60
1.60 1.60
1.71 1.51 1.61
1.61 1.61
1.57 1.66 1.62
1.62 1.62
1.63 1.63
1.63 1.63
1.51 1.75 1.63
1.63 1.63
1.59 1.69 1.64
1.51 1.77 1.64
1.58 1.70 1.64
1.76 1.53 1.65
1.63 1.67 1.65
1.65 1.65 1.65
1.65 1.65
1.81 1.53 1.67
1.55 1.79 1.67
1.67 1.67
1.78 1.56 1.67
1.67 1.67
1.68 1.68
1.58 1.79 1.68
1.69 1.69
1.69 1.69
1.69 1.69
1.60 1.79 1.69
1.57 1.82 1.70
1.70 1.70
1.76 1.65 1.70
ENSDARG00000008867:RAS related protein 1b [Source:RefSeq_peptide;Acc:NP_955827]; 
ENSDARG00000004169 clone CB959 5- similar to Stathmin 
CB516 5- similar to C-ets-1 protein, mRNA sequence
ENSDARG00000039211 :hypothetical protein LOC378987 [Source:RefSeq_peptide;Acc:NP_997966]; 
ENSDARG00000032802:kinectin 1 [Source:RefSeq__peptide;Acc:NP_956375]; 
ENSDARG00000012936:dishevelled 2, dsh homolog [Source:RefSeq_peptide;Acc:NP_997813]; 
ENSDARG00000005315:CUG triplet repeat, RNA-binding protein 1 [Source:RefSeq_peptide;Acc:NP_571688];
ENSDARESTG00000017103 CB193 5- similar to PROSTAGLANDINE D SYNTHASE, 
ENSDARG00000036516:hemoglobin beta embryonic-1 [Source:RefSeq_peptide;Acc:NP_571834]; 
ENSDARG00000022813:Dead end protein 1. [Source:Uniprot/SWISSPROT;Acc:Q7T1H5]; 
ENSDARG00000037846:histocompatibility 13 [Source:RefSeq_peptide;Acc:NP_997737]; 
ENSDARG00000036385rforkhead box A sequence [Source:RefSeq_peptide;Acc:NP_571357]; 
microphthalmia-associated transcription factor a (mitfa),
ENSDARG00000043071:Retinal homeobox protein Rx3. [Source:Uniprot/SWISSPROT;Acc:042358]; 
ENSDARG00000017422:bscv (C20orf3) homolog [Source:RefSeq_peptide;Acc:NP_997773]; 
ENSDARG00000025522:serum/glucocorticoid regulated kinase [Source:RefSeq_peptide;Acc:NP_954682]; 
ENSDARG00000042152:nudix-type motif 4 [Source:RefSeq_peptide;Acc:NP_956404];
ENSDARG00000002131 :CUG triplet repeat, RNA binding protein 2 [Source:RefSeq_peptide;Acc:NP_919382);
ENSDARG00000040004
ENSDARG00000040856:L-lactate dehydrogenase A chain (EC 1.1.1.27) (LDH-A). [Source:Uniprot/SWISSPROT;Acc:Q9PVK5]; 
ENSDARG00000004251:dihydrofolate reductase [Source:RefSeq_peptide;Acc:NP_571850];
ENSDARG00000035139
ENSDARG00000018174:guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide a [Source:RefSeq_peptide;Acc:NP_942100]; 
ENSDARG00000040469:hypothetical protein LOC541400 [Source:RefSeq_peptide;Acc:NP_001013545];
ENSDARG00000043495:hypothetical protein LOC492479 [Source:RefSeq_peptide;Acc:NP_001007352];
ENSDARG00000020103:calreticulin like [Source:RefSeq_peptide;Acc:NP_958873];
ENSDARG00000020261 :RAB2, member RAS oncogene family [Source:RefSeq_peptide;Acc:NP_958862];
ENSDARESTG00000014726
ENSDARG00000010791 :deltaA [Source:RefSeq_peptide;Acc:NP_571029];
ENSDARG00000020298:B-cell translocation gene 2 [Source:RefSeq_peptide;Acc:NP_570997];
238
NM_131802.1_3prime500bases421 
NM_198980.1_3prime500bases80 
NM_200075.1_3prime500bases326 
NM_130939.1_3prime500bases418 
NM_205728.1_3prime500bases429 
AJ245493.1_3prime500bases233 
ZfKif3a_3prime500bases159 
DIG0206_970 DIG0124_1096 
NM_199683.1_3prime500bases383 
NM_198810.1_3prime500bases2 36 
DIG0351J132
NM_201299.1 _3pri me500bases2 75 
NM_001007120.1_3prime500bases305 
BQ826572.1 _3prime500bases187 
NM_212790.1 _3pri me500bases415 
NM_001001725.1_3prime500bases42 
NM_173222.1_3prime500bases325 
CF417021,1_3prime500bases292 
NM_201577.1 _3prime500bases427 
NM_131184.2_3prime500bases100 
NM_153674.1_3prime500bases325 
N M_214808.1_3pri me500bases249 
NM_199481.1_3prime500bases292 
NM_131848.1_3prime500bases424 
NM_001003980.1_3prime500bases380 
BM402118.1_3prime500bases243 
CF416980.1_3prime500bases316 
CF417024.1_1
NM_130948.1_3prime500bases351 
NM_131271.1_3prime500bases267 
NM_131360.1_3prime500bases428 
NM_201461.1_3prime500bases414 
NM_181766.1 _3prime500bases400 
DIG0203 403
1.71 1.71
1.73 1.73
1.73 1.73
1.74 1.74
1.74 1.74
1.79 1.71 1.75
1.90 1.61 1.76
1.68 1.84 1.76
1.77 1.77
1.80 1.74 1.77
1.77 1.77
1.82 1.72 1.77
1.87 1.67 1.77
1.79 1.79
1.79 1.79
1.79 1.79
1.72 1.86 1.79
1.54 2.06 1.80
1.80 1.80
1.51 2.09 1.80
1.81 1.81
2.00 1.61 1.81
1.83 1.80 1.82
1.82 1.82
1.83 1.83
1.79 1.87 1.83
1.92 1.74 1.83
1.83 1.83
1.83 1.83
1.84 1.84
1.84 1.84
1.77 1.92 1.84
1.85 1.85
1.85 1.85
ENSDARG00000011683:HHGP protein [Source:RefSeq_peptide;Acc:NP_955812];
ENSDARG00000004311 :low density lipoprotein receptor adaptor protein 1 [Souroe:RefSeq_peptide;Acc:NP_945331]; 
ENSDARG00000007665:Similar to RIKEN cDNA 1500019G21 gene [Source:RefSeq_peptide;Acc:NP_956369]; 
cth1 (cth1),
ENSDARG00000040316:GLI-Kruppel family member GLI3 [Source:RefSeq_peptide;Acc:NP_991291]; 
hypothetical protein done sd70
ENSDARG00000006604:Poliovirus receptor-related protein 3 precursor. [Source:Uniprot/SWISSPROT;Acc:Q58EG3]; 
ENSDARG00000041607:Eukaryotic translation initiation factor 4E-1A binding protein (elF4E- 1A binding protein) (4E-BP).
ENSDARG00000025904:glycoprotein, synaptic 2 [Source:RefSeq_pepSde;Acc:NP_958456];
ENSDARG00000034731:homeodomain leudne zipper [Source:RefSeq_peptide;Acc:NP_001007121]; 
cDNA done CB349 5- similar to Complement component C7, mRNA sequence 
ENSDARG00000016424:yippee-like 3 [Source:RefSeq_peptide;Acc:NP_997955];
ENSDARESTG00000002678 intraflagellar transport 88 homolog (ift88),
ENSDARG00000043257:creatine kinase, brain [Source:RefSeq_peptide;Acc:NP_775329];
ENSDARESTG00000021028 CB817 5- similar to ZO-1 MDCK
ENSDARG00000005675
ENSDARG00000028148
ENSDARG00000027397:vang-like 2 (van gogh, Drosophila) (vangl2), mRNA [Source:RefSeq_dna;Acc:NM_153674]; 
ENSDARG00000023520:Fibroblast growth factor-17b precursor (FGF-17b). [Source:llniprot/SWISSPROT;Acc:Q6SJP8]; 
ENSDARG00000037742:cydin G1 (ccngl), mRNA [Source: RefSeq_dna;Acc:NM_199481];
ENSDARG00000004729:transcription factor binding to IGHM enhancer 3a [Source:RefSeq_peptide;Acc:NP_571923];
ENSDARG00000002330:LIM homeobox 8 [Source:RefSeq_peptide;Acc:NP_001003980];
ENSDARG00000014499:hypothetical protein LOC445204 [Source:RefSeq_peptide;Acc:NP_001003598];
ENSDARG00000042428 5- similar to Glutathione S-transfarase 1
ENSDARG00000024746:Novel protein similar to heat shock protein 90-alpha (Hsp90a).ENSDARG00000010478:Heat shock protein HSP 90-alpha. 
ENSDARG00000037995:DVR-1 protein precursor. [Source:Uniprot/SWISSPROT;Acc:P35621];
ENSDARG00000043147:forkhead box D1 [Source:RefSeq_peptide;Acc:NP_571346];
ENSDARG00000041430:bone morphogenetic protein 2b [Source:RefSeq_peptide;Acc:NP_571435];
ENSDARG00000029072:Kruppel-like factor 6 [Source:RefSeq_peptide;Acc:NP_958869];
ENSDARG00000002632
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NM_131348.2_3prime500bases108 
NM_199976.1 _3pri me500bases342 
Rab23_3prime500bases355 
NM_200086.1_3prime500bases368 
NM_131219.1 _3pri me500bases62 
NM_198877.1_3prime500bases272 
NM_131765.1_3prime500bases258 
DIG0118_859
NM_130940.1_3prime500bases425 
DIG0557_1492
NM_201213.1 _3prime500bases388 
AY576808.1 _3prime500bases157 
NM_131641.1 _3prime500bases408 
CF924885.1 _3prime500bases240 
NM_152948.1 _3pri me500bases351 
NM_199278.1_3prime500bases252 
DIG0046_445
NM_182940.2_3prime500bases403 
N M_212994.1 _3pri me500bases261 
N M_131362.1_3pri me500bases419 
NM_212791.1 _3prime500bases423 
NM_212761.1_2
NM_201468.1_3prime500bases429 
NM_001008581.1_3prime500bases 149 
NM_153668,3_3prime500bases276 
NM_201317.1 _3prime500bases349 
NM_131229.1_3prime500bases431 
NC_002333.2_3prime500bases20 
NM 131267.1_3prime500bases432 
NM_131117.2_3prime500bases3 
NM_200295.1_3prime500bases100 
NM_194374.1_3prime500bases181 
NM_001007364.1_3prime500bases393 
NM_131262.1 _3prime500bases166
1.65 2.10 1.87
1.85 1.90 1.87
1.71 2.04 1.87
1.88 1.88
1.88 1.88
1.87 1.90 1.88
1.98 1.81 1.89
1.90 1.90
1.89 1.93 1.91
1.91 1.91
1.74 2.10 1.92
2.10 1.74 1.92
1.93 1.93
2.03 1.84 1.93
1.88 1.99 1.93
1.80 2.10 1.95
1.95 1.95
2.12 1.80 1.96
1.81 2.14 1.97
2.00 2.00
2.01 2.01
2.01 2.01
2.04 2.04
1.83 2.26 2.05
2.25 1.84 2.05
2.11 1.99 2.05
2.06 2.06
1.84 2.28 2.06
2.07 2.07
2.18 1.97 2.07
2.15 2.05 2.10
1.66 2.53 2.10
2.21 2.02 2.12
1.78 2.45 2.12
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ENSDARG00000014125:friend leukemia integration 1 [Source:RefSeq_peptide;Acc:NP_571423];
ENSDARG00000042644:manganese-containing superoxide dismutase precursor [Source: RefSeq_peptide;Acc: NP 956270]; 
ENSDARG00000004151 hypothetical protein LOC553778 [Source:RefSeq_peptide;Acc:NP_001018579];
ENSDARG00000014351 ;ENSDARG00000035957:gemjnin, DNA replication inhibitor [Source:RefSeq_peptide;Acc:NP_956380]; 
ENSDARG00000038386:achaete-scute complex-like 1a [Source:RefSeq_peptide;Acc:NP_571294];
ENSDARG00000042931 :muscle-specific beta 1 integrin binding protein 2 [Source:RefSeq_peptide;Acc:NP_942578]; 
ENSDARG00000043128:claudin e [Source:RefSeq_peptide;Acc:NP_571840];
ENSDARG00000018065:lglon2 [Source:RefSeq_peptide;Acc:NP_001003852];
ENSDARG00000009737:bonnie and Clyde [Source:RefSeq_peptide;Acc:NP_571015];
ENSDARG00000010316:glutaminyl-tRNA synthetase [Source:RefSeq_peptide;Acc:NP_957507];
ENSDARG00000023532:pin2Arf1-interacting protein 1 [Source:RefSeq_peptide;Acc:NP_001013283];
ENSDAREST G00000016274
ENSDARESTG00000025399 done CB1014 5- similar to Q8wux2 Similar to RIKEN cDNA 2510006C20 gene 
ENSDARG00000043658:coxsackie virus and adenovirus receptor [Source:RefSeq_peptide;Acc:NP_694480]; 
ENSDARESTG00000024671
ENSDARG00000010025:hypothetical protein LOC553218 [Source:RefSeq_pepbde;Acc:NP_001020643];
ENSDARG00000036515 
ENSDARESTG00000019878
ENSDARG00000039772:sine oculis homeobox homolog 3a [Source:RefSeq_peptide;Acc:NP_571437]; 
ENSDARG00000039429:adenosine kinase a (adka), mRNA [Source:RefSeq_dna;Acc:NM_212791]; 
ENSDARG00000009978:ictacaldn [Source:RefSeq_peptide;Acc:NP_997926];
ENSDARG00000003920:SET translocation (myeloid leukemia-assodated) B [Source:RefSeq_peptide;Acc:NP_958876]; 
ENSDARG00000040046:hypothetical protein LOC494038 [Source:RefSeq_peptide;Acc:NP_001008581]: 
ENSDARESTG00000010313
ENSDARG00000037773:RlNG1 and YY1 binding protein [Source:RefSeq_peptide;Acc:NP_958474];
ENSDARG00000005541:Wnt inhibitory factor 1 precursor (WIF-1). [Source:Uniprot/SWISSPROT;Acc:Q9W6F9];
Danio rerio mitochondrion, complete genome
ENSDARG00000036097:iroquois homeobox protein 3a [Source:RefSeq_peptide;Acc:NP_571342]; 
ENSDARG00000029263:Homeobox protein Hox-B3a (Hox-B3). [Source:Uniprot/SWISSPROT;Acc:042368]; 
ENSDARG00000007279:golgi membrane protein SB140 [Source:RefSeq_peptide;Acc:NP_956589]; 
ENSDARG00000041217:exportin 6 [Source:RefSeq_peptide;Acc:NP_919355];
ENSDARESTG00000011774 zgc:103652 (zgc: 103652),
ENSDARG00000030110:Myoblast determination protein 1 homolog (Myogenic factor 1). [Source:Uniprot/SWISSPROT;Acc:Q90477];
NM_131875.1_3prime500bases0 
NM_131503.1_3prime500bases104 
NM_131311.1 _3pri me500bases2 74 
NM_200159.1_3prime500bases279 
NM_201493.1_3prime500bases125 
NM_201329.1_3prime500bases116 
NM_201496.1_3prime500bases203 
NM_200882.1_3prime500bases377 
N M_212 815.1 _3pri me500bases352 
NM_214734.1_3prime500bases256 
NM_001001402.1_3prime500bases397 
NM_178297.2_3prime500bases120 
NM_001001399.1_3prime600bases370 
NM_182878.1_3prime500bases422 
CA854263.1 _3pri me500bases 122 
NM_001007038.1_3prime500bases269 
NM_213172.1_3prime500bases365 
NM_130947.1_3prime500bases310 
NM_199217.1 _3prime500bases187 
DIG0565_1528
NM_001004578.1_3prime500bases336 
NM_205750.1_3prime500bases420 
NM_131807.1_3prime500bases404 
NM_213153.1_3prime500bases424 
NM_131077.1_3prime500bases386 
NM_131120.1_3prime500bases395 
NM_131305.1 _3prime500bases415 
NM_131881.1_3prime500bases266 
NM_201332.1_3prime500bases424 
NM_201587.1_3prime500bases206 
NM_199538.1_3prime500bases295 
NM_001002720.1_3prime500bases146 
NM_199532.1_3prime500bases125 
NM_213151.1_3prime500bases351
2.14 2.14
1.80 2.48 2.14
2.16 2.16 2.16
2.17 2.17
2.23 2.23
1.65 2.83 2.24
2.19 2.34 2.26
2.13 2.40 2.27
2.27 2.27
2.28 2.28
2.57 2.01 2.29
1.56 3.02 2.29
2.30 2.29 2.29
2.32 2.32
2.32 2.34 2.33
2.42 2.29 2.35
2.40 2.31 2.35
2.36 2.36
2.32 2.40 2.36
2.38 2.38
2.38 2.37 2.38
2.41 2.41
2.42 2.42
2.42 2.42
2.42 2.42
2.44 2.44
2.44 2.44
2.46 2.43 2.44
2.45 2.45
2.14 2.78 2.46
2.32 2.64 2.48
2.58 2.42 2.50
2.35 2.69 2.52
2.75 2.33 2.54
ENSDARG00000026534:Axin-1 (Axis inhibition protein 1). [Source:Uniprot/SWISSPROT;Acc:P57094];
ENSDARG00000014446:Homeobox protein Dlx2a (DLX-2). [Source:Uniprot/SWISSPROT;Acc:P50574];
ENSDARG00000008238:mannosidase, beta A, lysosomal [Source:RefSeq_peptide;Acc:NP_956453];
ENSDARG00000036291 :nudeobindin 2a [Source:RefSeq_peptide;Acc:NP_958901];
ENSDARG00000034771:RAB13, member RAS oncogene family [Source:RefSeq_peptide;Acc:NP_958486]; 
ENSDARG00000031915:Hypoxia-inducible factor 1 alpha inhibitor (EC 1.14.11.16) (Hypoxia- inducible factor asparagine hydroxylase). 
ENSDARG00000021140:poly A binding protein, cytoplasmic 1 a [Source:RefSeq_peptide;Acc:NP_957176];
ENSDARG00000026797:v-akt murine thymoma viral oncogene homolog 2, like [Source:RefSeq_peptide;Acc:NP_997980); 
ENSDARG00000033971:paired mesoderm homeobox 1a [Source:RefSeq_peptide;Acc:NP_999899];
ENSDARG00000043042:ectodermal-neural cortex (with BTB-like domain) [Source:RefSeq_peptide;Acc:NP_001001402];
ENSDAREST G00000020068
ENSDARG00000005230:signal sequence receptor, beta [Source:RefSeq_peptide;Acc:NP_001001399l;
ENSDARG00000013443:ATPase, H+ transporting, lysosomal, V1 subunit B, member a [Source:RefSeq_peptide;Acc:NP_878298]; 
ENSDARG00000043457:Hypothetical protein (Fragment). [Source:Uniprot/SPTREMBL;Acc:Q5XJ10];
ENSDARG00000044593:ATP-binding cassette, sub-family C (CFTR/MRP), member 4 (abcc4), mRNA [Source:RefSeq_dna;Acc:NM_001007038]; 
ENSDARG00000017602:cydin G2 [Source:RefSeq_peptide;Acc:NP_998337];
ENSDARG00000040836:Wnt-4a protein precursor. [Source:llniprot/SWISSPROT;Acc:P47793];
ENSDARG00000037493:hypothetical protein LOC553785 [Source:RefSeq_peptide;Acc:NP_001018583];
ENSDARG00000014793:zgc:92331 [Source:RefSeq_peptide;Acc:NP_001004578];
ENSDARG00000004305:vang-like 1 (van gogh, Drosophila) [Source:RefSeq_peptide;Acc:NP_991313];
ENSDARG00000008434:bd2-like [Source:RefSeq_peptide;Acc:NP_571882];
ENSDARG00000005464:deoxyribonudease l-like 3 [Source:RefSeq_peptide;Acc:NP_998318];
ENSDARG00000008796:hairy-related 5 [Source:RefSeq_peptide;Acc:NP_571152];
ENSDARG00000014115:Homeobox protein Hox-B8a (Hox-B8). [Source:llniprot/SWISSPROT;Acc:Q8AWZO]; 
ENSDARG00000013125:Homeobox protein Dlxla (DLX-1). [Source:Uniprot/SWISSPROT;Acc:Q98875];
ENSDARG00000002601 Iroquois homeobox protein 7 [Source:RefSeq_peptide;Acc:NP_571956];
OTTDARG00000005626:si:ch211 -150c22.4: Novel_CDS
ENSDARG00000033768:hypothetical protein LOC321203 [Source: RefSeq_peptide;Acc:NP_955832];
ENSDARG00000014013:lamin B receptor [Source:RefSeq__peptide;Acc:NP_001002720];
ENSDARG00000004402:ELOVL family member 6, elongation of long chain fatty adds [Source:RefSeq_peptide;Acc:NP_955826]; 
ENSDARG00000027860:glyoxalase 1 [Source:RefSeq_peptide;Acc:NP_998316];
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DIG0387_631 2.54 2.54
NM_199277.2_3prime500bases279 2.54 2.54 ENSDAREST G00000024128
NM_200106.1_3prime500bases20 2.58 2.58 ENSDARG00000012135:F-box and leucine-rich repeat protein 2 [Source:RefSeq_peptide;Acc:NP_956400];
NM_131682.2_3prime500bases18 2.73 2.54 2.63 ENSDARG00000041945:Aminolevulinate, delta-, synthetase 2 (Fragment). [Source:Uniprot/SPTREMBL;Acc:Q5RIZ3];
NM_131670.1 _3prime500bases344 2.64 2.64 ENSDARG00000042837:ATPase, Na+/K+ transporting, beta 3b polypeptide [Source:RefSeq_peptide;Acc:NP_571745];
NM_131450.2_3prime500bases260 2.83 2.52 2.68 ENSDARG00000020711:Ribonudeoside-diphosphate reductase M2 chain (EC 1.17.4.1) (Ribonucleotide reductase protein R2 class I).
NM_131506.1_3prime500bases351 2.68 2.68 ENSDARG00000005150:T-box 20 [Source:RefSeq_peptide;Acc:NP_571581];
NM_131323.1_3prime500bases422 2.05 3.41 2.73 ENSDARG00000042291 :Homeobox protein Dlx6a (DLX-6). [Source:Uniprot/SWISSPROT;Acc:Q98877];
NM_131679.3_3prime500bases168 2.07 3.47 2.77 ENSDARG00000006640:eomesodermin homolog [Source:RefSeq_peptide;Acc:NP_571754];
NM_131461.1_3prime500bases418 2.79 2.79
NM_130958.1_3prime500bases293 1.64 3.44 3.38 2.82 ENSDARG00000004232:deltaB [Source:RefSeq_peptide;Acc:NP_571033];
NM_153669.2_3prime500bases139 2.39 3.46 2.92 ENSDARG00000019137:translocating chain-associating membrane protein [Source:RefSeq_peptide;Acc:NP_705955];
NM_152956.1 _3prime500bases377 3.26 2.62 2.94 ENSDARG00000034785:dachshund b [Source: RefSeq_peptide;Acc:NP_694488);
NM_173283.3_3prime500bases165 2.25 3.76 3.01 ENSDARG00000014947:insulin-like growth factor binding protein 1 [Source:RefSeq_peptide;Acc:NP_775390];
NM_130975.1 _3prime500bases429 3.04 3.04 ENSDARG00000036192:Paired-like homeodomain transcription factor 2a. [Source:llniprot/SPTREMBL;Acc:Q568C4];
NM_198911,1_3prime500bases435 3.05 3.05 ENSDARG00000020235:septin 9 [Source:RefSeq_peptide;Acc:NP_944593];
NM _182884.1 _3prime500bases422 3.16 2.98 3.07 ENSDARG00000025302-.DIX domain containing 1 [Source:RefSeq_peptide;Acc:NP_878304];
NM_001007371.1_3prime500bases41 3.21 2.93 3.07 ENSDARG00000032640:zgc: 101900 (zgc:101900), mRNA [Source:RefSeq_dna;Acc:NMJ)01007371];
NM_131863.1_3prime500bases281 3.09 3.09
NM_153673.1_3prime500bases417 3.26 2.94 3.10 ENSDARG00000008433
NM_213556.3_3prime500bases194 3.01 3.19 3.10 ENSDARG00000036470:jun B proto-oncogene [Source:RefSeq_peptide;Acc:NP_998721];
zfp36H _3pri me500bases67 3.30 2.95 3.12 ENSDARG00000016154
NM_200551,1_3prime500bases42 3.68 2.61 3.15 ENSDARG00000020143:phenylalanine hydroxylase [Source:RefSeq_peptide;Acc:NP_956845];
NM_173224.1_3prime500bases147 2.96 3.34 3.15 ENSDARG00000033412:Epididymal secretory protein E1 precursor (Niemann Pick type C2 protein homolog) (16.5 kDa secretory protein).
NM_201326.2_3prime500bases287 2.71 3.61 3.16 ENSDARG00000037516
NM 131306.1 3prime500bases355 3.31 3.07 3.19 ENSDARG00000042296:Homeobox protein Dlx5a (DLX-4). [Source:Uniprot/SWISSPROT;Acc:P50576];
NM 212763.1 3prime500bases351
DIG0174_373 1.92 4.13 3.79 3.28 ENSDARG00000027345:epithelial V-like antigen 1 [Source:RefSeq_peptide;Acc:NP_997928];
NM_199276.1_3prime500bases122 3.81 2.90 3.36 ENSDARG00000028462-.H1 histone family, member X [Source: RefSeq_peptide;Acc:NP_954970];
N M_200105.1 _3pri me500bases210 3.13 3.59 3.36 ENSDARG00000026862:fused toes homolog [Source:RefSeq_peptide;Acc:NP_956399];
NM_183071,1_3prime500bases384 3.55 3.24 3.39 ENSDARG00000040344:linker histone H1M [Source:RefSeq_peptide;Acc:NP_898894];
NM_199519.2_3prime500bases22 2.76 4.04 3.40
NM_212796.1 _3pri me500bases2 31 3.60 3.23 3.41 ENSDAREST G00000020670
NM_131687.1_3prime500bases424 3.43 3.43 ENSDARG00000007739:ATPase, Na+/K+ transporting, alpha 1a.2 polypeptide [Source:RefSeq_peptide;Acc:NP_571762];
NM_178298.2_3prime500bases266 3.78 3.08 3.43 ENSDAREST G00000011008
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NM_199522.1_3prime500bases430 3.50 3.50 ENSDARG00000034539:ras homolog gene family, member E [Source:RefSeq_peptide;Acc:NP_955816];
NM_001004602.1_3prime500bases 143 3.28 3.73 3.50 zgc:86701 (zgc:86701),
NM_200109.1_3prime500bases196 3.42 3.61 3.52 ENSDARG00000039527
NM_181331.3_3prime500bases55 3.64 3.64 ENSDARG00000043483:orthodentide homolog 5 [Source:RefSeq_peptide;Acc:NP_851848];
NM_130970.1_3prime500bases144 4.44 3.30 3.87 ENSDARG00000003971 rlnsulin gene enhancer protein ISL-2 (Islet-2). [Source:Uniprot/SWISSPROT;Acc:P53406];
NM_214723.1 _3prime500bases352 3.89 3.89 ENSDARG00000039007:enolase 3, (beta, musde) [Source:RefSeq_peptide;Acc:NP_999888];
N M_131537.2_3pri me500bases37 5 3.91 3.91 ENSDARG00000005395:Homeobox protein Hox-B5b (Hox-B5-like) (Zf-54). [Source:Uniprot/SWISSPROT;Acc:P09013];
NM_201309.1_3prime500bases192 4.17 3.98 4.08
NM_153666.1_3prime500bases311 4.07 4.36 4.22 ENSDARG00000011785:T-box 24 [Source:RefSeq_peptide;Acc:NP_705952];
NM_199431,1_3prime500bases312 4.87 3.88 4.37 ENSDARG00000041703:ribosome binding protein 1 homolog (dog) [Source:RefSeq_peptide;Acc:NP_955463];
NM_152955.1_3prime500bases423 4.95 4.95 ENSDARESTG00000012272
NM_181735.1 _3prime500bases304 3.84 6.44 5.14 ENSDARG00000019659:forkhead box 11 [Source:RefSeq_peptide;Acc:NP_859424];
NM_213241,1_3prime500bases265 5.37 5.37 ENSDARG00000011870:sp8 transcription factor [Source:RefSeq_peptide;Acc:NP_998406];
NM_205569.1_3prime500bases115 5.08 6.20 5.64 ENSDARG00000031683:v-fos FBJ murine osteosarcoma viral oncogene homolog [Source:RefSeq_peptide;Acc:NP_991132];
NM_212654.1_3prime500bases404 5.96 5.77 5.86 ENSDARG00000035986:protein tyrosine phosphatase, non-receptor type 2, like [Source:RefSeq_peptide;Acc:NP_997819];
NM_201316.1 _3prime500bases415 5.98 5.98 ENSDARG00000035913:tyrosyl-tRNA synthetase [Source:RefSeq_peptide;Acc:NP_958473];
N M_131283.1 _3pri me500bases432 6.46 6.46 ENSDARG00000039228:forkhead box B1.1 [Source:RefSeq_peptide-,Acc:NP_571358];
NM_173218.1 _3prime500bases208 3.26 10.85 7.06 ENSDARG00000008937:neogenin 1 [Source:RefSeq_peptide;Acc:NP_775325];
NM_131571.1 _3prime500bases149 7.37 7.37 ENSDARG00000036096:MAD homolog 3 [Source:RefSeq_peptide;Acc:NP_571646];
NM_180965.3_3prime500bases316 8.37 9.43 8.90 ENSDARESTG00000019581
NM 131101.2 3prime500bases423 11.89 11.89
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